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Abstract 
 
The present thesis is dedicated to the design and synthesis of novel biologically relevant 
carbo- and heterocycles and describes the synthetic potential of different 3-substituted 
chromones, namely 3-acyl- and 3-halochromones, illustrated by the domino reactions with 
different binucleophiles. The reactions of 3-acylchromones with dimethyl 1,3-
acetonedicarboxylate and 1,3-diphenylacetone afforded a variety of functionalized 2-
hydroxybenzophenones, 6H-benzo[c]chromenes and benzo[c]coumarins, while reactions with 
heterocyclic ketene aminals proceeded to the formation of various fused pyridine-related 
heterocycles. An efficient and convenient method for the synthesis of functionalized 2-
salicyloylfurans and 2-benzoyl-8H-thieno[2,3-b]indoles was developed by the cyclization 
reactions of 3-halochromones with β-ketoamides and 1,3-dihydroindole-2-thiones, respectively. 
Electronic and steric effects play an important role in these reactions with regard to the product 
distribution. Synthesized compounds are of pharmacological relevance due to their structural 
similarity to bioactive natural products and synthetic drugs. Various fluorine-containing products 
were synthesized using 3-perfluoroacylchromones. Some synthesized compounds show 
promising photophysical properties. 
 
 
Kurzbeschreibung 
 
Die vorliegende Arbeit ist dem Design und der Synthese von neuartigen biologisch 
relevanten Carbo- und Heterocyclen gewidmet und beschreibt das synthetische Potential von 3-
Substituierten Chromonen, nämlich 3-Acyl- und 3-Halogenchromonen, durch Dominoreaktionen 
mit verschiedenen Dinukleophilien. Die Reaktionen von 3-Acylchromonen mit Dimethyl 1,3-
Acetondicarboxylat und 1,3-Diphenylaceton lieferten funktionalisierte 2-Hydroxybenzophenone, 
6H-Benzo[c]chromene und Benzo[c]coumarine, während die Reaktionen mit heterocyclischen 
Ketenaminalen verschiedene kondensierte Pyridin Derivate lieferten. Eine effiziente und 
günstige Methode für die Synthese von funktionalisierten 2-Salicyloylfuranen und 2-Benzoyl-
8H-thieno[2,3-b]indolen wurde durch die Zyklisierungsreaktionen von 3-Halogenchromonen mit 
β-Ketoamiden und 1,3-Dihydroindol-2-thionen entwickelt. Elektronische und sterische Effekte 
spielen eine entscheidende Rolle in diesen Reaktionen. Synthetisierte Verbindungen sind 
pharmakologisch relevant wegen ihrer Strukturähnlichkeit zu biologisch aktiven natürlichen und 
synthetischen Produkten. Verschiedene fluorierte Produkte wurden durch den Gebrauch von 3-
Fluoroacylchromonen hergestellt. Einige synthetisierte Substanzen zeigen vielversprechende 
Absorption- und Fluoreszenzeigenschaften. 
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Chapter 1 
 
Preface 
 
 
1.1 Task and Motivation 
 
Organic chemistry plays a great role in modern society. This fact can be well illustrated 
by the synthesis of drugs, new materials for technology, polymers and petrochemical industry.  
In 1763, Edward Stone isolated the active ingredient of aspirin.1 In 1853, acetylsalicylic 
acid was first prepared by Charles Gerhardt.2 By the late 1920s, only a few compounds were 
used as medicals, e.g. aspirin, codeine, morphine, nitroglycerin and insulin. In the 1930s, 
antibiotics including penicillin were discovered.3, 4 Since then, the development of new drugs 
increased with a huge speed. 
One of the main focuses of modern organic chemistry is the discovery of new 
biologically active compounds and drugs. An important method for the development of new 
pharmacologically valuable scaffolds is based on the diversity oriented synthesis of compound 
libraries, which are inspired by natural products.5, 6 This method is coupled with high-throughput 
biological screening. Therefore, development of simple, efficient and convenient methods for the 
synthesis of target compound collections is an important task for organic chemists nowadays. 
Among the various synthetic approaches, those that utilize cascade (domino) reactions of 
readily accessible starting materials are highly attractive owing to their simplicity and atom 
economy.7 Cascade reactions can be a powerful tool to construct diverse combinatorial 
compound libraries. In this context, 3-substituted chromones can be very good synthetic 
platforms due to the presence of several reactive centres. The multiplicity of electrophilic centres 
of 3-substituted chromones allows cascades of elemental steps, which can lead to the selective 
formation of elaborated molecular architectures.8-11 
On the other hand, many organofluorine compounds have found their use as 
pharmaceuticals and agrochemicals.12 Fluorine-containing compounds often show interesting 
biological activities, because of the unique properties of the fluorine atom, which is the most 
electronegative element. Thus, the carbon-fluorine bond is one of the strongest single bond in 
organic chemistry. As a result, organofluorine compounds are metabolically stable. Moreover, 
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fluorine acts as a bioisostere of the hydrogen atom due to its small size. In view of these facts, 3-
perfluoroacylchromones were suggested as fluorinated building blocks for the synthesis of a 
variety of perfluoroalkyl-substituted heterocycles. 
 
 
1.2 3-Substituted chromones as bielectrophiles for domino cyclization 
reactions 
 
Chromones (4H-chromen-4-ones) are an important class of oxygen-containing 
heterocyclic compounds, which represent a part of the flavonoid family (Figure 1.1).13 Many 
natural and synthetic chromone derivatives show a wide range of valuable biological activities, 
for example, anti-bacterial, anti-fungal, anti-cancer, anti-oxidant, anti-HIV, anti-ulcers, 
immunostimulators, biocidal, wound healing, anti-inflammatory and immune-stimulatory.13-16 
Chromones have occupied an important place in drug research and nowadays are so-called 
privileged drug scaffolds.6, 17 Very recently, Keri et al.14 and Gaspar et al.15 have published 
excellent reviews related to biological properties of chromones. Some examples of chromone-
based compounds, which have found their use as pharmaceutical agents, are shown in Figure 1.2. 
 
 
Figure 1.1 Chromone scaffold and flavonoids. 
 
Furthermore, the biological and industrial importance of chromones has led to a 
considerable amount of synthetic works in the field of these compounds. Nowadays, they are 
important building blocks in organic chemistry and are used as valuable synthetic intermediates 
in the preparation of new biologically relevant carbo- and heterocyclic systems.18-22  
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Figure 1.2 Chromone-based compounds used as pharmaceutical agents. 
 
3-Substituted chromones, for instance, 3-halo-,11 3-cyano-,23-25 3-nitro-,19, 20 and 3-
acylchromones,28-32 especially 3-formylchromones,33-43 have received much attention in last 
decades. One of the reasons behind the interest in 3-substituted chromones as building blocks is 
the presence of several reactive centres, which allows different domino reactions and formation 
of more complex molecules.  
3-Acylchromones are highly reactive molecules, which possess three electrophilic 
centres, namely С-2 and С-4 carbon atoms of the chromone system and carbonyl carbon atom of 
the acyl group (3-COR2), see Figure 1.3. Because of that, they can react with different 
nucleophiles. The 2-position of 3-acylchromones is the most electrophilic centre, because of 
electron-withdrawing effects of the oxygen atom O1 and two adjacent carbonyl groups. Hence, 
the reactions of 3-acylchromones usually proceed via initial nucleophilic conjugate addition at 
the 2-position of chromone. Nevertheless, because of electronic and steric effects, induced by the 
R2-substituent and the nature of the nucleophile, the initial attack can also be directed to the 
carbonyl group COR2. 
 
 
Figure 1.3 Reactive centres of 3-acylchromones.  
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According to the literature, the opening of the γ-pyrone ring of the chromone moiety, 
which leads to the formation of β-dicarbonyl intermediate A, is characteristic for the reactions of 
3-acylchromones with binucleophiles (Scheme 1.1).10 Ergo, 3-acylchromones can be considered 
as 1,3-dicarbonyl compounds with a masked salicyloyl fragment. β-Dicarbonyl intermediate A is 
capable of different intramolecular cyclizations. Two main general directions of the reaction are 
possible in this step, see Scheme 1.1. The second nucleophilic attack can be directed to the acyl 
carbonyl group COR2 (pathway I) or to the carbonyl carbon atom of the formed salicyloyl 
moiety (pathway II). Pathway II is often accompanied by additional cyclization of the phenolic 
hydroxyl group with remaining acyl carbonyl group. Nonetheless, other additional cyclizations 
can take place as well. In summary, different functionalized salicyloyl derivatives (structure I) or 
fused heterocycles (structure III) can be synthesized (Scheme 1.1).8-10 In the next chapters, based 
on the general Scheme 1.1, I will discuss possible mechanisms of the reactions of 3-
acylchromones, which are studied in this work. 
 
 
Scheme 1.1 General possible pathways of the reactions of 3-acylchromones with binucleophiles. 
 
3-Formylchromone is the simplest representative of 3-acylchromones and was first 
synthesized in the early 1970s. This chromone is well investigated and widely used in the 
synthesis of heterocycles. Excellent reviews, related to the chemical behaviour of 3-
formylchromones towards various nucleophiles, were published by Ghosh et al.,8 Ali et al.9 and 
Plaskon et al.10 It was shown that 3-formylchromones can react with simple nucleophiles, 
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specifically with amines or methylene active compounds, as ordinary aromatic aldehydes, where 
only formyl group is participating in the reaction.10 But, these reactions are less typical for 3-
formylchromones, because of the presence of several active centres, which can take part in the 
reaction. In most common cases, 3-formylchromones react as 1,3-bielectrophiles via C-2 carbon 
atom and aldehyde moiety, because of the higher reactivity of these centres compared to the C-4 
carbon atom. Though, it should be noticed that it is difficult to determine which part of 3-
formylchromone reacts at first: C-2 carbon atom or aldehyde group. Such reactions usually 
proceed with γ-pyrone ring opening accompanied by further recyclization (pathway I, Scheme 
1.1). This direction of chemical behaviour of 3-formylchromones can be illustrated by numerous 
reactions.10 The most well-known and studied of them are presented in the Scheme 1.2.  
 
       Scheme 1.2 Reactivity of 3-formylchromones towards different binucleophiles. 
  
In this way, different heterocycles, such as pyrazoles (structure I), pyrroles (structure II) 
and hetero-fused pyridine (structure III) derivatives, were synthesized via reactions of 3-
formylchromones with aryl hydrazines, hetarylmethylamines and aminoheterocycles, 
respectively (Scheme 1.2).10 Besides, three-component reactions of 3-formylchromones with 
active methylene compounds in the presence of  ammonia source have attracted much attention 
and led to the formation of pyridine derivatives (structure IV).10 In the group of Prof. Langer, 3-
formylchromones, as well as 3-acetylchrоmones, have received much attention in domino 
“Michael-retro-Michael-aldol” reactions with 1,3-bis-silyl enol ethers, which proceeded to the 
formation of different 2-hydroxybenzophenones (structure V).38, 44-47 In summary, reactions of 3-
formylchromones with different binucleophiles are a valuable approach to the synthesis of 
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various salicyloyl derivatives containing carbo- or heterocycles. Also, after the initial attack to 
the C-2 atom of 3-formylchromone, the second nucleophilic attack can occur at the C-4 atom 
(pathway II) followed by additional cyclization (structure III, Scheme 1.1). Thus, reactions of 3-
formylchromones with amidines, guanidines and urea under alkaline gave 5-
hydroxybenzopyrano[4,3-d]pyrimidine derivatives.10 However, other examples of such reactions 
are rare. Finally, 3-formylchromones, as well as 3-acetylchrоmones, can take part in heterodiene 
cycloaddition or other ring annulation reactions.10, 48-52 
It was proposed that the introduction of electron-withdrawing groups, like methoxalyl, 
polyfluoroacyl or aroyl (which also contain electron-withdrawing groups, for example, nitro-
group), into the 3-position of chromone can increase its reactivity towards nucleophiles and 
provide new synthetic applications of this important oxygen-containing heterocyclic system.  
3-Methoxalylchromone containing an additional ester group was first synthesized by the 
group of Prof. Langer in 2010.31 Its reactions with 1,3-bis-silyl enol ethers (1,3-C,C-
binucleophiles) and electron-excessive aminoheterocycles (1,3-C,N-binucleophiles) proceeded to 
the formation of functionalized 2-hydroxybenzophenones (structure I)28 or 2-salicyloylpyridines 
(structure II),29, 31 respectively (Scheme 1.3). Very recently, Bornadiego et al. reported the 
synthesis of polysubstituted 4-aminoxanthones (structure III) via multicomponent reactions using 
3-methoxalylchromone.53 Noteworthy, in all these mentioned reactions, 3-methoxalylchromone 
reacted via C-2 carbon atom and carbonyl carbon atom COCOOCH3 with a very good 
regioselectivity. Although there are only few reports dedicated to the reactivity of 3-
methoxalylchromones, these chromones have already proven themselves as promising building 
blocks for the synthesis of new carbo- and heterocycles.  
 
 
Scheme 1.3 Reactivity of 3-methoxalylchromones in reactions with binucleophiles. 
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Other useful examples of 3-substituted chromones, namely 3-polyfluoroacylchromones, 
were first synthesized by the group of Prof. Yokoe in the early 1990s.32 Since then, they have 
attracted much attention as fluorinated building blocks for the synthesis of a wide variety of 
polyfluoroalkylated heterocycles. Sosnovskikh et al. reported a significant number of articles, 
related to the reactivity of 3-polyfluoroacylchromones towards N,N-, C,N- and N,O-
binucleophiles, e.g. primary amines (reaction I),54, 55 diamines,56 heterocyclic amines and anilines 
(reaction II),57, 58 hydroxylamine (reaction IV), hydroxylamine hydrochloride (reaction V),59, 60 
amidines (reaction III)61 and hydrazines62 (Scheme 1.4). 
 
 
Scheme 1.4 Reactivity of 3-polyfluoroacylchromones towards different binucleophiles. 
 
It is interesting to notice that the formation of a stable cyclic semiketal forms containing 
the polyfluoroalkyl group is typical for reactions of 3-polyfluoroacylchromones (structures A, B, 
D, F). However, in some reactions of 3-polyfluoroacylchromones, mixtures of regioisomers due 
to competing pathways I and II (Scheme 1.1) were obtained. The structures of obtained products 
are often dependent on the reaction conditions. For instance, in the reaction with heterocyclic 
amines and anilines, different products (structures B, C, D) were obtained depending on the type 
of heterocycle and reaction conditions (reaction II, Scheme 1.4).57, 58 Another example is the 
reaction with hydroxylamine hydrochloride (NH2OH·HCl, MeOH, reflux), which gave 4-
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salicyloylisoxazoles (structure G), while reaction with hydroxylamine (NH2OH·HCl, KOH, 
MeOH, r. t.) proceeded to the formation of 4H-chromeno[3,4-d]isoxazol-4-ols (structure F).59, 60 
Examples of the participation of 3-polyfluoroacylchromones in the reactions with active 
methylene compounds or other C-nucleophiles are very scarce. Only three-component reactions 
of 3-polyfluoroacylchromones with acetoacetamide, ethyl acetoacetate and dimedone in the 
presence of ammonium acetate have been reported.63, 64 
Additionally, due to steric and electronic factors, 3-aroylchromones are less active than 
3-methoxalyl- and 3-polyfluoroacylchromones. For this reason, these chromones have not 
received much attention. Only a few reports, which describe reactions of 3-benzoylchromone 
with binucleophiles, have been reported.50, 65-70 In this work, it was proposed to synthesize new 
3-aroylchromones, which will be activated by electron-withdrawing substituents located at the 
aryl moiety, specifically nitro-group or fluorine atom. 
3-Halochromones are another class of 3-substituted chromones. They are highly 
functionalized molecules, which contain an α,β-unsaturated carbonyl moiety and a halogen atom 
as a good leaving group,71 and are used for the synthesis of various heterocycles.11, 52, 72-74  
Sosnovskikh et al. reported a very informative review related to the synthesis and reactivity of 3-
halochromones towards different substrates.11 It was shown that different reactions of 3-
halochromones with simple nucleophiles can proceed to the syntheses of 3-substituted 
chromones,11, 75 2,3-methanochromanones,76 2-substituted chromones77 and benzofuranone 
derivatives.11 In contrast, it should be noted that data on the reactions of 3-halochromones with 
binucleophiles are scarce. The reported transformations of 3-halochromones with binucleophiles 
show that, in general, there are two characteristic pathways of these reactions (Scheme 1.5). 
 
 
Scheme 1.5 Possible pathways of 3-halochromones in reactions with binucleophiles. 
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In this way, similar to other 3-substituted chromones, the first attack of binucleophile 
usually takes place at the carbon atom in the 2-position of 3-halochromones. The second 
nucleophilic attack can be directed to the carbon atom attached to the halogen (pathway I) or to 
the carbonyl group (pathway II). As a result, new synthetic ways can be developed for the 
synthesis of different salicyloyl derivatives (pathway I) or highly functionalized phenols 
(pathway II). The most attention have attracted the reactions of 3-halochromones with 1,3-
binucleophiles (Scheme 1.6). Commonly, they proceeded via pathway I giving different five-
membered heterocycles, for example, furan (structure I), pyrrole (structure II), imidazole-2-
thione (structre III) and imidazo[2,1-b]thiazole (structure IV)73 derivatives.11 Besides, it is 
known that 3-bromo- and 3-chlorochromones reacted with amidines via pathway II and gave 2-
(5-chloropyrimidin-4-yl)phenols (structure VI),78 while the reaction of 3-iodochromones 
proceeded to the formation of imidazole derivatives (structure V).79 It might be explained by the 
fact that iodine atom is a better leaving group than chlorine atom. Even so, it is necessary to 
mention that examples of formation of six-membered heterocycles are very rare.80 All these data 
illustrate the effectiveness of 3-halochromones as building blocks for the synthesis of different 
salicyloyl derivatives containing five-membered heterocycles. 
 
(M
eH
N
) 2
C
=S
 
Scheme 1.6 Reactivity of 3-halochromones towards different 1,3-binucleophiles. 
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In conclusion, all these above discussed facts show that transformations of 3-substituted 
chromones, such as 3-acylchromones and 3-halochromones, with binucleophiles demonstrate the 
broad synthetic potential of these compounds. Their high reactivity ensures the existence of 
several pathways of reaction. On the one hand, this diversity of properties complicates prediction 
of the structures of the final products, but, on the other hand, this fact makes 3-acyl- and 3-
halochromones attractive objects for further studies from the point of their chemo- and 
regioselectivity.  
In view of the various unique biological properties and a great synthetic potential of 
different chromones as building blocks, this thesis is dedicated to the design and synthesis of 
novel biologically relevant carbo- and heterocycles based on the domino reactions of 3-
substituted chromones, namely 3-acylchromones (3-methoxalyl-, 3-polyhaloacyl-, 3-
aroylchromones) and 3-halochromones, with various substrates, like 1,3-C,C-, 1,3-C,N-, 1,3-
C,O- and 1,3-C,S- binucleophiles. 
 Chapter 2. Synthesis of starting materials: 3-substituted chromones 
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Chapter 2 
 
Synthesis of starting materials: 3-substituted chromones 
 
 
2.1 Introduction  
 
The widespread usefulness of chromones in life sciences has stimulated the development 
of numerous methodologies for their synthesis. For this reason, a range of well-established 
classical methods for the synthesis of chromones is available and has been well documented in 
reviews reported by Ellis et al.81 and Gaspar et al.15 In general, the synthesis of chromones can 
be attained using phenols (for example, via Simonis or Ruhemann reactions), ortho-
hydroxyarylalkylketones or salicylic acids.15 One of the most common and widely used routes 
for the synthesis of chromones involves ortho-hydroxyarylalkylketones as starting materials. 
These methods include Vilsmeier-Haack reaction, Claisen condensation (classic Claisen 
condensation, Baker-Venkatamaran or Kostanecki-Robinson reactions), as well as reactions via 
benzopyrylium salts (Scheme 2.1).15 
 
 
Scheme 2.1 Classic methods of synthesis of chromones using ortho-hydroxyarylalkylketones.15 
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Over the years, a big number of modifications of these reactions has been reported. In 
1973, the Vilsmeier-Haack reaction using formylating agent (DMF, POCl3) was applied for the 
first time for the synthesis of 3-formylchromones.82 Since then, this methodology is widely used 
for the synthesis of different 3-substituted chromones.30-32, 54, 83, 84 In this work, a simple and 
convenient method, based on the modification of the Vilsmeier-Haack reaction, was chosen for 
the synthesis of different 3-acylchromones and 3-halochromones. 
 
 
2.2 Results and discussions 
 
As it was mentioned above, this work describes the reactivity of 3-substituted chromones 
towards different 1,3-binucleophiles. According to this task, various chromones containing 
different substituents R1 in the aryl moiety and different groups at the 3-position, namely acyl 
groups, containing a variety of substituents R2, or halogen atoms X, were synthesized (Schemes 
2.2 and 2.3). 
My initial point was the synthesis of a series of 3-acylchromones 4-8 by a modified 
Vilsmeier-Haack reaction using procedures reported already in the literature (Scheme 2.2, Table 
2.1).30-32, 54, 83, 84 
 
 
 
Scheme 2.2 Synthesis of 3-acylchromones 4-8. 
Reaction conditions: (i) 1 (1.0 equiv.), DMF-DMA (1.5 equiv.), 90 ºC, ≈ 2h;  
(ii) 2 (1.0 equiv.), 3 (1.1 equiv.), pyridine (3.3 equiv.), DCM or MeCN. 
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At first, commercially available 2-hydroxyacetophenones 1, which allowed the variation 
of substituents R1, were converted into 3-dimethylamino-1-(2-hydroxyaryl)prop-2-en-1-ones 2 
using DMF-DMA. Then, the acylation in the presence of electrophiles 3, which introduced the 
functional groups R2, has resulted in the formation of 3-acylchromones 4-8. In this way, different 
3-methoxalyl-, 3-perfluoroacyl-, 3-aroylchromones and also chromones 7 and 8 were 
synthesized in good to excellent yields (Table 2.1 (a-c)). Almost in all cases, corresponding acyl 
chlorides were used as acylation agents 3. Only for the synthesis of 3-trifluoroacetyl- and 3-
pentafluoropropanoylchromones, trifluoroacetyl and pentafluoropropanoyl anhydrides were 
used, respectively. In addition, the procedure for the synthesis of chromones 5-7 was improved 
in the acylation step by using MeCN instead of DCM.  
 
 Table 2.1 (a) Synthesis of 3-methoxalylchromones 4. 
2 3 4 R1 R2
 
Yield,a % 
a 
a 
 
a* H COOCH3 82 
b b* 6-CH3 COOCH3 93 
c c 7-OCH3 COOCH3 83 
d d 6-Cl COOCH3 90 
e e 6-Cl, 7-CH3 COOCH3 83 
f f* 6-Br COOCH3 95 
g g 7,8-benzo COOCH3 77 
* Compounds have already been reported. 
a Yields of isolated products. 
 
It is necessary to note that 3-perfluoroacylchromones 5 were obtained as a mixture of 
hydrated and non-hydrated forms (Table 2.1 (b)). It was proved according to 1H and 19F NMR 
spectral data, which showed two sets of signals. Nevertheless, this fact did not hinder the use of 
3-perfluoroacylchromones 5 in further investigations. They were used as intermediates and are 
not described in this work. 
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Table 2.1 (b) Synthesis of 3-perfluoroacylchromones 5. 
2 3 5b R1 R2 = RF Yield,a % 
a 
b 
ac,* H
 
CF3 60 
c b 7-OCH3 CF3 75 
d c 6-Cl CF3 84 
f d 6-Br CF3 80 
g e 7,8-benzo CF3 99 
a  f* H C2F5 96 
b  g* 6-CH3 C2F5 92 
h  h* 7-CH3 C2F5 88 
i  i 6-OCH3 C2F5 91 
c  j* 7-OCH3 C2F5 95 
j c k 6,7-(OCH3)2 C2F5 67 
d  l 6-Cl C2F5 99 
e  m 6-Cl, 7-CH3 C2F5 93 
f  n 6-Br C2F5 80 
k  o 7-F C2F5 58 
g  p 7,8-benzo C2F5 91 
a  q H C3F7 76 
b  r 6-CH3 C3F7 45 
c  s 7-OCH3 C3F7 36 
d d t 6-Cl C3F7 85 
e  u 6-Cl, 7-CH3 C3F7 86 
f  v 6-Br C3F7 95 
g  w 7,8-benzo C3F7 87 
* Compounds have already been reported. 
a Yields of isolated products. 
b A mixture of hydrated and non-hydrated forms:  
 
c Compound was purified by sublimation and used in non-hydrated form. 
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Table 2.1 (c) Synthesis of 3-aroylchromones 6 and chromones 7, 8. 
2 3 6 R1 R2 Yield,a % 
a e a* H Ph 80 
a f b H 2-FC6H4 86 
a g c H 2-C4H3S 81 
a h d H 2-NO2C6H4 70 
b i e 6-CH3 2-NO2C6H4 81 
c j f 7-OCH3 2-NO2C6H4 79 
a k g H 3-NO2C6H4 81 
b l h 6-CH3 3-NO2C6H4 85 
a m i H 4-NO2C6H4 83 
a n j H 3,5-(NO2)2C6H3 58 
a o 7* H 
  
68 
a p 8* H CHCl2 75 
* Compounds have already been reported. 
a
 Yields of isolated products. 
 
3-Aroylchromones are less reactive than 3-methoxalyl- and 3-perfluoroacylchromones. 
Therefore, electron-withdrawing groups, for example, nitro-group or a fluorine atom, were 
introduced into their aroyl moiety to increase their reactivity. In this way, the described protocol 
was first applied for the synthesis of a series of new 3-aroylchromones 6 (Table 2.1 (c)).  
Additionally, 3-[(2E)-3-phenylprop-2-enoyl]chromone 7 (3-cinnamoylchromone) was 
prepared. The synthesis of chromone 7 and some other its derivatives has already been reported. 
However, other synthetic approaches were used.85, 86 It should be emphasised that almost no data 
on the chemical properties of this molecule was reported. At the same time, it was found that 
some chromones, which contain hydrophobic side chain, possess antioxidant and 
acetylcholinesterase inhibitor activities.87 In the context of this work, it was assumed that the 
presence of a double bond as an additional reactive centre can allow alternative selectivity in the 
domino cyclization reactions apart from usual pathways reported for 3-substituted chromones.  
Finally, 3-(2,2-dichloroacetyl)chromone 8, which is a polydentate electrophilic agent 
utilized for the synthesis of dichloromethylated compounds, was first synthesized and studied by 
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my colleague Dr. Satenik Mkrtchyan.30 This chromone was also used for some experiments in 
the present work.  
As a second goal, the series of 3-halochromones 9-11 were prepared starting from already 
obtained 3-dimethylamino-1-(2-hydroxyaryl)prop-2-en-1-ones 2 by further halogenation using 
iodine, bromine or iodine monochloride, respectively (Scheme 2.3, Table 2.2).11, 32, 83 All 
obtained 3-halochromones 9-11 have already been reported and described. Nonetheless, the 
synthesis of 3-iodochromones 11 was optimized by using iodine in the presence of pyridine. 
Almost all obtained 3-halochromones 9-11 were purified by recrystallization from 
heptane/isopropanol. Only compounds 10a and 10d were purified using column chromatography 
in order to remove a dibrominated by-product. The yields of these compounds were lower. 
 
 
Scheme 2.3 Synthesis of 3-halochromones 9-11.  
Reaction conditions: (a) 2 (1.0 equiv.), I2 (1.5 equiv.), pyridine (2.0 equiv.), CHCl3;  
(b) 2 (1.0 equiv.), Br2 (1.1 equiv.), MeCN; (c) 2 (1.0 equiv.), ICl (1.3 equiv.), MeCN. 
 
 Table 2.2 Synthesis of 3-halochromones 9-11. 
3-Halochromone* X R1 Yield,a % 
9a I H 80 
9b I 7,8-benzo
 
86 
10a Br H
 
49 
10b Br 6-CH3 74 
10c Br 6-Cl, 7-CH3 81 
10d Br 7,8-benzo 58 
11a Cl H 82 
11b Cl 7-OCH3 86 
11c Cl 7,8-benzo 76 
*
 Compounds have already been reported 
a
 Yields of isolated products.  
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2.3 Conclusions  
 
The scope of the already known protocol of the modified Vilsmeier-Haack reaction was 
significantly expanded by the synthesis of various new 3-substituted chromones. In the following 
chapters, the use of synthesized 1,3-bielectrophiles 4-11 in cyclization reactions with different 
binucleophiles will be considered. 
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Chapter 3 
 
Reactions of 3-acylchromones with active methylene compounds:  
Synthesis of 2-hydroxybenzophenones, 6H-benzo[c]chromenes and 
benzo[c]coumarins 
 
 
3.1 Introduction  
 
Benzophenones represent a class of natural compounds, which consists of about 300 
members and exhibits a great structural diversity and various biological activities, like 
antifungal, anti-HIV, antimicrobial, antioxidant, antiviral and cytotoxic.88 Noteworthy, basic 
skeletons of natural benzophenones contain the structure of 2-hydroxybenzophenone (Figure 
3.1). For this reason, 2-hydroxybenzophenone derivatives are attractive targets from the point of 
their pharmacological properties.89-94 Furthermore, 2-hydroxybenzophenones are well-known 
UV-A/B filters widely used in sun-creams and as photostabilizers in cosmetics.95 
 
 
Figure 3.1 Basic skeletons of natural benzophenones.  
 
On the other hand, coumarins are a well-known class of natural products, which are 
extensively used as biologically active compounds.96-102 Natural and synthetic coumarins were 
verified to have antioxidant, antiinflammatory, antibacterial, antifungal,103 anticoagulating, 
estrogenic, dermal photosensitizing, vasodilator, analgesic, anticancer,104, 105 anti-HIV106 and 
other activities.107-109 Also, coumarins are widely used as additives in food, perfumes, cosmetics, 
also as optical brighteners110 and fluorescent or laser dyes.111 Some of the coumarins are of 
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economic importance. For instance, 3,4-dihydrocoumarin is used in the perfume industry, while 
7-hydroxycoumarin found its applications in sun-screens and fluorescent brighteners.111  
In addition, 6H-benzo[c]chromen-6-ones occur in a number of pharmacologically active 
natural products, e.g. autumnariol,99 autumnariniol,112 alternariol113 and altenuisol,102 and are 
specific inhibitors of the growth of endothelic cells114 and estrogen receptors.115, 116 Moreover, 
dibenzo[c,h]chromen-6-ones represent a class of natural antibiotics and antitumor agents, 
specifically, gilvocarcins, chrymycins and ravidomycins.117-120 Some of the important 
biologically active natural 6H-benzo[c]chromen-6-ones are shown in the Figure 3.2.  
 
 
Figure 3.2 Examples of biologically active natural 6H-benzo[c]chromen-6-ones. 
 
Classical methods for the synthesis of benzophenone derivatives mainly rely on the 
Friedel-Crafts acylation,121-124 while coumarins and their derivatives can be synthesized, for 
example, by Pechmann,125 Perkin,126, 127 Knoevenagel,128 Reformatsky129 and Wittig130-133 
reactions.108, 134 Besides, classical methods of the synthesis of 6H-benzo[c]chromen-6-ones are 
based on the cyclizations of o-bromobenzoic acid with phenols.135-138 Other modern methods 
including various metal-catalysed reactions have also been reported.139-143 Nevertheless, these 
methods are limited and are often expensive and complex. Therefore, the new routes of synthesis 
of benzophenones and coumarins are still of great interest due to the wide field of their 
applications.  
As illustrated in Chapter 1, chromones are valuable building blocks in organic chemistry 
nowadays. The use of the chromone derivatives for the synthesis of 2-hydroxybenzophenones,144, 
145
 coumarins144, 146-152 and 6H-benzo[c]chromen-6-ones153-155 has attracted much attention in 
recent years. Our research group has also reported new routes of the synthesis of functionalized 
2-hydroxybenzophenones,28, 38, 156-160 as well as 6H-benzo[c]chromen-6-ones,47, 161-164 by 
reactions of unsubstituted chromones as well as 3-formyl-, 3-acetyl- and 3-
methoxalylchromones. In these cases, 1,3-bis-silyl enol ethers were used as 1,3-C,C-
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binucleophiles. The examples of the participation of 3-acylchromones in the reactions with other 
1,3-C,C-binucleophiles, which also could proceed to the formation of interesting carbocycles, are 
very scarce. In this context, dimethyl 1,3-acetonedicarboxylate and 1,3-diphenylacetone were 
proposed to examine as 1,3-C,C-binucleophiles in the reactions with 3-acylchromones. 
Dialkyl 1,3-acetonedicarboxylates are well-known polyfunctional nucleophiles 
containing two active methylene components. They have already proven themselves as valuable 
substrates in the reactions with chromones. In this way, different carbo- and heterocycles were 
synthesized depending on the substituent in the 3-position of chromone (Scheme 3.1). 
 
 
      Scheme 3.1 Reactions of 3-substituted chromones with dialkyl 1,3-acetonedicarboxylates. 
Reaction conditions: (a) DBU, THF; (b) DABCO, EtOH, reflux; (c) piperidine, MeOH, reflux. 
 
So, the reactions of unsubstituted chromones165 and 3-nitrochromones154 with dialkyl 1,3-
acetonedicarboxylates proceeded to the formation of benzo[c]coumarins (structure I). 
Interestingly, the nitro-group of 3-nitrochromone did not take part in the reaction. At the same 
time, 5H-chromeno[2,3-b]pyridine derivatives were obtained from 3-cyanochromones due to the 
participation of the CN-group in the domino cyclization reaction (structure II).166, 167 3-
Formylchromones reacted with dimethyl 1,3-acetonedicarboxylate via C-2 carbon atom and 
formyl group giving functionalized 2-hydroxybenzophenones (structure III), while by the use of 
3-halochromone, namely 3-bromochromone, an unexpected compound containing a cyclopropyl 
ring was obtained as a major product (structure IV).165 It is necessary to underline that described 
reactions proceeded under basic reaction conditions in order to activate the methylene 
components of dialkyl 1,3-acetonedicarboxylate. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) 
was used for this purpose in almost all cases considered above (reaction conditions (a), Scheme 
3.1). 
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In addition, 1,3-diphenylacetone  also contains two methylene carbon atoms. This 
compound is less reactive than dialkyl 1,3-acetonedicarboxylates due to steric and electronic 
factors. Nonetheless, 1,3-diphenylacetone is frequently used in aldol condensation reactions with 
dicarbonyl compounds giving different polyphenyl compounds, which found their use for the 
synthesis of chromophores168, 169 and polymers.170 No data on the reactions of 1,3-
diphenylacetone with any chromones was reported before us. 
According to the importance of carbocycles, particularly, benzophenones and coumarins, 
and to the successful results obtained in the chemistry of chromones and dialkyl 1,3-
acetonedicarboxylates, I was motivated to study the reactions of different 3-acylchromones, such 
as 3-methoxalyl-, 3-perfluoroacyl- and 3-aroylchromones, with dimethyl 1,3-
acetonedicarboxylate and 1,3-diphenylacetone. One of the main points was the investigation of 
the influence of the acyl group at 3-position of chromone on the course of the reaction and the 
structure of obtained products. 
 
 
3.2 Results and discussions  
 
3.2.1 Reactions of 3-acylchromones with dimethyl 1,3-acetonedicarboxylate  
 
The investigation, related to the reactivity and chemical behaviour of 3-acylchromones 4-
6 in the presence of dimethyl 1,3-acetonedicarboxylate 12, was started by the study of the 
reactions of 3-methoxalylchromones 4 (R2 = COOCH3). A test reaction of chromone 4a with 
binucleophile 12 was performed under basic reaction conditions using DBU (1.3 equiv), which 
was well-proven in the reactions of 3-formyl- and other 3-substituted chromones with active 
methylene compounds,165 in dioxane at room temperature (Scheme 3.2, Table 3.1). The reaction 
was carried out approximately 10-12 h until full conversion of the chromone.  
 
 
Scheme 3.2 Synthesis of compounds 13.  
Reaction conditions: (i) 4 (1.0 equiv.), 12 (1.1 equiv.), DBU (1.3 equiv.), 1,4-dioxane, 20 ºC. 
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Gratifyingly, the experiment was successful. In spite of the multiplicity of reactive 
centres of 3-methoxalylchromones, 2-hydroxybenzophenone 13a was obtained in good yield 
(74%) with an excellent regioselectivity. Encouraged by the obtained result, the scope and 
limitation of proposed reaction protocol were next studied. Thus, reactions of 3-
methoxalylchromones 4 with dimethyl 1,3-acetonedicarboxylate 12 resulted in the formation of 
functionalized 2-hydroxybenzophenones 13a-g with a good regioselectivity in 46-87% yields 
(Scheme 3.2, Table 3.1). The highest yield (87%) was obtained for compound 13b (R1 = 5´-
CH3), while compound 13g with the largest substituent (R1 = 3´,4´-benzo) showed the lowest 
yield of 46%, probably caused by steric effect. 
 
Table 3.1 Synthesis of compounds 13. 
4 R1 R2
 
13 Yield,a % 
a H COOCH3 a 74 
b 6-CH3 COOCH3 b 87 
c 7-OCH3 COOCH3 c 73 
d 6-Cl COOCH3 d 72 
e 6-Cl, 7-CH3 COOCH3 e 71 
f 6-Br COOCH3 f 81 
g 7,8-benzo COOCH3 g 46 
a
 Yields of isolated products. 
 
Inspired by the obtained results, the reactions of 3-perfluoroacylchromones 5 (R2 = RF) 
with dimethyl 1,3-acetonedicarboxylate 12 under the same reaction conditions were next studied. 
Surprisingly, the reactions took an entirely different course and gave a series of 6H-
benzo[c]chromenes 14a-u with good yields in most cases (Scheme 3.3, Table 3.2).  
 
 
Scheme 3.3 Synthesis of compounds 14. 
Reaction conditions: (i) 5 (1.0 equiv.), 12 (1.1 equiv.), DBU (1.3 equiv.), 1,4-dioxane, 20 ºC. 
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Table 3.2 Synthesis of compounds 14. 
5 R1 R2 = RF 14 Yield,a % 
a 7-OCH3 CF3 a* 21 
b 6-Cl CF3 b 64 
c 6-Br CF3 c 59 
d H C2F5 d 65 
e 6-CH3 C2F5 e 31 
f 7-CH3 C2F5 f 40 
g 6-OCH3 C2F5 g** 27 
h 7-OCH3 C2F5 h 65 
i 6,7-(OCH3)2 C2F5 i 52 
j 6-Cl C2F5 j 67 
k 6-Cl, 7-CH3 C2F5 k 57 
l 6-Br C2F5 l 68 
m 7-F C2F5 m 33 
n 7,8-benzo C2F5 n 78 
o H C3F7 o 69 
p 6-CH3 C3F7 p 64 
q 7-OCH3 C3F7 q 67 
r 6-Cl C3F7 r 77 
s 6-Cl, 7-CH3 C3F7 s 71 
t 6-Br C3F7 t 56 
u 7,8-benzo C3F7 u 71 
a
 Yields of isolated products. 
*
 Besides, compound 15 was isolated in 23% yield (structure see below). 
 
**
 Besides, compound 16 was isolated in 33% yield (structure see below). 
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The study of scope and limitation of the reaction has shown that the present protocol 
could be applicable to various types of 3-perfluoroacylchromones 5 (RF = CF3, C2F5, C3F7) 
providing a convenient route for the synthesis of a wide range of the fluorine-containing 6H-
benzo[c]chromenes 14 (Scheme 3.3, Table 3.2). The highest yields were obtained for compounds 
14n and 14u (R1 = 3´,4´-benzo). The lowest yields were obtained for the products 14a and 14g. 
The low yield of compound 14a can be explained by the formation of side-product 15 formed by 
a competing pathway of the reaction. 2-Hydroxybenzophenone 15 could be isolated in 23% 
yield, its structure is similar to the obtained 2-hydroxybenzophenones 13 (Scheme 3.2). In 
contrast, the low yield of 14g can be explained by the formation of by-product 16 in 33% yield. 
Apparently, compound 14g has lost its perfluoroalkyl-group and thereby turned into coumarin 
16. Even so, it should be emphasised that synthesized 6H-benzo[c]chromenes 14 were stable and 
could be used for the further investigations. Furthermore, the formation of a stable cyclic 
semiketal form containing the polyfluoroalkyl group was already observed in reactions of 3-
polyfluoroacylchromones (Scheme 1.4). 
Motivated by the finding of significant influence of the acyl group of chromone on the 
course of the reaction, I was next interested to study the reactions of 3-aroylchromones 6 (R2 = 
Aryl) with binucleophile 12 using the same reaction conditions (Scheme 3.4, Table 3.3).  
 
 
Scheme 3.4 Synthesis of compounds 17 and 18. 
Reaction conditions: (i) 6 (1.0 equiv.), 12 (1.1 equiv.), DBU (1.3 equiv.), 1,4-dioxane, 20 ºC. 
 
It was found that 3-aroylchromones 6a-c (R2 = Ph, 2-FC6H4, 2-C4H3S) in reactions with 
dimethyl acetonedicarboxylate 12 gave mixtures of 2-hydroxybenzophenones 17 and 
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benzo[c]coumarins 18. Gratifyingly, compounds 17a-c and 18a-c could be isolated by column 
chromatography in a pure form. At the same time, 3-aroylchromones 6g, i, j (Ar = 3-NO2C6H4, 
4-NO2C6H4, 3,5-(NO2)2C6H3) containing nitro-group in the reactions with binucleophile 12 
delivered 2-hydroxybenzophenones 17d-f in good yields, 47-83%. Highly interestingly, in 
contrast, similar reactions of 3-(2-nitrobenzoyl)chromones 6d-f with substrate 12 proceeded to 
the formation of benzo[c]coumarins 18d-f with a very good regioselectivity in 72-84% yields. 
The structures and ratio of obtained products were dependent on the electronic and steric effects 
of the R2-substituent of 3-aroylchromones 6. It will be considered in details by the explanation of 
a reaction mechanism (see below). 
 
Table 3.3 Synthesis of compounds 17 and 18. 
6 R1 R2 = Ar 17 Yield,a % 18 Yield,a % 
a H Ph a 49 a 27 
b H 2-FC6H4 b 23 b 46 
c H 2-C4H3S c 7 c 63 
d H 2-NO2C6H4 __ __ d 72 
e 6-CH3 2-NO2C6H4 __ __ e 84 
f 7-OCH3 2-NO2C6H4 __ __ f 73 
g H 3-NO2C6H4 d 83 __ __ 
i H
 
4-NO2C6H4 e 47 __ __ 
j H
 
3,5-(NO2)2C6H3 f 70 __ __ 
a
 Yields of isolated products. 
 
 
3.2.1.1 Proposed reaction mechanism 
 
The proposed mechanism of the domino reactions of 3-acylchromones 4-6 with 1,3-C,C-
binucleophile, specifically dimethyl 1,3-acetonedicarboxylate 12, is outlined in the Scheme 3.5.  
According to the chemical behaviour of known 3-acylchromones towards binucleophiles, 
which was described in Chapter 1 (Scheme 1.1), and the structures of synthesized products 13, 
14, 17 and 18, it was suggested that all reactions of 3-acylchromones 4-6 have started by 
nucleophilic attack of one of the base-activated CH2-groups of dimethyl 1,3-
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acetonedicarboxylate 12, directed to the most electrophilic carbon atom С-2 of the chromone. 
Subsequent opening of the γ-pyrone ring of chromone proceeded to the formation of β-
dicarbonyl intermediate A containing several electrophilic centres (1,4-addition). In general, 
nucleophilic attack of the second active methylene component (CH2-group) of binucleophile 12 
can be directed to the acyl carbonyl group COR2 (pathway I) or to the carbonyl carbon atom of 
the formed salicyloyl moiety (pathway II) (Schemes 1.1 and 3.5). 
 
O
O
OH O
OH
COOCH3
COOCH3
+
R2
R1
O
R2
R1
R2 = COOCH3, Ar;
O
COOCH3
COOCH3
4-6
13: R2 = COOCH3; 17: R
2 = Ar;
O
H3COOC
O
COOCH3
O
R1
12
A
O
H3COOC
O
COOCH3
O
R1
I
II
O
R2
H
OH
R2
pathway I
R2 = RF
O O
OH
COOCH3
O
H3COOC
OH
COOCH3
RF
OH R1R1
O
Ar
R2 = Ar
14 18
pathway II
-H2O
B
OH
COOCH3
R1
OR
2
OH
O
H3CO
-CH3OH
i
Base
 
 
 
Scheme 3.5 Proposed reaction mechanism for the formation of compounds 13, 14, 17 and 18. 
Reaction conditions: (i) 4-6 (1.0 equiv.), 12 (1.1 equiv.), DBU (1.3 equiv.), 1,4-dioxane, 20 ºC. 
 
Ergo, 2-hydroxybenzophenones 13 were formed by reactions of 3-methoxalylchromones 
4 via the second nucleophilic attack of dimethyl 1,3-acetonedicarboxylate 12, directed to the acyl 
carbonyl group COR2 (pathway I). This trend can be explained by the higher electrophilicity of 
the carbonyl carbon atom of methoxalyl moiety (COCOOCH3) compared to the salicyloyl 
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carbonyl group, because of the activating (electron-withdrawing) effect of additional ester group. 
Noteworthy, the carbonyl group of the ester moiety itself did not take part in the reaction. 
In contrast, in the reactions of 3-perfluoroacylchromones 5, the second nucleophilic 
attack of binucleophile 12 was directed to the salicyloyl carbonyl group (pathway II). As a result, 
6H-benzo[c]chromenes 14 were formed including further additional intramolecular cyclization 
of phenolic OH-group with remained-free CORF-group (see intermediate B), delivering cyclic 
semiketal form (Scheme 3.5). This fact indicates that the perfluoroacyl-group of chromones 5 
was less active towards nucleophilic attack of compound 12 than the salicyloyl carbonyl group 
under the used reaction conditions. 
Finally, 2-hydroxybenzophenones 17 (pathway I) and benzo[c]coumarins 18 (pathway II) 
could be synthesized by reactions of 3-aroylchromones 6 with substrate 12. It should be noticed 
that coumarins 18 were formed via additional intramolecular cyclization of OH-group with 
carbonyl group of COOCH3 moiety (see intermediate B). Further fission of the OCH3-group led 
to the formation of the coumarin core (Scheme 3.5).  
Thus, mixtures of products 17 and 18 were formed by reactions of 3-aroylchromones 6a-
c (R2 = Ph, 2-FC6H4, 2-C4H3S) with binucleophile 12, because of similar electronic and steric 
properties of aroyl carbonyl COR2 and salicyloyl carbonyl groups of formed intermediate A 
(Table 3.3, Scheme 3.5). Nevertheless, reaction of chromone 6c (R2 = 2-C4H3S) proceeded via 
salicyloyl carbonyl group giving compound 18c as a major product in a good yield (63%), 
because of the deactivating (electron-donating) effect of thenoyl moiety on the acyl carbonyl 
group COR2. At the same time, a slightly activating influence of electron-withdrawing properties 
of ortho-fluorophenylene substituent on the carbonyl COR2 group caused that the product 17b 
was also formed (23%), while product 18b gave only 46% yield. Obviously, 3-aroylchromones 
6g, i, j containing electron-withdrawing NO2-groups, which activate the aroyl moiety COR2, in 
reactions with substrate 12 delivered 2-hydroxybenzophenones 17d-f (pathway I). Formation of 
coumarins 18d-f (pathway II) by similar reactions of 3-(2-nitrobenzoyl)chromones 6d-f can 
probably be explained by a steric effect of the NO2-group in ortho-position. This phenomenon 
was also observed for reactions of 3-aroylchromones with electron-rich aminoheterocyles in 
current study of our group. 
In summary, electronic and steric effects of acyl group COR2 play a great role in the 
cyclization reactions of 3-acylchromones 4-6 with dimethyl 1,3-acetonedicarboxylate 12 and 
have a huge influence on the course of the reaction. The structure of obtained products is mainly 
depend on the intramolecular cyclization step of intermediate A (Scheme 3.5). 
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3.2.1.2 Structure identification 
 
All structures were confirmed by spectroscopic methods, i.e. NMR, IR and mass 
spectrometry, as well as X-ray single crystal analysis. The characteristic signals of compounds 
13, 14, 17 and 18, observed from NMR-spectra, are shown in the Table 3.4.  
 
Table 3.4 Observation from NMR analyses for compounds 13, 14, 17 and 18. 
Compound Structure Characteristic signals in NMR-spectra 
13 
or 
17 
 
1H NMR:  
2 OH: s, δ = 10.5-13.5 ppm; 
C5-HAr: s, δ ≈ 8.1 ppm; 
3 OCH3: s, δ = 3.5-4.0 ppm, in the case of 13; 
2 OCH3: s, δ = 3.5-4.0 ppm, in the case of 17. 
13С NMR:  
С=O: s, δ = 192-202 ppm; 
3 OCH3: s, δ = 50-54 ppm, in the case of 13; 
2 OCH3: s, δ = 50-54 ppm, in the case of 17. 
14 
 
1H NMR:  
C9-OH: s, δ ≈ 11.0 ppm,  
C6-OH: d, δ ≈ 9.6 ppm (4JH,F  ≈ 4.0 Hz), 
C7-HAr: d, δ ≈ 8.1 ppm (5JH,F  ≈1.5 Hz); 
2 OCH3: s, δ = 3.5-4.0 ppm. 
13С NMR:  
if RF = CF3: C6: q, δ ≈ 95 ppm (2JC,F ≈ 32.5 Hz), 
                    CF3: q, δ ≈ 122 ppm (1JC,F  ≈ 291.0 Hz); 
if RF = C2F5, C3F7: C6: t, δ ≈ 97 ppm (2JC,F≈ 27.5 Hz); 
2 OCH3: s, δ = 50-54 ppm. 
19F NMR:  
if RF = CF3: s, δ ≈ -82 ppm; 
if RF = C2F5: s, δ ≈ -78 ppm, CF3, two d, δ ≈ -122 and 
-124 ppm, CF2, (2JF,F ≈ 279 Hz); 
if RF = C3F7: s, δ ≈ -80 ppm, CF3, two dq, δ ≈ -118 
and -121 ppm, CF2, (2JF,F ≈ 285 Hz, JF,F ≈ 8.5 Hz), 
two d, δ ≈ -123 and -124 ppm, CF2, (2JF,F ≈ 290 Hz). 
18 
 
1H NMR:  
OH: s, δ = 12.5-13.5 ppm; 
C9-HAr: s, δ ≈ 8.1 ppm; 
OCH3: s, δ = 3.5-4.0 ppm. 
13С NMR:  
С=O: s, δ = 188-197 ppm;  
OCH3: s, δ = 50-54 ppm. 
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In the low field of 1H-NMR spectra of 2-hydroxybenzophenones 13 and 17 in DMSO-d6, 
two phenolic OH-groups appeared as singlets at δ = 10.5-13.5 ppm. The shift of OH-groups to δ 
≈ 11.0 ppm can be explained by hydrogen bond formation involving neighbouring carbonyl 
group (O-H·· ·O=C). However, the values of chemical shifts of OH-group of the salicyloyl 
moiety were also dependent on the R1-substituent. A typical singlet of the aromatic hydrogen 
atom C5-HAr could be detected at δ ≈ 8.1 ppm. Expectedly, three and two singlets of OCH3-
groups were observed at δ = 3.5-4.0 ppm for compounds 13 and 17, respectively. In the 13C-
NMR spectra of products 13 and 17, the salicyloyl carbonyl carbon atom gave a signal in the low 
field at δ = 192-202 ppm. Additionally, a corresponding number of singlets of OCH3-groups 
were observed at δ = 50-54 ppm. 
In the low field of 1H-NMR spectra of 6H-benzo[c]chromenes 14 in DMSO-d6, three 
characteristic signals were found, which belong to two OH-groups (δ ≈ 9.6 and 11.00 ppm) and 
the aromatic hydrogen atom C7-HAr (δ ≈ 8.1 ppm). The shift of singlet of phenolic C9-OH-group 
to δ ≈ 11.0 ppm can be caused by the hydrogen bond formation. At the same time, C6-OH-group 
has not aromatic character (δ ≈ 9.6). It is necessary to note that signals of hydrogen atoms C6-
OH and C7-HAr appeared as doublets, because of the coupling with the fluorine nucleus. In 
contrast to compounds 13 and 17, in the low field of 13C-NMR spectra of compounds 14, no 
signals of any carbonyl groups were detected. In addition, 13C-NMR analyses gave spectra 
containing typical quartets at δ ≈ 95 and 122 ppm, caused by the presence of the CF3-group. In 
the cases of C2F5 and C3F7 moieties, it was possible to see only the triplets of the carbon atom C6 
at δ ≈ 97 ppm. Other signals of these moieties were too low to be detected due to the multiple C-
F couplings. In addition, two singlets of two OCH3-groups were observed at δ = 3.5-4.0 ppm and 
δ = 50-54 ppm in the 1H-NMR and 13C-NMR spectra, respectively. 
In the 1H-NMR spectra of benzo[c]coumarins 18 in DMSO-d6, the OH-group appeared as 
a singlet at δ = 12.5-13.5 ppm, indicating the possibility of hydrogen bond formation. A singlet 
of the aromatic hydrogen atom C9-HAr could be detected at δ ≈ 8.1 ppm. It is important to 
mention that, in contrast to the other products 13, 14 and 17, in the 1H-NMR spectra of 
compounds 18, only one singlet of OCH3-group was observed (δ = 3.5-4.0 ppm), since the other 
COOCH3-group, derived from binucleophile 12, was lost during the cyclization. In the 13C-NMR 
spectra, aroyl carbonyl group appeared at δ = 188-197 ppm.  
The structures of fluorine-containing compounds 14, 15, 17b and 18b were also 
confirmed by 19F-NMR. The CF3-group appeared as a singlet at δ ≈ -82 ppm. The C2F5-group 
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appeared as a singlet at δ ≈ -78 ppm (CF3-group) and two doublets at δ ≈ -122 and -124 ppm, 
indicating that two fluorine-atoms of CF2-group in the C2F5 moiety are not equivalent and couple 
to each other. The C3F7-group appeared as a singlet at δ ≈ -80 ppm (CF3-group), two double 
quartets at δ ≈ -118 and -121 ppm (CF2) and two doublets at δ ≈ -123 and -124 ppm (CF2). The 
fluorine atoms in aryl moieties of compounds 17b and 18b appeared as singlets at δ ≈ -113 and -
109 ppm, respectively. Besides, in the 13C-NMR spectra of 17b and 18b the corresponding 
doublets of carbon atoms of the aromatic ring containing a fluorine atom were observed. 
Due to the high diversity of potential intramolecular cyclizations of the studied reactions 
leading to the formation of different regioisomers, X-ray crystal analysis was crucial for initial 
structure determination. Thus, the structures of compounds 13b, 13c, 14o, 15, 16, 17a, 17b, 18a 
and 18d were unambiguously confirmed by X-ray single crystal analyses (Table. 3.5). In 
addition, X-ray analysis allowed to determine the presence of hydrogen bonds in the crystalline 
state of compounds due to the values of distances and angles between corresponding groups. A 
value for such bonds appears by summing the normal bond length of an H-X bond, where X is an 
electronegative atom, the covalent radius of hydrogen atom and the van der Waals radius of X. 
The calculated distance of O-H···O is ≈ 2.7 Å.171 Therefore, also in the present work, this value 
was considered as critical for the determination of plausible hydrogen bond formation. 
 
Table 3.5 Crystal structures of compounds 13b, c, 14o, 15, 16, 17a, b and 18a, d. 
Crystal structure Compound Structure 
 
13b 
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14o 
 
 
15 
 
 
16 
 
Chapter 3. Reactions of 3-acylchromones with active methylene compounds: 
Synthesis of 2-hydroxybenzophenones, 6H-benzo[c]chromenes and benzo[c]coumarins 
 
 
 
 
 40
 
 
 
17a 
O O
O
OCH3
O
H
H3CO O
H
 
 
17b 
 
 
18a 
 
 
18d 
O O
O
H
O
OCH3
O
N
O
O
H
 
Chapter 3. Reactions of 3-acylchromones with active methylene compounds: 
Synthesis of 2-hydroxybenzophenones, 6H-benzo[c]chromenes and benzo[c]coumarins 
 
 
 
 
 41
For all 2-hydroxybenzophenones 13b, 13c, 15, 17a and 17b, X-ray single crystal analyses 
showed distances of 1.7-1.9 Å between the hydrogen atom of OH-groups and oxygen atom of 
neighbouring carbonyl groups, indicating the presence of two hydrogen bonds of these groups 
for each structure. As expected, the molecules of 2-hydroxybenzophenones are not planar. The 
salicyloyl phenol ring of these compounds is in one plane with the linking carbonyl group 
twisted out of the plane with a torsion angle of 46-70º to another phenol ring. 
6H-Benzo[c]chromene 14o and benzo[c]coumarin 16 crystallized in a monoclinic system 
with space groups P21 and P21/c, respectively. The space group of the X-ray structure of 
compound 14o revealed that the obtained crystal consists of one pure R- or S-enantiomer. The 
presence of hydrogen bonds (about 1.9 Å) between OH and carbonyl oxygen atom was 
confirmed by crystal structures of compound 14o and 16. Moreover, X-ray structures of 
described products indicated weak intramolecular non-classical hydrogen bonds, involving 
aromatic hydrogen atoms172 (C12-H of 14o, C9-H of 16) and the oxygen atoms of carbonyl 
groups (O4 of 14o, O6 of 16) as distances of 2.7 Å and 2.5 Å, respectively.  
The presence of typical hydrogen bonds, involving an OH-group and the neighbouring 
C=O group, were indicated also for compounds 18a and 18d. In addition, the X-ray structure of 
18a indicated a non-classic hydrogen bond (2.6 Å) between the aromatic hydrogen atom C9-H 
and neighbouring C=O group of aroyl moiety, while crystal structure of 18d showed similar 
hydrogen bond (2.4 Å) between the hydrogen atom C5-H and oxygen atom O8 of NO2-group. 
Obviously, the core of benzo[c]coumarin moiety of compounds 16, 18a and 18d is 
planar. In contrast, the structure of 6H-benzo[c]chromene 14o is not planar, because of the 
presence of a quaternary carbon atom C17, whose configuration is near to tetrahedral. The values 
of angles lie within 104-113º. The theoretic value of a tetrahedral angle is about 109.47º. 
 
 
3.2.2 Reactions of 3-acylchromones with 1,3-diphenylacetone 
 
Encouraged by the successful results, obtained during the study of the reactions of 
different 3-acylchromones 4-6 with dimethyl 1,3-acetonedicarboxylate 12, I was next interested 
to examine the reaction of 3-acylchromones 4 and 6 with another 1,3-C,C-binucleophile, such as 
1,3-diphenylacetone 19 (Scheme 3.6). The condensations were performed under similar reaction 
conditions using DBU as a base, but at reflux, because of the less expressed nucleophilic 
properties of 1,3-diphenylacetone 19 in comparison with substrate 12. 
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The reactions of 3-methoxalylchromones 4 with binucleophile 19 proceeded to the 
formation of 2-hydroxybenzophenones 20a, b in moderate yields (Scheme 3.6, Table 3.6). 
Similar to the 2-hydroxybenzophenones 13 obtained by reactions of 3-methoxalylchromones 4 
with 1,3-C,C-binucleophile 12, these products were formed via initial 1,4-addition of substrate 
19 (CH2-group) to the C-2 carbon atom of chromone followed by γ-pyrone ring opening 
(intermediate A). Subsequent intramolecular nucleophilic attack of the second CH2-group of 19 
was directed to the acyl carbonyl group COR2 (R2 = COOCH3), activated by the electron-
withdrawing ester group (pathway I, Scheme 3.6, see also Schemes 1.1 and 3.5). Nonetheless, 
the regioselectivity of these reactions was lower than the regioselectivity of the reactions with 
substrate 12 (Scheme 3.2, Table 3.1). By-products were observed by TLC. However, it was not 
possible to isolate them.  
 
 
Scheme 3.6 Synthesis of compounds 20 and 21. 
Reaction conditions: (i) 4, 6 (1.0 equiv.), 19 (1.1 equiv.), DBU (1.3 equiv.), 1,4-dioxane, reflux. 
 
As the next step, I studied reactions of 3-aroylchromones 6 with 1,3-diphenylacetone 19 
(Scheme 3.6, Table 3.6). In this way, 2-hydroxybenzophenones 20c-g (pathway I) and phenols 
21a-e (pathway II) were obtained. It should be emphasised that synthesis of compounds 21 
proceeded without additional cyclization involving phenolic OH-group and acyl group COR2 (R2 
= Aryl), see also Scheme 1.1. As a result, highly functionalized phenols 21 were delivered. 
Noteworthy, these structures were not obtained by reactions of 3-aroylchromones 6 with 
substrate 12 due to the presence of active COOCH3-moiety, derived from 12, which took part in 
cyclization with phenolic OH-group (Schemes 3.4 and 3.5). 
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Table 3.6 Synthesis of compounds 20 and 21. 
4 or 6 R1 R2 20 Yield, a % 21 Yield, a % 
4a H
 
COOCH3 a 49 __ __ 
4f 6-Br COOCH3 b 54 __ __ 
6a H Ph c 32 a 25 
6c H 2-C4H3S d 29 b 18 
6d H 2-NO2C6H4 __ __ c 59 
6e 6-CH3 2-NO2C6H4 __ __ d 73 
6f 7-OCH3 2-NO2C6H4 __ __ e 61 
6g H 3-NO2C6H4 e 42 __ __ 
6i H
 
4-NO2C6H4 f 69 __ __ 
6j H
 
3,5-(NO2)2C6H3 g 74 __ __ 
a
 Yields of isolated products. 
 
Specifically, 3-benzoyl- and 3-(2-thenoyl)chromones 6a and 6c reacted with 1,3-
diphenylacetone 19 to give mixtures of compounds 20c, d (pathway I) and 21a, b (pathway II), 
which were possible to separate. However, due to the similar physical properties of compounds 
20 and 21, its separation by column chromatography was complicated, causing the losses in 
yields of isolated products (Table 3.6). The reactions of 3-aroylchromones 6g, i, j containing 
NO2-groups with binucleophile 19 led to the formation of 2-hydroxybenzophenones 20e-g with a 
good regioselectivity in 42-74% yields, because of the activating (electron-withdrawing) effect 
of the nitro-substituent on the aroyl group COR2 (pathway I). In contrast, because of the steric 
effect of the NO2-group in ortho-position of the aroyl moiety COR2, reactions of 3-(2-
nitrobenzoyl)chromones 6d-f resulted in the synthesis of phenols 21c-e in 59-73% yields 
(pathway II). 
In summary, all these results are in a good correspondence to the results obtained by the 
study of reactivity of 3-acylchromones 4 and 6 towards dimethyl 1,3-acetonedicarboxylate 12 
considered above. Synthesis of obtained products 20 and 21 can be explained by a similar 
reaction mechanism via β-dicarbonyl intermediate A formation, which was described for the 
reactions of 3-acylchromones 4-6 with binucleophile 12 (Schemes 1.1, 3.5 and 3.6). 
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3.2.2.1 Structure identification 
 
All structures of compounds 20 and 21 were confirmed by NMR, IR and mass 
spectrometry, as well as X-ray single crystal analysis. 
In the 1H-NMR spectra of compounds 20 in DMSO-d6, two OH-groups appeared as 
singlets at δ = 8.6-9.3 ppm and 10.5-11.6 ppm. Most probably, the signals shifted to δ ≈ 11 ppm 
belong to protons of OH-groups of salicyloyl moiety, which could form an intramolecular 
hydrogen bond with the neighbouring carbonyl group. In contrast, in the 1H-NMR spectra of 
compounds 21, two singlets of two OH-groups were observed at δ = 8.4-9.2 ppm. The shift of 
both signals of OH-groups to δ ≈ 9 ppm can indicate the absence of hydrogen bonds in both 
cases. In the 13C-NMR spectra, the salicyloyl carbonyl groups of compounds 20 and 21 appeared 
at δ = 193-202 ppm and δ = 188-193 ppm, respectively. In addition, the OCH3-group of 
compounds 20a and 20b obtained from 3-methoxalylchromones was observed as a singlet at δ = 
3.5-4.0 ppm in the 1H-NMR spectra and at δ = 50-54 ppm in the 13C-NMR spectra. 
The exact structures of compounds 20c, 20d, 20f, 21b and 21e were established by X-ray 
single crystal analysis (Table 3.7).  
 
Table  3.7 Crystal structures of compounds 20c, d, f and 21b, e. 
Crystal structure Compound Structure 
 
20c 
O O
OH
H
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Expectedly, X-ray analyses of compounds 20 confirmed the existence of an 
intramolecular hydrogen bond (about 1.8 Å), involving the salicyloyl phenolic OH-group and 
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neighbouring carbonyl group (C=O). In contrast, in crystal structures of compounds 21, the 
distances between the aroyl carbonyl group COR2 and OH-group of another phenol ring were too 
long for hydrogen bond formation, because of the significant torsion angle between phenolic 
rings. These facts correspond to the data obtained by 1H-NMR analyses. The structures of 
compounds 20 are also not planar. In the analyzed structures of compounds 20, the plane of 
salicyloyl moiety made a torsion angle of 57-64º to the adjacent phenol ring. 
 
 
3.3 Additional investigations 
 
Modification of benzophenones and benzo[c]coumarins is of interest, since these 
scaffolds are important structural fragments of many natural and biologically active substances, 
as mentioned in the introduction. Furthermore, some benzoylbenzoic acids exhibit attractive 
biological properties.173 In view of that, base-mediated hydrolysis of obtained 2-
hydroxybenzophenones 13 and 6H-benzo[c]chromenes 14 was performed. The obtained results 
are shown in the Scheme 3.7 and Table 3.8.  
 
 
Scheme 3.7 Synthesis of compounds 22 and 23. 
Reaction conditions: (i) 13 or 14 (1.0 equiv.), KOH (8.0 equiv.), methanol, reflux;  
(ii) aqueous solution of HCl (30%). 
 
Thereby, compounds 13 reacted with potassium hydroxide in methanol at reflux resulting 
in the formation of tricarboxylic acids 22 with excellent yields of 80-92%. Interestingly, 
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structurally similar 3-methoxybenzene-1,2,4-tricarboxylic acid was first obtained as the minor 
product of the oxidation of gladiolic acid.174 Likewise, 6H-benzo[c]chromenes 14d and 14u 
reacted with potassium hydroxide to produce products 23a and 23b in 70% and 92% yields, 
respectively. So far, acids, which are structurally similar to compounds 23, have not been 
described. All structures of compounds 22 and 23 were confirmed by NMR, IR and mass 
spectrometry. 
 
Table 3.8 Synthesis of compounds 22 and 23. 
13 R1 R2 22 Yield, a % 
a H
 
COOCH3 a 80 
b 5-CH3 COOCH3 b 84 
e 5-Cl, 4-CH3 COOCH3 c 92 
g 3,4-benzo COOCH3 d 89 
14 R1 R2 23 Yield, a % 
d H C2F5 a 70 
u 3,4-benzo C3F7 b 92 
a
 Yields of isolated products. 
 
 
3.4. Photophysical properties 
 
The sunlight ultraviolet radiation (UV) can cause photoallergic and cytotoxic reactions 
leading to skin cancer, because of the possibility of photochemical reactions of the DNA, for 
instance, [2+2] cycloadditions of thymine.95 The most dangerous radiation of sunlight for the 
human skin lies in the range of UV-A (400-320 nm) and UV-B (320-280 nm) bands, while the 
UV-light with shorter wavelengths in the range of UV-C (280−200 nm) bands is absorbed by 
ozone in the upper parts of the atmosphere.95 Organic compounds, which contain system with 
certain unsaturated groups (π orbitals) or atoms with unpaired electrons (n orbitals), can absorb 
UV radiation without decomposition by exciting an electron from its ground state into an excited 
state. In such way, these compounds can act as UV-filters. In an effort to protect the human skin 
from negative effects of UV light, a variety of personal care products containing UV filters has 
been investigated and produced.175 Optimal sun-protecting compounds should have a broad and 
Chapter 3. Reactions of 3-acylchromones with active methylene compounds: 
Synthesis of 2-hydroxybenzophenones, 6H-benzo[c]chromenes and benzo[c]coumarins 
 
 
 
 
 48
strong absorption of UV-A and UV-B radiation, be photo-, thermo- and chemically stable and 
have a moderate lipophilicity. Sun-creams can contain UV-A/B broad spectrum filters or a 
mixture of UV-A and UV-B filters. Many organic compounds, e.g. para-amino benzoates, 
salicylates, dibenzoyl methanes and camphor derivatives, are approved for use in sun-protecting 
materials.175 However, they do not possess full UV-light protecting properties. Besides, many of 
them are thought to be toxic, carcinogenic, aggressive or unstable and need photostabilizers.  
Benzophenone derivatives are an important class of organic UV-filters. 2-
Hydroxybenzophenones, like so called benzophenone-2, benzophenone-3 and benzophenone-8, 
are widely used as UV-filters in sun-protecting materials in cosmetics due to their ability to 
absorb in both the UV-A and UV-B ranges (Figure 3.3).175, 176 Benzophenone-3 is one of the 
most widely used UV filters in commercial sunscreens. Nonetheless, this compound is thought to 
be photocarcinogenic.177-180 In addition, the highly lipophilic properties of known 
benzophenones enable them to rapidly cross the dermal tissue, what can cause bioaccumulation 
in the human body. For these reasons, the development of new UV-A/B filters is still of much 
interest. The group of Prof. Langer has previously reported the synthesis of a series of new 2-
hydroxybenzophenones as novel UV-A/B filters, which have shown intensive absorption 
properties.28 
 
 
Figure 3.3 2-Hydroxybenzophenones approved as UV-A/B broad spectrum filters. 
 
On the other hand, coumarins are very attractive targets from the point of their absorption 
and especially emission properties. Coumarin derivatives present a wide range of fluorescence 
properties.181-184 They often exhibit high fluorescence quantum yields, large Stokes shifts, very 
good light stability and low toxicity. Because of that, these compounds have found use as optical 
brighteners110 and fluorescent and laser dyes. 7-Substituted coumarins, which contain electron-
withdrawing groups participating in the coumarin conjugation system, are the most important 
subsets, for example, 7-amino, 7-methoxy- and 7-hydroxycoumarins (Figure 3.4).184, 185 
Moreover, benzocoumarins and benzochromenones, which represent π-extended coumarin 
systems, have also attracted attention due to their interesting fluorescence properties.186-188 
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Additionally, some fluorinated coumarin derivatives have shown intensive fluorescence 
properties and improved photostability. These factors make them superior fluorescent dyes for 
use as reporter molecules in biological systems.189 
 
 
Figure 3.4 Commonly-used coumarin fluorescent probes. 
 
Taking into account the structural similarities of the synthesized carbocycles in this 
chapter with presently known UV-filter, it was proposed to study the UV-activity of 2-
hydroxybenzophenones 13, 6H-benzo[c]chromenes 14 and products of their hydrolysis 
(compounds 22 and 23). At the same time, one of the attractive features of the synthesized 6H-
benzo[c]chromenes 14 was their intensive fluorescence behaviour. Also, they can be considered 
as systems related to the coumarins. Therefore, it was proposed to start the investigation of the 
emission properties of compounds 14 in collaboration with Dr. S. Tschierlei and Prof. S. 
Lochbrunner (Institute of Physics, University of Rostock). 
The structure of benzophenones consists of two phenyl rings (π orbitals) connected 
through a carbonyl group (n orbitals) forming one conjugated system. Accordingly, 
benzophenones usually show n → π* and π → π* transitions, which result in two peaks in the 
UV-A and UV-B ranges, respectively.190 The low-energy transitions (320-340 nm) of o-
hydroxybenzophenone have been attributed to a charge-transfer transition involving the carbonyl 
and hydroxyl groups.191 In the structure of synthesized 2-hydroxybenzophenones 13, two 
hydroxyl groups form hydrogen bonds with their neighboring carbonyl groups. This fact lowers 
the energy required for the π → π* and n → π* transitions and increases the wavelength of the 
UV absorbance. In addition, the presence of a number of carbonyl and hydroxyl substituents in 
the phenyl rings provides different tautomeric forms. The electron density delocalization in the 
molecules of benzophenones 13 can be illustrated by resonance structures, which are shown in 
Scheme 3.8. 
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Scheme 3.8 Resonance structures of 2-hydroxybenzophenones 13. 
 
As expected, 2-hydroxybenzophenones 13 have shown intensive absorption resulting 
usually in three absorption maxima at 230 nm (UV-C), 240-290 nm (UV-C) and 315-380 nm 
(UV-A/B). The absorption coefficients are about ε = 45000-89000 cm-1mol-1l (Figure 3.5, Table 
3.9).  
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Figure 3.5 UV absorbance spectra of compounds 13. 
 
Continuing the investigation of absorption properties of the synthesized compounds, 6H-
benzo[c]chromenes 14 were next studied (Figure 3.6, Table 3.10). Compounds 14 have shown 
high absorption coefficients, which can be explained by the maximal overlapping between the 
orbitals of two benzene rings, caused by the rigidity of the structure. The absorption coefficients 
are about ε = 29000-88000 cm-1mol-1l. The highest absorption coefficient was measured for 
compound 14r, ε = 88200 cm-1mol-1l. It is necessary to underline that absorption coefficients 
obtained in this study for compounds 13 and 14 are significantly higher compared to other 
known UV-A/B filters.175  
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Table 3.9 The UV properties of compounds 13. 
13a c·10-5, mol·l-1 A λmax, nm ε, cm-1·mol-1· l log ε 
13a  
 
1.45 
 
0.656 
0.538 
0.268 
228 
252 
330 
45248 
37127 
18460 
4.66 
4.57 
4.27 
13b  
 
1.61 
 
0.872 
0.281 
229 
331 
54161 
17422 
4.73 
4.24 
13c  
 
1.61 
 
0.722 
0.324 
0.311 
204 
285 
328 
44870 
20114 
19307 
4.65 
4.30 
4.29 
13d  
 
2.38 
 
1.289 
0.358 
218 
341 
54151 
15024 
4.73 
4.18 
13e  0.57 
0.507 
0.088 
0.054 
227 
269 
344 
89745 
15585 
9554 
4.95 
4.19 
3.98 
13f  
 
1.70 
 
1.240 
0.320 
229 
331 
72935 
18834 
4.86 
4.27 
13g  
 
1.14 
 
0.690 
0.830 
0.175 
227 
262 
381 
60491 
72811 
15388 
4.78 
4.86 
4.19 
a
 Compounds were dissolved in DCM. 
c – concentration, A – absorption, ε – extinction coefficient. 
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Figure 3.6 UV absorbance spectra of compounds 14. 
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Table 3.10 The UV properties of compounds 14. 
14a c·10-5, mol·l-1 A λmax, nm ε, cm-1·mol-1· l log ε 
14b  1.21 
0.356 
0.340 
0.211 
232 
287 
337 
29421 
28099 
17438 
4.47 
4.45 
4.24 
14c 131 
0.578 
0.153 
0.105 
227 
288 
344 
44122 
11679 
8015 
4.64 
4.07 
3.90 
14db 1.38 
0.618 
0.302 
0.213 
215 
286 
333 
44783 
21884 
15435 
4.65 
4.34 
4.19 
14h 1.06 0.641 0.373 
228 
344 
60472 
35189 
4.78 
4.55 
14k 1.25 
0.445 
0.388 
0.288 
231 
291 
341 
35600 
31040 
23040 
4.55 
4.49 
4.36 
14l 0.69 
0.583 
0.152 
0.094 
227 
288 
344 
84249 
21965 
13584 
4.93 
4.34 
4.13 
14n 1.19 
0.812 
0.679 
0.336 
0.251 
232 
284 
325 
365 
68235 
57059 
28235 
21092 
4.83 
4.76 
4.45 
4.32 
14o 0.96 
0.630 
0.241 
0.168 
227 
289 
339 
65831 
25183 
17555 
4.82 
4.40 
4.24 
14p 1.31 
0.620 
0.305 
0.209 
216 
289 
339 
47328 
23282 
15954 
4.68 
4.37 
4.20 
14q 1.31 0.633 0.368 
227 
344 
48321 
28092 
4.68 
4.45 
14r 0.84 
0.740 
0.173 
0.106 
227 
287 
344 
88200 
20620 
12634 
4.95 
4.31 
4.10 
14s 1.09 
0.371 
0.308 
0.227 
232 
291 
341 
34037 
28257 
20826 
4.53 
4.45 
4.32 
14t 0.47 
0.361 
0.225 
0.146 
229 
288 
334 
76972 
47974 
31130 
4.89 
4.68 
4.49 
14u 1.04 
0.535 
0.450 
0.219 
0.159 
232 
283 
323 
365 
51442 
43269 
21058 
15288 
4.71 
4.64 
4.32 
4.18 
a
 Compounds were dissolved in DCM; b Compounds were dissolved in methanol; 
c – concentration, A – absorption, ε – extinction coefficient. 
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The study of fluorescence properties of 6H-benzo[c]chromenes 14 was started by the 
investigation of the influence of different substituents RF and R1 and their electronic effects on 
the emission properties. The comparison of absorption and emission spectra and calculated 
quantum yields of studied compounds 14 are shown in Figure 3.7 and Table 3.11.  
The study of compounds 14a, 14h and 14q which contain the same substituent R1 but 
different perfluoroalkyl-groups RF (CF3, C2F5, C3F7), has shown that the RF group does not have 
an influence on the absorption as well as the fluorescence spectra of these compounds (Figure 
3.7 (a)). With regards to the intensity of the fluorescence, the different substituents RF have a 
slight impact on the quantum yields: all 6H-benzo[c]chromenes 14a, 14h and 14q are very 
strong emitters in the order 54%, 63% and 73%, respectively (Table 3.11). 
 
Table 3.11 The quantum yields of studied 6H-benzo[c]chromenes 14. 
Compounda R1 R2 Φb 
14a 3-OCH3 CF3 0.54 
14d H
 
C2F5 0.06 
14e 2-CH3 C2F5 0.14 
14f 3-CH3 C2F5 0.21 
14h 3-OCH3 C2F5 0.63 
14j 2-Cl C2F5 0.08 
14k 2-Cl, 3-CH3 C2F5 0.15 
14l 2-Br C2F5 0.01 
14n 3,4-benzo C2F5 0.19 
14q 3-OCH3 C3F7 0.73 
a
 Compounds were dissolved in methanol.  
b
 Quantum yields were determined relative to quinine bisulfate in 0.05 M sulfuric acid as 
quantum yield standard (φ = 0.54).  
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  a)  (b)  
  
14a (R1 = 3-OCH3, RF = CF3), 
14h (R1 = 3-OCH3, RF = C2F5), 
14q (R1 = 3-OCH3, RF = C3F7); 
14d (R1 = H, RF = C2F5),  
14f (R1 = 3-CH3, RF = C2F5),  
14h (R1 = 3-OCH3, RF = C2F5); 
(c)  (d)  
 
 
14d (R1 = H, RF = C2F5),  
14f (R1 = 3-CH3, RF = C2F5),  
14e (R1 = 2-CH3, RF = C2F5),  
14k (R1 = 2-Cl, 3-CH3, RF = C2F5); 
14d (R1 = H, RF = C2F5),  
14j (R1 = 2-Cl, RF = C2F5),  
14l (R1 = 2-Br, RF = C2F5): 
(e)    
 
  
14d (R1 = H, RF = C2F5);  
14n (R1 = 3,4-benzo, RF = C2F5); 
  
 
 
 
Figure 3.7 Normalized absorption spectra (solid lines) and emission spectra of 6H-
benzo[c]chromenes 14 dissolved in methanol. 
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As a next step, different 6H-benzo[c]chromenes 14, which possess the similar 
perfluoroalkyl-group RF (C2F5) but different substituents R1, were studied. As a result, the first 
absorption maxima as well as the emission maxima of compounds 14d, 14f and 14h were shifted 
in the order of substituents R1: H < 3-CH3 < 3-OCH3 to higher wavelengths (Figure 3.7 (b)). 
Hence, the methoxy group at the 3-position has a stronger impact on the electronic properties 
compared to the methyl group. Similar results were obtained for the quantum yields. The 
quantum yield of compound 14d was only 6%. In contrast, the substituted systems 14f (3-CH3) 
and 14h (3-OCH3) gave quantum yields of 21% and 63%, respectively (Table 3.11).  
If the methyl group was located at the 2-position (14e), the emission maximum was 
shifted to higher wavelengths compared to the maximum obtained for compound 14f (3-CH3), 
(Figure 3.7 (c)). The quantum yields were approximately in the same range of 21% (14f) and 
14% (14e). Compounds 14j, 14k and 14l showed that Cl- or Br-substituents in the 2-position did 
not have any significant influence on the emission spectra (Figure 3.7 (c) and (d)). The quantum 
yields of products 14j and 14l were very low of 8% and 1%, respectively (Table 3.11). 
Finally, 6H-benzo[c]chromene 14n containing a 2,3-benzo-substituent has shown the 
biggest shift of emission maximum to higher wavelengths (Figure 3.7 (e)). Obviously, this result 
is caused by the extended π-system due to the presence of the additional benzo-substituent. 
However, the quantum yield was not strongly influenced. The compound emitted only 19% of 
the incoming photons (Table 3.11). 
In summary, substituents in the 3-position of compounds 14, which can take part in the 
conjugated π-system of two benzene rings of 6H-benzo[c]chromene moiety, have the biggest 
influence on the emission properties of these products. The great results were obtained for 
compounds 14a, 14h and 14q containing a methoxy group in the 3-position. The electron density 
delocalization in molecules of 6H-benzo[c]chromenes exemplified by compound 14h is shown 
in Scheme 3.9. The mechanism of photophysical properties of 6H-benzo[c]chromenes 14 is now 
under further studies in collaboration with Dr. S. Tschierlei and Prof. S. Lochbrunner. 
 
 
 
 
 
            
Scheme 3.9 Examples of possible resonance structures of 6H-benzo[c]chromene 14h. 
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The last goal of photophysical investigations was the study of absorption properties of 
compounds 22 and 23 (Figure 3.8, Table 3.12). Also for these compounds three absorption 
maxima were observed at ≈ 220 nm (UV-C), ≈ 260 nm (UV-C) and 310-360 nm (UV-A/B). In 
general, the absorption coefficients are very high, ε = 66000-99000 cm-1mol-1l. 
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Figure 3.8 UV absorbance spectra of compounds 22 and 23. 
 
Table 3.12 The UV properties of compounds 22 and 23. 
Compounda c·10-5, mol·l-1 A λmax, nm ε, cm-1·mol-1· l log ε 
22a  1.30 
0.860 
0.374 
0.224 
206 
256 
335 
66154 
28769 
17231 
4.82 
4.46 
4.24 
22b 1.20 
0.805 
0.422 
0.257 
218 
256 
346 
67083 
35167 
21417 
4.83 
4.55 
4.33 
22c 1.10 
0.831 
0.397 
0.235 
221 
259 
342 
75545 
36091 
21364 
4.88 
4.56 
4.33 
22d 1.32 
1.307 
1.076 
0.387 
0.298 
219 
260 
299 
360 
99015 
81515 
29318 
22576 
5.00 
4.91 
4.47 
4.35 
23 1.50 1.198 0.289 
264 
308 
79867 
19267 
4.90 
4.28 
a
 Compounds were dissolved in methanol; 
c – concentration, A – absorption, ε – extinction coefficient. 
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In summary, due to the intensive UV-absorption properties, investigated compounds 13, 
14, 22 and 23 might find use in the preparation of sun-protective materials. Moreover, some of 
6H-benzo[c]chromenes 14 have shown promising fluorescence properties with high quantum 
yields and might be useful as fluorescent dyes. 
 
 
3.5 Conclusions 
 
The domino reactions of different 3-acylchromones with 1,3-C,C-binucleophiles, namely 
dimethyl 1,3-acetonedicarboxylate and 1,3-diphenylacetone, were studied. It was found that 
electronic and steric effects of the acyl group of 3-acylchromones play an important role and 
have a huge influence on the course of the reaction. 
In this way, a simple and convenient method for the synthesis of functionalized 2-
hydroxybenzophenones was developed based on domino reactions of 3-methoxalylchromones 
and electron-deficient 3-aroylchromones with dimethyl 1,3-acetonedicarboxylate and 1,3-
diphenylacetone. At the same time, the domino reactions of 3-perfluoroacylchromones with 
dimethyl 1,3-acetonedicarboxylate afforded various fluorine-containing 6H-benzo[c]chromenes. 
Furthermore, the significant influence of the steric effect of the NO2-group in ortho-position in 
the aroyl moiety of 3-(2-nitrobenzoyl)chromones was found. Thus, reactions of these 3-
aroylchromones with dimethyl 1,3-acetonedicarboxylate proceeded to the formation of 
benzo[c]coumarin derivatives. In addition, their reactions with 1,3-diphenylacetone delivered 
highly functionalized phenols. 
The synthesized compounds might be very attractive objects from the point of their 
pharmacological properties, because of their structural similarity to bioactive natural and 
synthetic products. The biological evaluation of all obtained compounds described in this chapter 
is now in the study. Moreover, the synthesized 2-hydroxybenzophenones 13 and 6H-
benzo[c]chromenes 14 have shown strong UV-absorption properties. Therefore, they may find 
application in the preparation of the sun-protective materials. Additionally, some 6H-
benzo[c]chromenes 14 exhibit intensive fluorescence properties. 
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Chapter 4 
 
Reactions of 3-acylchromones with heterocyclic ketene aminals:  
Synthesis of functionalized fused pyridine derivatives 
 
 
4.1 Introduction  
 
Heteroannulated pyridines are present in a variety of natural and synthetic molecules 
exhibited a wide range of important biological activities.192-198 Pyridine derivatives fused with 
five- or six-membered nitrogen heterocycles, such as pyrrolopyridines,199-202 
pyrazolopyridines,203-212 imidazopyridines213 and pyridopyrimidines,214, 215 can be considered as 
purine isosteres. Purines are valuable components in a number of important biomolecules, 
namely DNA, RNA, ATP, GTP, AMP and NAD.216 Therefore, purine-related compounds are 
privileged scaffolds in drug discovery (Figure 4.1).17 Additionally, purine and pyridine 
derivatives, which possess an ester group at 2-position of the purine structure, are potent 
inhibitors of inosine-5′-monophosphate dehydrogenase (IMPDH).217  
 
 
Figure 4.1 Main purine-derived nucleobases. 
 
Chromenopyridines consist of two important moieties, like chromone and pyridine. Its 
core structure occurs in a number of pharmacologically active products, which show, for 
example, anticancer, anti-HIV-1, antibacterial and antistress activities.218-223 Noteworthy, 
chromenopyridines, specifically amlexanox and nedocromil, are used as medicals nowadays. 
Nedocromil is used for the treatment of asthma and other breathing problems (Figure 4.2).14 
Amlexanox is a commonly prescribed topical antiulcer and antiallergic agent.224 Other 5H-
chromeno[2,3-b]pyridin-5-ones (1-azaxanthones) have been reported to show antiallergic,225 
anti-tumor,226, 227 anticancer228, 229 and acetylcholinesterase inhibitor230 activities. Moreover, 1-
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azaxanthones have been designed and developed as novel fluorescent231, 232 and optical probes,233, 
234
 as well as effective sensitizers for terbium and europium luminescence.235-238 In addition, 
other pyridine derivatives 3-salicyloylpyridines also exhibit interesting biological activities239-242 
and are effective ultraviolet absorbers.243-246 
 
 
Figure 4.2 Biologically active chromenopyridines. 
 
In a view of unique biological properties of pyridines, the development of new synthetic 
approaches for their preparation is of much interest for organic chemists.247 One of the 
convenient and efficient methods for the synthesis of fused pyridine derivatives is based on the 
cyclization reactions of enamine-like substrates (N-source) as 1,3-C,N-binucleophiles with 
different bielectrophiles.248-251 In this context, chromones can be proposed as 1,3-C,C-
bielectrophiles. In the last decades, Langer et al.,26, 27, 29-31 Sosnovskikh et al.33, 57, 58, 63 and other 
groups39, 252 have studied the cyclization reactions of different 3-substituted chromones, 
especially 3-acylchromones, with enamine-like binucleophiles (electron-excessive 
aminoheterocyles and anilines). This methodology was successfully applied for the synthesis of 
various fused pyridine derivatives. Besides, 3-substituted chromones are also known as building 
blocks for the synthesis of chromeno[2,3-b]pyridines. As mentioned in the introduction of 
Chapter 3, 5H-chromeno[2,3-b]pyridine derivatives were synthesized by reactions of 3-
cyanochromones with dialkyl 1,3-acetonedicarboxylates (Scheme 3.1).166, 167 Moreover, different 
three-component reactions using 3-formylchromones and amines resulted in the synthesis of 
chromeno[2,3-b]pyridines.253, 254  
Heterocyclic ketene aminals (HKAs) are polyfunctional molecules containing three 
nucleophilic centres (C-2 carbon and two nitrogen atoms), which can react with various 
electrophilic agents. HKAs can also be considered as highly active enamines. For these reasons, 
HKAs are widely used in efficient domino and multi-component255, 256 reactions for the synthesis 
of various fused heterocyclic systems containing, for instance, indoles,257 quinolines, 
naphthyridines,258 1,2,3-triazoles, coumarins,259 pyridines and pyrimidines.260 In most these 
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cases, HKAs react as 1,3-C,N-binucleophiles. The double bond of HKAs is highly polarized due 
to the presence of two electron-donating amino groups and the electron-withdrawing carbonyl 
group. For this reason, the C-2 carbon atom is the most nucleophilic centre. Therefore, the first 
electrophilic attack is usually directed to the C-2 carbon atom. It is also interesting to note that 
many reactions of HKAs are catalyst-free261 or/and solvent-free representing green chemistry. 
However, the reactions of HKAs with chromone-related compounds have not received much 
attention so far. In fact, only a few articles related to the reactions of coumarins and 
naphthoquinones with HKAs have been reported (Scheme 4.1).257, 262, 263 Thereby, different fused 
pyridine derivatives were synthesized (structures I, II, IV). Recently, the reaction of 3-
formylchromone with HKAs was described to form very attractive tetracyclic fused 
chromenopyridine derivatives (structure IV), which are structurally similar to some natural 
alkaloids, particularly, circumdatin D and E.264 It is necessary to mention that this reaction 
proceeded under base-free conditions. 
 
 
Scheme 4.1 Reactions of HKAs with chromone-related compounds and naphthoquinones. 
Reaction conditions: (a) Et3N, EtOH, 20 ºC; (b) EtOH, 20 ºC; (c) Et3N, 120 ºC; (d) DCM, reflux. 
 
Being inspired by the biological importance of fused pyridine derivatives and the great 
chemical potential of HKAs for the synthesis of nitrogen heterocycles, and continuing the 
research program dedicated to the study of reactivity of 3-acylchromones, I was interested to 
investigate the reactions of 3-acylchromones 4-8 with HKAs in a role of 1,3-C,N-binucleophiles. 
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4.2 Results and discussions  
 
4.2.1 Reactions of 3-methoxalyl-, 3-aroyl- and 3-cinnamoylchromones with HKAs 
 
HKAs 24 containing five- or six-membered heterocyclic rings were prepared in 
collaboration with group colleagues265 according to reported literature procedures. At first, a-
oxoketene dithioacetals were synthesized starting from corresponding aryl ketones by reaction 
with carbon bisulphide in the presence of potassium tert-butoxide followed by alkylation with 
methyliodide.266 In the second step, obtained a-oxoketene dithioacetals were used in the 
reactions with diamines to give the corresponding HKAs 24.267, 268 
The investigation of reactivity of different 3-acylchromones 4-8 towards HKAs was 
started by the study of the reactions of 3-methoxalylchromones 4 (R2 = COOCH3). The test 
reactions of 3-methoxalylchromone 4a were performed with HKA 24a (n = 1) and 24b (n = 2) in 
1,4-dioxane at room temperature (Scheme 4.2, Table 4.1). The reactions were carried out 
approximately two days. As a result, tetracyclic fused chromenopyridine derivatives 25a and 25d 
were obtained with an excellent regioselectivity in yields of 71% and 91%, respectively.  
 
 
Scheme 4.2 Synthesis of compounds 25. 
Reaction conditions: (i) 4 (1.0 equiv.), 24 (1.1 equiv.), 1,4-dioxane, 20 ºC.  
 
In an effort to decrease the reaction time, reactions of 3-methoxalylchromone 4a with 
HKA 24a (n = 1) and 24b were carried out in 1,4-dioxane at reflux, as well as in solvent with 
higher polarity, namely DCM, at room temperature. Both procedures resulted in an acceleration 
of the reactions, full conversion of the starting materials took about 3-4 h. However, more side-
products were detected by TLC and the regioselectivity of the reaction decreased. In the reaction 
proceeded in the presence of DBU (1.3 equiv.), in 1,4-dioxane at room temperature, 
chromenopyridine derivatives were not observed by TLC. In contrast, another product was 
detected. Most probably, it was a salicyloyl derivative with remained open γ-pyrone ring of the 
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chromone moiety, without additional cyclization into chromenopyridine derivative. Based on the 
performed experiments, mild reaction conditions, specifically stirring in 1,4-dioxane at room 
temperature, was preferred to use for the further investigations. Noteworthy, the reactions of 3-
formylchromones with HKAs, which proceeded to the formation of chromenopyridine 
derivatives, showed the best results without the use of any additives.264 
 
Table 4.1 Synthesis of compounds 25. 
3-Methoxalylchromone HKA Product 
4 R1 R2 24 n R3 25 Yield, a % 
a H COOCH3 a 1 Ph a 71 
c 7-OCH3 COOCH3 a 1 Ph b 72 
g 7,8-benzo
 
COOCH3 a 1 Ph c 77 
a H COOCH3 b 2 Ph d 91 
c 7-OCH3 COOCH3 b 2 Ph e 88 
d 6-Cl COOCH3 b 2 Ph f 77 
g 7,8-benzo COOCH3 b 2 Ph g 94 
a
 Yields of isolated products. 
 
The preparative scope was next studied. Products 25 were obtained with an excellent 
regioselectivity and in very good yields of 72-94% (Table 4.1). In general, the yields of 
compounds 25d-g containing a six-membered heterocyclic ring derived from the HKA were 
slightly higher than the yields of compounds 25a-c with a five-membered heterocyclic ring. The 
difference might be explained by the slight influence of the steric effect of the heterocyclic ring 
of the HKAs. The highest yield (94%) was obtained for product 25g containing a benzo-
substituent in the case of reaction of HKA 24b (n = 2). In addition, it is worth mentioning that 
the obtained tetracyclic fused chromenopyridine derivatives 25 showed intensive fluorescence 
properties observed under the UV-light. 
Following the initial successful results, as a next goal, a set of other 3-acylchromones, 
such as 3-aroylchromones 6 and 3-cinnamoylchromone 7, were studied. A test reaction of 3-
benzoylchromone 6a with HKA 24a using proposed reaction conditions afforded the expected 
chromenopyridine derivative 26a, albeit, only in 14% yield (Scheme 4.3, Table 4.2). 
Surprisingly, 2H,3H-imidazo[1,2-a]pyridine 27a was isolated as a major product in 76% yield. 
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Gratifyingly, because of the different physical properties of products 26a and 27a, they could be 
easily separated. Thus, because of low solubility of compound 27a in 1,4-dioxane, this product 
was isolated by simple filtration of the precipitate formed in the reaction mixture. Afterwards, 
product 26a was isolated from the filtrate using column chromatography (ethyl acetate-heptane). 
Accordingly, non-polar solvent (1,4-dioxane) was very useful to perform this reaction. 
 
 
Scheme 4.3 Synthesis of compounds 26 and 27. 
Reaction conditions: (i) 6 or 7 (1.0 equiv.), 24 (1.1 equiv.), 1,4-dioxane, 20 ºC.  
  
For a deeper understanding of the reaction course, the preparative scope was next studied 
(Scheme 4.3, Table 4.2). It was found that reactions of 3-acylchromones 6 and 3-
cinnamoylchromone 7 with HKA 24a (n = 1) delivered 2H,3H-imidazo[1,2-a]pyridine 
derivatives 27a-f, h in moderate to excellent yields (51-96%). In contrast, reactions of the same 
chromones with HKA 24b or 24c (n = 2) resulted in the formation of chromenopyridine 
derivatives 26d-n with an excellent regioselectivity and in very good yields (60-98%).  
Thereby, obtained results show the huge influence of the size of the heterocyclic moiety 
of HKAs 24 on the course of the reaction and the structures of formed products. At the same 
time, talking about 3-acylchromones 6 and 7, their substituent (R2 = Aryl or cinnamoyl) in 3-
position seems not to have a significant influence on the structure of obtained products. An 
exception from this trend was observed only in the reaction of 3-(2-nitrobenzoyl)chromone 6d 
resulting in the formation of 2H,3H,4H-pyrido[1,2-a]pyrimidine 27g in 92% yield, because of a 
steric effect of the NO2-group in ortho-position. This fact corresponds to the results obtained 
during the study of the reactions of 3-(2-nitrobenzoyl)chromones with dimethyl 1,3-
acetonedicarboxylate 12 described in Chapter 3 (Scheme 3.4, Table 3.3). It should be noted that 
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a steric influence of the substituent in ortho-position of the aroyl moiety was observed only for 
the NO2-group, while the fluorine atom of 3-(2-fluorobenzoyl)chromone 6b did not show such 
an effect, obviously, because of its small size. In addition, the electron-withdrawing character of 
the NO2-group of chromones 6h and 6i also had an influence on the product distribution. This 
was observed during the synthesis of 2H,3H-imidazo[1,2-a]pyridines 27e and 27f, where by-
products 26b and 26c could be isolated in 42% and 32% yields, respectively. 
 
Table 4.2 Synthesis of compounds 26 and 27. 
3-Aroylchromone HKA Product (pathway I) Product (pathway II) 
6 R1 R2 = Ar 24 n R3 26 Yield, a % 27 Yield, a % 
a H Ph a 
1 
Ph a 14 a 76 
b H 2-FC6H4 a Ph __ __ b 96 
c H 2-C4H3S a Ph __ __ c 62 
d H 2-NO2C6H4 a Ph __ __ d 78 
h 6-CH3 3-NO2C6H4 a Ph b 42 e 54 
i H
 
4-NO2C6H4 a Ph c 32 f 51 
a H Ph b  
 
 
 
 
2 
Ph d 91 __ __ 
a H Ph c 4-ClC6H4 e 98 __ __ 
b H 2-FC6H4 b Ph f 92 __ __ 
c H 2-C4H3S b Ph g 63 __ __ 
d H 2-NO2C6H4 b Ph __ __ g 92 
g H
 
3-NO2C6H4 b Ph h 75 __ __ 
g H 3-NO2C6H4 c 4-ClC6H4 i 60 __ __ 
i H
 
4-NO2C6H4 b Ph j 70 __ __ 
i H 4-NO2C6H4 c 4-ClC6H4 k 62 __ __ 
j H 3,5-(NO2)2C6H3 b Ph l 88 __ __ 
7 H 
 
a 1 Ph __ __ h 65 
7 H 
 
b 2 
2 
Ph m 84 __ __ 
7 H 
 
c 4-ClC6H4 n 87 __ __ 
a
 Yields of isolated products. 
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In summary, by means of the steric effect of the heterocyclic moiety of HKAs 24, the 
course of the reactions of 3-aroylchromones 6 and 3-cinnamoylchromone 7 and the structure of 
obtained products can be controlled. It is necessary to emphasise that 3-formylchromones in the 
reactions with HKAs proceeded only to the formation of chromenopyridine derivatives; 2H,3H-
imidazo[1,2-a]pyridine derivatives were not obtained.264 In addition, obtained tetracyclic fused 
chromenopyridine derivatives 26 showed intensive fluorescence properties under the UV-light. 
 
 
4.2.2 Reactions of 3-polyhaloacylchromones with HKAs 
 
To further explore the potential of proposed methodology, the reactions of 3-
perfluoroacylchromones 5 with HKAs 24 were studied. Obtained results are presented in the 
Schemes 4.4 and 4.5, Tables 4.3 and 4.4.  
At first, 3-trifluoroacetylchromones were investigated. Unexpectedly, the reactions of 3-
trifluoroacetylchromones 5 with HKA 24a (n = 1) afforded mixtures of 2-salicyloylpyridines 28 
and coumarin derivatives 29 in 34-61% and 29-46% yields, respectively (Schemes 4.4, Tables 
4.3).  
 
 
Scheme 4.4 Synthesis of compounds 28 and 29 starting from 3-trifluoroacetylchromones 5. 
Reaction conditions: (i) 5 (1.0 equiv.), 24 (1.1 equiv.), 1,4-dioxane, 20 ºC.  
 
Compounds 28 and 29 were separated by column chromatography using ethyl acetate-
heptane for the isolation of products 28 and methanol for the elution of coumarins 29. However, 
in case of the reaction of chromone 5c, only product 28c could be isolated, because of the 
formation of a number of other by-products in small amounts. Nonetheless, during the synthesis 
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of compounds 28d and 29c, by-product (chromenopyridine derivative 26o) was isolated in 18% 
yield. Noteworthy, in the case of formation of coumarin derivatives 29 the intermediate semi-
ketal form containing OH- and CF3-groups was not stable (Scheme 1.4, Scheme 3.3). Therefore, 
the reactions proceeded with elimination of the CF3-group as a leaving group.  
At the same time, reactions of the same 3-trifluoroacetylchromones 5 with HKAs 24b (n 
= 2) delivered functionalized 2-salicyloylpyridine derivatives 28e-h with an excellent 
regioselectivity and in very good yields (78-95%). Obtained results again display the significant 
steric influence of the heterocyclic moiety of HKAs 24 on the product distribution. 
 
Table 4.3 Synthesis of compounds 28 and 29 starting from 3-trifluoroacetylchromones 5. 
a
 Yields of isolated products. 
*
 Сompound 26o was isolated in 18% yield (structure see below). 
 
 
As the second step, 3-heptafluorobutanoylchromones were studied. Coumarin derivatives 
29a and 29c were obtained by the reactions of 3-heptafluorobutanoylchromones 5q and 5w with 
HKA 24a (n = 1) with excellent regioselectivity, in yields of 84 and 91%, respectively (Scheme 
4.5, Table 4.4). This finding shows the influence of the electronic and steric effects of the 
perfluoroalkyl-group on the regioselectivity of the reaction and the product distribution. It is 
worth mentioning that during the attempt to prepare compounds 29a and 29c at first mixtures of 
the fluorinated semi-ketal and product 29 were observed by NMR. The products were not 
possible to separate, because of the unstable nature of the fluorinated product. For this reason, 
5 R1 24 n 28 Yield,a % 29 Yield,a % 
a H 
a 1 
a 47 a 46 
b 7-OCH3 b 61 b 31 
c 6-Cl c 48 __ __ 
e 7,8-benzo d 34* c 29 
a H 
b 2 
e 88 __ __ 
b 7-OCH3 f 72 __ __ 
c 6-Cl g 95 __ __ 
e 7,8-benzo h 78 __ __ 
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the reactions were carried out at reflux until full conversion of the fluorinated semi-ketals into 
coumarin derivatives 29.  
As could be expected, similar to the reactions of 3-trifluoroacetylchromones, reactions of 
3-heptafluorobutanoylchromones 5 with HKAs 24b and 24c (n = 2) afforded 2-
salicyloylpyridine-related derivatives 30 in good yields of 60-76% (Scheme 4.5, Table 4.4). 
However, the reactions also involved elimination of the heptafluoropropyl-group. A small 
amount of fluorinated 2-salicyloylpyridine derivatives could be detected on the TLC. In addition, 
it should be mentioned that all described reactions of 3-perfluoroacylchromones 5 with HKAs 24 
continued approximately 10-12 h. 
 
 
Scheme 4.5 Synthesis of compounds 29 and 30 using 3-heptafluorobutanoylchromones 5. 
Reaction conditions: (i) 5 (1.0 equiv.), 24 (1.1 equiv.), 1,4-dioxane, reflux; (ii) 5 (1.0 equiv.),  
24 (1.1 equiv.), 1,4-dioxane, 20 ºC. 
 
Table 4.4 Synthesis of compounds 29 and 30 using 3-heptafluorobutanoylchromones 5. 
a
 Yields of isolated products. 
 
5 R1 24 n R3 30 Yield,a % 29 Yield,a % 
q H a 
a 
1 
Ph __ __ a 91 
w 7,8-benzo Ph __ __ c 84 
r 6-CH3 b 
c 
b 
b 
2 
Ph a 76 __ __ 
t 6-Cl 4-ClC6H4 b 60 __ __ 
v 6-Br Ph c 76 __ __ 
w 7,8-benzo Ph d 70 __ __ 
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Unfortunately, the use of 3-pentafluoropropanoylchromones in the reactions with HKAs 
was unsuccessful, because of the formation of inseparable mixture of products. Most probably, it 
was a mixture of fluorinated and non-fluorinated 2-salicyloylpyridine and coumarin derivatives. 
Additionally, the reactions of 3-(2,2-dichloroacetyl)chromone 8 with HKAs 24 were 
carried out using the described protocol (Scheme 4.6). The treatment of chromone 8 with HKA 
24a (n = 1) proceeded to the formation of tetracyclic chromenopyridine derivative 26p in 41% 
yield, while the reaction of the same chromone with HKA 24b (n = 2) delivered 2-
salicyloylpyridine derivative 28i in 50% yield. The reaction times were about 10-12 h. 
Noteworthy, in both cases the reaction proceeded via the 2,2-dichloroacetyl carbonyl fragment 
by the second nucleophilic attack. Nonetheless, product 26p was formed via an additional 
intramolecular cyclization involving the phenolic OH-group and semi-ketal centre. The moderate 
yields can be explained by the formation of a number of by-products detected by TLC. 
Unfortunately, these by-products could not be isolated. 
 
 
Scheme 4.6 Reaction of 3-(2,2-dichloroacetyl)chromone 8 with HKAs 24. 
Reaction conditions: (i) 8 (1.0 equiv.), 24 (1.1 equiv.), 1,4-dioxane, 20 ºC.  
 
 
4.2.3 Proposed reaction mechanism 
 
The proposed mechanism of the domino reactions of 3-acylchromones 4-8 with 1,3-C,N-
binucleophile, namely HKAs 24, is outlined in the Scheme 4.7.  
Based on the chemical behaviour of 3-acylchromones in the reactions with 1,3-
binucleophiles described in Chapter 1 and Chapter 3, it was suggested that all studied reactions 
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of chromones 4-8 with HKAs 24 have started by nucleophilic 1,4-addition, directed to the С-2 
atom of the chromone. As usual, the HKAs acted first as C-nucleophile via the most nucleophilic 
C-2 carbon atom. Afterwards, opening of the γ-pyrone ring proceeded to the formation of β-
dicarbonyl intermediate A, which is capable to different intramolecular cyclizations. The second 
nucleophilic attack of HKAs 24 (amino-group) could be directed to the acyl carbonyl group 
COR2 (pathway I) or to the carbonyl group of salicyloyl moiety (pathway II).  
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H
HN NH
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+
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R1
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O
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H
i
N
H
HN
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27: R2 = Ar, n = 1;
R1
n
N
N
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O
OO 29
R1
2
2
RF = C3F7
-CF3H
or -C3F7H
 
Scheme 4.7 Proposed reaction mechanism for the formation of compounds 25-30. 
Reaction conditions: (i) 4-8 (1.0 equiv.), 24 (1.1 equiv.), 1,4-dioxane. 
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In this way, 2-salicyloylpyridine derivatives 28 (R2 = CF3, n = 1, 2; R2 = CHCl2, n = 2) 
and 30 (R2 = C3F7), as well as chromenopyridine derivatives 25 (R2 = COOCH3) and 26 (R2 = 
Aryl, n = 2; R2 = CHCl2, n = 1), were formed via pathway I. It is necessary to note that, in case 
of the synthesis of chromenopyridine derivatives 25 and 26, an additional cyclization involving 
the phenolic OH-group and semi-ketal centre, followed by fission of a water molecule, took 
place. 2-Pyridone-related derivatives 30 were obtained starting from 3-
heptafluorobutanoylchromones 5 and HKAs 24b, c (n = 2) including elimination of the 
heptafluoropropyl-moiety as a leaving group in the last step of the reaction.  
Compounds 27 (R2 = Aryl, n = 1) and fused coumarin derivatives 29 (R2 = CF3, C3F7, n = 
1) were formed via pathway II. Synthesis of compounds 29 included additional cyclization of the 
phenolic OH-group with acyl group CORF eliminating the perfluoroalky-group, resulting in the 
formation of the fused coumarin core. 
In summary, reactions of different 3-acylchromones 4-8 with HKAs 24 led to the 
formation of various types of products 25-30 due to the electronic and steric effects of the 
substituent in 3-position of the 3-acylchromones and the ring size of the heterocyclic moiety of 
the HKAs. The last factor played the most significant role. The intramolecular cyclization of β-
dicarbonyl intermediate A is the most important step determining the structure of formed 
products. 
 
 
4.2.4 Structure identification 
 
All structures of synthesized compounds 25-30 were confirmed by spectroscopic 
methods, specifically NMR, IR and mass spectrometry, as well as X-ray crystal analysis. The 
characteristic signals observed from NMR spectra of compounds 25-30 are shown in Table 4.5.  
All obtained compounds 25-30 contain an alkyl-chain of heterocyclic moiety derived 
from the HKAs ( N-CH2-(CH2)n-N ). The alkyl-chain appeared as multiplets (or bright 
singlets) of four hydrogen atoms (2ˣNCH2) in the range of δ ≈ 3.2-4.3 ppm of 1H-NMR spectra 
and two singlets of carbon atoms (2ˣNCH2) at δ ≈ 40-44 ppm in the 13C-NMR spectra. In case of 
the alkyl chain derived from the HKAs containing a six-membered heterocyclic ring (n = 2), 
signals of additional -CH2-group were detected: two multiplets of two hydrogen atoms at δ ≈ 2.0 
ppm and one signal of carbon atom at δ ≈ 19 ppm in the 1H- and 19C-NMR spectra, respectively. 
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Observed multiplets of hydrogen atoms of alkyl-chain showed their non-equivalence. In 
addition, in most cases, typical singlet of the hydrogen atom of pyridine-related ring of 
synthesized compounds 25-30 could be seen at δ ≈ 8 ppm in the 1H-NMR spectra.  
 
Table 4.5 Observation from NMR analyses for compounds 25-30. 
Compound Structure Characteristic signals in NMR-spectra 
25  
or 
26 
 
1H NMR:  
NH: if n = 1: s, δ ≈ 9.6 ppm;  
        if n = 2: s, δ = 11.5-12.5 ppm; 
H (pyridine-related ring): s, δ ≈ 7.8 ppm; 
OCH3: s, δ = 3.5-4.0 ppm, in the case of 25; 
13С NMR:  
С=O: s, δ = 189-193 ppm; 
C: s, δ = 90-94 ppm; 
C*: s, δ = 90-94 ppm; 
OCH3: s, δ ≈ 54.0 ppm, in the case of 25; 
27 
 
1H NMR:  
OH: s, δ ≈ 10.3 ppm;  
H (pyridine-related ring): s, δ ≈ 7.7 ppm; 
13С NMR:  
2 C=O: s, δ = 188-195 ppm; 
28 
 
1H NMR:  
2OH and NH: if n=1: s, δ = 8.78-10.76 ppm, 
                        if n=2: s, δ = 9.72-11.46 ppm; 
H (pyridine-related ring): s, δ ≈ 7.3 ppm; 
13С NMR:  
2 C=O: s, δ = 188-197 ppm; 
C*: q, δ ≈ 84 ppm (2JC,F ~ 32.5 Hz); 
CF3: q, δ ≈ 125 ppm (1JC,F ~ 296.0 Hz); 
19F NMR: CF3: s, δ ≈ -83 ppm;  
29 
 
1H NMR:  
H (pyridine-related ring): s, δ ≈ 7.6 ppm;  
13С NMR:  
С=O: s, δ ≈ 191 ppm; 
30 
 
1H NMR:  
OH and NH: s, δ = 10.2-13.5 ppm; 
H (pyridine-related ring): s, δ ≈ 7.9 ppm; 
13С NMR:  
2 C=O: s, δ = 190-197 ppm; 
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In the low field of 1H-NMR spectra of chromenopyridine derivatives 25 and 26 in 
DMSO-d6, the NH-group appeared as a singlet at δ ≈ 9.6 ppm (if n = 1) and δ = 11.5-12.5 ppm 
(if n = 2). In the low field of 13C-NMR spectra, the carbonyl group COR3 gave a signal at δ = 
189-193 ppm. Besides, two typical signals were found at δ = 90-94 ppm, related to the chiral 
carbon atom and the carbon atom attached to the COR3-group (proved by 2D NMR).  
Similar to compounds 25 and 26, in the low field of 1H-NMR spectra of 2H,3H-
imidazo[1,2-a]pyridine derivatives 27 in DMSO-d6, one singlet (OH-group) was observed at δ ≈ 
10.3 ppm. At the same time, in contrast to compounds 25 and 26, in the 13C-NMR spectra of 
products 27, two signals stemming from two carbonyl groups were detected at δ = 188-195 ppm 
and no signals were found in the range of δ = 90-94 ppm. Therefore, compounds 26 and 27, 
which were formed in the reactions of 3-aroyl- and 3-cinnamoylchromones, could be 
distinguished by the 13C-NMR spectra. 
In the low field of 1H-NMR spectra of compounds 28, three characteristic proton signals 
of two OH- and one NH-groups appeared as a singlets at δ = 8.78-10.76 ppm (if n = 1) and δ = 
9.72-11.46 ppm (if n = 2), showing that the γ-pyrone ring of the chromone moiety is opened. In 
the low field of 13C-NMR spectra, two signals of two carbonyl groups were observed at δ = 188-
197 ppm. The presence of CF3-group in the structures of compounds 28 was confirmed by 13C-
NMR analysis, which showed typical quartets at δ ≈ 84 ppm (chiral carbon atom) and δ ≈ 125 
ppm (CF3), and by 19F-NMR spectra, where the CF3-group appeared as a singlet at δ ≈ -83 ppm.  
In contrast to products 27, for compounds 29 the absence of any signals in the low field 
of 1H-NMR spectra was typical, indicating that the phenolic OH-group of opened γ-pyrone ring 
was involved in intramolecular cyclization. In the low field of 13C-NMR spectra, one carbonyl 
group (COR3) was detected at δ ≈ 191 ppm, indicating that formed salicyloyl carbonyl group of 
opened γ-pyrone ring and carbonyl carbon atom COR2 were involved in the interaction during 
the reaction. 
In contrast to compounds 28, in the low field of the 1H-NMR spectra of products 30, only 
two signals belonging to the OH- and NH-groups were observed at δ = 10.2-13.5 ppm. This 
confirms the elimination of the perfluoroalkyl-group and the conversion of the OH-group into a 
keto-group. In the 13C-NMR spectra, two carbonyl groups appeared at δ = 190-197 ppm. 
Compounds 29 and 30, which synthesis proceeded involving the elimination of the 
perfluoroalkyl-group, did not show any signals in the 13C- and 19F-NMR spectra, which could 
indicate the presence of fluorine atoms in these molecules. The fluorine atom in the aryl moiety 
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of compounds 26k and 27e appeared in the 19F-NMR spectra as a singlet at δ ≈ -114.16 and -
114.40 ppm, respectively. In the 13C-NMR spectra of these products, the corresponding doublets 
of the carbon atoms of the aromatic ring containing a fluorine atom were detected. 
For an additional examining of the obtained structures, HMBC NMR analyses were 
performed for compounds 26b and 30b. The most important correlations are shown in Figure 
4.3. In the HMBC spectrum of compound 26b the cross-peaks between the carbonyl group 
(δ = 177.0 ppm) and the aromatic hydrogen atoms (δ = 7.19-7.39 ppm) of chromone moiety 
could be detected through 3 and 4 bonds. Besides, correlations between the hydrogen atom of the 
formed pyridine-related ring (δ = 7.82 ppm) and two neighbouring carbonyl groups (δ = 177.0 
and 189.6 ppm), the chiral carbon atom (δ = 90.5 ppm) and the carbon atom attached to COPh 
(δ = 91.2 ppm) were observed.  
 
                        
Figure 4.3 Observations from 2D HMBC analyses for compounds 26b and 30b. 
 
The HMBC spectrum of 30b displayed cross-peaks between the salicyloyl carbonyl 
carbon atom (δ = 190.7 ppm) and the hydrogen atoms: C3'-H, C6'-H (δ = 6.82-7.29 ppm) and 
C8-H (δ = 7.88 ppm), as well as correlations between another carbonyl group (δ = 192.1 ppm) 
attached to the carbon atom C9 and the hydrogen atoms of 4-chlorophenylene moiety (δ = 7.45-
7.61 ppm) and C8-H (Figure 4.3). 
The structures of compounds 25f, 26g, m, n, o, p, 27b, e, g, 28e, 29b, 30b and 31 were 
unambiguously established by X-ray single crystal analysis (Table. 4.6).  
With the aid of the X-ray crystal analysis for chromenopyridine-related derivatives 25f 
and  26g, m, n, o, p, the presence of intermolecular hydrogen bonds between the NH-group and 
the neighbouring carbonyl group C=O was confirmed (if n = 1, ≈ 2.2 Å; if n = 2, 1.8-1.9 Å). 
Likewise, the X-ray analyses of compounds 28e and 30b indicated the hydrogen bonds between 
OH- and NH-groups and the neighbouring carbonyl groups C=O as distances of 1.7-1.9 Å. In the 
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cases of compounds 27e and 27g, weak hydrogen bonds with molecules of solvents could be 
indicated by X-ray structure analysis. The distances are 2.7 and 2.1 Å long, respectively. 
Expectedly, the structures of the fused chromenopyridine derivatives 25f and 26g, m, n, 
o, p and the pyridopyrimidine-related system of compound 28e are not planar, because of the 
presence of a quaternary carbon atom (chiral centre), which configuration is near to tetrahedral 
(the values of angles lie within 106-113º). In contrast, the heterocyclic core of the 2H,3H-
imidazo[1,2-a]pyridine moiety of compounds 27b, e, g and fused coumarin system of compound 
29b is near to planar. Interestingly, in the cases of compounds 27b and 27e, the phenolic ring 
and the phenylene moiety of the aroyl-group (COR3) approximate to be parallel to each other. 
Noteworthy, the alkyl chain of the six-membered heterocyclic ring derived from the HKAs is in 
a half-chair conformation in all crystal structures. The analyzed crystals of chiral compounds 
25f, 26g, m, n, o, p and 28e consisted of a racemic mixture, in contrast to previously obtained 
6H-benzo[c]chromene 14o, which crystallized as one enantiomer (see Chapter 3). 
 
Table 4.6 Crystal structures of compounds 25f, 26g, m, n, o, p, 27b, d , h, 28e, 29b and 30b. 
Crystal structure Compound Structure 
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4.3 Conclusions 
 
The reactions of different 3-acylchromones, such as 3-methoxalyl-, 3-aroyl-, 3-cinnamoyl 
and 3-polyhaloacylchromones, with HKAs afforded a variety of different pyridine-related 
heterocycles. Electronic and steric effects of the acyl group of the 3-acylchromones and the ring 
size of the heterocyclic moiety of the HKAs play a great role in these reactions with regard to the 
product distribution.  
In this way, an efficient and convenient method was proposed for the synthesis of 
tetracyclic fused chromenopyridine derivatives via domino reactions of 3-methoxalylchromones 
with HKAs, as well as via domino reactions of 3-aroyl- and 3-cinnamoylchromones with HKAs 
containing six-membered heterocyclic ring. In contrast, functionalized 2H,3H-imidazo[1,2-
a]pyridine derivatives were synthesized with excellent regioselectivity by domino reactions of 3-
aroyl- and 3-cinnamoylchromones with five-membered HKAs. Fluoroalkylated 2-
salicyloylpyridine derivatives were delivered by reactions of 3-trifluoroacetylchromones with 
HKAs. 
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The synthesized pyridine-related heterocycles might exhibit useful biological properties. 
The investigation of biological activity of compounds 25, 26 and 27 is currently in progress. 
Furthermore, obtained chromenopyridine derivatives 25 and 26 might be of interest due to their 
promising fluorescence properties, which are now being studied. 
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Chapter 5 
 
Reactions of 3-halochromones with β-ketoamides and 1,3-dihydroindole-2-
thiones: Synthesis of functionalized 2-salicyloylfurans and 2-benzoyl-8H-
thieno-[2,3-b]indoles 
 
 
5.1 Introduction  
 
Five-membered heterocycles are immensely important organic compounds, which occur 
in an enormous number of natural products and demonstrate a wide range of biological 
activities.269-271 
Furans, specifically polysubstituted furans, are key structural units in a variety of natural 
products and pharmaceuticals.271-274 Among different substituted furans, 2-benzoylfurans have 
received much attention. For example, the natural product morachalcone C displays cytotoxic 
activity against HCT-8 and BGC823 human cancer cell lines.275 2-Benzoylfurans, such as 
benziodarone, benzbromarone and amiodarone, are clinically used nowadays (Figure 5.1). 
Benziodarone possesses vasodilation activity,276 while benzbromarone is a uricosuric agent used 
in the treatment of gout, because of its xanthine oxidase inhibitor activity.277 Amiodarone is 
applied as an antiarrhythmic agent.278 Besides, another benzoylfuran, furidarone, is a coronary 
vasodilator.279, 280 In addition, benzofuran befunolol exhibits antiglaucoma activity.17 
 
 
Figure 5.1 Pharmacologically relevant furan and 2-benzoylfuran derivatives. 
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At the same time, the indole ring system is one of the most important privileged scaffolds 
in medicinal chemistry.17 Indoles fused to a sulfur containing ring systems281-283 have attracted 
considerable attention due to their presence in natural products, for instance, thienodolin,284, 285 
brassilexin286-290 and sinalexin286, 291 (Figure 5.2). Furthermore, synthetic thienoindoles exhibit 
antifungal,284, 288 anticancer292, 293 activities and are used in the treatment of different 
neurological diseases.294 In addition, thienoindoles are used in organic electronics as 
electroluminescence materials295, 296 and conducting polymers.297, 298 
 
 
Figure 5.2 Pharmacologically relevant indoles fused with sulfur-containing heterocycles. 
 
A number of approaches for the synthesis of furan derivatives,299-301 as well as thieno[2,3-
b]indole derivatives,302-310 are reported. However, most of these methods suffer from some 
drawbacks and are limited in scope and generality. Therefore, flexible and efficient general 
methods for the preparation of new multiply substituted furan and thieno[2,3-b]indole 
derivatives are still desirable. 
As already mentioned in Chapter 1, 3-halochromones are other representatives of 3-
substituted chromones, which are well-proven bielectrophiles for the synthesis of different five-
membered heterocycles (Scheme 1.6). In this context, it was proposed to consider 3-
halochromones as potential building blocks for the synthesis of new furan and thiophene-related 
molecules. A few works related to the synthesis of these derivatives starting from 3-
halochromones were already reported.11, 73, 311-313 
1,3-Dicarbonyl compounds are exceptional synthetic platforms widely used in domino 
and multicomponent reactions.314 3-Halochromones, especially 3-bromochromone, have also 
attracted attention in the reactions with 1,3-dicarbonyl compounds (Scheme 5.1). Thus, 3-
bromochromone reacted with various β-diketones and β-ketoesters giving highly functionalized 
furans (structure I).11, 315 Nevertheless, the addition of diethyl malonate to 3-bromochromone 
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afforded the 3-substituted chromone (structure II).316 At the same time, the reaction of 3-
iodochromone with dimethyl malonate gave unexpected 2,3-methanochromanone containing a 
cyclopropyl ring (structure III).76 Additionally, the reaction of 3-bromochromone with 
tricarbonyl compounds, specifically dimethyl 1,3-acetonedicarboxylate, was also reported and 
proceeded to the formation of furan derivative containing cyclopropyl ring (structure IV), due to 
the additional interaction with a second molecule of chromone.165 Interestingly, in this case the 
carbonyl group (C=O) of dimethyl 1,3-acetonedicarboxylate was involved in the interaction, in 
contrast to the reactions with 3-acylchromones described in Chapter 3, where it played a role of a 
1,3-C,C-binucleophile. Predictably, all described reactions were carried out under basic reaction 
conditions for the activation of the methylene component of 1,3-dicarbonyl compounds. 
Noteworthy, similar to reactions of 3-acylchromones with active methylene compounds studied 
in this work and before (see Chapter 3), most of the mentioned above reactions of 3-
halochromones were performed using DBU as a base. 
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Scheme 5.1 Reactions of 3-halochromones with 1,3-dicarbonyl compounds. 
Reaction conditions: (a) DBU, MeCN, 20 ºC; (b) K2CO3, DMF, 20 ºC; (c) DBU, THF, 20 ºC;  
(d) DBU or DBN, CHCl3, 20 ºC; 
 
The structure of β-ketoamides compared to β-diketones contains an additional 
nucleophilic centre, namely the nitrogen atom of the amide group. These compounds are widely 
used substrates. They can react as C,O-,317-331 C,N-,332-338 N,O-,339 or O,O-binucleophiles340 in 
different cyclization reactions. By now, the use of β-ketoamides in the reactions with chromones 
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has not been reported. The investigation of the reactions of 3-halochromones with β-ketoamides 
is mechanistically very interesting, because of the presence of a multiplicity of reactive centres in 
the molecule of these nucleophiles, such as an active methylene component, two oxygen and one 
nitrogen atoms, which can react by electrophilic attack leading to the synthesis of highly 
functionalized furan, pyrrole or other derivatives . 
On the other hand, powerful 1,3-C,S-binucleophiles, like 1,3-dihydroindole-2-thiones, are 
widely used as building blocks in cyclization reactions with diverse bielectrophiles for the 
synthesis of various sulfur-containing heterocycles.341-347 Such reactions have also attracted 
attention in our group.348, 349 The interaction of α-halocarbonyl compounds, which are 
structurally similar to the 3-halochromones, with 1,3-dihydroindole-2-thione derivatives is 
reported and led to the synthesis of thieno[2,3-b]indoles.304 The reactions of 3-halochromones 
with S-nucleophiles are very rare. Only reactions of 3-iodochromones with 1-methyl-2-
sulfanylimidazole, 1,2,4-triazole derivatives, N,N′-dimethylthiourea and 2-mercapto-
benzimidazoles were reported.11, 73 
All these facts have inspired me to study the reactions of 3-halochromones with β-
ketoamides and 1,3-dihydroindole-2-thiones, which have not been studied previously. It is worth 
mentioning that there are only a few reports, which contain the comparison of the reactivity of 
different 3-halochromones towards binucleophiles.78-81 Another aspect of this part of my work 
was to study the influence of the type of halogen atom on the selectivity of the reactions of 3-
halochromones. This project was performed with help from Tim Gläsel during his work on 
bachelor thesis. 
 
 
5.2 Results and discussions 
 
5.2.1 Reactions of 3-halochromones with β-ketoamides 
 
The investigation was started with a study of reactions of 3-halochromones 9-11 with β-
ketoamides 31. It was suggested to perform a test reaction using the well-proven general 
procedure, described in Chapter 3 during the study of reactivity of 3-acylchromones towards 
active methylene compounds. The treatment of 3-bromochromone 10a with β-ketoamide 31a 
(1.1 eqiuv.) in the presence of DBU (1.3 equiv.) in 1,4-dioxane at room temperature proceeded 
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in the formation of 2-salicyloylfuran 32a with an excellent regioselectivity, in 87% yield 
(Scheme 5.2, Table 5.1). The reaction time was about 10-12 hours. Interestingly, in spite of the 
high nucleophilicity of a nitrogen atom of the amide group, 2-benzoylpyrrole 32′ was not 
observed. 
 
 
Scheme 5.2 Synthesis of compounds 32. 
Reaction conditions: (i) 9-11 (1.0 equiv.), 31 (1.1 equiv.), DBU (1.3 equiv.), 1,4-dioxane, 20 ºC. 
 
The preparative scope was next studied. The investigation has shown that the present 
protocol could be applicable to various types of β-ketoamides 31 providing a convenient route 
for the synthesis of a wide range of 2-salicyloylfurans 32 (Scheme 5.2, Table 5.1). 2-
Salicyloylfurans 32a-x were obtained in moderate to excellent yields (46-99%). Gratifyingly, 
most products could be isolated by simple filtration of the formed precipitate. Otherwise, 
recrystallization from heptane/isopropanol or column chromatography was used. In the case of 
the synthesis of compound 32o, a by-product, isomeric 2-benzoylfuran 33, could be isolated and 
identified. 
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Table 5.1 Synthesis of compounds 32. 
3-Halochromone X 31 32 R1 R2 R3 Yield,a % 
10a Br a a H Ph CH3 87 
10c Br a b 5-Cl, 4-CH3 Ph CH3 99 
11b Cl a c 4-OCH3 Ph CH3 98 
11c Cl a d 3,4-benzo
 
Ph CH3 53 
10a Br b e H 2,4-(CH3)2C6H3 CH3 93 
11b Cl b f 4-OCH3 2,4-(CH3)2C6H3 CH3 69 
11c Cl b g 3,4-benzo 2,4-(CH3)2C6H3 CH3 76 
11a Cl c h H 2-CH3C6H4 CH3 85 
10c Br c i 5-Cl, 4-CH3 2-CH3C6H4 CH3 99 
11b Cl c j 4-OCH3 2-CH3C6H4 CH3 98 
11c Cl c k 3,4-benzo 2-CH3C6H4 CH3 93 
9a I d l H 4-ClC6H4 CH3 46 
10b Br d m 5-CH3 4-ClC6H4 CH3 99 
10c Br d n 5-Cl, 4-CH3 4-ClC6H4 CH3 98 
11b Cl d o 4-OCH3 4-ClC6H4 CH3 47* 
9b I d p 3,4-benzo 4-ClC6H4 CH3 56 
11a Cl e q H H
 
OCH3 98 
10b Br e r 5-CH3 H OCH3 90 
11b Cl e s 4-OCH3 H OCH3 79 
11c Cl e t 3,4-benzo H
 
OCH3 88 
11a Cl f u H Ph Ph 81 
10c Br f v 5-Cl, 4-CH3 Ph Ph 72 
11b Cl f w 4-OCH3 Ph Ph 69 
11c Cl f x 3,4-benzo Ph Ph 70 
a
 Yields of isolated products.  
*
 Compound 33 was isolated in 7% yield (structure see below). 
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In addition, the influence of the halogen atom of the 3-halochromone 9-11 on the yields 
of compounds 32 was studied for each type of β-ketoamides 31 (see Table 5.2). Thus, 3-
chlorochromone 11a gave the best yields of products 32q and 32u, while 3-bromochromone 10a 
gave a little bit lower yields. Though, for the synthesis of compound 32a 3-bromochromone 10a 
showed to give the best yield (87%), slightly higher than 3-chlorochromone 11a (83%). The use 
of 3-iodochromone 9a resulted in a dramatic decrease of the yields (45-53%). Besides, the type 
of halogen had also an influence on the reaction time. The reactions of 3-chlorochromones 
proceeded approximately 3-4 h, while reactions of 3-bromo and 3-iodochromones required 10-12 
h to reach full conversion. In this way, it was shown that the yields of obtained 2-benzoylfurans 
32 strongly depend on the type of halogen substituent of the 3-halochromones 9-11. 3-Bromo- 
and 3-chlorochromones were the most effective for the synthesis of compounds 32. 
 
Table 5.2 The influence of the halogen atom of 3-halochromones on the obtained yields. 
3-Halochromone X β-Ketoamide Product Yield, %a 
9a I 31a 
32a 
53 
10a Br 31a 87 
11a Cl 31a 83 
9a I 31e 
32q 
49 
10a Br 31e 79 
11a Cl 31e 98 
9a I 31f 
32u 
45 
10a Br 31f 63 
11a Cl 31f 81 
a
 Yields of isolated products. 
 
 
5.2.2 Reactions of 3-halochromones with 1,3-dihydroindole-2-thiones 
 
The next goal in this investigation was to study the reactions of 3-halochromones 9-11 
with 1,3-dihydroindole-2-thiones 34 (Scheme 5.3, Table 5.3). In order to activate the 
binucleophiles, DBU and potassium carbonate were examined as bases. The reaction of 3-
chlorochromone 11a with 3H-indole-2-thione 34a, in the presence of DBU (1.3 equiv.) in 1,4-
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dioxane, afforded 2-{8H-thieno[2,3-b]indole-2-carbonyl}-phenol 35a in 57% yield (Method A). 
The same reaction using K2CO3 (4.0 equiv.) in DMF gave product 35a in an improved yield of 
74% (Method B). Further studies of the preparative scope showed that by the use of DBU more 
by-products were formed (detected by TLC) and the yields of obtained products 35 (35-60%) 
were lower than using a less strong base, like K2CO3 (56-78%), see Table 5.3. Both methods 
were carried out at room temperature for 3-4 hours (monitored by TLC). The products were 
isolated by column chromatography.  
 
 
Scheme 5.3 Synthesis of compounds 35.  
Reaction conditions: (i) 9-11 (1.0 equiv.), 34 (1.1 equiv.), DBU (1.3 equiv.), 1,4-dioxane, 
20 ºC (method A); K2CO3 (4.0 equiv.), DMF, 20 ºC (method B). 
 
Table 5.3 Synthesis of compounds 35. 
3-Halochromone X 34 35 R1 R2 Yield, a % 
11a Cl a a H H 57,b  74c 
9a I a a H H 30c 
11b Cl a b 5-OCH3 H 56c 
11c Cl a c 5,6-benzo H 78c 
10b Br b d 4-CH3 CH3 43b 
11b Cl b e 5-OCH3 CH3 46b 
11c Cl b f 5,6-benzo CH3 55b 
11a Cl c g H Ph 60b 
11b Cl c h 5-OCH3 Ph 35b 
11c Cl c i 5,6-benzo Ph 58b 
a
 Yields of isolated products. 
b
 Reaction was carried out using method A. 
c
 Reaction was carried out using method B. 
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Expectedly, 3-bromo and 3-chlorochromones showed the highest activity in reactions 
with 1,3-dihydroindole-2-thiones 34. The use of 3-iodochromone 9a instead of 3-
chlorochromone 11a employing method B dramatically decreased the yield of product 35a to 
only 30% (Table 5.3). This fact demonstrates the significant influence of the type of halogen 
atom in the 3-position of chromones 9-11 on the yields of obtained products. This finding 
corresponds to the results obtained in the reaction with β-ketoamides 31. 
 
 
5.2.3 Proposed reaction mechanism 
 
The proposed mechanism of the reactions of 3-halochromones 9-11 with β-ketoamides 31 
and 1,3-dihydroindole-2-thiones 34 is outlined in Scheme 5.4.  
In all described cases, 3-halochromones 9-11 reacted as 1,3-C,C-bielectrophiles. The first 
attack of binucleophiles 31 or 34 took place at the most electrophilic carbon atom at 2-position 
of 3-halochromones giving intermediate A (1,4-addition). The second nucleophilic attack of 
substrates 31 and 34 was directed to the halogen-substituted carbon atom. Further elimination of 
the halogen atom led to the formation of intermediates B and B′, respectively (Scheme 5.4). 
These intermediates underwent the cleavage of the carbon-oxygen bond to give new compounds 
32 and 35 containing five-membered heterocyclic ring (see pathway I, Scheme 1.6, Chapter 1). It 
should be noted that products containing a six-membered ring, formed via a second attack of the 
nucleophile directed to the carbonyl group of the chromone moiety, were not observed (pathway 
II, Scheme 1.6, Chapter 1). 
Regarding binucleophiles, in the first step, β-ketoamides 31 and 1,3-dihydroindole-2-
thiones 34 reacted as C-nucleophiles via their methylene component activated by base. At the 
second electrophilic attack, two oxygen and nitrogen atoms of β-ketoamides 31 could be exposed 
providing several possible isomers, specifically 2-benzoylfurans 32 and 33, as well as 2-
benzoylpyrroles 32′ mentioned above. Obviously, the amide oxygen atom is more nucleophilic 
than the other oxygen. It could be expected that the second electrophilic attack would be directed 
to the most nucleophilic centre, the amide nitrogen atom. Nonetheless, it was mechanistically 
interesting to discover that the cyclizations proceeded via the amide oxygen atom of β-
ketoamides 31 giving 2-benzoylfurans 32. Isomeric 2-benzoylpyrroles 32′ were not detected, 
while isomeric 2-benzoylfuran 33 was isolated in a small amount as a by-product. As for 
nucleophiles 34, the cyclization via the nitrogen atom by the second electrophilic attack was not 
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possible due to a steric hindrance. Therefore, the subsequent attack was directed to the sulfur 
atom, followed by elimination of the halogen atom. The γ-pyrone ring opening resulted in the 
formation of compounds 35. 
 
 
Scheme 5.4 Proposed reaction mechanism for the formation of compounds 32 and 35. 
 
 
5.2.4 Structure identification 
 
All structures were confirmed by NMR, IR, MS and X-ray single crystal analyses. 
In the low field of 1H-NMR spectra of compounds 32 in DMSO-d6, two singlets of NH- 
and OH-groups were observed at δ = 10.2-13.9 ppm. The shift of these groups to δ ≈ 11.0 ppm 
can be caused by the presence of intramolecular hydrogen bond with the neighbouring carbonyl 
group. Nevertheless, the values of chemical shifts of OH-group were also dependent on the R1-
substituent in the salicyloyl moiety. In the 13C-NMR spectra, two carbonyl groups appeared at δ 
≈ 180 and 190 ppm. Similar observations were seen in the 1H- and 13C-NMR spectra of isomeric 
2-benzoylfurans 33. In the 1H-NMR spectra of compounds 35 in DMSO-d6, the singlet of 
phenolic OH-group appeared at δ = 10.6-13.9 ppm indicating also in this case the hydrogen bond 
formation. For compounds 35a-c, an additional singlet of the NH-group was detected in the low 
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field of 1H-NMR spectra (δ ≈ 11 ppm). The signal of the carbonyl group was observed at δ ≈ 190 
ppm in the 13C-NMR spectra. 
The structures of compounds 32e, 32x, 33 and 35i were independently established by X-
ray crystal structure analysis (Table 5.4). Typical hydrogen bonds involving OH- or NH-groups 
and oxygen atom of neighbouring carbonyl groups (C=O) were confirmed as well (1.5-2.1 Å). 
Obviously, the structures of products 32e, 32x and 35i are not planar. The torsion angles between 
the salicyloyl moiety and heterocyclic ring are in the range of 15-22º. A planar core of 
thieno[2,3-b]indole was observed in the molecule of compound 35i. Interestingly, the structure 
of product 33 is planar including 2-salicyloylfuran and amide moieties. Most likely, a non-
classical hydrogen bond (C11-H···O1, 2.1 Å) plays a significant role in the formation of such 
planar crystal structure.  
 
Table 5.4 Crystal structures of compounds 32e, 32x, 33 and 35i. 
Crystal structure Compound Structure 
 
32e 
 
 
32x 
 
 
33 
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35i 
 
 
 
5.3 Additional investigations 
 
Furochromones contain two important fragments, like chromone and furan moieties, and 
are of much interest, because of their biological properties. For example, phytoestrogen 
lupinalbin A represents a selective estrogen receptor modulator (Figure 5.3).350 
Broussofluorenones A and B show potent α-glucosidase and anticholinesterase inhibitions.351, 352  
Due to continued interest in furochromones as pharmacological agents, it was interesting for me 
to study the transformation of 2-benzoylfurans 32 to furo[3,2-b]chromen-9-ones. 
 
 
Figure 5.3 Pharmacologically relevant furochromones. 
 
For this purpose, the use of various oxidizing agents (iodine,73 o-chloranil and DDQ350), 
which were applied in similar cyclizations, different bases (DBU and potassium carbonate) and 
solvents (DCM, MeCN and DMF) were studied. The best yield of the furo[3,2-b]chromen-9-one 
36a (up to 32%) was obtained using iodine
 
(2 equiv.) and DBU (3 equiv.) in MeCN (Scheme 5.5, 
Table 5.5). The rather low yield can be explained by the instability and decomposition of the 
formed product. A metal-catalyzed reaction using Cu(OAc)2 (catalyst) in the presence of 
Zn(OTf)2 (additive) was also applied for the synthesis of target structure.353 However, this 
method was not successful and no product could be isolated. 
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Scheme 5.5 Synthesis of compounds 36 and 37. 
Reaction conditions: (i) 10 or 11 (1.0 equiv.), 31 (1.1 equiv.), DBU (1.3 equiv.), 1,4-
dioxane, 20 °C; (ii) I2 (2.0 equiv.), DBU (3 equiv.), DCM or DMF. 
 
Table 5.5 Synthesis of compounds 36 and 37. 
3-Halochromone X β-Ketoamide Product R1 R2 R3 Yield, a % 
Starting from 32m 36a 7-CH3 CH3 4-ClC6H4 32 
10a Br 31a 36b H CH3 Ph 37 
11b Cl 31a 36c 6-OCH3 CH3 Ph 28 
10d Br 31a 36d 5,6-benzo CH3 Ph 14 
11a Cl 31f 36e H Ph Ph 42 
11b Cl 31f 36f 6-OCH3 Ph Ph 21 
10a Br 31e 37a H OCH3 H 30 
11b Cl 31e 37b 6-OCH3 OCH3 H 27 
a
 Yields of isolated products. 
 
As a next step, I have studied a one-pot protocol for the direct preparation of furo[3,2-
b]chromen-9-ones starting from 3-halochromones (Scheme 5.5, Table 5.5). The reaction of 
chromone 10a with β-ketoamide 31a in the presence of DBU (1.3 equiv.) in 1,4-dioxane 
followed by subsequent oxidative cyclization by addition iodine (2 equiv.), DBU (3 equiv.) and 
DCM gave product 36b in 37% yield. The obtained yield is slightly higher than the yield in the 
stepwise process. The main loss in yield took place in the cyclization of 2-benzoylfuran. 
In view of the obtained results and operational simplicity, the preparative scope was next 
studied using the one-pot protocol, starting from 3-bromo- and 3-chlorochromones 10 and 11, as 
they proved to give better yields than 3-iodochromones 9 for the synthesis of 2-benzoylfurans. 
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Accordingly, reactions of chromones 10 and 11 with β-ketoamides 31 with subsequent oxidative 
cyclization gave furo[3,2-b]chromen-9-ones 36b-f in moderate or low yields (Scheme 5.5, Table 
5.5). The lowest yield was obtained for the benzo-substituted product 36d (14%) with, 
presumably due to a steric hindrance. It is necessary to emphasise that, in the case of reaction of 
3-halochromones with methyl 2-carbamoylacetate 31e, the interesting unexpected spiro-
compounds 37 were obtained. The spiro-structure formation can be explained by the nucleophilic 
attack of phenolic OH-group of formed 2-benzoylfuran 32, directed to the position 5 (instead of 
position 4) of the activated double bond, followed by further additional oxidation at 4-position.  
All structures of compounds 36 and 37 were confirmed by NMR, mass spectrometry and 
IR. In contrast to 2-benzoylfurans 32, in the low field of 1H-NMR spectra of furo[3,2-
b]chromen-9-ones 36 in DMSO-d6, only one singlet (NH-group) was detected at δ ≈ 10.6 ppm. 
At the same time, the 1H-NMR spectra of spiro-compounds 37 showed two singlets of NH2 
group (δ ≈ 9.1 and 10.1 ppm), indicating non-equivalence of these hydrogen atoms. In the low 
field of the 13C-NMR spectra of products 37, typical signals of carbon atoms C-3, C3´, C-5´, C-
7a and the carbonyl carbon atom of the ester group were observed (δ = 163-192 ppm). In 
contrast, for compounds 36 only one signal of the carbonyl group was detected in the low field 
of the 13C-NMR spectra (δ ≈ 190 ppm).  
The structure of 37b was additionally confirmed using 2D NMR analysis (COSY, 
HMBC). In the HMBC spectrum, cross-peaks between carbon atom C-3 (δ = 189.0 ppm) and the 
aromatic hydrogen atoms (δ = 6.86-7.67 ppm) of chromone moiety were detected through three 
and four bonds (see Figure 5.4). Besides, carbon atom C-5′ (δ = 178.0 ppm) gave cross-peak 
with one of the hydrogen atoms of the amino group (δ = 9.06 ppm). Expectedly, the spiro-carbon 
(δ = 102.7 ppm) did not show significant cross-peaks with any hydrogen atoms. 
 
 
Figure 5.4 Observations from 2D HMBC analysis for compound 37b. 
 
The structure of 36e was independently confirmed by X-ray crystal structure analysis 
(Table 5.6). The hydrogen bond between NH-group and the oxygen atom O4 of the carbonyl 
group was indicated as a distance of 2.0 Å. Predictably, the furo[3,2-b]chromen-9-one moiety is 
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planar. In addition, based on the X-ray crystal structure analysis of derivative 37b, the 
spirocyclic structure of compounds 37a and 37b was suggested. This structure is also in 
accordance with 2D NMR analysis. Nonetheless, due to the relatively low quality of the obtained 
crystal data, the X-ray structure of 37b cannot be published. 
 
Table 5.6 Crystal structure of compound 36e. 
Crystal structure Compound Structure 
 
36e O
O
O
N
O
H
 
 
Unfortunately, the attempts to carry out the oxidative cyclizations of obtained 2-benzoyl-
8H-thieno[2,3-b]indoles 35 under the same reaction conditions did not give any results. On the 
TLC, no conversion of the starting materials was observed. 
 
 
5.4 Conclusions  
 
A new efficient and convenient method for the synthesis of functionalized 2-
salicyloylfurans and 2-benzoyl-8H-thieno[2,3-b]indoles was developed via cyclization reactions 
of 3-halochromones with β-ketoamides and 1,3-dihydroindole-2-thiones, respectively. The 
influence of the halogen atom of the 3-halochromones on the yields of obtained products was 
studied. 3-Bromo- and 3-chlorochromones proved to be more active than 3-iodochromones in 
this type of reactions. In addition, furo[3,2-b]chromen-9-ones were synthesized using a one-pot 
two-step protocol starting from 3-halochromones and β-ketoamides followed by subsequent 
oxidative cyclization of formed 2-salicyloylfurans using iodine. The products obtained during 
this study might be of pharmacological relevance. The biological properties of compounds 32 
and 33 are presently being studied.  
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Chapter 6 
 
Summary 
 
This thesis was dedicated to the study of the chemical potential of different 3-substituted 
chromones, namely 3-acylchromones 4-8 and 3-halochromones 9-11, as building blocks for the 
synthesis of new interesting carbo- and heterocycles. The overview containing the number of 
structural classes synthesized via domino reactions of 3-substituted chromones with different 
binucleophiles is shown in Scheme 6.1. 
 
In Chapter 2, an already known protocol of the modified Vilsmeier-Haack reaction was 
applied for the synthesis of various 3-substituted chromones. New 3-methoxalyl-, 3-
perfluoroacyl- and 3-aroylchromones derivatives were prepared.  
 
According to Chapter 3, the domino reactions of 3-acylchromones 4-6 with 1,3-C,C-
binucleophiles, such as dimethyl 1,3-acetonedicarboxylate and 1,3-diphenylacetone, led to the 
formation of various functionalized 2-hydroxybenzophenones, fluorine-containing 6H-
benzo[c]chromones, benzo[c]coumarins and phenols depending on the substituent at the 3-
position of chromone and used 1,3-C,C-binucleophile. Photophysical properties of synthesized 
products were studied. It was found that 2-hydroxybenzophenones 13, 6H-benzo[c]chromenes 
14 and products of their hydrolysis exhibit strong UV-absorption properties. Furthermore, some 
of 6H-benzo[c]chromenes 14 demonstrate intensive fluorescence behaviour. 
 
As described in Chapter 4, a simple and efficient method for the synthesis of various 
pyridine-related heterocycles was developed based on domino reactions of 3-acylchromones 4-8 
with heterocyclic ketene aminals (HKAs). It was discovered that the ring size of the heterocyclic 
moiety of the HKAs, as well as electronic and steric effects of the acyl group of 3-
acylchromones, play an important role in these reactions and have a significant influence on the 
structure of the formed products. Moreover, the synthesized tetracyclic fused chromenopyridine 
derivatives 25 and 26 show promising fluorescence properties, which are now in the study. 
 
Finally, in Chapter 5, an efficient and convenient method for the synthesis of 
functionalized 2-salicyloylfurans and 2-benzoyl-8H-thieno[2,3-b]indoles was proposed via 
cyclization reactions of 3-halochromones with β-ketoamides and 1,3-dihydroindole-2-thiones, 
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respectively. Furo[3,2-b]chromen-9-ones were synthesized using a one-pot two steps protocol 
starting from 3-halochromones and β-ketoamides with subsequent oxidative cyclization. 
 
The products obtained in this thesis are not readily available by other methods and might 
be of pharmacological relevance due to their structural similarity to bioactive natural products 
and synthetic drugs. The biological evaluation of synthesized compounds is now in progress. 
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Scheme 6.1 The chemical potential of 3-substituted chromones 4-11. 
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Supplement 1 
 
Experimental part 
 
 
1.1. Analytics 
 
1H-NMR-Spectroscopy:  
Bruker AVANCE 250 II (250 MHz), Bruker AVANCE 300 III (300 MHz), Bruker AVANCE 
500 (500 MHz). The spectra were calibrated according to the solvent signals: 7.26 ppm for 
CDCl3, 2.50 ppm for DMSO-d6.354 Peak characterization: s = singlet, d = doublet, t = triplet, dd 
=double of doublets, td = triplet of doublets, dt = doublet of triplets, q = quartet, m = multiplet.  
 
13C-NMR-Spectroscopy:  
Bruker AVANCE 250 II (62.9 MHz), Bruker AVANCE 300 III (75.5 MHz), Bruker AVANCE 
500 (125 MHz). The spectra were calibrated according to the solvent signals: 77.00 ppm for 
CDCl3, 39.5 ppm for DMSO-d6. Peak characterization: t = triplet, q = quartet. DEPT method was 
used for determining the presence of primary, secondary, tertiary and quaternary carbon atoms. 
 
19F-NMR-Spectroscopy:  
Bruker AVANCE 300 III (282 MHz). 
 
All chemical shifts are given in ppm. All coupling constants J are indicated in Hz. 
 
Mass spectrometry (MS):  
GC 6890N / MSD 5973 (Agilent) or Finnigan MAT 95-XP (Thermo Electron). 
 
High resolution MS (HRMS):  
Finnigan MAT 95 XP (Thermo Electron) (electron ionisation EI, 70 eV) or 6210 Time-of-Flight 
LC/MS (Agilent) (electrospray ionization, ESI). Only the measurements with an average 
deviation from the theoretical mass of ± 2 μDa were accounted as correct. 
Infrared spectroscopy (IR):  
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Nicolet 380 FT-IR spectrometer with ATR sampling technique for solids as well as liquids. 
Abbreviations for signal allocations: w = weak, m = medium, s = strong. 
 
X-ray crystallography:  
Bruker-Nonius Apex X8 or Bruker Apex Kappa-II diffractometers with CCD-Kamera (Mo-Kα 
and graphite monochromator, λ = 0.71073 Å). 
 
Absorption spectroscopy: 
Lambda 2 (Perkin Elmer) or Specord 50 spectrophotometer. Cuvette length l = 1 cm. 
 
Fluorescence spectroscopy: 
Spectrafluorometer FluoroMax-4P, Horiba Scientific. The luminescence quantum yields were 
determined relative to quinine bisulfate (Sigma Aldrich Co.) in 0.05 M sulfuric acid (Titripu, 
Merck AG) as quantum yield standard (φ = 0.54). The optical densities of all solutions were 
below an absorbance of 0.1. 
 
Melting point determination (mp):  
Microscope Laborlux 12 Pol S, Mettler FP90 central Processor, SNT 12 V 100 K. The melting 
points are uncorrected. 
 
Thin layer chromatography (TLC):  
Merck silica gel 60 F254. Detection under UV light at 254 nm and 366 nm without dipping 
reagent. 
 
Column chromatography:  
Chromatography was performed over Merck silica gel 60 (0.063-0.200 mm, 70-230 mesh). All 
solvents were distilled before use. 
 
All chemicals and solvent (extra dry) for carring out of reactions were purchased from the 
standard chemical suppliers, such as Sigma-Aldrich®, Arcos®, Merck® and others. All 
reactions were monitored by TLC using UV light to visualize the course of reaction.  
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1.2 General synthetic procedures and product characterization 
 
1.2.1 Supplement for Chapter 2 
 
Starting 3-acylchromones 4-8 were prepared according to described procedures.30-31, 54, 83, 84 
 
General procedure for the synthesis of 3-methoxalylchromones 4: 
To a round-bottom 50 ml flask, fitted with a septum, containing corresponding 3-
(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one 2 (10.0 mmol) dissolved in 25 ml of dry 
DCM, dry pyridine (3.3 equiv.) was added. The solution was set on stirring on ice bath and 
acylation agent 3a (methyl oxalyl chloride) (1,1 equiv.) was added dropwise. The reaction 
mixture was stirred at the room temperature for 8 hours (approximately) and after was stripped 
of solvents and liquid residues. The obtained solid was well washed with water to give the 
corresponding 3-methoxalylchromones 4. 
 
3-Methoxalylchromone 4a has already been described and reported by Dr. S. Mkrtchyan in the 
group of Prof. Langer.31  
 
3-Methoxalyl-6-methylchromone (4b): 
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxy-5-methyl-
phenyl)prop-2-en-1-one 2b (4.105 g, 20.0 mmol) and methyl 2-
chloro-2-oxoacetate 3a (2.0 mL, 22.0 mmol) and pyridine (5.3 
mL, 66.0 mmol) in DCM (25 mL), the product 4b was isolated as a yellow solid (4.580 g, 93%), 
mp = 134-136 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.44 (s, 3H, CH3), 3.87 (s, 3H, OCH3), 7.66-7.74 (m, 2H, 
7,8-HAr), 7.89 (s, 1H, 5-HAr), 9.08 (s, 1H, 2-HAr); 13C NMR (62.9 MHz, DMSO-d6): δ = 20.4 
(CH3), 52.7 (OCH3), 118.4, 118.7, 123.6, 124.5, 136.5, 136.9, 153.9, 164.0, 164.4, 174.1, 184.7; 
MS (GC, 70 eV) m/z (%): 246 ([M]+, 5), 218 (19), 203 (15), 187 (100), 135 (29), 77 (12), 53 (9); 
HRMS (EI): calcd for C13H10O5 ([M]+) 246.05227, found 246.05262; IR (ATR, cm-1): ~ν  = 3056 
(w), 2954 (w), 1749 (s), 1715 (w), 1685 (s), 1658 (s), 1596 (s), 1553 (s), 1475 (s), 1430 (s), 1377 
(w), 1338 (m), 1295 (s), 1239 (s), 1204 (s), 1135 (m), 1116 (m), 1029 (s), 998 (m), 976 (m), 960 
(m), 914 (m), 872 (m), 830 (s), 816 (m), 795 (s), 762 (m), 746 (s), 712 (s), 658 (m), 550 (m).  
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7-Methoxy-3-methoxalylchromone (4c):  
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxy-4-methoxy-
phenyl)prop-2-en-1-one 2c (4.442 g, 20.0 mmol) and methyl 2-
chloro-2-oxoacetate 3a (2.0 mL, 22.0 mmol) and pyridine (5.3 
mL, 66.0 mmol) in DCM (25 mL), the product 4c was isolated 
as a yellow solid (4.353 g, 83%), mp = 152-154 ºC; 
 
1H NMR (300 MHz, DMSO-d6): δ = 3.87 (s, 3H, OCH3), 3.92 (s, 3H, OCH3), 7.15 (dd, 3J = 8.9 
Hz, 4J = 2.3 Hz, 1H, 6-HAr), 7.28 (d, 4J = 2.3 Hz, 1H, 8-HAr), 8.00 (d, 1H, 3J = 8.9 Hz, 5-HAr), 
9.04 (s, 1H, 2-HAr); 13C NMR (75.5 MHz, DMSO-d6): δ = 52.6 (OCH3), 56.4 (OCH3), 101.6, 
115.9, 117.3, 118.5, 126.7, 157.6, 164.1, 164.2, 164.8, 173.3, 184.8; MS (GC, 70 eV) m/z (%): 
262 ([M+], 2), 234 (23), 219 (24), 203 (100), 151 (54), 119 (12), 63 (10), 53 (16); HRMS (ESI): 
calcd for C13H11O6 ([M+H]+) 263.05501, found 263.05528; IR (ATR, cm-1): ~ν  = 3043 (w), 2967 
(w), 2848 (w), 1743 (m), 1683 (m), 1650 (s),1614 (s), 1552 (w), 1504 (m), 1464 (w), 1436 (s), 
1393 (m), 1350 (w), 1326 (m), 1276 (s), 1226 (s), 1197 (m), 1179 (m), 1143 (m), 1104 (s), 1030 
(m), 1012 (s), 971 (m), 943 (m), 921 (w), 879 (m), 849 (s), 818 (s), 785 (s), 748 (s), 721 (s), 677 
(m), 633 (w), 599 (m), 578 (m), 543 (m). 
 
6-Chloro-3-methoxalylchromone (4d):  
Starting with (2E)-1-(5-chloro-2-hydroxyphenyl)-3-(dimethyl-
amino)prop-2-en-1-one 2d (4.513 g, 20.0 mmol) and methyl 2-
chloro-2-oxoacetate 3a (2.0 mL, 22.0 mmol) and pyridine (5.3 mL, 
66.0 mmol) in DCM (25 mL), the product 4d was isolated as a yellow solid (4.799 g, 90%), mp 
= 137-139 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 3.88 (s, 3H, OCH3), 7.84 (d, 3J = 9.0 Hz, 1H, 8-HAr), 7.93 
(dd, 3J = 9.0 Hz, 4J = 2.6 Hz, 1H, 7-HAr), 8.01 (d, 4J = 2.6 Hz, 1H, 5-HAr), 9.13 (s, 1H, 2-HAr); 
13C NMR (62.9 MHz, DMSO-d6): δ = 52.8 (OCH3), 118.5, 121.4, 124.3, 125.2, 131.5, 135.3, 
154.3, 163.8, 164.8, 173.2, 184.2; MS (GC, 70 eV) m/z (%): 266 ([M]+, 4), 238 (12), 223 (10), 
207 (100), 155 (34), 123 (13), 63 (12), 53 (30); HRMS (ESI): calcd for C12H835ClO5 ([M+H]+) 
267.00548, found 267.00586, calcd for C12H837ClO5 ([M+H]+) 269.00298, found 269.00315; IR 
(ATR, cm-1): ~ν  = 3068 (w), 2956 (w), 1739 (m), 1688 (m), 1651 (s), 1607 (m), 1553 (s), 1482 
(w), 1464 (s), 1439 (s), 1391 (w), 1372 (w), 1327 (s), 1297 (s), 1253 (m), 1219 (m), 1191 (m), 
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1173 (m), 1139 (w), 1121 (m), 1073 (m), 1023 (s), 955 (s), 899 (m), 868 (m), 840 (s), 816 (s), 
795 (s), 761 (s), 744 (m), 715 (s), 685 (m), 665 (s), 633 (s), 590 (w), 543 (s).  
 
6-Chloro-7-methyl-3-methoxalylchromone (4e):  
Starting with  (2E)-1-(5-chloro-2-hydroxy-4-methyl-phenyl)-3-
(dimethylamino)prop-2-en-1-one 2e  (4.794 g, 20.0 mmol) and 
methyl 2-chloro-2-oxoacetate 3a (2.0 mL, 22.0 mmol) and 
pyridine (5.3 mL, 66.0 mmol) in DCM (25 mL), the product 4e 
was isolated as a white solid (4.659 g, 83%), mp = 184-186 ºC; 
1H NMR (300 MHz, CDCl3): δ = 2.52 (s, 3H, CH3), 3.98 (s, 3H, OCH3), 7.43 (s, 1H, 8-HAr), 
8.16 (s, 1H, 5-HAr), 8.60 (s, 1H, 2-HAr); 13C NMR (75.5 MHz, CDCl3): δ = 20.9 (CH3), 53.0 
(OCH3), 119.7, 120.3, 123.6, 125.9, 133.7, 144.7, 154.2, 162.1, 164.0, 173.4, 184.1; MS (GC, 70 
eV) m/z (%): 280 ([M]+, 4), 252 (15), 237 (13), 221 (100), 169 (30), 53 (12); HRMS (EI): calcd 
for C13H935ClO5 ([M]+) 280.01324, found 280.01330; IR (ATR, cm-1): ~ν  = 3067 (w), 2956 (w), 
1739 (m), 1683 (m), 1650 (s), 1615 (m), 1588 (m), 1541 (m), 1454 (m), 1436 (m), 1414 (s), 1383 
(w), 1367 (w), 1332 (m), 1290 (s), 1247 (m), 1217 (m), 1167 (w), 1128 (m), 1029 (s), 995 (m), 
952 (w), 941 (m), 901 (m), 885 (s), 823 (m), 796 (s), 761 (s), 714 (s), 689 (m), 651 (s), 595 (w), 
552 (w).  
 
6-Bromo-3-methoxalylchromone (4f):  
Starting with (2E)-1-(5-bromo-2-hydroxy-phenyl)-3-(dimethyl-
amino)prop-2-en-1-one 2f (5.402 g, 20.0 mmol) and methyl 2-
chloro-2-oxoacetate 3a (2.0 mL, 22.0 mmol) and pyridine (5.3 mL, 
66.0 mmol) in DCM (25 mL), the product 4f was isolated as a 
yellow solid (6.549 g, 95%), mp = 138-140 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.88 (s, 3H, OCH3), 7.79 (d, 3J = 8.9 Hz, 1H, 8-HAr), 8.07 
(dd, 3J = 8.9 Hz, 4J = 2.5 Hz, 1H, 7-HAr), 8.17 (d, 4J = 2.5 Hz, 1H, 5-HAr), 9.14 (s, 1H, 2-HAr); 
13C NMR (62.9 MHz, DMSO-d6): δ = 52.8 (OCH3), 118.6, 119.5, 121.6, 125.5, 127.4, 138.1, 
154.7, 163.8, 164.9, 173.1, 184.2; MS (GC, 70 eV) m/z (%): 310 ([M]+, 6), 284 (11), 282 (13), 
269 (12), 253 (100), 199 (26), 88 (9), 53 (18); HRMS (EI): calcd for C12H779BrO5 [M]+ 
309.94714, found 309.94763, calcd for C12H781BrO5 [M]+ 311.94509, found 311.94583; IR 
(ATR, cm-1): ~ν  =  3078 (w), 2961 (w), 1731 (m), 1691 (m), 1651 (s), 1605 (m), 1552 (m), 1504 
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(w), 1461 (s), 1435 (s), 1380 (w), 1365 (m), 1326 (s), 1295 (s), 1260 (s), 1223 (m), 1179 
(m),1119 (m), 1061 (w), 1021 (s), 949 (m), 886 (m), 862 (m), 829 (s), 812 (s), 795 (s), 770 (s), 
744 (m), 705 (s), 674 (m),655 (m), 604 (s), 536 (s). 
 
3-Methoxalylbenzo[h]chromone (4g):  
Starting with (2E)-3-(dimethylamino)-1-(1-hydroxy-naphthalen-2-
yl)prop-2-en-1-one 2g (4.826 g, 20.0 mmol) and methyl 2-chloro-2-
oxoacetate 3a (2.0 mL, 22.0 mmol) and pyridine (5.3 mL, 66.0 
mmol) in DCM (25 mL), the product 4g was isolated as a pale 
yellow solid (4.347 g, 77%), mp = 112-114 ºC; 
1H NMR (300 MHz, CDCl3): δ = 4.02 (s, 3H, OCH3), 7.68-7.82 (m, 3H, HAr), 7.92 (d, 3J = 7.3 
Hz, 1H, HAr), 8.08 (d, 3J = 8.8 Hz, 1H, HAr), 8.42 (d, 3J = 7.5 Hz, 1H, HAr), 8.74 (s, 1H, 2-HAr); 
13C NMR (75.5 MHz, CDCl3): δ = 53.0 (OCH3), 120.2, 120.9, 121.3, 122.0, 123.4, 126.9, 127.9, 
128.2, 130.1, 136.2, 153.6, 161.0, 164.1, 174.3, 184.5; MS (GC, 70 eV) m/z (%): 282 ([M]+, 7), 
254 (22), 239 (29), 223 (100), 171 (49), 139 (33), 114 (16), 53 (21); HRMS (ESI): calcd for 
C16H11O5 ([M+H]+) 283.06010, found 283.06061; IR (ATR, cm-1): ~ν  = 3078 (w), 2961 (w), 
1727 (w), 1690 (w), 1641 (s), 1633 (s), 1601 (m), 1590 (m), 1557 (m), 1509 (m), 1462 (m), 1440 
(m), 1410 (m), 1402 (m), 1384 (s), 1360 (m), 1338 (m), 1303 (s), 1259 (m), 1236 (m), 1215 (m), 
1176 (m), 1153 (w), 1132 (m), 1064 (m), 1039 (m), 1021 (s), 959 (w), 935 (w), 924 (w), 865 
(w), 830 (m), 808 (s), 798 (s), 755 (s), 745 (s), 708 (m), 691 (m), 639 (m), 605 (w), 574 (s), 547 
(m).  
 
General procedure for the synthesis of 3-perfluoroacylchromones 5: 
To a stirred reaction mixture of the corresponding 3-(dimethylamino)-1-(2-hydroxyphenyl)prop-
2-en-1-one 2 (10.0 mmol) and pyridine (3.3 equiv.) in 25 ml of dry MeCN, the corresponding 
acylation agent 3 (trifluoroacetyl anhydride 3b, pentafluoropropanoyl anhydride 3c or 
heptafluorobutanoyl chloride 3d) (2.2 equiv.) was added slowly via a syringe at room 
temperature. The reaction mixture was stirred for one-two hours and after was stripped of 
solvents and liquid residues. The obtained solid was washed well with water to give the 
corresponding 3-perfluoroacylchromones 5. 
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3-Perfluoroacylchromones 5 were obtained as mixture of hydrated and non-hydrated forms and 
were used in the further investigations without additional purification. They were used as 
intermediate products and are not described in this thesis. 
 
General procedure for the synthesis of 3-aroylchromones 6: 
To a stirred reaction mixture of the corresponding 3-(dimethylamino)-1-(2-hydroxy-
phenyl)prop-2-en-1-one 2 (10.0 mmol) and pyridine (3.3 equiv.) in 25 ml of dry MeCN, the 
corresponding benzoylchloride 3e-k (1.1 equiv.) was added slowly via a syringe at room 
temperature. The reaction mixture was stirred at reflux for 10-12 hours and after was stripped of 
solvents and liquid residues. The obtained solid was washed well with water to give the 
corresponding 3-aroylchromones 6. In some cases, it was necessary to use column 
chromatography. 
 
3-Benzoylchromone (6a): 
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one 
2a (3.825 g, 20.0 mmol) and benzoylchloride 3e (2.6 mL, 22.0 mmol) and 
pyridine (5.3 mL, 66.0 mmol) in MeCN (25 mL), the product 6a was isolated 
as a white solid (4.004 g, 80%), mp = 129-131 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 7.50-7.59 (m, 3H, HAr), 7.67 (tt, 3J = 7.4 Hz, 4J = 1.3 Hz, 
1H, HAr), 7.75 (dd, 3J = 8.4 Hz, 4J = 0.6 Hz, 1H, HAr), 7.86-7.92 (m, 3H, HAr), 8.09 (dd, 3J = 7.9 
Hz, 4J = 1.5 Hz, 1H, HAr), 8.72 (s, 1H, 2-HAr); 13C NMR (62.9 MHz, DMSO-d6): δ = 118.7, 
124.2, 124.5, 125.3, 126.1, 128.5, 128.6, 129.4, 129.5, 133.6, 134.8, 136.9, 155.8, 158.8, 174.3, 
191.6; MS (GC, 70 eV) m/z (%): 250 ([M]+, 27), 249 (43), 221 (100), 194 (13), 173 (22), 121 
(28), 105 (20), 77 (47), 63 (11), 51 (18); IR (ATR, cm-1): ~ν  = 3060 (w), 1946 (w), 1823 (w), 
1644 (s), 1610 (s), 1563 (s), 1461 (s), 1383 (m), 1340 (m), 1308 (s), 1251 (m), 1210 (m), 1156 
(w), 1135 (s), 1031 (w), 999 (w), 968 (m), 920 (m), 862 (s), 808 (w), 787 (m), 758 (s), 717 (s), 
688 (s), 632 (s), 558 (w).  
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3-(2-Fluorobenzoyl)chromone (6b):  
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)-prop-2-en-1-
one 2a (3.825 g, 20.0 mmol) and 2-fluorobenzoyl chloride 3f (2.6 mL, 
22.0 mmol) and pyridine (5.3 mL, 66.0 mmol) in MeCN (25 mL), the 
product 6b was isolated as a pale yellow solid (4.613 g, 86%), mp 143-144 ºC; 
1H NMR (300 MHz, CDCl3): δ = 7.04-7.11 (m, 1H, HAr), 7.27 (td, 3J = 7.5 Hz, 4J = 1.0 Hz, 1H, 
HAr), 7.44 (td, 3J = 7.5 Hz, 4J = 1.0 Hz, 1H, HAr), 7.50-7.58 (m, 2H, HAr), 7.69-7.78 (m, 2H, HAr), 
8.22 (dd, 3J = 8.0 Hz, 4J = 1.5 Hz, 1H, HAr), 8.44 (s, 1H, 2-HAr); 13C NMR (75.5 MHz, CDCl3): δ 
= 115.8 (d, JC,F = 22.1 Hz), 118.3, 124.4 (d, JC,F = 3.3 Hz), 124.9, 125.8, 126.1, 126.4, 127.4 (d, 
JC,F = 12.6 Hz), 130.4 (d, JC,F = 2.2 Hz), 134.3 (d, JC,F = 4.4 Hz), 134.4 (d, JC,F = 4.4 Hz), 156.0, 
159.5, 161.2 (d, 1JC,F = 252.7 Hz, CArF), 174.4 (d, JC,F = 2.0 Hz), 188.7 (C=O); 19F NMR (282.4 
MHz, CDCl3): δ = -111.4 (s, F); MS (GC, 70 eV) m/z (%): 268 ([M]+, 63), 239 (100), 221 (34), 
173 (28), 121 (30), 95 (31), 75 (21), 63 (13), 53 (12); HRMS (EI): calcd for C16H9FO3 ([M]+) 
268.05302, found 268.05295; IR (ATR, cm-1): ~ν  = 3081 (w), 1664 (m), 1644 (s), 1609 (s), 1563 
(m), 1477 (w), 1460 (s), 1388 (m), 1339 (m), 1314 (m), 1261 (w), 1240 (m), 1207 (m), 1152 (w), 
1136 (m), 1099 (m), 1029 (w), 1002 (w), 973 (m), 933 (w), 864 (s), 817 (w), 758 (s), 706 (m), 
679 (w), 665 (m), 629 (s), 565 (w), 538 (m). 
 
3-(2-Thenoyl)chromone (6c):  
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-
one 2a (3.825 g, 20.0 mmol) and thiophene-2-carbonyl chloride 3g (2.4 
mL, 22.0 mmol) and pyridine (5.3 mL, 66.0 mmol) in MeCN (25 mL), 
the product 6c was isolated as a white solid (4.152 g, 81%), mp 145-147 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 7.24 (t, 3J = 4.4 Hz, 1H, HAr), 7.56 (td, 3J = 7.5 Hz, 4J = 1.0 
Hz, 1H, HAr), 7.73 (d, 3J = 7.8 Hz, 1H, HAr), 7.84-7.90 (m, 2H, HAr), 8.10-8.15 (m, 2H, HAr), 
8.76 (s, 1H, 2-HAr); 13C NMR (75.5 MHz, DMSO-d6): δ = 118.6, 124.1, 124.2, 125.4, 126.1, 
128.9, 134.8, 136.5, 136.6, 143.5, 155.6, 158.1, 173.9, 182.7; MS (GC, 70 eV) m/z (%): 256 
([M]+, 71), 228 (87), 200 (24), 173 (35), 121 (52), 111 (100), 92 (25), 83 (17), 63 (26), 53 (30), 
39 (50); HRMS (EI): calcd for C14H8O3S ([M]+) 256.01887, found 256.01828; IR (ATR, cm–1): 
~ν
 = 3097 (w), 1699 (w), 1646 (s), 1606 (s), 1564 (s), 1525 (m), 1460 (s), 1434 (m), 1406 (s), 
1381 (s), 1353 (s), 1340 (s), 1308 (s), 1253 (m), 1212 (s), 1168 (m), 1130 (s), 1102 (m), 1084 
O
O O F
O
O O
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(m), 1059 (m), 1029 (m), 955 (w), 937 (w), 918 (m), 851 (m), 816 (s), 793 (s), 751 (s), 722 (s), 
677 (s), 628 (s), 557 (m), 534 (w). 
 
3-(2-Nitrobenzoyl)chromone (6d):  
Starting with  (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)-prop-2-en-
1-one 2a (3.825 g, 20.0 mmol) and 2-nitrobenzoyl chloride 3h (2.9 mL, 
22.0 mmol) and pyridine (5.3 mL, 66.0 mmol) in MeCN (25 mL), the 
product 6d was isolated as pale brown solid (4.132 g, 70%), mp 155-157 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 7.51-7.57 (m, 2H, HAr), 7.74-7.80 (m, 2H, HAr), 7.85-7.91 
(m, 2H, HAr), 7.97 (dd, 3J = 7.9 Hz, 4J = 1.4 Hz, 1H, HAr), 8.26 (d, 3J = 7.5 Hz, 1H, HAr), 9.17 (s, 
1H, 2-HAr); 13C NMR (62.9 MHz, DMSO-d6): δ = 118.7, 120.5, 123.7, 124.3, 125.4, 126.7, 
127.8, 130.7, 134.8, 135.2, 137.4, 145.9, 155.5, 164.0, 173.7, 189.6; MS (EI, 70 eV) m/z (%): 
249 ([M-NO2], 100), 173 (6), 121 (10), 57 (5); HRMS (ESI): calcd for C16H10NO5 ([M+H]+) 
296.05535, found 296.05606; IR (ATR, cm–1): ~ν  = 3108 (w), 3078 (w), 2861 (w), 1671 (m), 
1652 (m), 1611 (m), 1574 (w), 1552 (m), 1517 (s), 1463 (s), 1404 (w), 1388 (m), 1349 (s), 1307 
(s), 1205 (m), 1175 (w), 1156 (m), 1141 (m), 1105 (w), 1084 (w), 1028 (w), 996 (w), 957 (m), 
888 (w), 869 (m), 850 (s), 808 (w), 792 (m), 764 (s), 745 (m), 734 (s), 705 (s), 658 (m), 638 (m), 
575 (m), 535 (s). 
 
6-Methyl-3-(2-nitrobenzoyl)chromone (6e):  
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxy-5-methyl-
phenyl)prop-2-en-1-one 2b b(4.105 g, 20.0 mmol) and 2-
nitrobenzoyl chloride 3h (2.9 mL, 22.0 mmol) and pyridine (5.3 
mL, 66.0 mmol) in MeCN (25 mL), the product 6e was isolated as pale brown solid (5.010 g, 
81%), mp 168 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.38 (s, 3H, CH3), 7.54 (dd, 3J = 7.5 Hz, 4J = 1.4 Hz, 1H, 
HAr), 7.62–7.69 (m, 2H, HAr), 7.74–7.79 (m, 2H, HAr), 7.86 (td, 3J = 7.5 Hz, 4J = 1.2 Hz, 1H, 
HAr), 8.25 (dd, 3J = 8.1 Hz, 4J = 1.1 Hz, 1H, HAr), 9.12 (s, 1H, 2-HAr); 13C NMR (62.9 MHz, 
DMSO-d6): δ = 20.4 (CH3), 118.5, 120.3, 123.6, 124.0, 124.8, 127.8, 130.7, 134.7, 136.1, 136.5, 
137.5, 145.9, 153.8, 163.8, 173.6, 189.7; MS (EI, 70 eV) m/z (%): 264 ([M-NO2+H], 33), 263 
(100), 187 (6), 135 (13), 76 (5); HRMS (ESI): calcd for C17H12NO5 ([M+H]+) 310.07100, found 
310.07139; IR (ATR, cm–1): ~ν  = 3061 (w), 2921 (w), 2859 (w), 1668 (m), 1650 (m), 1615 (m), 
O
O O NO2
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1574 (m), 1552 (m), 1517 (s), 1478 (s), 1440 (m), 1348 (s), 1306 (s), 1229 (m), 1186 (w), 1163 
(m), 1132 (m), 1082 (w), 1041 (w), 1018 (w), 959 (w), 910 (m), 853 (s), 814 (s), 786 (s), 753 
(m), 731 (s), 702 (s), 640 (s), 575 (m), 541 (m). 
 
7-Methoxy-3-(2-nitrobenzoyl)chromone (6f): 
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxy-4-methoxy-
phenyl)prop-2-en-1-one 2c (4.442 g, 20.0 mmol) and 2-
nitrobenzoyl chloride 3h (2.9 mL, 22.0 mmol) and pyridine (5.3 
mL, 66.0 mmol) in MeCN (25 mL), the product 6f was isolated as pale brown solid (5.139 g, 
79%), mp 146-148 ºC; 
 
1H NMR (300 MHz, DMSO-d6): δ = 3.90 (s, 3H, OCH3), 7.08 (dd, 3J = 8.9 Hz, 4J = 2.3 Hz, 1H, 
HAr), 7.24 (d, 4J = 2.3 Hz, 1H, HAr), 7.54 (dd, 3J = 7.5 Hz, 4J = 1.4 Hz, 1H, HAr), 7.75 (td, 3J = 
7.5 Hz, 4J = 1.4 Hz, 1H, HAr), 7.83–7.89 (m, 2H, HAr), 8.24 (dd, 3J = 8.1 Hz, 4J = 1.0 Hz, 1H, 
HAr), 9.08 (s, 1H, 2-HAr); 13C NMR (75.5 MHz, DMSO-d6): δ = 56.3 (OCH3), 101.3, 115.7, 
117.8, 120.4, 123.6, 126.9, 127.8, 130.7, 134.7, 137.6, 145.9, 157.3, 163.6, 164.5, 172.9, 189.8; 
MS (GC, 70 eV) m/z (%): 279 ([M-NO2], 100), 236 (23), 151 (12), 76 (6), 63 (5); HRMS (ESI): 
calcd for C17H12NO6 ([M+H]+) 326.06591, found 326.06567; IR (ATR, cm–1): ~ν  = 3065 (w), 
2952 (w), 2845 (w), 1673 (w), 1621 (s), 1552 (m), 1514 (s), 1435 (s), 1385 (m), 1341 (s), 1302 
(s), 1271 (s), 1237 (m), 1207 (m), 1143 (m), 1090 (m), 1035 (w), 1020 (m), 939 (s), 879 (w), 850 
(s), 804 (m), 786 (s), 753 (s), 733 (m), 718 (m), 701 (s), 627 (s), 590 (w), 562 (s), 529 (m). 
 
3-(3-Nitrobenzoyl)chromone (6g): 
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)-prop-2-
en-1-one 2a (3.825 g, 20.0 mmol) and 3-nitrobenzoyl chloride 3i 
(4.082 g, 22.0 mmol) and pyridine (5.3 mL, 66.0 mmol) in MeCN 
(25 mL), the product 6g was isolated as a white solid (4.783 g, 81%), mp = 209-211 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 7.58 (td, 3J = 7.5 Hz, 4J = 1.1 Hz, 1H, HAr), 7.77-7.84 (m, 
2H, HAr), 7.91 (td, 3J = 7.8 Hz, 4J = 1.7 Hz, 1H, HAr), 8.08 (dd, 3J = 7.9 Hz, 4J = 1.5 Hz, 1H, 
HAr), 8.27 (dt, 3J = 7.7 Hz, 4J = 1.3 Hz, 1H, HAr), 8.48 (dq, 3J = 8.2 Hz, 4J = 1.0 Hz, 1H, HAr), 
8.56 (t, 4J = 1.8 Hz, 1H, HAr), 8.83 (s, 1H, 2-HAr); 13C NMR (75.5 MHz, DMSO-d6): δ = 118.7, 
123.3, 123.4, 124.3, 125.4, 126.4, 127.5, 130.3, 135.0, 135.6, 138.4, 147.9, 155.7, 160.8, 174.2, 
190.2; MS (GC, 70 eV) m/z (%): 295 ([M]+, 48), 278 (100), 266 (93), 248 (56), 220 (73), 173 
O
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(71), 165 (13), 150 (10), 121 (95), 104 (20), 92 (26), 76 (35), 63 (19), 53 (27); HRMS (EI): calcd 
for C16H9NO5 ([M]+) 295.04752, found 295.04744; IR (ATR, cm–1): ~ν  = 3087 (w), 1843 (w), 
1668 (m), 1634 (s), 1611 (s), 1559 (w), 1533 (s), 1463 (s), 1384 (m), 1345 (s), 1316 (m), 1292 
(m), 1210 (w), 1177 (w), 1141 (m), 1100 (w), 1081 (m), 1030 (w), 992 (m), 966 (w), 924 (m), 
897 (m), 854 (m), 823 (w), 802 (w), 757 (s), 739 (m), 715 (s), 661 (m), 630 (m), 556 (w). 
 
6-Methyl-3-(3-Nitrobenzoyl)chromone (6h): 
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxy-5-methyl-
phenyl)prop-2-en-1-one 2b (4.105 g, 20.0 mmol) and 3-
nitrobenzoyl chloride 3i (4.082 g, 22.0 mmol) and pyridine 
(5.3 mL, 66.0 mmol) in MeCN (25 mL), the product 6h was isolated as a white solid (5.258 g, 
85%), mp 232-234 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.44 (s, 3H, CH3), 7.65-7.73 (m, 2H, HAr), 7.78-7.86 (m, 
2H, HAr), 8.25 (d, 3J = 7.6 Hz, 1H, HAr), 8,48 (d, 3J = 8.2 Hz, 1H, HAr), 8.53 (s, 1H, HAr), 8.80 (s, 
1H, 2-HAr);  13C NMR (75.5 MHz, DMSO-d6): δ = 20.4 (CH3), 118.5, 123.2, 123.3, 123.9, 124.6, 
127.5, 130.3, 135.5, 135.9, 136.1, 138.4, 147.8, 154.0, 160.6, 174.2, 190.3; MS (GC, 70 eV) m/z 
(%): 309 ([M]+, 57), 292 (82), 280 (100), 262 (55), 234 (70), 187 (54), 135 (74), 104 (19), 89 
(10), 76 (35), 63 (10), 53 (17); HRMS (EI): calcd for C17H11NO5 ([M]+) 309.06317, found 
309.06329; IR (ATR, cm–1): ~ν  = 3088 (w), 3049 (w), 2919 (w), 2864 (w), 1661 (m), 1636 (s), 
1614 (s), 1564 (w), 1526 (s), 1478 (w), 1438 (m), 1373 (w), 1339 (s), 1321 (s), 1253 (m), 1234 
(m), 1159 (m), 1081 (m), 1024 (w), 991 (w), 954 (m), 923 (m), 879 (m), 845 (m), 816 (s), 796 
(s), 710 (s), 662 (s), 638 (m), 561 (w), 539 (m). 
 
3-(4-Nitrobenzoyl)chromone (6i):  
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)-prop-2-
en-1-one 2a (3.825 g, 20.0 mmol) and 4-nitrobenzoyl chloride 3j 
(4.082 g, 22.0 mmol) and pyridine (5.3 mL, 66.0 mmol) in MeCN 
(25 mL), the product 6i was isolated as a white solid (4.901 g, 83%), mp 239-240 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 7.58 (t, 3J = 7.6 Hz, 1H, HAr), 7.77 (d, 3J = 8.4 Hz, 1H, 
HAr), 7.90 (td, 3J = 7.6 Hz, 4J = 1.4 Hz, 1H, HAr), 8.06–8.09 (m, 3H, HAr), 8.30–8.33 (m, 2H, 
HAr), 8.83 (s, 1H, 2-HAr); 13C NMR (62.9 MHz, DMSO-d6): δ = 118.8, 123.5, 123.6, 123.7, 
124.3, 125.4, 126.4, 130.5, 130.6, 135.1, 142.1, 149.9, 155.8, 160.7, 174.3, 191.1; MS (GC, 70 
O
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eV) m/z (%): 295 ([M]+, 29), 278 (64), 266 (100), 248 (29), 220 (50), 173 (40), 165 (12), 121 
(65), 104 (18), 92 (25), 76 (25), 63 (15), 53 (21); HRMS (EI): calcd for C16H9NO5 ([M]+) 
295.04752, found 295.04745; IR (ATR, cm–1): ~ν  = 3107 (w), 2848 (w), 1949 (w), 1661 (w), 
1633 (s), 1604 (m), 1563 (w), 1516 (m), 1461 (m), 1406 (w), 1379 (m), 1318 (m), 1287 (m), 
1253 (m), 1215 (m), 1150 (w), 1132 (m), 1028 (w), 962 (w), 926 (m), 868 (s), 842 (m), 798 (m), 
775 (m), 755 (s), 709 (s), 687 (s), 634 (s), 596 (w), 549 (m), 534 (w). 
 
3-(3,5-Dinitrobenzoyl)chromone (6j):  
Starting with (2E)-3-(dimethylamino)-1-(2-hydroxyphenyl)-prop-2-
en-1-one 2a (3.825 g, 20.0 mmol) and 3,5-dinitrobenzoyl chloride 
3k (5.072 g, 22.0 mmol) and pyridine (5.3 mL, 66.0 mmol) in 
MeCN (25 mL), the product 6j was isolated as a brown solid (3.947 
g, 58%), mp 181-183 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 7.59 (t, 3J = 7.6 Hz, 1H, HAr), 7.80 (d, 3J = 8.5 Hz, 1H, 
HAr), 7.89–7.95 (m, 1H, HAr), 8.08 (d, 3J = 7.9 Hz, 1H, HAr), 8.91–8.93 (m, 3H, HAr), 9.03 (s, 1H, 
2-HAr); 13C NMR (62.9 MHz, DMSO-d6): δ = 118.7, 122.0, 122.5, 124.4, 125.4, 126.5, 128.8, 
128.9, 135.1, 140.1, 148.1, 148.2, 155.7, 162.5, 174.3, 188.6; MS (GC, 70 eV) m/z (%): 340 
([M]+, 32), 323 (100), 311 (59), 293 (35), 265 (35), 247 (17), 219 (39), 173 (67), 121 (81), 92 
(16), 75 (24), 53 (17); HRMS (EI): calcd for C16H8N2O7 ([M]+) 340.03260, found 340.03257; IR 
(ATR, cm–1): ~ν  = 3100 (w), 1644 (m), 1611 (m), 1538 (m), 1463 (m), 1384 (w), 1341 (m), 1314 
(m), 1290 (m), 1211 (w), 1173 (w), 1105 (m), 1031 (w), 1004 (m), 917 (m), 854 (m), 831 (m), 
745 (m), 714 (s), 644 (m), 557 (w). 
 
General procedure for the synthesis of 3-[(2E)-3-phenylprop-2-enoyl]chromone (7): 
To a round-bottom 50 ml flask, fitted with a septum, containing 3-(dimethylamino)-1-(2-
hydroxyphenyl)prop-2-en-1-one 2a (10.0 mmol), dissolved in 25 ml of dry MeCN, dry pyridine 
(3.3 equiv.) was added. The solution was set on stirring on the ice bath, and (2E)-3-phenylprop-
2-enoyl chloride 3l (1,1 equiv.) was added slowly. The reaction mixture stirred at the room 
temperature for 3 days (controlled by TLC). The formed precipitate was filtrated and well 
washed with water to give the chromone 7.  
 
3-[(2E)-3-phenylprop-2-enoyl]chromone 7 has already been reported and described. However, 
another synthetic approach was used.85 
O
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3-Dichloroacetylchromone 8 has been synthesized and reported by the group of Prof. Langer.28  
 
 
1.2.2 Supplement for Chapter 3 
 
General procedure for the synthesis of compounds 13-18: 
To a stirred reaction mixture of the corresponding 3-acylchromone 4-6 (1.0 mmol) and dimethyl 
1,3-acetonedicarboxylate 12 (1.1 mmol) in 1,4-dioxane (6-7 mL), DBU (1.3 mmol) was added 
slowly via a syringe at room temperature. Stirring at room temperature was continued until 
chromone was consumed completely (followed by TLC, approximately 10-12 h). The reaction 
mixture was quenched with an aqueous solution of 10% NH4Cl, extracted with CHCl3 and dried 
(Na2SO4). The solvent was distilled off under reduced pressure. The resulting residue was 
subjected to column chromatography on silica gel using heptane-ethylacetate (5:1) as eluent, 
slowly increasing the polarity up to 3:1 to give the isolated products. 
 
Trimethyl 3-hydroxy-6-(2-hydroxybenzoyl)benzene-1,2,4-tricarboxylate (13a): 
Starting with 3-methoxalylchromone 4a (0.232 g, 1.0 mmol), 
dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
13a was isolated as a pale yellow solid (0.298 g, 74%), mp 138-
140 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.63 (s, 3H, OCH3), 3.94 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 
6.85 (ddd, 3J = 8.0 Hz, 3J = 7.3 Hz, 4J = 1.0 Hz, 1H, 5′-HAr), 7.06 (dd, 3J = 8.4 Hz, 4J = 1.0 Hz, 
1H, 3′-HAr), 7.29 (dd, 3J = 8.0 Hz, 4J = 1.6 Hz, 1H, 6′-HAr), 7.51 (ddd, 3J = 8.4 Hz, 3J = 7.3 Hz, 
4J = 1.6 Hz, 1H, 4′-HAr), 8.04 (s, 1H, 5-HAr), 11.56 (s, 1H, OH), 11.63 (s, 1H, OH); 13C NMR 
(62.9 MHz, CDCl3): δ = 52.9 (OCH3), 53.0 (OCH3), 53.2 (OCH3), 114.3, 118.4, 119.1, 119.4, 
124.0, 129.3, 131.9, 132.4, 136.4, 136.8, 160.2, 162.7, 165.2, 165.3, 168.8, 199.3 (C=O); MS 
(GC, 70 eV) m/z (%): 388 ([M]+, 7), 356 (40), 297 (92), 265 (100), 238 (10); HRMS (EI): calcd 
for C19H16O9 ([M]+) 388.07888, found 388.07794; IR (ATR, cm–1): ~ν  = 2951 (w), 1732 (s), 
1682 (m), 1631 (m), 1611 (m), 1581 (m), 1514 (w), 1484 (w), 1443 (s), 1415 (w), 1353 (m), 
1323 (m), 1295 (s), 1234 (s), 1193 (s), 1140 (s), 1049 (s), 992 (m), 949 (m), 904 (m), 883 (m), 
O
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847 (m), 809 (m), 785 (s), 756 (s), 731 (s), 719 (s), 706 (s), 652 (s), 607 (m), 578 (m), 561 (s), 
530 (m). 
 
Trimethyl 3-hydroxy-6-(2-hydroxy-5-methylbenzoyl)benzene-1,2,4-tricarboxylate (13b):  
Starting with 3-methoxalyl-6-methylchromone 4b (0.246 g, 1.0 
mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) 
and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
13b was isolated as a white solid (0.350 g, 87%), mp 136-138 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 2.22 (s, 3H, CH3), 3.59 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 
3.90 (s, 3H, OCH3), 6.88 (d, 3J = 8.4 Hz, 1H, 3′-HAr), 7.21 (s, 1H, 6′-HAr), 7.31 (dd, 3J = 8.4 Hz, 
4J = 1.9 Hz, 1H, 4′-HAr), 7.98 (s, 1H, 5-HAr), 10.40 (s, 1H, OH), 11.30 (s, 1H, OH); 13C NMR 
(62.9 MHz, DMSO-d6): δ = 19.8 (CH3), 2ˣ52.8 (OCH3), 53.2 (OCH3), 115.5, 117.1, 122.2, 
122.8, 128.0, 129.8, 131.1, 133.0, 136.0, 136.3, 156.4, 158.5, 164.8, 165.8, 167.4, 194.9 (C=O); 
MS (GC, 70 eV) m/z (%): 402 ([M]+, 10), 370 (31), 311 (71), 279 (100); HRMS (EI): calcd for 
C20H18O9 ([M]+) 402.09453, found 402.09435; IR (ATR, cm–1): ~ν  = 2952 (w), 1733 (s), 1682 
(w), 1633 (m), 1606 (w), 1582 (m), 1484 (w), 1441 (m), 1408 (w), 1372 (w), 1352 (m), 1320 
(w), 1283 (m), 1232 (s), 1206 (s), 1153 (s), 1137 (s), 1048 (m), 1014 (m), 993 (m), 983 (m), 953 
(m), 931 (w), 882 (w), 828 (m), 809 (m), 787 (s), 767 (m), 728 (m), 708 (m), 670 (s), 607 (w), 
575 (w), 538 (m). 
 
Trimethyl 3-hydroxy-6-(2-hydroxy-4-methoxybenzoyl)benzene-1,2,4-tricarboxylate (13c):  
Starting with 7-methoxy-3-methoxalylchromone 4c (0.262 g, 
1.0 mmol), dimethyl 1,3-acetone-dicarboxylate 12 (0.16 mL, 
1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-
7 mL), the product 13c was isolated as a white solid (0.305 g, 
73%), mp 137-139 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.61 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 3.83 (s, 3H, 
OCH3), 3.91 (s, 3H, OCH3), 6.50-6.54 (m, 2H, 3′, 5′-HAr), 7.36 (d, 3J = 8.5 Hz, 1H, 6′-HAr), 7.97 
(s, 1H, 5-HAr), 11.24 (s, 1H, OH), 11.52 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 52.8 
(OCH3), 53.0 (OCH3), 53.2 (OCH3), 55.8 (OCH3), 101.2, 107.4, 114.3, 115.6, 123.3, 129.6, 
132.3, 134.1, 135.7, 158.0, 163.3, 164.8, 165.5, 165.8, 167.4, 195.3 (C=O); MS (GC, 70 eV) m/z 
(%): 418 ([M]+, 16), 386 (14), 359 (12), 327 (92), 295 (100), 151 (11); HRMS (ESI): calcd for 
OH O COOCH3
COOCH3
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COOCH3CH3
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C20H19O10 ([M+H]+) 419.09727, found 419.09759; IR (ATR, cm–1): ~ν  = 2960 (w), 1738 (s), 
1691 (m), 1639 (m), 1601 (m), 1573 (m), 1505 (w), 1429 (m), 1345 (m), 1299 (s), 1248 (s), 1216 
(s), 1195 (s), 1165 (s), 1128 (s), 1053 (m), 1002 (m), 973 (m), 950 (m), 922 (m), 870 (m), 817 
(m), 780 (s), 712 (s), 624 (m), 558 (m), 531 (m).  
 
Trimethyl 3-hydroxy-6-(5-chloro-2-hydroxybenzoyl)benzene-1,2,4-tricarboxylate (13d):  
Starting with 6-chloro-3-methoxalylchromone 4d (0.266 g, 1.0 
mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) 
and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
13d was isolated as a yellow solid (0.304 g, 72%), mp 172-174 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.61 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 3.91 (s, 3H, 
OCH3), 6.97 (d, 3J = 8.8 Hz, 1H, 3′-HAr), 7.40 (d, 4J = 2.7 Hz, 1H, 6′-HAr), 7.50 (dd, 3J = 8.8 Hz, 
4J = 2.7 Hz, 1H, 4′-HAr), 7.99 (s, 1H, 5-HAr), 10.65 (s, 1H, OH), 11.33 (s, 1H, OH); 13C NMR 
(62.9 MHz, DMSO-d6): δ = 2ˣ52.8 (OCH3), 53.2 (OCH3), 115.5, 119.0, 122.7, 122.9, 124.9, 
129.4, 129.9, 133.3, 134.1, 136.5, 156.2, 158.8, 164.8, 165.9, 167.3, 192.4 (C=O); MS (GC, 70 
eV) m/z (%): 422 ([M]+, 5), 392 (12), 391 (15), 390 (30), 333 (22), 332 (12), 331 (65), 301 (36), 
300 (22), 299 (100), 272 (8), 155 (8), 99 (8); HRMS (ESI): calcd for C19H1535ClNaO9 ([M+Na]+) 
445.02968, found 445.03049, calcd for C19H1537ClNaO9 ([M+Na]+) 447.02767, found 
447.02796; IR (ATR, cm–1): ~ν  = 3019 (w), 2957 (w), 1742 (m), 1730 (w), 1693 (m), 1682 (m), 
1667 (m), 1622 (m), 1602 (m), 1564 (w), 1525 (w), 1471 (w), 1434 (m), 1402 (w), 1359 (m), 
1338 (m), 1317 (m), 1287 (m), 1269 (s), 1229 (s), 1203 (s), 1154 (s), 1104 (m), 1048 (m), 1008 
(w), 978 (m), 944 (m), 915 (w), 869 (w), 842 (m), 823 (m), 810 (s), 798 (s), 778 (m), 749 (s), 
730 (s), 691 (s), 647 (m), 622 (m), 601 (s), 559 (m), 530 (m). 
 
Trimethyl 6-(5-chloro-2-hydroxy-4-methylbenzoyl)-3-hydroxybenzene-1,2,4-tricarboxylate 
(13e): 
Starting with 6-chloro-7-methyl-3-methoxalylchromone 4e 
(0.280 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 
(0.16 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-
dioxane (6-7 mL), the product 13e was isolated as a yellow 
solid (0.310 g, 71%), mp 175-177 ºC; 
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1H NMR (300 MHz, DMSO-d6): δ = 2.32 (s, 3H, CH3), 3.61 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 
3.90 (s, 3H, OCH3), 6.94 (s, 1H, 3′-HAr), 7.41 (s, 1H, 6′-HAr), 7.99 (s, 1H, 5-HAr), 10.65 (s, 1H, 
OH), 11.30 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 20.0 (CH3), 52.8 (OCH3), 52.9 
(OCH3), 53.2 (OCH3), 115.5, 119.6, 122.2, 122.8, 123.5, 129.7, 130.5, 133.0, 136.2, 142.9, 
156.7, 158.6, 164.8, 165.8, 167.4, 192.7 (C=O); MS (EI, 70 eV) m/z (%): 436 ([M]+, 9), 406 
(13), 405 (16), 404 (31), 347 (24), 346 (15), 345 (76), 313 (100), 77 (8); HRMS (ESI): calcd for 
C20H1735ClNaO9 ([M+Na]+) 459.04533, found 459.04554, calcd for C20H1737ClNaO9 ([M+Na]+) 
461.04388, found 461.04340; IR (ATR, cm–1): ~ν  = 3060 (w), 2951 (w), 2847 (w), 1731 (s), 
1682 (m), 1567 (w), 1482 (w), 1449 (m), 1433 (m), 1360 (w), 1315 (m), 1287 (m), 1252 (s), 
1223 (s), 1194 (s), 1179 (s), 1155 (s), 1132 (s), 1058 (m), 1016 (w), 993 (s), 961 (w), 944 (m), 
918 (m), 896 (m), 872 (w), 842 (w), 794 (s), 778 (s), 751 (m), 727 (s), 702 (m), 675 (s), 645 (m), 
609 (m), 593 (m), 531 (w). 
 
Trimethyl 6-(5-bromo-2-hydroxybenzoyl)-3-hydroxybenzene-1,2,4-tricarboxylate (13f): 
Starting with 6-bromo-3-methoxalylchromone 4f (0.311 g, 1.0 
mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) 
and DBU (0.20 mL, 1,3 mmol) in 1,4-dioxane (6-7 mL), the product 
13f was isolated as a white solid (0.378 g, 81%), mp 192-194 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.69 (s, 3H, OCH3), 3.95 (s, 3H, OCH3), 4.00 (s, 3H, OCH3), 
6.97 (d, 3J = 8.9 Hz, 1H, 3′-HAr), 7.38 (d, 4J = 2.4 Hz, 1H, 6′-HAr), 7.58 (dd, 3J = 8.9 Hz, 4J = 
2.4 Hz, 1H, 4′-HAr), 8.00 (s, 1H, 5-HAr), 11.56 (s, 1H, OH), 11.60 (s, 1H, OH); 13C NMR (75.5 
MHz, CDCl3): δ = 53.0 (OCH3), 53.1 (OCH3), 53.3 (OCH3), 110.7, 114.5, 120.5, 120.7, 124.3, 
128.7, 131.6, 134.3, 136.2, 139.5, 160.5, 161.7, 165.0, 165.1, 168.7, 198.6 (C=O); MS (EI, 70 
eV) m/z (%): 466 ([M]+, 7), 437 (16), 436 (46), 435 (167), 434 (44), 378 (12), 377 (89), 376 (14), 
375 (88), 346 (19), 345 (100), 344 (19), 343 (98), 201 (10), 69 (8); HRMS (EI): calcd for 
C19H1579BrO9 ([M]+) 465.98940, found 465.98946, calcd for C19H1581BrO9 ([M]+) 467.98735, 
found 467.98749; IR (ATR, cm–1): ~ν  = 2956 (w), 1743 (m), 1730 (m), 1688 (m), 1651 (w), 1623 
(m), 1598 (m), 1584 (m), 1531 (w), 1465 (w), 1468 (w), 1440 (m), 1403 (w), 1354 (m), 1318 
(m), 1289 (m), 1271 (m), 1257 (m), 1233 (s), 1206 (s), 1164 (s), 1139 (s), 1048 (w), 1006 (w), 
984 (m), 943 (m), 904 (w), 878 (w), 838 (m), 812 (m), 789 (m), 761 (m), 728 (m), 686 (s), 632 
(w), 616 (m), 562 (m), 546 (w).  
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Trimethyl 3-hydroxy-6-(1-hydroxy-2-naphthoyl)benzene-1,2,4-tricarboxylate (13g): 
Starting with 3-methoxalylbenzo[h]chromone 4g (0.282 g, 1.0 
mmol), dimethyl 1,3-acetone-dicarboxylate 12 (0.16 mL, 1.1 
mmol) and DBU (0.20 mL, 1,3 mmol) in 1,4-dioxane (6-7 mL), 
the product 13g was isolated as a yellow solid (0.201 g, 46%), 
mp 187-188 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.64 (s, 3H, OCH3), 3.96 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 
7.19-7.25 (m, 2H, HAr), 7.53-7.59 (m, 1H, HAr), 7.63-7.68 (m, 1H, HAr), 7.74-7.76 (m, 1H, HAr), 
8.08 (s, 1H, 5-HAr), 8.50 (d, 3J = 8.3 Hz, 1H, HAr), 11.56 (s, 1H, OH), 13.47 (s, 1H, OH); 13C 
NMR (75.5 MHz, CDCl3): δ = 2ˣ53.0 (OCH3), 53.2 (OCH3), 112.8, 114.3, 118.5, 123.9, 124.4, 
125.0, 126.0, 126.2, 127.5, 129.5, 130.6, 131.9, 136.4, 137.4, 160.1, 163.4, 165.3, 168.9, 199.0 
(C=O); MS (EI, 70 eV) m/z (%): 438 ([M]+, 10), 406 (23), 347 (64), 315 (100); HRMS (EI): 
calcd for C23H18O9 ([M]+) 438.09453, found 438.09494; IR (ATR, cm–1): ~ν  = 3019 (w), 2960 
(w), 1753 (m), 1738 (m), 1690 (m), 1628 (w), 1598 (m), 1568 (m), 1503 (w), 1463 (w), 1439 
(m), 1418 (w), 1389 (w), 1334 (m), 1297 (s), 1272 (m), 1245 (s), 1217 (s), 1192 (s), 1167 (s), 
1128 (s), 1065 (m), 1024 (w), 1009 (w), 988 (s), 949 (m), 930 (w), 890 (w), 868 (w), 832 (w), 
808 (s), 795 (s), 765 (s), 730 (s), 709 (s), 667 (w), 640 (w), 615 (m), 593 (m), 574 (m), 560 (m). 
  
8,10-Dimethyl 6,9-dihydroxy-3-methoxy-6-(trifluoromethyl)-6H-benzo[c]-chromene-8,10-
dicarboxylate (14a): 
Starting with 7-methoxy-3-(trifluoroacetyl)chromone 5b (0.272 
g, 1.0 mmol), dimethyl 1,3-acetone-dicarboxylate 12 (0.16 mL, 
1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 
mL), the product 14a was isolated as a white solid (0.090 g, 
21%), mp 244-246 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.82 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 3.96 (s, 3H, 
OCH3), 6.73 (d, 4J = 2.6 Hz, 1H, 4-HAr), 6.78 (d, 3J = 8.9 Hz, 4J = 2.6 Hz, 1H, 2-HAr), 7.38 (d, 3J 
= 8.9 Hz, 1H, 1-HAr), 8.07 (s, 1H, 7-HAr), 9.29 (s, 1H, 6-OH), 11.05 (s, 1H, 9-OH); 13C NMR 
(62.9 MHz, DMSO-d6): δ = 52.9 (OCH3), 53.0 (OCH3), 55.7 (OCH3), 95.1 (q, 2JC,F = 32.1 Hz, 6-
C), 102.5, 110.1, 110.3, 111.4, 117.9, 119.7, 126.2, 129.5, 133.1, 153.4, 158.5, 162.4, 167.4, 
168.0; 19F NMR (282.4 MHz, DMSO-d6): δ = -82.5 (s, 3F, CF3); MS (GC 70 eV) m/z (%): 428 
([M]+, 33), 397 (12), 359 (27), 327 (100), 295 (86), 211 (10), 151 (61), 108 (10); HRMS (ESI): 
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calcd for C19H16F3O8 ([M+H]+) 429.07918, found 429.07901, calcd for C19H15F3NaO8 
([M+Na]+) 451.06112, found 451.06158; IR (ATR, cm–1): ~ν  = 3233 (w), 2964 (w), 2941 (w), 
2845 (w), 1684 (m), 1611 (m), 1591 (m), 1559 (w), 1514 (w), 1505 (w), 1457 (w), 1440 (m), 
1432 (m), 1355 (m), 1336 (w), 1298 (m), 1276 (m), 1253 (m), 1214 (s), 1182 (s), 1162 (s), 1137 
(s), 1111 (s), 1070 (m), 1035 (s), 980 (s), 942 (m), 925 (m), 897 (m), 882 (w), 865 (s), 809 (w), 
795 (s), 770 (m), 743 (m), 724 (m), 707 (m), 679 (s), 660 (m), 638 (m), 628 (m), 578 (m), 543 
(m). 
 
Dimethyl 2-chloro-6,9-dihydroxy-6-(trifluoromethyl)-6H-benzo[c]chromene-8,10-
dicarboxylate (14b):  
Starting with 6-chloro-3-(trifluoroacetyl)chromone 5c (0.272 g, 1.0 
mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) 
and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the 
product 14b was isolated as a yellow solid (0.276 g, 64%), mp 
212-214 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.92 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 7.26 (d, 3J = 8.7 
Hz, 1H, 4-HAr), 7.42 (d, 4J = 2.4 Hz, 1H, 1-HAr), 7.54 (dd, 3J = 8.7, 4J = 2.4 Hz, 1H, 3-HAr), 8.13 
(s, 1H, 7-HAr), 9.49 (s, 1H, 6-OH), 11.09 (s, 1H, 9-OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 
53.0 (OCH3), 53.2 (OCH3), 95.3 (q, 2JC,F = 32.6 Hz, 6-C), 113.8, 119.3, 119.4, 119.9, 120.8, 
122.4 (q, 1JC,F = 290.6 Hz, CF3), 124.3, 126.8, 129.7, 131.1, 131.9, 150.5, 158.4, 167.1, 167.6; 
19F NMR (282.4 MHz, DMSO-d6): δ = -82.3 (s, 3F, CF3); MS (GC, 70 eV) m/z (%): 402 ([M-
OCH3+H], 15), 400 (45), 369 (22), 333 (33), 332 (17), 331 (91), 301 (34), 300 (16), 299 (100), 
264 (10), 231 (13); HRMS (ESI): calcd for C18H1335ClF3O7 ([M+H]+) 433.02964, found 
433.03073, calcd for C18H1337ClF3O7 ([M+H]+) 435.02750, found 435.02865; IR (ATR, cm–1): ~ν  
= 3425 (w), 2951 (w), 1705 (m), 1687 (m), 1615 (w), 1594 (w), 1563 (w), 1482 (w), 1461 (w), 
1445 (m), 1432 (m), 1408 (w), 1340 (m), 1310 (m), 1272 (w), 1246 (m), 1227 (s), 1191 (s), 1176 
(s), 1144 (s), 1056 (m), 996 (s), 947 (m), 937 (m), 924 (m), 887 (w), 858 (m), 825 (m), 806 (s), 
778 (m), 759 (m), 746 (m), 721 (m), 703 (s), 665 (s), 619 (w), 591 (m), 568 (w), 545 (m).  
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Dimethyl 2-bromo-6,9-dihydroxy-6-(trifluoromethyl)-6H-benzo[c]chromene-8,10-
dicarboxylate (14c):  
Starting with 6-bromo-3-(trifluoroacetyl)chromone 5d (0.321 g, 
1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 
mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), 
the product 14c was isolated as a white solid (0.281 g, 59%), mp 
204-206 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.92 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 7.19 (d, 3J = 8.7 
Hz, 1H, 4-HAr), 7.56 (d, 4J = 2.3 Hz, 1H, 1-HAr), 7.65 (dd, 3J = 8.7 Hz, 4J = 2.3 Hz, 1H, 3-HAr), 
8.12 (s, 1H, 7-HAr), 9.50 (s, 1H, 6-OH), 11.09 (s, 1H, 9-OH); 13C NMR (62.9 MHz, DMSO-d6): 
δ = 53.0 (OCH3), 53.2 (OCH3), 95.3 (q, 2JC,F = 32.5 Hz, 6-C), 113.8, 114.4, 119.3, 119.8, 120.2, 
120.7, 122.4 (q, 2JC,F = 291.3 Hz, CF3), 127.3, 129.7, 131.0, 134.7, 150.9, 158.3, 167.1, 167.6; 
19F NMR (282.4 MHz, DMSO-d6): δ = -82.3 (s, 3F, CF3); MS (GC, 70 eV) m/z (%): 476 ([M]+, 
23), 447 (12), 446 (11), 445 (15), 378 (14), 377 (74), 376 (12), 375 (71), 346 (15), 345 (100), 
344 (16), 343 (90), 201 (23), 200 (34), 199 (25), 198 (39), 173 (23), 172 (16); HRMS (ESI): 
calcd for C18H1279BrF3O7 ([M+H]+) 476.97913, found 476.97958, calcd for C18H1281BrF3O7 
([M+H]+) 478.97733, found 478.97748; IR (ATR, cm–1): ~ν  = 3434 (w), 3076 (w), 2953 (w), 
1922 (w), 1717 (s), 1677 (m), 1614 (w), 1593 (w), 1557 (w), 1462 (w), 1446 (m), 1403 (w), 
1346 (w), 1312 (m), 1229 (s), 1197 (s), 1174 (s), 1143 (s), 1082 (w), 1051 (m), 995 (s), 933 (w), 
921 (w), 878 (w), 853 (w), 835 (m), 806 (s), 788 (w), 750 (m), 699 (m), 662 (m), 587 (m), 569 
(w), 536 (w). 
 
Dimethyl 6,9-dihydroxy-6-(pentafluoroethyl)-6H-benzo[c]chromene-8,10-dicarboxylate 
(14d): 
Starting with 3-(pentafluoropropanoyl)chromone 5f (0.292 g, 1.0 
mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) 
and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
14d was isolated as a white solid (0.291 g, 65%), mp 221-223 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.92 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 7.10-7.20 (m, 2H, 
2,4-HAr), 7.43-7.50 (m, 2H, 1,3-HAr), 8.13 (d, 5JH,F = 1.6 Hz, 1H, 7-HAr), 9.46 (d, 4JH,F = 3.9 Hz, 
1H, 6-OH), 11.08 (s, 1H, 9-OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 53.0 (OCH3), 53.1 
(OCH3), 96.7 (t, 2JC,F = 28.2 Hz, 6-C), 112.8, 117.7, 117.9, 119.0, 120.9, 123.3, 124.9, 130.6, 
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132.4, 133.2, 151.8, 158.6, 167.3, 167.9; 19F NMR (282.4 MHz, DMSO-d6): δ = –77.9 (s, 3F, 
CF3), –121.8 (d, 2J = 279.5 Hz, 1F, CFF), –124.0 (d, 2J = 279.5 Hz, 1F, CFF); MS (EI, 70 eV) 
m/z (%): 448 ([M]+, 3), 417 (10), 385 (18), 329 (86), 297 (100), 265 (70), 210 (12), 133 (9); 
HRMS (ESI): calcd for C19H14F5O7 ([M+H]+) 449.06542, found 449.06548; IR (ATR, cm–1): ~ν  
= 3420 (w), 2959 (w), 1712 (m), 1676 (m), 1608 (w), 1596 (w), 1568 (w), 1494 (w), 1464 (w), 
1433 (m), 1393 (w), 1337 (m), 1319 (m), 1298 (w), 1273 (w), 1251 (m), 1222 (s), 1175 (s), 1143 
(s), 1072 (s), 1052 (m), 1042 (m), 998 (s), 970 (m), 946 (w), 933 (m), 908 (m), 877 (w), 863 (w), 
842 (m), 806 (m), 778 (s), 759 (s), 736 (s), 709 (m), 687 (m), 662 (m), 645 (w), 614 (m), 579 
(w), 533 (m). 
 
8,10-Dimethyl 6,9-dihydroxy-4-methyl-6-(pentafluoroethyl)-6H-benzo[c]chromene-8,10-
dicarboxylate (14e): 
Starting with 6-methyl-3-(pentafluoropropanoyl)chromone 5g 
(0.306 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 
mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-
7 mL), the product 14e was isolated as a white solid (0.143 g, 
31%), mp 239-241 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.29 (s, 3H, CH3), 3.91 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 
7.01 (d, 3J = 8.1 Hz, 1H, 4-HAr), 7.24-7.28 (m, 2H, 1,3-HAr), 8.11 (d, 5JH,F = 1.5 Hz, 1H, 7-HAr), 
9.39 (d, 4JH,F = 3.9 Hz, 1H, 6-OH), 11.07 (s, 1H, 9-OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 
20.5 (CH3), 52.9 (OCH3), 53.1 (OCH3), 96.7 (t, 2JC,F = 27.3 Hz, 6-C), 112.7, 117.5, 117.6, 118.9, 
121.0, 125.0, 130.5, 131.9, 133.0, 133.2, 149.7, 158.6, 167.3, 167.9; 19F NMR (282.4 MHz, 
DMSO-d6): δ = –77.9 (s, 3F, CF3), –121.7 (d, 2J = 279.4 Hz, 1F, CFF), –123.9 (d, 2J = 279.4 Hz, 
1F, CFF); MS (EI, 70 eV) m/z (%): 462 ([M]+, 7), 430 (17), 399 (17), 343 (79), 311 (100), 279 
(69), 140 (9), 69 (8); HRMS (ESI): calcd for C20H16F5O7 ([M+H]+) 463.08107, found 463.08170, 
calcd for C20H15F5NaO7 ([M+Na]+) 485.06301, found 485.06357; IR (ATR, cm–1): ~ν  = 3412 
(w), 3012 (w), 2958 (w), 2932 (w), 1726 (s), 1676 (m), 1616 (w), 1597 (w), 1574 (w), 1490 (w), 
1444 (m), 1383 (w), 1371 (w), 1348 (m), 1339 (m), 1315 (w), 1293 (w), 1273 (w), 1255 (m), 
1215 (s), 1182 (s), 1155 (m), 1143 (s), 1130 (m), 1075 (s), 1048 (m), 1011 (m), 977 (w), 950 
(w), 932 (w), 911 (m), 880 (w), 848 (w), 817 (s), 804 (m), 786 (w), 775 (w), 740 (w), 732 (m), 
716 (w), 676 (w), 664 (w), 640 (m), 611 (w), 584 (w), 564 (w), 534 (w).  
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8,10-Dimethyl 6,9-dihydroxy-3-methyl-6-(pentafluoroethyl)-6H-benzo[c]chromene-8,10-
dicarboxylate (14f): 
Starting with 7-methyl-3-(pentafluoropropanoyl)chromone 5h 
(0.306 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 
mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-
7 mL), the product 14f was isolated as a white solid (0.185 g, 
40%), mp 225-227 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.33 (s, 3H, CH3), 3.90, 3.97 (both s, 3H, OCH3), 6.94-7.00 
(m, 2H, 2,4-HAr), 7.34 (d, 3J = 8.1 Hz, 1H, 1-HAr), 8.10 (d, 5JH,F = 1.6 Hz, 1H, 7-HAr), 9.41 (d, 
4JH,F = 4.0 Hz, 1H, 6-OH), 11.06 (s, 1H, 9-OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 20.8 
(CH3), 52.9 (OCH3), 53.1 (OCH3), 96.8 (t, 2JC,F = 27.0 Hz, 6-C), 112.2, 115.1, 117.8, 118.6, 
120.5, 124.1, 124.7, 130.6, 133.4, 143.0, 151.8, 158.6, 167.3, 168.0; 19F NMR (282.4 MHz, 
DMSO-d6): δ = –77.8 (s, 3F, CF3), –121.8 (d, 2J = 278.5 Hz, 1F, CFF), –124.1 (d, 2J = 278.5 Hz, 
1F, CFF); MS (EI, 70 eV) m/z (%): 462 ([M]+, 8), 431 (11), 399 (19), 343 (95), 311 (100), 279 
(56), 224 (11), 140 (11); HRMS (ESI): calcd for C20H16F5O7 ([M+H]+) 463.08107, found 
463.08133, calcd for C20H15F5NaO7 ([M+Na]+) 485.06301, found 485.06367; IR (ATR, cm–1): ~ν  
= 3324 (w), 3009 (w), 2956 (w), 2853 (w), 1703 (s), 1681 (m), 1614 (m), 1593 (m), 1563 (w), 
1512 (w), 1460 (w), 1443 (m), 1435 (m), 1392 (w), 1332 (m), 1276 (w), 1257 (m), 1213 (s), 
1182 (s), 1164 (s), 1146 (s), 1137 (s), 1073 (s), 1045 (m), 997 (s), 972 (m), 963 (m), 931 (s), 922 
(m), 891 (m), 866 (s), 825 (w), 814 (m), 802 (s), 783 (m), 765 (m), 742 (m), 730 (s), 705 (m), 
672 (w), 662 (m), 648 (w), 620 (m), 582 (m), 540 (m). 
 
8,10-Dimethyl 6,9-dihydroxy-4-methoxy-6-(pentafluoroethyl)-6H-benzo[c]-chromene-8,10-
dicarboxylate (14g): 
 Starting with 6-methoxy-3-(pentafluoropropanoyl)chromone 5i 
(0.322 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 
(0.16 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-
dioxane (6-7 mL), the product 14g was isolated as a pale yellow 
solid (0.116 g, 27%), mp 226-228 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.75 (s, 3H, OCH3), 3.92 (s, 3H, OCH3), 3.97 (s, 3H, 
OCH3), 7.01-7.06 (m, 3H, 1,3,4-HAr), 8.11 (s, 1H, 7-HAr), 9.36 (d, 4JH,F = 3.8 Hz, 1H, 6-OH), 
11.06 (s, 1H, 9-OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 53.0 (OCH3), 53.2 (OCH3), 55.5 
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(OCH3), 97.1 (t, 2JC,F = 27.0 Hz, 6-C), 109.2, 112.9, 118.3, 118.4, 118.6, 119.1, 121.3, 130.5, 
133.0, 145.7, 154.5, 158.5, 167.4, 167.8; 19F NMR (282.4 MHz, CDCl3): δ = –77.8 (s, 3F, CF3), 
–121.5 (d, 2J = 279.6 Hz, 1F, CFF), –123.7 (d, 2J = 279.6 Hz, 1F, CFF); MS (EI, 70 eV) m/z 
(%): 478 ([M+], 45), 447 (19), 446 (38), 415 (23), 359 (100), 327 (92), 295 (91), 268 (22), 240 
(15), 148 (19); HRMS (ESI): calcd for C20H16F5O8 ([M+H]+) 479.07598, found 479.07630, calcd 
for C20H15F5NaO8 ([M+Na]+) 501.05793, found 501.05833; IR (ATR, cm–1): ~ν  = 3403 (w), 
3004 (w), 2960 (w), 2924 (w), 2850 (w), 1717 (m), 1673 (w), 1615 (w), 1570 (w), 1490 (w), 
1470 (w), 1444 (m), 1342 (m), 1314 (m), 1295 (w), 1247 (m), 1207 (s), 1173 (s), 1144 (s), 1109 
(m), 1068 (s), 1041 (s), 998 (s), 946 (m), 937 (m), 912 (m), 882 (m), 849 (m), 810 (s), 799 (s), 
771 (s), 731 (s), 680 (m), 665 (m), 649 (m), 611 (m), 577 (w), 535 (w). 
 
Dimethyl 6,9-dihydroxy-3-methoxy-6-(pentafluoroethyl)-6H-benzo[c]chromene-8,10-
dicarboxylate (14h): 
Starting with 7-methoxy-3-(pentafluoropropanoyl)chromone 5j 
(0.322 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 
(0.16 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-
dioxane (6-7 mL), the product 14h was isolated as a pale yellow 
solid (0.185 g, 65%), mp 217-219 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.81 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 3.97 (s, 3H, 
OCH3), 6.65 (d, 4J = 2.5 Hz, 1H, 4-HAr), 6.79 (dd, 3J = 9.0 Hz, 4J = 2.6 Hz, 1H, 2-HAr), 7.38 (d, 
3J = 9.0 Hz, 1H, 1-HAr), 8.08 (d, 5JH,F  = 1.4 Hz, 1H, 7-HAr), 9.43 (d, 1H, 4JH,F = 3.8 Hz, 6-OH), 
11.07 (s, 1H, 9-OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 52.9 (OCH3), 53.0 (OCH3), 55.7 
(OCH3), 97.0 (t, 2JC,F = 28.1 Hz, 6-C), 102.5, 109.9, 110.5, 111.5, 117.9, 119.7, 126.3, 130.6, 
133.5, 153.5, 158.8, 162.4, 167.4, 168.1; 19F NMR (282.4 MHz, DMSO-d6):  δ = –77.8 (s, 3F, 
CF3), –122.0 (d, 2J = 279.5 Hz, 1F, CFF), –124.4 (d, 2J = 279.5 Hz, 1F, CFF); MS (EI, 70 eV) 
m/z (%): 478 ([M]+, 9), 446 (16), 415 (12), 359 (42), 327 (100), 295 (61), 240 (7), 148 (7); 
HRMS (ESI): calcd for C20H16F5O8 ([M+H]+) 479.07598, found 479.07621; IR (ATR, cm–1): ~ν  
= 3287 (w), 2960 (w), 2847 (w), 1716 (m), 1668 (w), 1606 (m), 1567 (w), 1512 (w), 1442 (m), 
1392 (w), 1361 (w), 1315 (m), 1283 (w), 1236 (s), 1218 (s), 1192 (s), 1168 (s), 1146 (s), 1111 
(s), 1070 (s), 1028 (m), 997 (s), 973 (m), 940 (w), 929 (m), 890 (m), 843 (m), 811 (w), 797 (s), 
767 (w), 744 (m), 727 (m), 709 (m), 650 (m), 619 (m), 608 (m), 596 (m), 536 (w). 
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8,10-Dimethyl 6,9-dihydroxy-2,3-dimethoxy-6-(pentafluoroethyl)-6H-benzo[c]-chromene-
8,10-dicarboxylate (14i): 
Starting with 6,7-dimethoxy-3-(pentafluoropropanoyl)chromone 
5k (0.352 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 
(0.16 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-
dioxane (6-7 mL), the product 14i was isolated as a yellow solid 
(0.264 g, 52%), mp 209-211 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.72 (s, 3H, OCH3), 3,82 (s, 3H, OCH3), 3.92 (s, 3H, 
OCH3), 3.96 (s, 3H, OCH3), 6.71 (s, 1H, 4-HAr), 6.97 (s, 1H, 1-HAr), 8.06 (s, 1H, 7-HAr), 9.36 (s, 
1H, 6-OH), 11.07 (s, 1H, 9-OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 52.9 (OCH3), 53.1 
(OCH3), 55.9 (OCH3), 56.0 (OCH3), 96.9 (t, 2JC,F = 26.7 Hz, 6-C), 101.5, 107.1, 108.9, 111.3, 
117.8, 119.9, 130.4, 133.6, 144.4, 147.2, 152.4, 158.7, 167.7, 168.0; 19F NMR (282.4 MHz, 
DMSO-d6): δ = –77.7 (s, 3F, CF3), –122.0 (d, 2J = 277.4 Hz, 1F, CFF), –124.2 (d, 2J = 277.4 Hz, 
1F, CFF); MS (EI, 70 eV) m/z (%): 508 ([M]+, 22), 477 (13), 476 (48), 445 (13), 389 (52), 358 
(20), 357 (100), 341 (13), 325 (41), 222 (10); HRMS (EI): calcd for C21H17F5O9 ([M]+) 
508.07872, found 477.07925; IR (ATR, cm–1): ~ν  = 3265 (w), 2956 (w), 2921 (w), 2851 (w), 
1712 (m), 1672 (m), 1614 (w), 1595 (w), 1569 (w), 1518 (w), 1465 (w), 1439 (m), 1409 (w), 
1348 (m), 1337 (m), 1306 (m), 1284 (w), 1266 (m), 1232 (s), 1199 (s), 1177 (s), 1162 (s), 1145 
(s), 1113 (m), 1079 (s), 1048 (m), 1035 (m), 1006 (m), 990 (m), 973 (m), 937 (m), 889 (m), 877 
(w), 819 (w), 800 (s), 782 (m), 769 (m), 748 (m), 717 (m), 683 (w), 670 (m), 645 (m), 622 (m), 
595 (w), 579 (w), 534 (w). 
 
8,10-Dimethyl 4-chloro-6,9-dihydroxy-3-methyl-6-(pentafluoroethyl)-6H-benzo[c]-
chromene-8,10-dicarboxylate (14j): 
Starting with 6-chloro-3-(pentafluoropropanoyl)chromone 5l 
(0.327 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 
mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 
mL), the product 14j was isolated as a white solid (0.323 g, 67%), 
mp 236-238 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.92 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 7.18 (d, 3J = 8.7 
Hz, 1H, 4-HAr), 7.41 (d, 4J = 2.1 Hz, 1H, 1-HAr), 7.53 (d, 3J = 8.7 Hz, 4J = 2.1 Hz, 1H, 3-HAr), 
8.13 (s, 1H, 7-HAr), 9.63 (d, 4JH,F = 3.7 Hz, 1H, 6-OH), 11.10 (s, 1H, 9-OH); 13C NMR (62.9 
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MHz, DMSO-d6): δ = 53.2 (OCH3), 53.1 (OCH3), 97.1 (t, 2JC,F = 27.3 Hz, 6-C), 113.8, 119.2, 
119.4, 119.7, 120.7, 124.2, 126.8, 130.7, 131.5, 131.9, 150.6, 158.5, 167.1, 167.6; 19F NMR 
(282.4 MHz, DMSO-d6): δ = –77.9 (s, 3F, CF3), –121.7 (d, 2J = 277.8 Hz, 1F, CFF), –123.9 (d, 
2J = 277.8 Hz, 1F, CFF); MS (EI, 70 eV) m/z (%): 482 ([M]+, 2), 452 (10), 451 (16), 450 (23), 
419 (26), 365 (32), 364 (15), 363 (87), 333 (58), 332 (25), 331 (100), 301 (29), 300 (13), 299 
(86), 244 (12), 209 (11), 150 (13); HRMS (ESI): calcd for C19H1235ClF5NaO7 ([M+Na]+) 
505.00839, found 505.00853; IR (ATR, cm–1): ~ν  = 3416 (w), 2960 (w), 1719 (s), 1674 (m), 
1614 (w), 1593 (w), 1562 (w), 1480 (w), 1461 (w), 1443 (m), 1405 (w), 1383 (w), 1343 (m), 
1309 (m), 1285 (w), 1253 (m), 1217 (s), 1176 (s), 1162 (m), 1144 (s), 1127 (m), 1093 (w), 1070 
(s), 1043 (m), 998 (s), 972 (m), 939 (m), 910 (m), 886 (w), 877 (w), 845 (m), 820 (s), 808 (m), 
786 (w), 776 (m), 756 (m), 738 (m), 725 (m), 712 (s), 666 (m), 636 (m), 611 (w), 562 (w). 
 
Dimethyl 2-chloro-6,9-dihydroxy-3-methyl-6-(pentafluoroethyl)-6H-benzo[c]-chromene-
8,10-dicarboxylate (14k): 
Starting with 6-chloro-7-methyl-3-(pentafluoropropanoyl)-
chromone 5m (0.341 g, 1.0 mmol), dimethyl 1,3-
acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and DBU (0.20 
mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 14k was 
isolated as a white solid (0.283 g, 57%), mp 223-225 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.35 (s, 3H, CH3), 3.92 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 
7.18 (s, 1H, 4-HAr), 7.41 (s, 1H, 1-HAr), 8.11 (d, 5JH,F = 1.4 Hz, 1H, 7-HAr), 9.59 (d, 4JH,F = 3.9 
Hz, 1H, 6-OH), 11.09 (s, 1H, 9-OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 19.6 (CH3), 53.0 
(OCH3), 53.1 (OCH3), 97.1 (t, 2JC,F  = 28.8 Hz, 6-C), 113.3, 117.0, 118.8, 120.0, 120.4, 124.5, 
127.2, 130.8, 131.7, 140.5, 150.5, 158.5, 167.2, 167.7; 19F NMR (282.4 MHz, DMSO-d6): δ = –
77.9 (s, 3F, CF3), –122.8 (d, 2J = 279.5 Hz, 1F, CFF), –124.1 (d, 2J = 279.5 Hz, 1F, CFF); MS 
(EI, 70 eV) m/z (%): 496 ([M]+, 7), 465 (11), 464 (18), 433 (18), 379 (27), 378 (15), 377 (88), 
347 (48), 346 (23), 345 (100), 315 (21), 314 (10), 313 (74), 258 (11), 157 (11); HRMS (ESI): 
calcd for C20H1535ClF5O7 ([M+H]+) 497.04210, found 497.04264, calcd for C20H1537ClF5O7 
([M+H]+) 499.04007, found 499.04068; IR (ATR, cm–1): ~ν  = 3434 (w), 3006 (w), 2953 (w), 
1713 (s), 1687 (m), 1613 (m), 1592 (w), 1552 (w), 1497 (w), 1443 (m), 1385 (w), 1336 (s), 1306 
(m), 1289 (w), 1261 (m), 1228 (s), 1188 (s), 1171 (s), 1155 (s), 1140 (s), 1080 (s), 1053 (s), 1016 
(m), 998 (s), 974 (m), 935 (m), 926 (m), 898 (m), 887 (m), 868 (m), 818 (m), 808 (s), 783 (m), 
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767 (m), 744 (m), 731 (m), 710 (s), 665 (m), 641 (w), 631 (s), 615 (w), 603 (m), 583 (w), 550 
(m), 535 (w). 
  
Dimethyl 2-bromo-6,9-dihydroxy-6-(pentafluoroethyl)-6H-benzo[c]chromene-8,10-
dicarboxylate (14l):  
Starting with 6-bromo-3-(pentafluoropropanoyl)chromone 5n 
(0.371 g, 1.0 mmol), dimethyl 1,3-acetone-dicarboxylate 12 (0.16 
mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 
mL), the product 14l was isolated as a white solid (0.358 g, 68%), 
mp 225-227 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.93 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 7.13 (d, 3J = 8.7 
Hz, 1H, 4-HAr), 7.55 (d, 4J = 2.2 Hz, 1H, 1-HAr), 7.65 (dd, 3J = 8.7 Hz, 4J = 2.2 Hz, 1H, 3-HAr), 
8.12 (d, 5JH,F  = 1.3 Hz, 1H, 7-HAr), 9.65 (d, 4JH,F = 3.6 Hz, 1H, 6-OH), 11.10 (s, 1H, 9-OH); 13C 
NMR (75.5 MHz, DMSO-d6): δ = 53.0 (OCH3), 53.2 (OCH3), 97.1 (t, 2JC,F = 28.8 Hz, 6-C), 
113.8, 114.4, 119.2, 119.9, 120.1, 120.7, 127.2, 130.8, 131.4, 134.8, 151.0, 158.5, 167.2, 167.6; 
19F NMR (282.4 MHz, DMSO-d6): δ = –78.0 (s, 3F, CF3), –121.8 (d, 2J = 279.7 Hz, 1F, CFF), –
124.0 (d, 2J = 279.7 Hz, 1F, CFF); MS (EI, 70 eV) m/z (%): 496 ([M-OCH3+H], 14), 494 (13), 
465 (12), 463 (12), 410 (10), 409 (57), 408 (10), 407 (57), 378 (15), 377 (100), 376 (15), 375 
(99), 345 (34), 343 (34), 265 (12), 264 (62), 236 (13), 173 (10), 172 (10), 44 (11); HRMS (ESI): 
calcd for C19H1279BrF5NaO7 ([M+Na]+) 548.95788, found 548.95771, calcd for 
C19H1281BrF5NaO7 ([M+Na]+) 550.95610, found 550.95591; IR (ATR, cm–1): ~ν  = 3427 (w), 
2957 (w), 1722 (s), 1674 (m), 1650 (w), 1613 (w), 1592 (w), 1556 (w), 1480 (w), 1442 (m), 
1341 (m), 1308 (m), 1253 (m), 1217 (s), 1177 (s), 1143 (s), 1071 (s), 1043 (m), 997 (s), 937 (m), 
908 (m), 877 (m), 843 (m), 819 (s), 775 (m), 748 (s), 708 (s), 664 (m), 628 (s), 561 (w), 542 (m). 
 
8,10-Dimethyl 3-fluoro-6,9-dihydroxy-6-(pentafluoroethyl)-6H-benzo[c]chromene-8,10-
dicarboxylate (14m):  
Starting with 7-fluoro-3-(pentafluoropropanoyl)chromone 5o (0.310 
g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 
mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the 
product 14m was isolated as a white solid (0.154 g, 33%), mp 213-
214 ºC;  
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1H NMR (300 MHz, DMSO-d6): δ = 3.92 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 7.05-7.11 (m, 2H, 
HAr), 7.48-7.53 (m, 1H, HAr), 8.11 (d, 5J = 1.5 Hz, 1H, 7-HAr), 9.63 (d, 4JH,F = 3.9 Hz, 1H, 6-
OH), 11.09 (s, 1H, 9-OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 53.1 (OCH3), 53.2 (OCH3), 
97.3 (t, 2JC,F = 27.4 Hz, 6-C), 105.2 (d, JC,F = 25.0 Hz), 110.8 (d, JC,F = 22.4 Hz), 112.8, 114.7 (d, 
JC,F = 3.6 Hz), 118.8, 120.1, 127.0 (d, JC,F = 10.6 Hz), 130.7 (d, JC,F = 2.2 Hz), 132.4, 153.4 (dd, 
JC,F = 12.1 Hz, JC,F = 1.2 Hz), 158.7, 163.7 (d, 1JC,F = 250.2 Hz, CArF), 167.2, 167.8; 19F NMR 
(282.4 MHz, DMSO-d6): δ = –77.9 (s, 3F, CF3), –106.9 (s, 1F, F),  –121.9 (d, 2J = 279.5 Hz, 1F, 
CFF), –124.2 (d, 2J = 279.5 Hz, 1F, CFF); MS (GC, 70 eV) m/z (%): 434 ([M-OCH3-H], 18), 
403 (21), 316 (14), 315 (77), 284 (16), 283 (100), 215 (24), 144 (11); HRMS (ESI): calcd for 
C19H11F6O7 ([M-H]-) 465.04145, found 465.04137; IR (ATR, cm–1): ~ν  = 3424 (w), 3086 (w), 
3010 (w), 2959 (w), 2927 (w), 2872 (w), 2857 (w), 1709 (s), 1682 (m), 1616 (m), 1602 (m), 
1510 (w), 1458 (w), 1431 (m), 1389 (w), 1360 (w), 1335 (m), 1310 (w), 1280 (m), 1262 (m), 
1225 (s), 1209 (s), 1184 (s), 1158 (s), 1142 (s), 1121 (s), 1106 (m), 1073 (s), 1040 (m), 997 (s), 
980 (m), 968 (m), 931 (m), 923 (m), 891 (m), 870 (s), 824 (w), 815 (w), 803 (s), 784 (m), 769 
(m), 757 (m), 743 (s), 730 (m), 704 (m), 674 (m), 663 (m), 646 (w), 626 (m), 606 (m), 577 (w), 
540 (w). 
 
Dimethyl 6,9-dihydroxy-6-(pentafluoroethyl)-6H-dibenzo[c,h]chromene-8,10-dicarboxylate 
(14n): 
Starting with 3-(pentafluoropropanoyl)benzo[h]chromone 5p (0.342 
g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 
mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the 
product 14n was isolated as a pale yellow solid (0.388 g, 78%), mp 
233-235 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.94 (s, 3H, OCH3), 3.99 (s, 3H, OCH3), 7.53 (d, 3J = 8.9 
Hz, 1H, HAr), 7.64-7.72 (m, 3H, HAr), 7.93-7.97 (m, 1H, HAr), 8.17-8.23 (m, 2H, HAr), 9.74 (d, 
4JH,F = 3.8 Hz, 1H, 6-OH), 11.14 (s, 1H, 9-OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 53.0 
(OCH3), 53.1 (OCH3), 97.6 (t, 2JC,F = 28.6 Hz, 6-C), 112.4, 118.9, 120.1, 120.7, 120.9, 121.8, 
122.5, 123.8, 127.0, 127.7, 128.6, 130.5, 133.6, 134.6, 147.9, 158.8, 167.3, 167.9; 19F NMR 
(282.4 MHz, DMSO-d6): δ = –77.5 (s, 3F, CF3), –121.8 (d, 2J = 277.9 Hz, 1F, CFF), –124.6 (d, 
2J = 277.9 Hz, 1F, CFF); MS (EI, 70 eV) m/z (%): 498 ([M]+, 11), 466 (64), 435 (10), 379 (20), 
347 (100), 315 (91), 287 (13), 259 (9), 231 (10), 157 (15), 97 (10), 57 (15); HRMS (ESI): calcd 
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for C23H16F5O7 ([M+H]+) 499.08107, found 499.08116; IR (ATR, cm–1): ~ν  = 3282 (w), 3107 
(w), 2953 (w), 1708 (m), 1679 (m), 1633 (w), 1615 (m), 1603 (w), 1589 (w), 1565 (w), 1479 
(w), 1443 (m), 1433 (m), 1403 (w), 1383 (w), 1327 (m), 1306 (w), 1251 (m), 1205 (s), 1174 (s), 
1156 (s), 1140 (s), 1087 (s), 1049 (m), 1031 (m), 1016 (m), 984 (m), 964 (m), 949 (w), 926 (m), 
907 (m), 876 (m), 827 (w), 812 (m), 794 (s), 780 (m), 761 (w), 751 (m), 712 (s), 660 (m), 627 
(w), 608 (m), 687 (w), 572 (m), 555 (w). 
 
Dimethyl 6-(heptafluoropropyl)-6,9-dihydroxy-6H-benzo[c]chromene-8,10-dicarboxylate 
(14o): 
Starting with 3-(heptafluorobutanoyl)chromone 5q (0.342 g, 1.0 
mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) 
and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
14o was isolated as a white solid (0.344 g, 69%), mp 211-212 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.92 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 7.09-7.20 (m, 2H, 
2,4-HAr), 7.43-7.50 (m, 2H, 1,3-HAr), 8.13 (s, 1H, 7-HAr), 9.51 (d, 4JH,F = 4.1 Hz, 1H, 6-OH), 
11.08 (s, 1H, 9-OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 52.3 (OCH3), 53.1 (OCH3), 97.4 (t, 
2JC,F = 29.1 Hz, 6-C), 112.8, 115.2, 117.7, 119.0, 121.0, 123.2, 124.9, 130.7, 132.3, 133.1, 151.7, 
158.6, 167.3, 167.9; 19F NMR (282.4 MHz, DMSO-d6): δ = –80.0 (s, 3F, CF3), –118.3, –120.7 
(both dq, 2J = 284.6 Hz, J = 8.5 Hz, 1F, CF2), –123.5 (d, 2J = 289.7 Hz, 1F, CF2), –124.2 (d, 2J = 
289.4 Hz, 1F, CF2); MS (EI, 70 eV) m/z (%): 498 ([M]+, 2), 466 (12), 435 (18), 329 (62), 297 
(100), 265 (85), 238 (10), 210 (11), 133 (10); HRMS (ESI): calcd for C20H14F7O7 ([M+H]+) 
499.06223, found 499.06318; IR (ATR, cm–1): ~ν  = 3417 (w), 2960 (w), 1716 (m), 1675 (m), 
1607 (w), 1567 (w), 1494 (w), 1454 (w), 1440 (m), 1392 (w), 1336 (m), 1319 (m), 1297 (w), 
1213 (s), 1143 (s), 1115 (s), 1058 (m), 997 (s), 927 (m), 903 (w), 882 (m), 837(w), 810 (m), 774 
(m), 759 (s) 735 (s), 712 (s), 694 (w), 678 (m), 646 (w), 618 (m), 582 (w), 532 (m).  
 
Dimethyl 6-(heptafluoropropyl)-6,9-dihydroxy-2-methyl-6H-benzo[c]chromene-8,10-
dicarboxylate (14p): 
Starting with 3-(heptafluorobutanoyl)-6-methylchromone 5r 
(0.356 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 
mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-
7 mL), the product 14p was isolated as a white solid (0.328 g, 
O C3F7
OH
OH
COOCH3H3COOC
O
H3COOC
OH
COOCH3
C3F7
OH
H3C
 Supplement 1. Experimental part 
 
 
 
 
 123
64%), mp 322-324 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.29 (s, 3H, CH3), 3.91 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 
7.00 (d, 3J = 8.2 Hz, 1H, 4-HAr), 7.24-7.28 (m, 2H, 1,3-HAr), 8.11 (d, 5JH,F = 1.6 Hz, 1H, 7-HAr), 
9.44 (d, 4JH,F = 4.3 Hz, 1H, 6-OH), 11.07 (s, 1H, 9-OH); 13C NMR (62.9 MHz, CDCl3): δ = 19.0 
(CH3), 50.8 (OCH3), 51.1 (OCH3), 95.4 (t, 2JC,F = 27.1 Hz, 6-C), 109.7, 115.7, 116.4, 118.6, 
123.6, 128.5, 130.2, 130.7, 132.3, 147.5, 158.2, 166.4, 167.4; 19F NMR (282.4 MHz, DMSO-d6): 
δ = –80.0 (t, J = 8.7 Hz, 3F, CF3), –118.3 (dq, 2J = 284.9 Hz, J = 9.1 Hz, 1F, CF2), –120.7 (dq, 2J 
= 284.9 Hz, J = 8.4 Hz, 1F, CF2), –123.5 (d, 2J = 290.2 Hz, 1F, CF2), –124.2 (d, 2J = 289.0 Hz, 
1F, CF2); MS (EI, 70 eV) m/z (%): 512 ([M]+, 4), 480 (20), 449 (16), 343 (53), 311 (100), 279 
(80), 251 (8), 224 (15), 139 (13); HRMS (ESI): calcd for C21H16F7O7 ([M+H]+) 513.07788, 
found 513.07787; IR (ATR, cm–1): ~ν  = 3234 (w), 2958 (w), 2925 (w), 2853 (w), 1709 (m), 1682 
(m), 1616 (w), 1596 (w), 1573 (w), 1491 (w), 1439 (m), 1405 (w), 1337 (m), 1317 (w), 1291 
(m), 1275 (m), 1223 (s), 1186 (s), 1147 (s), 1116 (s), 1072 (m), 1017 (m), 995 (s), 949 (m), 928 
(w), 890 (m), 841 (w), 822 (m), 803 (s), 781 (w), 741 (m), 728 (m), 679 (m), 642 (m), 599 (w), 
564 (m), 533 (w). 
 
Dimethyl 6-(heptafluoropropyl)-6,9-dihydroxy-3-methoxy-6H-benzo[c]chromene-8,10-
dicarboxylate (14q): 
Starting with 3-(heptafluorobutanoyl)-7-methoxy-chromone 5s 
(0.372 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 
(0.16 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-
dioxane (6-7 mL), the product 14q was isolated as a white solid 
(0.354 g, 67%), mp 193-195 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.81 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 3.97 (s, 3H, 
OCH3), 6.62 (d, 4J = 2.1 Hz, 1H, 4-HAr), 6.79 (dd, 3J = 8.9 Hz, 4J = 2.1 Hz, 1H, 2-HAr), 7.38 (d, 
3J = 8.9 Hz, 1H, 1-HAr), 8.09 (s, 1H, 7-HAr), 9.49 (s, 1H, 6-OH), 11.08 (s, 1H, 9-OH); 13C NMR 
(62.9 MHz, DMSO-d6): δ = 52.9 (OCH3), 53.1 (OCH3), 55.7 (OCH3), 97.7 (t, 2JC,F = 29.0 Hz, 6-
C), 102.5, 109.9, 110.4, 111.5, 117.9, 119.7, 126.2, 130.7, 133.5, 153.4, 158.8, 162.4, 167.4, 
168.1; 19F NMR (282.4 MHz, DMSO-d6): δ = –80.0 (t, J = 8.7 Hz, 3F, CF3), –118.5 (dq, 2J = 
284.2 Hz, J = 8.5 Hz, 1F, CF2), –121.2 (dq, 2J = 284.2, J = 8.7 Hz, 1F, CF2), –123.4 (d, 2J = 
290.1 Hz, 1F, CF2), –124.1 (d, 2J = 289.4 Hz, 1F, CF2); MS (EI, 70 eV) m/z (%): 528 ([M]+, 7), 
496 (19), 465 (13), 359 (43), 327 (100), 295 (70), 240 (7), 148 (8), 97 (9), 57 (15); HRMS (ESI): 
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calcd for C21H16F7O8 ([M+H]+) 529.07279, found 529.07372; IR (ATR, cm–1): ~ν  = 3271 (w), 
2960 (w), 1714 (m), 1673 (m), 1651 (w), 1607 (m), 1537 (w), 1512 (w), 1444 (m), 1352 (m), 
1331 (m), 1314 (m), 1291 (w), 1212 (s), 1189 (s), 1141 (s), 1110 (s), 1058 (m), 1028 (m), 994 
(s), 958 (m), 920 (s), 882 (m), 861 (m), 836 (m), 816 (w), 797 (s), 764 (m), 739 (m), 713 (m), 
672 (m), 618 (s), 579 (m), 548 (m), 535 (m). 
  
Dimethyl 2-chloro-6-(heptafluoropropyl)-6,9-dihydroxy-6H-benzo[c]chromene-8,10-
dicarboxylate (14r): 
Starting with 6-chloro-3-(heptafluorobutanoyl)chromone 5t (0.377 
g, 1.0 mmol), dimethyl 1,3-acetone-dicarboxylate 12 (0.16 mL, 1.1 
mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the 
product 14r was isolated as a pale yellow solid (0.410 g, 77%), mp 
200-201 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.92 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 7.17 (d, 3J = 8.7 
Hz, 1H, 4-HAr), 7.42 (d, 4J = 2.4 Hz, 1H, 1-HAr), 7.53 (dd, 3J = 8.7, 4J = 2.4 Hz, 1H, 3-HAr), 8.13 
(d, 5JH,F = 1.7 Hz, 1H, 7-HAr), 9.69 (d, 4JH,F = 3.8 Hz, 1H, 6-OH), 11.10 (s, 1H, 9-OH); 13C NMR 
(62.9 MHz, DMSO-d6): δ = 53.1 (OCH3), 53.2 (OCH3), 97.8 (t, 2JC,F = 26.2 Hz, 6-C), 113.8, 
119.2, 119.3, 119.7, 120.8, 124.3, 126.8, 130.9, 131.5, 131.9, 150.5, 158.5, 167.2, 167.6; 19F 
NMR (282.4 MHz, DMSO-d6): δ = –80.1 (t, 3J = 8.9 Hz, 3F, CF3), –118.3 (dq, 2J = 285.2 Hz, J 
= 9.2 Hz, 1F, CF2), –120.7 (dq, 2J = 285.2 Hz, J = 8.6 Hz, 1F, CF2), –123.5, –124.2 (both d, 2J = 
289. Hz, 1F, CF2); MS (EI, 70 eV) m/z (%): 532 ([M]+, 3), 501 (10), 469 (14), 365 (23), 364 
(12), 363 (78), 333 (33), 332 (16), 331 (100), 301 (16), 299 (54), 244 (11), 150 (10); HRMS 
(ESI): calcd for C20H1235ClF7NaO7 ([M+Na]+) 555.00520, found 555.00474, calcd for 
C20H1237ClF7NaO7 ([M+Na]+) 557.00317, found 557.00270; IR (ATR, cm–1): ~ν  = 3426 (w), 
2956 (w), 2850 (w), 1721 (s), 1675 (m), 1643 (w), 1616 (w), 1563 (w), 1484 (w), 1462 (w), 1443 
(m), 1407 (w), 1385 (w), 1347 (m), 1310 (m), 1253 (m), 1212 (s), 1193 (s), 1174 (s), 1142 (s), 
1120 (s), 1098 (m), 1054 (m), 996 (s), 962 (m), 939 (m), 905 (m), 885 (m), 824 (m), 809 (m), 
773 (m), 756 (s), 738 (m), 726 (m), 715 (m), 684 (w), 664 (w), 632 (m), 597 (w), 552 (w), 533 
(w).  
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Dimethyl 2-chloro-6-(heptafluoropropyl)-6,9-dihydroxy-3-methyl-6H-benzo[c]-chromene-
8,10-dicarboxylate (14s): 
Starting with 6-chloro-3-(heptafluorobutanoyl)-7-methyl-
chromone 5u (0.391 g, 1.0 mmol), dimethyl 1,3-
acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and DBU (0.20 
mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 14s was 
isolated as a pale yellow solid (0.388 g, 71%), mp 207-208 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.35 (s, 3H, CH3), 3.92 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 
7.17 (s, 1H, 4-HAr), 7.41 (s, 1H, 1-HAr), 8.12 (s, 1H, 7-HAr), 9.64 (d, 4JH,F = 4.2 Hz, 1H, 6-OH), 
11.09 (s, 1H, 9-OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.6 (CH3), 53.0 (OCH3), 53.2 
(OCH3), 97.8 (t, 2JC,F  = 29.4 Hz, 6-C), 113.3, 116.9, 118.8, 120.0, 120.4, 124.5, 127.2, 130.9, 
131.7, 140.5, 150.4, 158.5, 167.2, 167.7; 19F NMR (282.4 MHz, DMSO-d6): δ = –80.0 (t, 3J = 
8.3 Hz, 3F, CF3), –118.4 (dq, 2J = 284.8, J = 9.0 Hz, 1F, CF2), –120.8 (dq, 2J = 284.8, J = 8.5 
Hz, 1F, CF2), –123.4 (d, 2J = 289.8 Hz, 1F, CF2), –124.2 (d, 2J = 289.4 Hz, 1F, CF2); MS (GC, 
70 eV) m/z (%): 514 ([M-OCH3-H], 21), 483 (14), 347 (32), 346 (18), 345 (100), 315 (29), 314 
(14), 313 (81), 278 (16), 245 (9), 139 (10); HRMS (ESI): calcd for C21H1435ClF7NaO7 ([M+Na]+) 
569.02085, found 569.02137, calcd for C21H1437ClF7NaO7 ([M+Na]+) 571.01888, found 
571.01913; IR (ATR, cm–1): ~ν  = 3272 (w), 2956 (w), 2853 (w), 1707 (m), 1687 (m), 1652 (w), 
1613 (m), 1589 (w), 1549 (w), 1496 (w), 1436 (m), 1395 (w), 1352 (m), 1336 (m), 1295 (m), 
1259 (m), 1207 (s), 1169 (s), 1144 (s), 1120 (s), 1075 (m), 1018 (m), 988 (m), 949 (w), 920 (m), 
885 (m), 856 (m), 825 (m), 801 (m), 777 (w), 769 (w), 744 (m), 720 (m), 704 (s), 692 (m), 665 
(m), 645 (m), 595 (m), 561 (m), 554 (m), 535 (w). 
  
Dimethyl 2-bromo-6-(heptafluoropropyl)-6,9-dihydroxy-6H-benzo[c]chromene-8,10-
dicarboxylate (14t): 
Starting with 6-bromo-3-(heptafluorobutanoyl)chromone 5v (0.421 
g, 1.0 mmol), dimethyl 1,3-acetone-dicarboxylate 12 (0.16 mL, 1.1 
mmol) and DBU (0.20 mL, 1,3 mmol) in 1,4-dioxane (6-7 mL), the 
product 14t was isolated as a white solid (0.323 g, 56%), mp 205-
207ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.93 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 7.11 (d, 3J = 8.7 
Hz, 1H, 4-HAr), 7.55 (d, 4J = 2.3 Hz, 1H, 1-HAr), 7.65 (dd, 3J = 8.7, 4J = 2.3 Hz, 1H, 3-HAr), 8.12 
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(d, 5JH,F = 1.4 Hz, 1H, 7-HAr), 9.69 (d, 4JH,F = 4.3 Hz, 1H, 6-OH), 11.10 (s, 1H, 9-OH); 13C NMR 
(75.5 MHz, DMSO-d6): δ = 53.0 (OCH3), 53.2 (OCH3), 97.6 (t, 2JC,F = 29.6 Hz, 6-C), 113.8, 
114.4, 119.1, 119.8, 120.0, 120.7, 127.2, 130.9, 131.4, 134.8, 150.9, 158.5, 167.1, 167.5; 19F 
NMR (282.4 MHz, DMSO-d6): δ = –80.0 (t, 3J = 8.7 Hz, 3F, CF3), –118.3, –120.7 (both dq, 2J = 
285.5 Hz, J = 8.7 Hz, 2F, CF2), –123.5 (d, 2J = 290.0 Hz, 1F, CF2), –124.2 (d, 2J = 289.7 Hz, 1F, 
CF2); MS (EI, 70 eV) m/z (%): 546 ([M-OCH3-H], 15), 544 (14), 515 (10), 513 (10), 409 (42), 
407 (42), 378 (14), 377 (100), 376 (15), 375 (99), 345 (28), 343 (28), 265 (10), 264 (61), 236 (9); 
HRMS (EI): calcd for C20H1279BrF7O7 ([M]+) 575.96491, found 575.96594, calcd for 
C20H1281BrF7O7 ([M]+) 577.96287, found 577.96435; IR (ATR, cm–1): ~ν  = 3341 (w), 2962 (w), 
1715 (w), 1688 (w), 1617 (w), 1595 (w), 1562 (w), 1462 (w), 1440 (w), 1403 (w), 1333 (w), 
1290 (w), 1258 (m), 1213 (m), 1191 (m), 1143 (m), 1118 (s), 1089 (s), 1055 (s), 994 (s), 397 
(m), 878 (m), 839 (m), 800 (s), 731 (s), 709 (s), 657 (m), 628 (m), 599 (m), 534 (m). 
  
Dimethyl 6-(heptafluoropropyl)-6,9-dihydroxy-6H-dibenzo[c,h]chromene-8,10-
dicarboxylate (14u): 
Starting with 3-(heptafluorobutanoyl)benzo[h]chromone 5w (0.392 
g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 
mmol) and DBU (0.20 mL, 1,3 mmol) in 1,4-dioxane (6-7 mL), the 
product 14u was isolated as a pale yellow solid (0.389 g, 71%), mp 
210-211ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.94 (s, 3H, OCH3), 3.99 (s, 3H, OCH3), 7.53 (d, 3J = 8.9 
Hz, 1H, HAr), 7.64-7.72 (m, 3H, HAr), 7.93-7.96 (m, 1H, HAr), 8.19-8.22 (m, 2H, HAr), 9.81 (s, 
1H, 6-OH), 11.14 (s, 1H, 9-OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 52.9 (OCH3), 53.1 
(OCH3), 98.3 (t, 2JC,F = 29.2 Hz, 6-C), 112.3, 112.4, 118.9, 120.2, 120.9, 121.8, 122.5, 123.8, 
127.0, 127.7, 128.5, 130.5, 133.6, 134.6, 147.9, 158.9, 167.3, 168.0; 19F NMR (282.4 MHz, 
DMSO-d6): δ = –80.2 (t, 3J = 9.2 Hz, 3F, CF3), –118.0 (dq, 2J = 283.1 Hz, J = 8.8 Hz, 1F, CF2), 
–121.5 (dq, 2J = 288.1, J = 8.7 Hz, 1F, CF2), –122.8 (d, 2J = 289.0 Hz, 1F, CF2), –124.0 (d, 2J = 
287.7 Hz, 1F, CF2); MS (EI, 70 eV) m/z (%): 548 ([M]+, 6), 516 (26), 378 (100), 347 (80), 315 
(99), 288 (32), 260 (10), 231 (13), 175 (13), 88 (6); HRMS (ESI): calcd for C24H16F7O7 
([M+H]+) 549.07788, found 549.07701; IR (ATR, cm–1): ~ν  = 3271 (w), 2953 (w), 1738 (w), 
1704 (m), 1683 (m), 1634 (w), 1616 (w), 1591 (w), 1565 (w), 1539 (w), 1476 (w), 1444 (m), 
1351 (m), 1333 (m), 1315 (w), 1252 (m), 1220 (s), 1152 (m), 1138 (m), 1119 (s), 1059 (w), 1040 
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(m), 1020 (w), 910 (m), 971 (m), 961 (w), 923 (w), 888 (m), 875 (m), 796 (s), 780 (w), 769 (w), 
759 (w), 738 (s), 714 (m), 685 (m), 663 (w), 648 (w), 608 (m), 572 (m), 530 (m). 
 
1,3-Dimethyl 2-hydroxy-5-(2-hydroxy-4-methoxybenzoyl)-4-(trifluoromethyl)-benzene-1,3-
dicarboxylate (15): 
Starting with 7-methoxy-3-(trifluoroacetyl)chromone 5b 
(0.272 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 
(0.16 mL, 1.1 mmol) and DBU (0.20 mL, 1,3 mmol) in 1,4-
dioxane (6-7 mL), the product 15 was isolated as a white 
solid (0.098 g, 23%), mp 147-148 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 3.83 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 3.90 (s, 3H, 
OCH3), 6.49-6.53 (m, 2H, 3′,5′-HAr), 7.35 (d, 3J = 9.1 Hz, 1H, 6′-HAr), 7.89 (s, 1H, 5-HAr), 11.12 
(s, 1H, OH), 11.55 (s, 1H, OH); 13C NMR (125.8 MHz, DMSO-d6): δ = 53.1 (OCH3), 53.2 
(OCH3), 55.9 (OCH3), 101.1, 107.7, 114.2, 117.5, 122.4 (q, 1JC,F = 276.2 Hz, CF3), 123.6 (m), 
127.9 (q, 2JC,F = 32.1 Hz, 1-C), 129.4 (m), 130.8, 134.6, 156.6, 163.9, 164.6, 166.4, 166.7, 195.1 
(C=O); 19F NMR (282.4 MHz, DMSO-d6): δ = –55.1 (s, 3F, CF3); MS (GC 70 eV) m/z (%): 428 
([M]+, 37), 397 (12), 359 (30), 328 (19), 327 (100), 296 (17), 295 (92), 151 (82), 150 (31); 
HRMS (EI): calcd for C19H15F3O8 ([M]+) 428.07135, found 428.07183; IR (ATR, cm–1): ~ν  = 
3229 (w), 3057 (w), 2991 (w), 2958 (w), 2852 (w), 1749 (m), 1707 (w), 1685 (m), 1607 (m), 
1590 (m), 1508 (w), 1488 (w), 1459 (w), 1437 (m), 1403 (w), 1384 (w), 1360 (m), 1333 (m), 
1306 (m), 1289 (m), 1255 (s), 1219 (s), 1194 (s), 1159 (s), 1149 (s), 1120 (s), 1028 (m), 1016 
(m), 1000 (m), 962 (m), 947 (m), 941 (m), 922 (m), 899 (w), 874 (w), 835 (m), 820 (m), 806 (s), 
793 (m), 779 (m), 751 (m), 719 (m), 709 (m), 690 (m), 681 (m), 651 (w), 609 (s), 598 (m), 564 
(m), 533 (w).  
 
8,10-Dimethyl 9-hydroxy-2-methoxy-6-oxo-6H-benzo[c]chromene-8,10-dicarboxylate (16): 
Starting with 6-methoxy-3-(pentafluoropropanoyl)chromone 5i 
(0.322 g, 1.0 mmol), dimethyl 1,3-acetonedicarboxylate  12 
(0.16 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-
dioxane (6-7 mL), the product 16 was isolated as a white solid 
(0.118 g, 33%), mp 219-222 ºC; 
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1H NMR (300 MHz, CDCl3): δ = 3.83 (s, 3H, OCH3), 4.04 (s, 3H, OCH3), 4.07 (s, 3H, OCH3), 
7.09-7.13 (m, 1H, 4-HAr), 7.27-7.31 (m, 2H, 1,3-HAr), 9.03 (s, 1H, 7-HAr), 11.74 (s, 1H, 9-OH); 
13C NMR (62.9 MHz, CDCl3): δ = 2ˣ53.2 (OCH3), 55.8 (OCH3), 108.7, 113.4, 113.9, 116.3, 
118.6, 119.2, 119.5, 135.4, 137.0, 146.5, 156.1, 160.0, 162.8, 167.7, 169.2; MS (GC, 70 eV) m/z 
(%): 358 ([M+], 100), 327 (18), 326 (51), 298 (10), 296 (10), 295 (57), 268 (28), 267 (14); 
HRMS (ESI): calcd for C18H13O8 ([M-H]-) 357.06159, found 357.06066; IR (ATR, cm–1): ~ν  = 
3402 (w), 3049 (w), 3004 (w), 2959 (w), 2925 (w), 2849 (w), 1717 (s), 1673 (m), 1615 (w), 1570 
(w), 1490 (w), 1471 (w), 1443 (m), 1424 (w), 1381 (w), 1342 (m), 1313 (m), 1294 (w), 1247 
(m), 1207 (s), 1173 (s), 1144 (s), 1110 (m), 1068 (s), 1041 (s), 997 (s), 978 (m), 945 (m), 937 
(m), 912 (s), 882 (m), 849 (m), 810 (s), 799 (s), 771 (s), 750 (m), 738 (m), 731 (s), 716 (m), 680 
(m), 665 (m), 649 (m), 611 (m), 590 (w), 577 (w), 567 (w), 535 (w). 
 
Dimethyl 3-hydroxy-6-(2-hydroxybenzoyl)[1,1'-biphenyl]-2,4-dicarboxylate (17a):  
Starting with 3-benzoylchromone 6a (0.250 g, 1.0 mmol), dimethyl 
1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and DBU (0.20 
mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 17a was 
isolated as a white solid (0.199 g, 49%), mp 178-180 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.52 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 6.76-6.82 (m, 2H, 
HAr), 7.12-7.16 (m, 2H, HAr), 7.24-7.26 (m, 3H, HAr), 7.29 (dd, 3J = 7.7 Hz, 4J = 1.5 Hz, 1H, 
HAr), 7.37 (td, 3J = 7.7 Hz, 4J = 1.5 Hz, 1H, HAr), 7.95 (s, 1H, 5-HAr), 10.78 (s, 1H, OH), 11.11 
(s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 52.1 (OCH3), 53.0 (OCH3), 112.1, 117.1, 
119.0, 122.4, 124.8, 2ˣ127.9, 128.2, 2ˣ128.3, 130.7, 131.6, 132.0, 135.5, 136.3, 144.2, 157.5, 
159.2, 165.8, 168.1, 197.9 (C=O); MS (GC, 70 eV) m/z (%): 406 ([M]+, 38), 374 (67), 342 (13), 
314 (27), 297 (100), 286 (16), 265 (28), 223 (14), 196 (17), 171 (13), 139 (13), 121 (52), 65 (10); 
HRMS (EI): calcd for C23H18O7 ([M]+) 406.10470, found 406.10499; IR (ATR, cm–1): ~ν  = 2953 
(w), 2923 (w), 2852 (w), 1733 (m), 1679 (w), 1625 (m), 1607 (w), 1582 (w), 1564 (w), 1486 
(w), 1433 (m), 1348 (w), 1324 (w), 1293 (m), 1272 (w), 1260 (w), 1238 (m), 1198 (s), 1160 (s), 
1147 (m), 1123 (m), 1111 (m), 1075 (w), 1034 (w), 1010 (w), 987 (m), 945 (w), 926 (w), 907 
(w), 876 (w), 817 (w), 802 (w), 788 (w), 764 (s), 738 (m), 724 (m), 704 (s), 677 (m), 644 (s), 619 
(m), 603 (w), 584 (m), 565 (w), 536 (m).  
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Dimethyl 2'-fluoro-3-hydroxy-6-(2-hydroxybenzoyl)[1,1'-biphenyl]-2,4-dicarboxylate (17b):  
Starting with 3-(2-fluorobenzoyl)chromone 6b (0.268 g, 1.0 mmol), 
dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 17b 
was isolated as a white solid (0.098 g, 23%), mp 170-173 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.59 (s, 3H, OCH3), 3.96 (s, 3H, 
OCH3), 6.76 (t, 3J = 7.6 Hz, 1H, HAr), 6.89–6.96 (m, 2H, HAr), 7.06 (t, 3J = 7.5 Hz, 1H, HAr), 
7.18-7.28 (m, 2H, HAr), 7.34-7.43 (m, 2H, HAr), 8.02 (s, 1H, 5-HAr), 11.50 (s, 2H, 2OH); 13C 
NMR (75.5 MHz, CDCl3): δ = 52.4 (OCH3), 53.0 (OCH3), 111.8, 115.4 (d, JC,F = 21.5 Hz), 
118.1, 118.8, 119.4, 123.9 (d, JC,F = 3.4 Hz), 124.0 (d, JC,F = 15.5 Hz), 125.4, 130.3, 130.7 (d, 
JC,F = 2.7 Hz), 130.8 (d, JC,F = 7.7 Hz), 131.4, 133.1, 136.6, 140.0, 158.9 (d, 1JC,F = 247.5 Hz, 
CArF), 159.9, 162.8, 165.8, 169.4, 200.1 (C=O); 19F NMR (282.4 MHz, CDCl3): δ = –113.4 (s, 
1F); MS (EI, 70eV) m/z (%): 392 (M-OCH3-H], 100), 359 (50), 332 (16), 297 (19), 265 (37), 237 
(18), 180 (12), 123 (53), 95 (13); HRMS (EI): calcd for C23H17FO7 ([M]+) 424.09528, found 
424.09549; IR (ATR, cm–1): ~ν  = 3000 (w), 2946 (w), 2839 (w), 1711 (m), 1678 (s), 1602 (s), 
1503 (w), 1480 (w), 1444 (s), 1351 (w), 1302 (m), 1274 (m), 1238 (s), 1198 (s), 1168 (s), 1115 
(m), 1036 (w), 1005 (m), 968 (m), 942 (w), 913 (m), 884 (w), 858 (w), 814 (m), 793 (m), 765 
(s), 742 (s), 686 (w), 665 (s), 641 (s), 568 (m).  
 
Dimethyl 2-hydroxy-5-(2-hydroxybenzoyl)-4-(2-thienyl)isophthalate (17c):  
Starting with 3-(2-thenoyl)chromone 17c (0.256 g, 1.0 mmol), 
dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 17c 
was isolated as a white solid (0.029 g, 7%), mp 205-207 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.72 (s, 3H, OCH3), 3.96 (s, 3H, 
OCH3), 6.69 (td, 3J = 7.6 Hz, 4J = 1.1 Hz, 1H, HAr), 6.84-6.91 (m, 2H, HAr), 6.97 (dd, 3J = 3.6 
Hz, 4J = 1.2 Hz, 1H, HAr), 7.18 (dd, 3J = 8.0 Hz, 4J = 1.6 Hz, 1H, HAr), 7.22-7.24 (m, 1H, HAr), 
7.37 (td, 3J = 7.8 Hz, 4J = 1.6 Hz, 1H, HAr), 7.97 (s, 1H, 5-HAr), 11.38 (s, 1H, OH), 11.70 (s, 1H, 
OH); 13C NMR (62.9 MHz, CDCl3): δ = 52.7 (OCH3), 53.0 (OCH3), 111.9, 118.1, 118.8, 119.8, 
127.4, 128.3, 129.2, 129.4, 130.6, 130.8, 133.0, 136.3, 136.7, 137.7, 159.3, 162.6, 166.2, 169.4, 
201.2 (C=O); MS (GC, 70 eV) m/z (%): 412 ([M]+, 100), 380 (37), 362 (14), 348 (63), 330 (12), 
320 (68), 292 (54), 260 (48), 229 (19), 202 (29), 174 (26), 145 (15), 121 (48), 93 (17), 65 (23); 
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HRMS (EI): calcd for C21H16O7S ([M]+) 412.06112, found 412.06127; IR (ATR, cm–1): ~ν  = 
3110 (w), 2956 (w), 2923 (w), 2853 (w), 1732 (s), 1682 (m), 1622 (s), 1606 (s), 1568 (m), 1527 
(w), 1505 (w), 1486 (w), 1433 (s), 1415 (m), 1353 (m), 1323 (m), 1294 (s), 1269 (m), 1237 (s), 
1198 (s), 1159 (s), 1122 (m), 1100 (s), 1081 (m), 1045 (m), 1035 (m), 985 (s), 944 (s), 914 (m), 
890 (w), 874 (m), 851 (m), 841 (w), 816 (m), 798 (s), 762 (s), 721 (s), 708 (s), 645 (s), 633 (s), 
596 (m), 587 (m), 562 (m), 535 (m).  
 
Dimethyl 3'-nitro-3-hydroxy-6-(2-hydroxybenzoyl)[1,1'-biphenyl]-2,4-dicarboxylate (17d): 
Starting with 3-(3-nitrobenzoyl)chromone 6g (0.295 g, 1.0 mmol), 
dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 17d 
was isolated as a yellow solid (0.374 g, 83%), mp 214-216 ºC;  
1H NMR (300 MHz, DMSO-d6): δ = 3.54 (s, 3H, OCH3), 3.93 (s, 
3H, OCH3), 6.73-6.78 (m, 2H, HAr), 7.26-7.33 (m, 2H, HAr), 7.57-7.59 (m, 2H, HAr), 7.99 (s, 1H, 
HAr), 8.00 (s, 1H, HAr), 8.10-8.14 (m, 1H, HAr), 10.48 (s, 1H, OH), 11.17 (s, 1H, OH); 13C NMR 
(75.5 MHz, DMSO-d6): δ = 52.3 (OCH3), 53.1 (OCH3), 113.2, 116.8, 119.1, 123.0, 123.1, 124.0, 
124.9, 129.7, 131.1, 131.6, 131.9, 134.7, 135.1, 137.9, 141.8, 147.0, 157.7, 157.8, 165.6, 167.8, 
196.9 (C=O); MS (GC, 70 eV) m/z (%): 451 ([M]+, 24), 419 (56), 388 (10), 359 (18), 297 (100), 
265 (38), 193 (16), 121 (57), 93 (10), 65 (12); HRMS (EI): calcd for C23H17NO9 ([M]+) 
451.08978, found 451.09001; IR (ATR, cm–1): ~ν  = 3079 (w), 3045 (w), 2965 (w), 2855 (w), 
1726 (m), 1678 (m), 1622 (m), 1602 (m), 1573 (w), 1533 (m), 1487 (w), 1441 (m), 1408 (w), 
1344 (m), 1296 (m), 1219 (s), 1164 (s), 1132 (m), 1081 (w), 991 (m), 930 (w), 882 (w), 843 (w), 
806 (w), 765 (s), 752 (s), 735 (s), 694 (s), 637 (s), 597 (m), 563 (w), 534 (w). 
 
Dimethyl 4'-nitro-3-hydroxy-6-(2-hydroxybenzoyl)[1,1'-biphenyl]-2,4-dicarboxylate (17e):  
Starting with 3-(4-nitrobenzoyl)chromone 6i (0.295 g, 1.0 mmol), 
dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 17e 
was isolated as a white solid (0.212 g, 47%), mp 185-187 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.54 (s, 3H, OCH3), 3.92 (s, 
3H, OCH3), 6.79-6.83 (m, 2H, HAr), 7.31-7.41 (m, 2H, HAr), 7.42 (d, 
3J = 8.8 Hz, 2H, HAr), 7.99 (s, 1H, 5-HAr), 8.15 (d, 3J = 8.8 Hz, 2H, HAr), 10.52 (s, 1H, OH), 
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11.19 (s, 1H, OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 52.4 (OCH3), 53.1 (OCH3), 113.1, 
117.0, 119.1, 123.0, 123.1, 123.5, 124.8, 129.9, 130.0, 131.4, 131.5, 131.6, 135.1, 142.3, 143.5, 
147.0, 157.7, 158.2, 165.5, 167.8, 196.1 (C=O); MS (EI, 70 eV) m/z (%): 451 ([M]+, 25), 419 
(77), 388 (10), 359 (21), 297 (100), 265 (25), 241 (9), 121 (52); HRMS (EI): calcd for 
C23H17NO9 ([M]+) 451.08978, found 451.09051; IR (ATR, cm–1): ~ν  = 3089 (w), 3004 (w), 2950 
(w), 2850 (w), 1745 (m), 1690 (m), 1622 (m), 1604 (m), 1572 (m), 1518 (m), 1482 (m), 1438 
(m), 1347 (s), 1296 (m), 1266 (m), 1234 (m), 1208 (s), 1159 (s), 1147 (s), 1119 (m), 1106 (m), 
1035 (w), 1001 (m), 949 (m), 931 (w), 917 (w), 877 (w), 864 (m), 854 (m), 845 (m), 799 (m), 
767 (s), 740 (m), 713 (s), 698 (s), 664 (m), 642 (m), 623 (m), 599 (m), 562 (m), 534 (m). 
 
Dimethyl 3',5'-dinitro-3-hydroxy-6-(2-hydroxybenzoyl)[1,1'-biphenyl]-2,4-dicarboxylate 
(17f): 
Starting with 3-(3,5-dinitrobenzoyl)chromone 6j (0.340 g, 1.0 
mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) 
and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
17f was isolated as a yellow solid (0.347 g, 70%), mp 198-200 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.58 (s, 3H, OCH3), 3.84 (s, 
3H, OCH3), 6.69-6.77 (m, 2H, HAr), 7.23-7.28 (m, 2H, HAr), 8.09 (s, 
1H, 5-HAr), 8.38 (d, 4J = 2.1 Hz, 2H, 2′′,6′′-HAr), 8.72 (t, 4J = 2.1 Hz, 1H, 4′′-HAr), 10.35 (s, 1H, 
OH), 11.27 (s, 1H, OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 52.6 (OCH3), 53.1 (OCH3), 
114.1, 116.6, 118.3, 119.2, 124.9, 125.0, 2ˣ128.8, 130.6, 131.6, 132.4, 134.3, 139.5, 140.0, 
2ˣ147.3, 156.8, 158.0, 165.4, 167.6, 194.8 (C=O); MS (GC, 70 eV) m/z (%): 496 ([M]+, 28), 464 
(65), 433 (11), 404 (22), 297 (100), 265 (48), 216 (13), 120 (66), 93 (11), 65 (12); HRMS (ESI): 
calcd for C23H17N2O11 ([M+H]+) 497.08270, found 497.08200; IR (ATR, cm–1): ~ν  = 3090 (w), 
2958 (w), 1732 (m), 1682 (m), 1651 (w), 1622 (m), 1593 (m), 1568 (m), 1538 (s), 1485 (m), 
1442 (s), 1341 (s), 1298 (s), 1256 (m), 1209 (s), 1163 (s), 1116 (m), 1075 (m), 1033 (m), 997 
(m), 957 (w), 938 (m), 922 (m), 908 (m), 878 (w), 855 (w), 839 (m), 804 (m), 761 (s), 728 (s), 
707 (s), 680 (m), 650 (s), 609 (m), 565 (m), 530 (m). 
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Methyl 10-benzoyl-7-hydroxy-6-oxo-6H-benzo[c]chromene-8-carboxylate (18a): 
Starting with 3-benzoylchromone 6a (0.250 g, 1.0 mmol), dimethyl 
1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and DBU (0.20 mL, 
1.3 mmol) in 1,4-dioxane (6-7 mL), the product 18a was isolated as a 
yellow solid (0.101 g, 27%), mp 144-146 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 3.84 (s, 3H, OCH3), 7.12-7.18 
(m, 1H, HAr), 7.50-7.59 (m, 5H, HAr), 7.64-7.70 (m, 1H, HAr), 7.85 (d, 3J = 7.8 Hz, 2H, HAr), 
8.08 (s, 1H, 9-HAr), 12.80 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 52.4 (OCH3), 
108.6, 116.1, 116.7, 117.8, 124.9, 126.4, 127.3, 129.1, 129.2, 129.9, 130.0, 132.3, 134.5, 135.9, 
137.0, 137.8, 150.7, 162.4, 164.3, 164.4, 196.4 (C=O); MS (EI, 70 eV) m/z (%): 374 ([M]+, 100), 
343 (23), 297 (22), 265 (28), 183 (20), 105 (43), 77 (24); HRMS (EI): calcd for C22H14O6 ([M]+) 
374.07849, found 374.07772; IR (ATR, cm–1): ~ν  = 3063 (w), 2952 (w), 1693 (s), 1651 (m), 
1639 (m), 1607 (w), 1593 (m), 1576 (w), 1556 (m), 1538 (w), 1519 (m), 1488 (w), 1441 (s), 
1408 (w), 1352 (w), 1311 (m), 1279 (w), 1228 (s), 1178 (s), 1163 (s), 1144 (s), 1082 (m), 1008 
(w), 978 (w), 939 (w), 923 (w), 849 (w), 823 (m), 783 (w), 758 (m), 734 (s), 720 (w), 698 (m), 
673 (s), 647 (m), 633 (s), 567 (w), 551 (w).  
 
Methyl 7-hydroxy-10-(2-fluorobenzoyl)-6-oxo-6H-benzo[c]chromene-8-carboxylate (18b): 
Starting with 3-(2-fluorobenzoyl)chromone 6b (0.268 g, 1.0 mmol), 
dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and DBU 
(0.20 mL, 1,3 mmol) in 1,4-dioxane (6-7 mL), the product 18b was 
isolated as a white solid (0.180 g, 46%), mp 158-160 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.92 (s, 3H, OCH3), 7.03-7.13 
(m, 2H, HAr), 7.24-7.28 (m, 1H, HAr), 7.36 (dd, 3J = 8.3 Hz, 4J = 1.2 
Hz, 1H, HAr), 7.46 (td, 3J = 7.3 Hz, 4J = 1.3 Hz, 1H, HAr), 7.52-7.60 (m, 1H, HAr), 7.67 (dd, 3J = 
8.2 Hz, 4J = 1.2 Hz, 1H, HAr), 7.84 (td, 3J = 7.6 Hz, 4J = 1.8 Hz, 1H, HAr), 8.23 (s, 1H, 9-HAr), 
13.05 (s, 1H, OH); 13C NMR (62.9MHz, DMSO-d6): δ = 52.6 (OCH3), 108.2, 116.2, 116.4, 
117.1 (d, JC,F = 21.5 Hz), 117.8, 124.8, 125.0 (d, JC,F = 8.8 Hz), 125.1 (d, JC,F = 3.2 Hz), 127.4, 
127.9, 132.1, 132.5, 136.4 (d, JC,F = 9.4 Hz), 137.1 (d, JC,F = 1.1 Hz), 137.6, 151.0, 161.2 (d, 
1JC,F = 257.0Hz, CArF), 165.5, 164.1, 164.3, 192.7 (d, 3JC,F = 1.1 Hz, C=O); 19F NMR (282.4 
MHz, CDCl3): δ = –109.0 (s, 1F); MS (GC, 70 eV) m/z (%): 392 ([M]+, 100), 359 (40), 332 (13), 
297 (15), 265 (36), 237 (22), 181 (13), 123 (68), 95 (35), 75 (18); HRMS (ESI): calcd for 
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C22H14FO6 ([M+H]+) 393.07689, found 393.07703, calcd for C22H13FNaO6 ([M+Na]+) 
416.06222, found 416.06204; IR (ATR, cm–1): ~ν  = 3108 (w), 2923 (w), 2851 (w), 1712 (m), 
1679 (s), 1602 (s), 1574 (m), 1504 (w), 1480 (w), 1444 (m), 1350 (w), 1302 (m), 1274 (m), 1259 
(m), 1238 (s), 1221 (s), 1198 (s), 1185 (s), 1168 (s), 1152 (s), 1134 (m), 1101 (m), 1006 (s), 968 
(m), 941 (w), 913 (m), 858 (m), 814 (s), 793 (s), 763 (s), 742 (s), 701 (m), 686 (m), 665 (s), 641 
(m), 625 (m), 567 (m), 550 (m). 
 
Methyl 7-hydroxy-10-(2-thenoyl)-6-oxo-6H-benzo[c]chromene-8-carboxylate (18c): 
Starting with 3-(2-thenoyl)chromone 6c (0.256 g, 1.0 mmol), dimethyl 
1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and DBU (0.20 mL, 
1,3 mmol) in 1,4-dioxane (6-7 mL), the product 18c was isolated as a 
yellow solid (0.239 g, 63%), mp 175-178 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.85 (s, 3H, OCH3), 7.14-7.26 (m, 
2H, HAr), 7.50-7.67 (m, 4H, HAr), 8.16-8.19 (m, 2H, HAr), 12.81 (s, 1H, OH); 13C NMR (75.5 
MHz, DMSO-d6): δ = 52.4 (OCH3), 108.7, 116.1, 116.6, 117.8, 125.0, 126.1, 127.0, 129.3, 
132.3, 136.7, 137.3, 137.8, 138.0, 143.1, 150.7, 162.4, 164.2, 164.4, 188.6 (C=O); MS (EI, 70 
eV) m/z (%): 380 ([M]+, 50), 347 (49), 315 (50), 292 (19), 265 (12), 237 (11), 181 (17), 131 (13), 
111 (100), 83 (14), 69 (43), 57 (10), 44 (33); HRMS (EI): calcd for C20H12O6S ([M]+) 
380.03491, found 380.03487; IR (ATR, cm–1): ~ν  = 3107 (w), 2945 (w), 1712 (m), 1681 (m), 
1651 (m), 1595 (m), 1516 (w), 1431 (m), 1409 (m), 1351 (w), 1308 (m), 1275 (m), 1250 (s), 
1185 (s), 1132 (m), 1100 (m), 1056 (m), 991 (w), 971 (w), 944 (w), 920 (w), 889 (w), 852 (m), 
815 (m), 794 (w), 761 (s), 738 (s), 671 (m), 649 (s), 627 (s), 564 (m). 
 
Methyl 7-hydroxy-10-(2-nitrobenzoyl)-6-oxo-6H-benzo[c]chromene-8-carboxylate (18d): 
Starting with 3-(2-nitrobenzoyl)chromone 6d (0.295 g, 1.0 mmol), 
dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 mmol) and 
DBU (0.20 mL, 1,3 mmol) in 1,4-dioxane (6-7 mL), the product 18d 
was isolated as a white solid (0.302 g, 72%), mp 330-332 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.91 (s, 3H, OCH3), 7.23-7.28 (m, 
1H, HAr), 7.41 (d, 3J = 8.4 Hz, 1H, HAr), 7.53-7.58 (m, 2H, HAr), 
7.66-7.76 (m, 2H, HAr), 8.01 (dd, 3J = 7.8 Hz, 4J = 1.4 Hz, 1H, HAr), 8.20 (s, 1H, 9-HAr), 8.28 
(dd, 3J = 8.3 Hz, 4J = 1.2 Hz, 1H, HAr), 13.31 (s, 1H, OH); 13C NMR (75.5 MHz, CDCl3): δ = 
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52.7 (OCH3), 116.1, 116.2, 117.6, 124.8, 125.5, 129.5, 131.2, 132.9, 133.0, 133.3, 133.4, 134.9, 
140.5, 141.1, 148.8, 151.2, 164.7, 164.9, 165.1, 165.6, 191.9 (C=O); MS (EI, 70 eV) m/z (%): 
419 ([M]+, 8), 388 (8), 285 (100), 265 (10), 253 (70), 225 (11), 134 (29), 104 (17); HRMS (EI): 
calcd for C22H13NO8 ([M]+) 419.06357, found 419.06374; IR (ATR, cm–1): ~ν  = 3032 (w), 2949 
(w), 2824 (w), 1711 (s), 1678 (s), 1594 (m), 1541 (s), 1434 (m), 1366 (m), 1352 (w), 1307 (m), 
1274 (m), 1245 (s), 1198 (s), 1167 (s), 1107 (m), 1006 (w), 973 (m), 950 (w), 914 (w), 852 (w), 
815 (s), 775 (s), 743 (s), 711 (m), 669 (m), 638 (m), 584 (w), 569 (w).  
 
Methyl 7-hydroxy-2-methyl-10-(2-nitrobenzoyl)-6-oxo-6H-benzo[c]chromene-8-carboxylate 
(18e): 
Starting with 6-methyl-3-(2-nitrobenzoyl)chromone 6e (0.309 g, 
1.0 mmol), dimethyl 1,3-acetonedicarboxylate 12 (0.16 mL, 1.1 
mmol) and DBU (0.20 mL, 1,3 mmol) in 1,4-dioxane (6-7 mL), 
the product 18e was isolated as a yellow solid (0.364 g, 84%), mp 
326-328 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.18 (s, 3H, CH3), 3.85 (s, 
3H, OCH3), 7.37-7.39 (m, 2H, HAr), 7.48-7.57 (m, 2H, HAr), 7.63 (s, 1H, 1-HAr), 7.77 (td, 3J = 
7.5 Hz, 4J = 1.6 Hz, 1H, HAr), 8.01 (d, 3J = 8.0 Hz, 1H, HAr), 8.24 (s, 1H, 9-HAr), 13.00 (s, 1H, 
OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.9 (CH3), 52.5 (OCH3), 109.0, 115.6, 116.8, 
117.2, 124.0, 124.5, 128.4, 130.5, 131.6, 132.7, 133.6, 134.1, 134.4, 138.9, 140.5, 148.8, 149.0, 
163.7, 164.2, 164.4, 191.8 (C=O); MS (EI, 70 eV) m/z (%): 433 ([M]+, 17), 402 (11), 299 (100), 
267 (87), 239 (15), 134 (29), 104 (15), 44 (11); HRMS (ESI): calcd for C23H16NO8 ([M+H]+) 
434.08704, found 434.08618; IR (ATR, cm–1): ~ν  = 3030 (w), 2951 (w), 1707 (m), 1672 (s), 
1590 (m), 1550 (s), 1430 (m), 1403 (w), 1368 (m), 1350 (w), 1299 (m), 1273 (w), 1245 (s), 1183 
(s), 1137 (m), 1111 (m), 1024 (w), 977 (w), 921 (m), 816 (s), 779 (s), 760 (s), 711 (m), 679 (m), 
657 (m), 637 (s), 615 (m), 589 (m), 532 (m).  
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Methyl 7-hydroxy-3-methoxy-10-(2-nitrobenzoyl)-6-oxo-6H-benzo[c]chromene-8-
carboxylate (18f): 
Starting with 7-methoxy-3-(2-nitrobenzoyl)chromone 6f (0.325 
g, 1.0 mmol), dimethyl 1,3-acetone-dicarboxylate 12 (0.16 mL, 
1.1 mmol) and DBU (0.20 mL, 1,3 mmol) in 1,4-dioxane (6-7 
mL), the product 18f was isolated as a yellow solid (0.328 g, 
73%), mp 370-372 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.81 (s, 3H, OCH3), 3.83 
(s, 3H, OCH3), 6.80 (dd, 3J = 9.1 Hz, 4J = 2.6 Hz, 1H, HAr), 7.07 (d, 4J = 2.5 Hz, 1H, HAr), 7.62-
7.72 (m, 2H, HAr), 7.81-7.86 (m, 2H, HAr), 8.06-8.11 (m, 2H, HAr), 12.95 (s, 1H, OH); 13C NMR 
(75.5 MHz, DMSO-d6): δ = 52.3 (OCH3), 56.1 (OCH3), 101.3, 108.8, 112.3, 115.1, 123.2, 124.7, 
130.0, 131.3, 131.8, 132.0, 133.3, 134.0, 139.9, 140.2, 148.7, 152.6, 162.6, 164.1, 164.3, 164.6, 
192.0 (C=O); MS (EI, 70 eV) m/z (%): 449 ([M]+, 31), 419 (24), 386(18), 343 (10), 315 (100), 
300 (19), 283 (94), 255 (33), 227 (10), 207 (12), 134 (30), 104 (20), 77 (11), 44 (65); HRMS 
(ESI): calcd for C23H16NO9 ([M+H]+) 450.08196, found 450.08216; IR (ATR, cm–1): ~ν  = 3035 
(w), 2944 (w), 1716 (m), 1670 (m), 1593 (m), 1537 (s), 1433 (m), 1362 (m), 1321 (w), 1288 (m), 
1241 (s), 1201 (s), 1162 (m), 1111 (m), 1027 (m), 989 (w), 948 (w), 918 (w), 841 (m), 804 (s), 
742 (m), 710 (w), 692 (m), 650 (w), 618 (m), 580 (w), 546 (w).  
 
General procedure for the synthesis of compounds 20 and 21: 
To a stirred reaction mixture of the corresponding 3-acylchromone 4 or 6 (1.0 mmol) and 1,3-
diphenylacetone 19 (1.1 mmol) in 1,4-dioxane (6-7 mL), DBU (1.3 mmol) was added slowly via 
a syringe at room temperature. Stirring at reflux was continued until chromone was consumed 
completely (followed by TLC, approximately 10-12 h). The reaction mixture was quenched with 
an aqueous solution of 10% NH4Cl, extracted with chloroform and dried (Na2SO4). The solvent 
was distilled off under reduced pressure. The resulting residue was subjected to column 
chromatography on silica gel using heptane-ethylacetate (5:1) as eluent, slowly increasing the 
polarity up to 3:1 to give the isolated products. 
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Methyl 3-hydroxy-6-(2-hydroxybenzoyl)-2,4-diphenylbenzoate (20a): 
Starting with 3-methoxalylchromone 6a (0.232 g, 1.0 mmol), 1,3-
diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 
mmol) in 1,4-dioxane (6-7 mL), the product 20a was isolated as a white 
solid (0.208 g, 49%), mp 180-182 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.34 (s, 3H, OCH3), 6.91-7.00 (m, 2H, HAr), 7.29-7.53 (m, 
13H, HAr), 9.22 (s, 1H, 3-OH), 11.64 (s, 1H, 2′-OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 51.6 
(OCH3), 117.0, 119.1, 123.4, 127.6, 127.7, 2ˣ128.0, 2ˣ128.4, 2ˣ129.2, 129.6, 2ˣ130.0, 131.2, 
132.8, 132.9, 134.1, 134.2, 134.6, 134.8, 137.1, 154.6, 157.9, 167.9, 196.3 (C=O); MS (GC, 70 
eV) m/z (%): 424 ([M]+, 10), 392 (100), 375 (18), 363 (36), 347 (13), 315 (54), 274 (7), 215 (19), 
121 (11), 65 (7); HRMS (ESI): calcd for C27H21O5 ([M+H]+) 425.13835, found 425.13906; IR 
(ATR, cm–1): ~ν  = 3432 (w), 2952 (w), 1731 (s), 1628 (m), 1599 (w), 1579 (w), 1568 (w), 1487 
(m), 1443 (w), 1430 (w), 1406 (m), 1353 (w), 1332 (w), 1312 (w), 1284 (m), 1268 (s), 1244 (s), 
1217 (m), 1193 (m), 1172 (w), 1152 (m), 1132 (s), 1120 (m), 1082 (m), 1030 (m), 998 (m), 967 
(m), 921 (w), 899 (w), 868 (w), 840 (m), 821 (w), 801 (w), 790 (w), 774 (m), 763 (s), 745 (s), 
708 (m), 696 (s), 672 (m), 663 (m), 638 (w), 608 (m), 596 (m), 567 (m), 545 (m).  
 
Methyl 3-hydroxy-6-(5-bromo-2-hydroxybenzoyl)-2,4-diphenylbenzoate (20b): 
Starting with 6-bromo-3-methoxalylchromone 6f (0.311 g, 1.0 mmol), 
1,3-diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 
mmol) in 1,4-dioxane (6-7 mL), the product 20b was isolated as a yellow 
solid (0.271 g, 54%), mp 256-258 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.37 (s, 3H, OCH3), 6.93 (d, 3J = 8.8 Hz, 1H, HAr), 7.28-
7.31 (m, 2H, HAr), 7.36-7.57 (m, 11H, HAr), 9.30 (s, 1H, 3-OH), 10.52 (s, 1H, 2′-OH); 13C NMR 
(75.5 MHz, DMSO-d6): δ = 51.6 (OCH3), 110.1, 119.0, 126.7, 127.1, 127.7, 127.8, 2ˣ128.0, 
2ˣ128.5, 2ˣ129.1, 129.4, 129.9, 2ˣ130.0, 132.3, 133.6, 134.6, 134.8, 135.5, 137.1, 155.2, 155.6, 
167.9, 193.2 (C=O); MS (EI, 70 eV) m/z (%): 502 ([M]+, 7), 473 (28), 472 (100), 471 (43), 470 
(96), 469 (13), 444 (11), 443 (25), 441 (15), 395 (18), 393 (19), 391 (15), 215 (24), 69 (17), 41 
(10); HRMS (ESI): calcd for C27H2079BrO5 ([M+H]+) 503.04886, found 503.04855, calcd for 
C27H2081BrO5 ([M+H]+) 505.04724, found 505.04682; IR (ATR, cm–1): ~ν  = 3397 (w), 3025 (w), 
2945 (w), 1743 (s), 1629 (m), 1600 (w), 1580 (w), 1568 (w), 1492 (w), 1464 (m), 1446 (w), 
1431 (m), 1409 (m), 1352 (m), 1321 (w), 1288 (m), 1271 (m), 1251 (s), 1201 (s), 1173 (m), 1122 
OH O COOCH3
Ph
OH
PhBr
O
OH
Ph
Ph
COOCH3
1
2
3
4
5
61'
2'
3'
4'
5'
6'
OH
 Supplement 1. Experimental part 
 
 
 
 
 137
(s), 1089 (m), 1080 (m), 1028 (m), 1010 (m), 972 (m), 959 (w), 909 (m), 889 (w), 847 (w), 829 
(m), 821 (m), 800 (m), 779 (m), 755 (m), 740 (m), 699 (s), 657 (m), 646 (w), 609 (s), 594 (m), 
552 (m). 
 
4-(2-Hydroxybenzoyl)-2,3,6-triphenylphenol (20c): 
Starting with 3-benzoylchromone 6a (0.250 g, 1.0 mmol), 1,3-
diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) 
in 1,4-dioxane (6-7 mL), the product 20c was isolated as a yellow solid 
(0.141 g, 32%), mp 209-212 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 6.79-6.98 (m, 7H, HAr), 7.09-7.23 (m, 5H, HAr), 7.33-7.48 
(m, 6H, HAr), 7.60-7.63 (m, 2H, HAr), 8.56 (s, 1H, 3-OH), 11.44 (s, 1H, 2′-OH); 13C NMR (75.5 
MHz, DMSO-d6): δ = 117.2, 118.9, 126.4, 126.6, 2ˣ127.0, 127.3, 2ˣ127.5, 2ˣ128.3, 129.2, 
2ˣ129.3, 2ˣ130.0, 131.1, 2ˣ131.2, 131.3, 133.2, 135.8, 135.9, 137.6, 138.4, 140.0, 152.6, 160.7, 
201.9 (C=O); MS (GC, 70 eV) m/z (%): 442 ([M]+, 63), 365 (50), 322 (100), 302 (14), 215 (12), 
121 (19); HRMS (EI): calcd for C31H22O3 ([M]+) 442.15635, found 442.15625; IR (ATR, cm–1): 
~ν
 = 3467 (w), 3429 (w), 3053 (w), 3025 (w), 2918 (w), 2851 (w), 1714 (w), 1622 (m), 1601 (m), 
1575 (w), 1557 (w), 1539 (w), 1532 (w), 1520 (w), 1514 (w), 1504 (w), 1495 (w), 1485 (w), 
1471 (w), 1456 (w), 1446 (w), 1403 (w), 1342 (m), 1310 (w), 1274 (m), 1234 (m), 1211 (s), 
1186 (m), 1155 (s), 1130 (m), 1107 (m), 1075 (m), 1064 (m), 1028 (m), 1001 (m), 966 (m), 924 
(w), 897 (m), 866 (w), 852 (w), 835 (m), 820 (m), 801 (m), 783 (w), 748 (s), 697 (s), 669 (m), 
638 (m), 630 (m), 618 (m), 594 (m), 568 (m), 541 (m).  
 
4-(2-Hydroxybenzoyl)-2,6-diphenyl-3-(2-thienyl)phenol (20d): 
Starting with 3-(2-thenoyl)chromone 6c (0.256 g, 1.0 mmol), 1,3-
diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) 
in 1,4-dioxane (6-7 mL), the product 20d was isolated as a yellow solid 
(0.130 g, 29%), mp 207-210 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 6.56 (dd, 3J = 3.5 Hz, 4J = 1.2 Hz, 
1H, HAr), 6.63-6.66 (m, 1H, HAr), 6.78-6.87 (m, 2H, HAr), 7.16-7.21 (m, 3H, HAr), 7.22-7.30 (m, 
3H, HAr), 7.34 (s, 1H, 5-HAr), 7.37-7.48 (m, 5H, HAr), 7.60-7.63 (m, 2H, HAr), 8.61 (s, 1H, 3-
OH), 11.50 (s, 1H, 2′-OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 117.2, 118.9, 120.9, 126.1, 
127.1, 127.3, 127.4, 2ˣ127.7, 2ˣ128.3, 128.9, 129.0, 2ˣ129.2, 129.3, 2ˣ130.9, 131.7, 132.1, 132.2, 
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133.0, 135.8, 136.0, 137.4, 138.9, 152.6, 160.7, 201.9 (C=O); MS (GC, 70 eV) m/z (%): 448 
([M]+, 100), 413 (14), 353 (16), 328 (96), 295 (15), 121 (18); HRMS (EI): calcd for C29H20O3S 
([M]+) 448.11277, found 448.11285; IR (ATR, cm–1): ~ν  = 3422 (w), 3055 (w), 3029 (w), 2961 
(w), 2924 (w), 2853 (w), 1622 (m), 1579 (w), 1531 (w), 1483 (w), 1458 (w), 1445 (w), 1425 (w), 
1398 (w), 1343 (m), 1308 (w), 1277 (m), 1266 (m), 1239 (w), 1219 (m), 1210 (m), 1192 (m), 
1147 (m), 1101 (w), 1072 (w), 1039 (m), 1028 (w), 976 (w), 962 (w), 921 (w), 903 (w), 878 (w), 
868 (w), 849 (w), 839 (w), 819 (w), 793 (w), 778 (w), 755 (s), 726 (m), 709 (m) , 698 (s), 666 
(m), 635 (w), 621 (m), 608 (w), 596 (m), 573 (w), 531 (w).  
 
4-(2-Hydroxybenzoyl)-2,6-diphenyl-3-(3-nitrophenyl)phenol (20e): 
Starting with 3-(3-nitrobenzoyl)chromone 6g (0.295 g, 1.0 mmol), 1,3-
diphenylacetone 19 (0.22 mL 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) 
in 1,4-dioxane (6-7 mL), the product 20e was isolated as a white solid 
(0.205 g, 42%), mp 211-213 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 6.78-6.83 (m, 2H, HAr), 7.14-7.28 
(m, 5H, HAr), 7.31-7.50 (m, 8H, HAr), 7.60-7.63 (m, 2H, HAr), 7.73 (s, 1H, 5-HAr), 7.82-7.86 (m, 
1H, HAr), 8.81 (s, 1H, 3-OH), 10.92 (s, 1H, 2′-OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 117.0, 
118.9, 121.2, 121.3, 122.7, 124.7, 127.0, 127.4, 127.7, 127.8, 128.3, 128.4, 128.6, 129.1, 129.2, 
129.3, 130.3, 131.1, 131.2, 131.4, 132.3, 135.2, 135.3, 136.7, 137.4, 138.0, 140.5, 146.4, 153.2, 
159.3, 199.9 (C=O); MS (EI, 70 eV) m/z (%): 487 ([M]+, 90), 367 (100), 289 (10), 121 (50); 
HRMS (EI): calcd for C31H21NO5 ([M]+) 487.14142, found 487.14136; IR (ATR, cm–1): ~ν  = 
3533 (w), 3502 (w), 1599 (w), 1529 (m), 1483 (m), 1443 (w), 1402 (w), 1348 (m), 1304 (w), 
1278 (m), 1239 (m), 1214 (m), 1158 (m), 1129 (m), 1030 (w), 971 (w), 933 (w), 903 (w), 860 
(w), 822 (w), 789 (w), 761 (m), 731 (m), 698 (s), 666 (m), 619 (m), 594 (w), 547 (w).531 (w).  
 
4-(2-Hydroxybenzoyl)-2,6-diphenyl-3-(4-nitrophenyl)phenol (20f): 
Starting with 3-(4-nitrobenzoyl)chromone 6i (0.295 g, 1.0 mmol), 1,3-
diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) 
in 1,4-dioxane (6-7 mL), the product 20f was isolated as a yellow solid 
(0.336 g, 69%), mp 231-235 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 6.83-6.87 (m, 2H, HAr), 7.11-7.16 
(m, 2H, HAr), 7.18-7.25 (m, 5H, HAr), 7.35-7.40 (m, 3H, HAr), 7.44-7.51 
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(m, 3H, HAr), 7.60-7.62 (m, 2H, HAr), 7.85-7.88 (m, 2H, HAr), 8.82 (s, 1H, 3-OH), 11.01 (s, 1H, 
2′-OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 117.2, 119.0, 122.0, 122.1, 122.4, 127.0, 127.4, 
127.7, 127.8, 128.2, 128.4, 128.5, 129.0, 129.2, 129.3, 130.4, 131.0, 131.1, 131.2, 131.3, 131.4, 
132.5, 135.3, 135.4, 137.4, 138.5, 145.7, 146.4, 153.2, 159.7, 199.9 (C=O); MS (GC, 70 eV) m/z 
(%): 487 ([M]+, 63), 367 (100), 289 (16), 121 (51); HRMS (EI): calcd for C31H21NO5 ([M]+) 
487.14142, found 487.14134; IR (ATR, cm–1): ~ν  = 3453 (w), 3077 (w), 2925 (w), 2849 (w), 
1623 (w), 1597 (m), 1578 (w), 1515 (s), 1481 (w), 1446 (w), 1394 (w), 1339 (s), 1285 (m), 1240 
(m), 1209 (s), 1156 (m), 1128 (m), 1106 (m), 1031 (m), 967 (m), 901 (w), 852 (m), 749 (s), 700 
(s), 638 (w), 617 (m), 571 (w), 545 (w).  
 
4-(2-Hydroxybenzoyl)-2,6-diphenyl-3-(3,5-dinitrophenyl)phenol (20g): 
Starting with 3-(3,5-dinitrobenzoyl)chromone 6j (0.340 g, 1.0 mmol), 
1,3-diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 
mmol) in 1,4-dioxane (6-7 mL), the product 20g was isolated as a yellow 
solid (0.394 g, 74%), mp 100-102 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 6.74-6.81 (m, 2H, HAr), 7.13-7.31 
(m, 6H, HAr), 7.36-7.41 (m, 2H, HAr), 7.45-7.50 (m, 3H, HAr), 7.55-7.61 (m, 2H, HAr), 8.14 (d, 4J 
= 2.1 Hz, 2H, HAr), 8.48 (t, 4J = 2.1 Hz, 1H, HAr), 9.04 (s, 1H, 3-OH), 10.53 (s, 1H, 2′-OH); 13C 
NMR (75.5 MHz, DMSO-d6): δ = 116.4, 116.8, 116.9, 119.0, 119.1, 124.5, 127.3, 127.6, 128.0, 
128.1, 128.4, 128.5, 129.2, 129.3, 129.7, 130.3, 130.4, 131.1, 131.2, 131.3, 131.4, 134.3, 134.8, 
136.6, 137.3, 142.6, 146.6, 146.7, 153.8, 157.8, 197.9 (C=O); MS (EI, 70 eV) m/z (%): 532 
([M]+, 62), 438 (10), 412 (81), 365 (84), 289 (19), 121 (100), 93 (11), 65 (11); HRMS (EI): calcd 
for C31H20N2O7 ([M]+) 532.12650, found 532.12681; IR (ATR, cm–1): ~ν  = 3507 (w), 3086 (w), 
2921 (w), 1622 (m), 1605 (w), 1579 (w), 1538 (s), 1481 (w), 1446 (w), 1401 (w), 1342 (s), 1313 
(m), 1286 (m), 1212 (m), 1170 (m), 1154 (m), 1127 (m), 1075 (w), 1031 (w), 1001 (w), 979 (w), 
952 (w), 908 (w), 867 (w), 848 (w), 832 (w), 758 (m), 725 (s), 699 (s), 670 (m), 618 (m), 595 
(w), 567 (w), 530 (w).  
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4-Benzoyl-2,6-diphenyl-3-(2-hydroxyphenyl)phenol (21a): 
Starting with 3-benzoylchromone 6a (0.250 g, 1.0 mmol), 1,3-
diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 
1,4-dioxane (6-7 mL), the product 21a was isolated as a yellow solid 
(0.111 g, 25%), mp 145-148 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 6.35-6.45 (m, 2H, HAr), 6.67 (d, 3J = 
7.5 Hz, 1H, HAr), 6.75 (td, 3J = 7.2 Hz, 4J = 1.5 Hz, 1H, HAr), 7.07-7.15 (m, 4H, HAr), 7.26 (s, 
1H, 5-HAr), 7.34-7.50 (m, 7H, HAr), 7.60 (d, 3J = 7.2 Hz, 2H, HAr), 7.70 (d, 3J = 7.1 Hz, 2H, HAr), 
8.39 (s, 1H, OH), 9.07 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 114.3, 117.5, 125.6, 
126.4, 127.1, 127.2, 127.4, 127.6, 127.7, 2ˣ127.9, 2ˣ128.3, 128.9, 2ˣ129.2, 2ˣ129.5, 129.7, 130.6, 
131.7, 131.8, 132.2, 132.3, 136.4, 137.7, 137.9, 138.0, 152.6, 154.1, 196.1 (C=O); MS (EI, 70 
eV) m/z (%): 426 ([M-OH+H], 32), 425 (18), 424 (28), 423 (50), 350 (18), 349 (71), 138 (17), 
105 (28), 96 (13), 95 (10), 83 (16), 82 (14), 81 (15), 77 (10), 71 (12), 70 (13), 69 (15), 67 (14), 
57 (19), 56 (12), 55 (23), 45 (11), 43 (100), 41 (18); HRMS (EI): calcd for C31H22O3 ([M]+) 
442.15635, found 442.15592; IR (ATR, cm–1): ~ν  = 3518 (w), 3508 (w), 3360 (w), 3057 (w), 
3029 (w), 2920 (w), 2851 (w), 1732 (w), 1653 (m), 1634 (w), 1598 (w), 1575 (w), 1557 (w), 
1539 (w), 1486 (w), 1462 (w), 1442 (m), 1397 (w), 1343 (w), 1319 (w), 1300 (w), 1286 (w), 
1258 (m), 1220 (m), 1153 (m), 1108 (w), 1075 (w), 1049 (w), 1022 (w), 993 (m), 967 (m), 939 
(w), 918 (w), 899 (m), 861 (w), 822 (w), 822 (w), 767 (m), 749 (s), 734 (s), 721 (m), 692 (s), 667 
(m), 639 (m), 614 (m), 604 (m), 590 (m), 562 (w), 539 (w).  
 
2,6-Diphenyl-3-(2-hydroxyphenyl)-4-(2-thenoyl)phenol (21b):  
Starting with 3-(2-thenoyl)chromone 6c (0.256 g, 1.0 mmol), 1,3-
diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 
1,4-dioxane (6-7 mL), the product 21b was isolated as a yellow solid (0.081 
g, 18%), mp 175-177 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 6.39-6.50 (m, 2H, HAr), 6.70 (d, 3J = 
7.4 Hz, 1H, HAr), 6.80 (t, 3J = 7.6 Hz, 1H, HAr), 7.12-7.14 (m, 6H, HAr), 7.33-7.49 (m, 4H, HAr), 
7.60-7.65 (m, 3H, HAr), 7.90 (dd, 3J = 4.9 Hz, 4J = 1.0 Hz, 1H, HAr), 8.40 (s, 1H, OH), 9.08 (s, 
1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 114.4, 117.6, 125.6, 126.4, 127.1, 127.2, 127.7, 
127.8, 128.2, 2ˣ128.3, 2ˣ129.3, 129.5, 130.5, 130.6, 130.7, 131.6, 131.9, 132.0, 134.5, 135.1, 
136.4, 137.7, 137.9, 144.4, 152.7, 154.2, 188.0 (C=O); MS (GC, 70 eV) m/z (%): 448 ([M]+, 31), 
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111 (100), 39 (6); HRMS (ESI): calcd for C29H21O3S ([M+H]+) 449.12059, found 449.12008; IR 
(ATR, cm–1): ~ν  = 3508 (w), 3390 (w), 3055 (w), 2922 (w), 2852 (w), 1622 (m), 1603 (w), 1580 
(w), 1557 (w), 1539 (w), 1505 (w), 1495 (w), 1446 (w), 1435 (w), 1408 (m), 1353 (m), 1343 
(m), 1318 (w), 1284 (m), 1259 (m), 1228 (m), 1150 (m), 1120 (w), 1099 (w), 1075 (w), 1063 
(w), 1046 (w), 1028 (w), 1001 (w), 958 (w), 940 (w), 903 (w), 889 (w), 854 (w), 821 (w), 796 
(w), 749 (s), 721 (s), 698 (s), 674 (m), 637 (w), 618 (m), 610 (m), 593 (s), 549 (w).  
 
2,6-Diphenyl-3-(2-hydroxyphenyl)-4-(2-nitrobenzoyl)phenol (21c): 
Starting with 3-(2-nitrobenzoyl)chromone 6d (0.295 g, 1.0 mmol), 1,3-
diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) 
in 1,4-dioxane (6-7 mL), the product 21c was isolated as a yellow solid 
(0.287 g, 59%), mp 119-121 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 6.28-6.32 (m, 2H, HAr), 6.57 (dd, 3J 
= 7.8 Hz, 4J = 1.5 Hz, 1H, HAr), 6.67 (td, 3J = 7.7 Hz, 4J = 1.6 Hz, 1H, HAr), 7.02-7.18 (m, 5H, 
HAr), 7.34-7.51 (m, 4H, HAr), 7.53-7.62 (m, 5H, HAr), 7.89 (dd, 3J = 7.8 Hz, 4J = 1.3 Hz, 1H, 
HAr), 8.72 (s, 1H, OH), 9.15 (s, 1H, OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 114.2, 117.7, 
123.7, 123.8, 125.5, 126.6, 127.3, 127.4, 128.0, 128.2, 128.5, 129.1, 129.2, 129.3, 130.6, 130.7, 
130.7, 130.8, 131.9, 132.4, 133.2, 133.3, 136.0, 136.4, 137.6, 139.9, 146.3, 154.1, 155.0, 170.4, 
193.1 (C=O); MS (EI, 70 eV) m/z (%): 487 ([M]+, 100), 470 (37), 455 (16), 438 (72), 365 (84), 
337 (40), 319 (11), 289 (14), 44 (13); HRMS (ESI): calcd for C31H22NO5 ([M+H]+) 488.14925, 
found 488.15003; IR (ATR, cm–1): ~ν  = 3494 (w), 3058 (w), 1651 (w), 1606 (w), 1575 (w), 1553 
(w), 1524 (m), 1445 (w), 1403 (w), 1344 (m), 1281 (m), 1217 (m), 1151 (m), 1123 (w), 1103 
(w), 1028 (w), 966 (w), 902 (w), 855 (w), 825 (w), 788 (w), 748 (m), 699 (s), 609 (m), 547 (w).  
 
2,6-Diphenyl-3-(2-hydroxy-5-methylphenyl)-4-(2-nitrobenzoyl)phenol (21d): 
Starting with 6-methyl-3-(2-nitrobenzoyl)chromone 6e (0.309 g, 1.0 
mmol), 1,3-diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 
mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 21d was isolated 
as a yellow solid (0.366 g, 73%), mp 211-213 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.86 (s, 3H, CH3), 6.15 (d, 3J = 
7.5 Hz, 1H, HAr), 6.33 (s, 1H, 6′-HAr), 6.44 (d, 3J = 7.5 Hz, 1H, HAr), 6.91-7.10 (m, 5H, HAr), 
7.36-7.39 (m, 2H, HAr), 7.45-7.59 (m, 6H, HAr), 7.65 (s, 1H, 5-HAr), 7.86 (d, 3J = 7.6 Hz, 1H, 
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HAr), 8.71 (s, 1H, OH), 8.90 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.8 (CH3), 
114.0, 123.5, 125.0, 125.6, 126.6, 127.2, 127.3, 128.2, 2ˣ128.5, 128.6, 129.1, 2ˣ129.2, 130.3, 
131.4, 131.7, 132.3, 133.2, 136.0, 136.5, 137.7, 140.0, 146.0, 151.9, 154.9, 193.3 (C=O); MS 
(EI, 70 eV) m/z (%): 501 ([M]+, 49), 484 (12), 452 (33), 379 (20), 351 (21), 287 (72), 273 (100), 
215 (33), 197 (96), 183 (68), 165 (12), 135 (72), 121 (55), 73 (56); HRMS (ESI): calcd for 
C32H24NO5 ([M+H]+) 502.16490, found 502.16558; IR (ATR, cm–1): ~ν  = 3509 (w), 3350 (w), 
2920 (w), 1732 (w), 1651 (m), 1591 (w), 1556 (w), 1529 (s), 1443 (w), 1402 (w), 1341 (m), 
1312 (m), 1257 (m), 1223 (s), 1149 (m), 1130 (m), 1061 (w), 1030 (m), 1001 (w), 968 (w), 911 
(m), 887 (w), 857 (m), 819 (m), 774 (s), 742 (s), 697 (s), 667 (m), 610 (s), 591 (m), 566 (m).  
 
2,6-Diphenyl-3-(2-hydroxy-4-methoxyphenyl)-4-(2-nitrobenzoyl)phenol (21e): 
Starting with 7-methoxy-3-(2-nitrobenzoyl)chromone 6f (0.325 g, 1.0 
mmol), 1,3-diphenylacetone 19 (0.22 mL, 1.1 mmol) and DBU (0.20 
mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 21e was isolated 
as a yellow solid (0.315 g, 61%), mp 198-200 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.50 (s, 3H, OCH3), 5.82 (d, 4J 
= 2.4 Hz, 1H, HAr), 5.89 (dd, 3J = 8.4 Hz, 4J = 2.4 Hz, 1H, HAr), 6.44 (d, 3J = 8.4 Hz, 1H, HAr), 
6.99-7.28 (m, 5H, HAr), 7.34-7.40 (m, 2H, HAr), 7.45-7.52 (m, 3H, HAr), 7.54-7.59 (m, 3H, HAr), 
7.62 (s, 1H, 5-HAr), 7.88 (dd, 3J = 7.9 Hz, 4J = 1.3 Hz, 1H, HAr), 8.68 (s, 1H, OH), 9.19 (s, 1H, 
OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 54.6 (OCH3), 100.1, 103.5, 118.2, 123.6, 126.5, 
127.3, 127.4, 128.2, 128.4, 128.5, 129.1, 129.2, 129.6, 130.2, 130.3, 131.2, 131.3, 132.1, 132.3, 
132.4, 133.2, 133.3, 136.2, 136.6, 137.7, 139.7, 146.0, 154.9, 155.0, 159.1, 193.4 (C=O); MS 
(EI, 70 eV) m/z (%): 517 ([M]+, 100), 500 (25), 485 (10), 468 (40), 395 (74), 367 (25), 351 (10), 
276 (8), 151 (8); HRMS (ESI): calcd for C32H24NO6 ([M+H]+) 518.15981, found 518.16061; IR 
(ATR, cm–1): ~ν  = 3480 (w), 2917 (w), 2849 (w), 1711 (w), 1674 (w), 1640 (m), 1615 (m), 1552 
(w), 1525 (s), 1464 (w), 1440 (m), 1346 (m), 1292 (m), 1244 (s), 1197 (m), 1149 (s), 1099 (s), 
1025 (m), 966 (m), 915 (m), 853 (m), 822 (m), 791 (m), 764 (m), 744 (m), 724 (m), 701 (s), 609 
(s), 559 (m), 531 (m). 
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General procedure for the synthesis of compounds 22 and 23: 
To a stirred reaction mixture of the corresponding compound 13 or 14 (1.0 mmol) in methanol (6-7 
mL) potassium hydroxide (4.0 mmol) was added. Stirring at reflux was continued until the reagent 
was consumed completely (followed by TLC, approximately 2 days). The solvent was distilled off in 
a vacuum, and the resulting residue was quenched with water, then, neutralized with an aqueous 
solution of HCl (30%). The resulting residue was filtered and dried. 
 
Some of protons in the low field of 1H NMR spectra of compounds 22 and 23 could not be 
detected due to their fast exchange. 
 
3-Hydroxy-6-(2-hydroxybenzoyl)-1,2,4-benzenetricarboxylic acid (22a): 
Starting with trimethyl 3-hydroxy-6-(2-hydroxybenzoyl)-benzene-
1,2,4-tricarboxylate 13a (0.116 g, 0.3 mmol) and potassium hydroxide 
(0.134 g, 2.4 mmol) in methanol (2-3 mL), the product 22a was 
isolated as a white solid (0.083 g, 80%), mp 279-281 ºC; 
1H NMR (300 MHz, CDCl3): δ = 6.87-6.95 (m, 2H, HAr), 7.30 (d, 3J = 7.5 Hz, 1H, HAr), 7.42 (t, 
3J = 7.5 Hz, 1H, HAr), 7.85 (s, 1H, 5-HAr); 13C NMR (62.9 MHz, CDCl3): δ = 116.0, 116.4, 
117.2, 118.8, 122.3, 124.5, 130.9, 133.7, 136.3, 144.5, 158.1, 167.0, 167.7, 169.6, 170.8, 196.8 
(C=O); HRMS (ESI): calcd for C16H9O9 ([M-H]-) 345.02521, found 345.02546; IR (ATR, cm–1): 
~ν
 = 3401 (w), 1660 (w), 1643 (w), 1623 (m), 1588 (s), 1537 (w), 1485 (w), 1462 (w), 1446 (m), 
1332 (m), 1291 (m), 1224 (s), 1157 (w), 1039 (w), 968 (w), 944 (w), 888 (w), 844 (w), 827 (m), 
806 (w), 787 (w), 757 (s), 699 (m), 639 (s), 589 (m), 553 (m), 530 (w). 
 
3-Hydroxy-6-(2-hydroxy-5-methylbenzoyl)-1,2,4-benzenetricarboxylic acid (22b): 
Starting with trimethyl 3-hydroxy-6-(2-hydroxy-5-methylbenzoyl)-
benzene-1,2,4-tricarboxylate 13b (0.121 g, 0.3 mmol) and potassium 
hydroxide (0.134 g, 2.4 mmol) in methanol (2-3 mL), the product 22b 
was isolated as a white solid (0.091 g, 84%), mp 298-300 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.21 (s, 3H, CH3), 6.88 (d, 3J = 8.4 Hz, 1H, 3′-HAr), 7.11 (s, 
1H, 6′-HAr), 7.28 (dd, 3J = 8.4 Hz, 4J = 2.0 Hz, 1H, 4′-HAr), 7.93 (s, 1H, 5-HAr), 10.47 (s, 1H, 
OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.9 (CH3), 115.4, 117.0, 119.1, 123.0, 124.4, 127.8, 
131.0, 135.1, 135.6, 140.7, 156.2, 166.1, 167.1, 167.9, 168.5, 196.1 (C=O); MS (EI, 70 eV) m/z 
(%): 343 ([M-OH-H], 76), 342 (71), 297 (21), 280 (23), 279 (100), 270 (13), 252 (21), 224 (12), 
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135 (14), 134 (21), 77 (11), 44 (22); HRMS (ESI): calcd for C17H11O9 ([M-H]-) 359.04086, 
found 359.04120; IR (ATR, cm–1): ~ν  = 2858 (w), 1704 (w), 1681 (w), 1651 (w), 1644 (m), 1582 
(m), 1519 (w), 1504 (w), 1434 (m), 1384 (w), 1334 (s), 1292 (s), 1222 (s), 1169 (m), 1037 (w), 
974 (w), 880 (w), 822 (m), 793 (m), 745 (m), 700 (m), 672 (m), 640 (m), 582 (m), 534 (m).  
 
3-Hydroxy-6-(5-chloro-2-hydroxy-4-methylbenzoyl)-1,2,4-benzenetricarboxylic acid (22c): 
Starting with trimethyl 6-(5-chloro-2-hydroxy-4-methylbenzoyl)-
3-hydroxybenzene-1,2,4-tricarboxylate 13e (0.131 g, 0.3 mmol) 
and potassium hydroxide (0.134 g, 2.4 mmol) in methanol (2-3 
mL), the product 22c was isolated as a white solid (0.109 g, 
92%), mp 362-364 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.32 (s, 3H, CH3), 6.96 (s, 1H, 3′-HAr), 7.33 (s, 1H, 6′-HAr), 
7.91 (s, 1H, 5-HAr), 10.71 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 20.0 (CH3), 114.7, 
119.6, 122.3, 122.5, 123.3, 127.0, 130.7, 133.4, 138.6, 142.7, 157.1, 162.6, 166.1, 167.3, 169.8, 
194.2 (C=O); MS (EI, 70 eV) m/z (%): 376 ([M-OH-H], 76), 331 (15), 313 (100), 286 (23), 258 
(11), 168 (17), 139 (11), 77 (19); HRMS (ESI): calcd for C17H1035ClO9 ([M-H]-) 393.00188, 
found 393.00275; IR (ATR, cm–1): ~ν  = 3490 (w), 2848 (w), 2521 (w), 1704 (m), 1688 (m), 1622 
(m), 1599 (m), 1574 (m), 1476 (w), 1434 (w), 1392 (w), 1374 (w), 1334 (m), 1239 (s), 1212 (s), 
1179 (s), 1160 (s), 1052 (m), 1009 (w), 952 (w), 884 (m), 826 (m), 816 (w), 803 (m), 792 (m), 
747 (s), 722 (m), 709 (m), 686 (s), 635 (m), 619 (m), 596 (s).  
 
3-Hydroxy-6-(1-hydroxy-2-naphthoyl)benzene-1,2,4-tricarboxylic acid (22d): 
Starting with trimethyl 3-hydroxy-6-(1-hydroxy-2-
naphthoyl)benzene-1,2,4-tricarboxylate 13g (0.131 g, 0.3 mmol) 
and potassium hydroxide (0.134 g, 2.4 mmol) in methanol (2-3 mL), 
the product 22d was isolated as a yellow solid (0.106 g, 89%), mp 
304-306 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 7.32-7.42 (m, 2H, HAr), 7.63 (t, 3J = 7.2 Hz, 1H, HAr), 7.74 
(t, 3J = 7.1 Hz, 1H, HAr), 7.93 (d, 3J = 8.0 Hz, 1H, HAr), 7.98 (s, 1H, 5-HAr), 8.38 (d, 3J = 8.2 Hz, 
1H, HAr), 13.37 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 113.5, 116.4, 117.4, 118.3, 
122.1, 123.6, 124.4, 126.4, 127.0, 127.8, 130.4, 135.2, 136.8, 141.7, 161.4, 166.2, 167.6, 168.1, 
169.7, 199.3 (C=O); MS (EI, 70 eV) m/z (%): 378 ([M-OH-H], 58), 360 (10), 315 (45), 288 (20), 
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260 (13), 217 (11), 170 (32), 144 (29), 115 (25), 97 (30), 78 (76), 69 (56), 63 (100), 43 (86); 
HRMS (ESI): calcd for C20H11O9 ([M-H]-) 395.04086, found 395.04184; IR (ATR, cm–1): ~ν  = 
3391 (w), 2916 (w), 2590 (w), 1714 (w), 1651 (w), 1627 (w), 1584 (m), 1514 (m), 1504 (m), 
1485 (w), 1455 (s), 1413 (m), 1384 (m), 1329 (m), 1271 (s), 1250 (s), 1210 (s), 1151 (m), 1108 
(w), 1054 (w), 1023 (w), 991 (w), 946 (w), 876 (w), 829 (w), 778 (s), 742 (m), 717 (m), 685 (w), 
660 (w), 640 (w), 612 (m), 601 (m), 575 (w), 557 (m). 
 
9-Hydroxy-6-oxo-6H-benzo[c]chromene-8,10-dicarboxylic acid 
(23a): 
Starting with dimethyl 6,9-dihydroxy-6-(pentafluoroethyl)-6H-
benzo[c]chromene-8,10-dicarboxylate 14d (0.134 g, 0.3 mmol) and 
potassium hydroxide (0.134 g, 2.4 mmol) in methanol (2-3 mL), the 
product 23a was isolated as a white solid (0.063 g, 70%), mp 361 ºC; 
1H NMR (300 MHz, CDCl3): δ = 7.37-7.44 (m, 2H, HAr), 7.61 (t, 3J = 7.7 Hz, 1H, HAr), 8.13 (d, 
3J = 7.8 Hz, 1H, HAr), 8.68 (s, 1H, 7-HAr); 13C NMR (62.9 MHz, CDCl3): δ = 109.9, 116.3, 
116.9, 117.9, 120.5, 124.4, 125.1, 133.6, 131.7, 133.6, 151.4, 159.6, 166.1, 169.2, 169.6; MS 
(EI, 70 eV) m/z (%): 256 ([M-CO2], 86), 239 (28), 238 (100), 211 (16), 210 (90), 182 (21), 154 
(15), 126 (48), 119 (11), 91 (27), 78 (21), 63 (31), 44 (87); HRMS (ESI): calcd for C15H7O7 ([M-
H]-) 299.01973, found 299.02026; IR (ATR, cm–1): ~ν  = 2849 (w), 1704 (m), 1682 (m), 1651 
(m), 1594 (s), 1557 (m), 1495 (w), 1446 (w), 1417 (w), 1318 (m), 1286 (m), 1200 (s), 1148 (s), 
1113 (s), 932 (m), 893 (m), 855 (m), 809 (m), 744 (s), 727 (s), 713 (s), 686 (s), 640 (s).  
 
9-Hydroxy-6-oxo-6H-dibenzo[c,h]chromene-8,10-dicarboxylic acid (23b): 
Starting with dimethyl 6-(heptafluoropropyl)-6,9-dihydroxy-6H-
dibenzo[c,h]chromene-8,10-dicarboxylate 14u (0.164 g, 0.3 mmol) 
and potassium hydroxide (0.134 g, 2.4 mmol) in methanol (2-3 mL), the 
product 23b was isolated as a pale yellow solid (0.097 g, 92%), mp 
310-312 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 7.70-7.73 (m, 2H, HAr), 7.87 (d, 3J = 9.2 Hz, 1H, HAr), 
7.99-8.02 (m, 1H, HAr), 8.12 (d, 3J = 9.1 Hz, 1H, HAr), 8.39-8.42 (m, 1H, HAr), 8.76 (s, 1H, 7-
HAr); 13C NMR (75.5 MHz, DMSO-d6): δ = 111.2, 112.1, 115.0, 120.5, 120.7, 122.0, 123.0, 
124.0, 127.6, 127.7, 129.0, 133.8, 134.1, 135.2, 147.9, 159.2, 163.3, 168.6, 170.3; MS (EI, 70 
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eV) m/z (%): 306 ([M-CO2], 87), 288 (100), 260 (33), 232 (11), 204 (14), 176 (30), 144 (8), 116 
(11), 88 (21), 63 (10), 44 (39); HRMS (ESI): calcd for C19H9O7 ([M-H]-) 349.03538, found 
349.03602; IR (ATR, cm–1): ~ν  = 3418 (w), 2872 (w), 2538 (w), 1713 (s), 1699 (s), 1682 (s), 
1668 (s), 1633 (m), 1587 (s), 1557 (m), 1505 (w), 1495 (w), 1477 (w), 1446 (s), 1424 (m), 1353 
(m), 1336 (m), 1302 (m), 1257 (s), 1216 (s), 1195 (s), 1164 (s), 1145 (s), 1122 (s), 1034 (m), 
1013 (m), 964 (m), 939 (m), 895 (m), 870 (w), 800 (s), 773 (s), 736 (s), 680 (s), 666 (s), 634 (s), 
622 (s), 609 (s), 563 (s), 537 (m). 
 
 
1.2.3 Supplement for Chapter 4 
 
General procedure for the synthesis of compounds 25-30: 
Reaction mixture of the corresponding 3-acylchromone 4-8 (1.0 mmol) and HKAs 24 (1.1 
mmol) in 1,4-dioxane (6-7 mL) was stirred at room temperature. Stirring was continued until 
chromone was consumed completely (followed by TLC). The reaction time was dependent on 
solubility and activity of 3-acylchromones: the reaction time of 3-metoxalylchromones was 
about 2 days, for 3-aroylchromones about 1-7 days and for 3-polyhaloacylchromones about 10-
12 h. Compounds 27 and 29 (synthesized starting from 3-heptafluorobutanoylchromones) were 
formed as a precipitate. They were filtered and washed with a mixture of ethyl acetate and 
heptane (1:3) to give pure products. The filtrates or reaction mixtures of other syntheses were 
distilled off under reduced pressure. The resulting residues were purified by column 
chromatography (silica gel, heptane/ethyl acetate) to isolate compounds 25, 26, 28 and 30. 
Compounds 29 synthesized from 3-trifluoroacetylchromones were purified by column 
chromatography using ethyl acetate/methanol. In the case of synthesis of compounds 29a and 
29c using 3-heptafluorobutanoylchromones, the reactions were carried out under reflux. 
 
Methyl 16-benzoyl-2-oxo-9-oxa-11,14-diazatetracyclo[8.7.0.03,8.011,15]heptadeca-
1(17),3(8),4,6,15-pentaene-10-carboxylate (25a): 
Starting with 3-methoxalylchromone 4a (0.232 g, 1.0 mmol) and HKA 
24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 25a was 
isolated as a yellow solid (0.285 g, 71%), mp 207-208 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.65 (s, 3H, OCH3), 3.82-4.10 (m, 
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4H, CH), 7.08-7.10 (m, 2H, HAr), 7.45-7.73 (m, 8H, HAr), 9.68 (s, 1H, NH); 13C NMR (75.5 
MHz, DMSO-d6): δ = 43.6 (NCH2), 43.7 (NCH2), 53.6 (OCH3), 90.2 and 91.8 (10-C and 16-C), 
105.8, 117.3, 121.8, 122.4, 126.4, 2ˣ127.6, 2ˣ128.4, 130.2, 135.4, 138.2, 139.7, 155.5, 158.4, 
167.2, 175.8, 189.6 (C=O); MS (EI, 70 eV) m/z (%): 402 ([M]+, 3), 401 (6), 345 (55), 344 (92), 
343 (100), 342 (12), 341 (29), 315 (12), 314 (10), 313 (15), 265 (17), 171 (13), 105 (20), 77 (26); 
HRMS (ESI): calcd for C23H19N2O5 ([M+H]+) 403.12885, found 403.12894, calcd for 
C23H18NaN2O5 ([M+Na]+) 425.11079, found 425.11082; IR (ATR, cm–1): ~ν  = 3345 (w), 3308 
(w), 3061 (w), 2963 (w), 2902 (w), 1731 (w), 1644 (w), 1604 (w), 1578 (m), 1548 (s), 1476 (m), 
1461 (s), 1443 (s), 1376 (w), 1321 (s), 1286 (m), 1244 (m), 1194 (s), 1134 (m), 1101 (m), 1088 
(m), 1074 (m), 997 (s), 952 (m), 926 (w), 838 (w), 820 (w), 800 (w), 782 (m), 744 (s), 705 (s), 
660 (m), 626 (s), 584 (m), 561 (m), 528 (m). 
 
Methyl 16-benzoyl-6-methoxy-2-oxo-9-oxa-11,14-diazatetracyclo[8.7.0.03,8.011,15]heptadeca-
1(17),3(8),4,6,15-pentaene-10-carboxylate (25b): 
Starting with 7-methoxy-3-methoxalylchromone 4c (0.262 g, 1.0 
mmol) and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 
mL), the product 25b was isolated as a yellow solid (0.311 g, 
72%), mp 240-241 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.69 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 3.89-4.25 (m, 4H, 
CH), 6.48 (d, 4J = 2.1 Hz, 1H, HAr), 6.62 (dd, 4J = 2.1 Hz, 3J = 8.8 Hz, 1H, HAr), 7.42-7.54 (m, 
5H, HAr), 7.85-7.88 (m, 2H, HAr), 9.50 (s, 1H, NH); 13C NMR (75.5 MHz, CDCl3): δ = 43.3 
(NCH2), 44.0 (NCH2), 53.4 (OCH3), 55.6 (OCH3), 90.6 and 91.9 (10-C and 16-C), 100.8, 107.5, 
110.1, 115.9, 2ˣ128.1, 2ˣ128.3, 129.0, 130.4, 137.8, 139.3, 157.7, 160.1, 165.6, 167.3, 176.8, 
191.6 (C=O); MS (EI, 70 eV) m/z (%): 432 ([M]+, 2), 431 (4), 376 (11), 375 (61), 374 (52), 373 
(100), 186 (7); HRMS (ESI): calcd for C24H21N2O6 ([M+H]+) 433.13941, found 433.13959, 
calcd for C24H20NaN2O6 ([M+Na]+) 455.12136, found 455.12152; IR (ATR, cm–1): ~ν  = 3295 
(w), 3053 (w), 2949 (w), 2888 (w), 2848 (w), 1741 (m), 1629 (w), 1606 (m), 1575 (m), 1546 (s), 
1500 (w), 1482 (m), 1441 (s), 1428 (s), 1381 (m), 1316 (s), 1243 (s), 1212 (s), 1163 (s), 1127 
(m), 1106 (s), 1019 (s), 1005 (s), 979 (s), 959 (m), 933 (m), 885 (w), 871 (w), 837 (s), 813 (w), 
787 (m). 756 (s), 710 (m), 663 (s), 627 (s), 593 (s), 543 (m). 
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Methyl 9-benzoyl-12-oxo-2-oxa-4,7-diazapentacyclo[11.8.0.03,11.04,8.016,21]henicosa-
1(13),8,10,14,16(21),17,19-heptaene-3-carboxylate (25c): 
Starting with 3-methoxalylbenzo[h]chromone 4g (0.282 g, 1.0 
mmol)and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), 
the product 25c was isolated as a yellow solid (0.348 g, 77%), mp 
244-246 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.63 (s, 3H, OCH3), 3.70-3.77 (m, 1H, CH), 3.88-4.03 (m, 
2H, CH), 4.40-4.42 (m, 1H, CH), 7.48-7.75 (m, 10H, HAr), 7.95 (d, 3J = 7.8 Hz, 1H, HAr), 8.37 
(d, 3J = 8.0 Hz, 1H, HAr), 9.73 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 43.6 (NCH2), 
43.7 (NCH2), 53.7 (OCH3), 91.0 and 91.6 (3-C and 9-C), 105.8, 116.6, 121.6, 121.9, 123.0, 
123.8, 126.7, 2ˣ127.6, 127.9, 2ˣ128.4, 129.5, 130.2, 136.7, 137.7, 139.8, 152.8, 158.3, 166.9, 
175.9, 189.6 (C=O); MS (EI, 70 eV) m/z (%): 452 ([M]+, 18), 395 (59), 394 (100), 393 (59), 391 
(18), 315 (11), 196 (29), 105 (17), 77 (21); HRMS (ESI): calcd for C27H21N2O5 ([M+H]+) 
453.14450, found 453.14454, calcd for C27H20NaN2O5 ([M+Na]+) 475.12636, found 475.12644; 
IR (ATR, cm–1): ~ν  = 3578 (w), 3311 (w), 3055 (w), 2955 (w), 2905 (w), 2852 (w), 1738 (m), 
1626 (m), 1596 (w), 1572 (w), 1543 (s), 1506 (m), 1482 (m), 1468 (s), 1426 (s), 1378 (m), 1350 
(w), 1324 (m), 1288 (w), 1269 (s), 1236 (s), 1221 (s), 1200 (m), 1187 (s), 1133 (s), 1094 (s), 
1071 (m), 1036 (m), 1017 (s), 971 (m), 957 (m), 926 (m), 871 (w), 843 (w), 828 (m), 811 (m), 
799 (m), 792 (m), 769 (s), 746 (s), 729 (m), 702 (s), 681 (m), 665 (s), 650 (s), 632 (s), 601 (m), 
579 (m), 548 (m). 
 
Methyl 13-benzoyl-11-oxo-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphene-5a-
carboxylate (25d): 
Starting with 3-methoxalylchromone 4a (0.232 g, 1.0 mmol) and HKA 
24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 25d was 
isolated as a green-brown solid (0.379 g, 91%), mp 253-255 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.81-1.95 (m, 1H, CH), 2.07-2.16 
(m, 1H, CH), 3.41-3.52 (m, 2H, CH), 3.59-3.65 (m, 1H, CH), 3.67 (s, 3H, OCH3), 3.78-3.87 (m, 
1H, CH), 7.07-7.12 (m, 2H, HAr), 7.39-7.42 (m, 2H, HAr), 7.46-7.59 (m, 5H, HAr), 7.70 (dd, 4J = 
1.6 Hz, 3J = 7.9 Hz, 1H, HAr), 11.69 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 18.6 
(CH2), 38.4 (NCH2), 41.4 (NCH2), 53.7 (OCH3), 91.1 and 93.2 (5a-C and 13-C), 104.1, 117.2, 
121.6, 122.3, 126.1, 2ˣ127.7, 2ˣ128.3, 129.9, 135.3, 138.3, 140.3, 154.6, 155.6, 167.7, 175.7, 
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191.1 (C=O); MS (EI, 70 eV) m/z (%): 359 ([M-COOCH3+2H], 31), 358 (62), 357 (100), 329 
(34), 178 (13), 105 (12), 91 (40), 77 (14); HRMS (ESI): calcd for C24H21N2O5 ([M+H]+) 
417.14450, found 417.14448, calcd for C24H20NaN2O5 ([M+Na]+) 439.12644, found 439.12618; 
IR (ATR, cm–1): ~ν  = 3021 (w), 2959 (w), 2940 (w), 1738 (w), 1643 (w), 1607 (m), 1581 (m), 
1564 (s), 1480 (m), 1458 (s), 1441 (s), 1382 (w), 1365 (m), 1333 (m), 1304 (w), 1290 (m), 1274 
(s), 1243 (s), 1219 (s), 1204 (m), 1173 (m), 1143 (m), 1103 (m), 1081 (m), 1058 (w), 1027 (m), 
1004 (m), 951 (w), 920 (w), 887 (w), 873 (w), 829 (w), 801 (w), 777 (m), 752 (s), 742 (s), 698 
(m), 682 (m), 675 (m), 629 (s), 601 (m), 575 (w), 554 (w), 528 (w). 
 
Methyl 13-benzoyl-8-methoxy-11-oxo-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphene-
5a-carboxylate (25e): 
Starting with 7-methoxy-3-methoxalylchromone 4c (0.262 g, 1.0 
mmol) and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 
mL), the product 25e was isolated as a yellow solid (0.392 g, 
88%), mp 250-251 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.85-1.98 (m, 1H, CH), 2.06-2.15 (m, 1H, CH), 3.42-3.55 
(m, 2H, CH), 3.58-3.65 (m, 1H, CH), 3.68 (s, 3H, OCH3), 3.78-3.88 (m, 1H, CH), 3.83 (s, 3H, 
OCH3), 6.62 (d, 4J = 2.3 Hz, 1H, HAr), 6.67 (dd, 3J = 8.7 Hz, 4J = 2.4 Hz, 1H, HAr), 7.37-7.40 (m, 
2H, HAr), 7.45-7.52 (m, 4H, HAr), 7.62 (d, 3J = 8.7 Hz, 1H, HAr), 11.73 (s, 1H, NH); 13C NMR 
(75.5 MHz, DMSO-d6): δ = 18.7 (CH2), 38.3 (NCH2), 41.4 (NCH2), 53.7 (OCH3), 55.8 (OCH3), 
91.3 and 92.7 (5a-C and 13-C), 100.9, 104.3, 110.1, 115.2, 2ˣ127.6, 127.9, 2ˣ128.2, 129.8, 137.3, 
140.4, 154.6, 157.6, 165.0, 167.6, 175.0, 190.8 (C=O); MS (EI, 70 eV) m/z (%): 388 ([M-
COOCH3+H], 56), 387 (100), 359 (15), 193 (9), 105 (7), 91 (20); HRMS (EI): calcd for 
C25H22N2O6 ([M]+) 446.14724, found 446.14589; IR (ATR, cm–1): ~ν  = 3055 (w), 2996 (w), 
2978 (w), 2946 (w), 1742 (m), 1641 (w), 1605 (s), 1584 (m), 1559 (s), 1498 (w), 1476 (s), 1459 
(m), 1426 (s), 1381 (m), 1364 (m), 1347 (m), 1325 (m), 1293 (w), 1283 (w), 1238 (s), 1217 (s), 
1196 (m), 1175 (m), 1162 (s), 1140 (s), 1101 (s), 1078 (m), 1058 (m), 1014 (s), 990 (m), 965 (s), 
930 (m), 903 (w), 883 (w), 874 (w), 864 (w), 839 (s), 811 (m), 800 (s), 785 (s), 767 (s), 748 (s), 
706 (s), 679 (m), 661 (s), 646 (s), 639 (m), 627 (s), 596 (s), 561 (m), 550 (m). 
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Methyl 13-benzoyl-9-chloro-11-oxo-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphene-5a-
carboxylate (25f): 
Starting with 6-chloro-3-methoxalylchromone 4d (0.266 g, 1.0 
mmol) and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), 
the product 25f was isolated as a yellow solid (0.347 g, 77%), mp 
254-255 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.85-1.94 (m, 1H, CH), 2.07-2.15 (m, 1H, CH), 3.41-3.54 
(m, 2H, CH), 3.62-3.66 (m, 1H, CH), 3.68 (s, 3H, OCH3), 3.76-3.85 (m, 1H, CH), 7.15 (d, 3J = 
8.3 Hz, 1H, HAr), 7.38-7.42 (m, 2H, HAr), 7.46-7.53 (m, 3H, HAr), 7.57-7.61 (m, 3H, HAr), 11.64 
(s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 18.5 (CH2), 38.4 (NCH2), 41.6 (NCH2), 53.8 
(OCH3), 91.4 and 93.7 (5a-C and 13-C), 103.1, 119.5, 122.8, 125.1, 126.4, 2ˣ127.8, 2ˣ128.3, 
130.1, 134.7, 139.1, 140.1, 154.3, 154.5, 167.5, 174.3, 191.4 (C=O); MS (EI, 70 eV) m/z (%): 
391 ([M-COOCH3], 100), 363 (17), 105 (5), 91 (19), 77 (5); HRMS (ESI): calcd for 
C24H2035ClN2O5 ([M+H]+) 451.10553, found 451.10509, calcd for C24H2037ClN2O5 ([M+H]+) 
453.10368, found 453.10405; IR (ATR, cm–1): ~ν  = 2961 (w), 2909 (w), 2847 (w), 2749 (w), 
2675 (w), 1740 (w), 1644 (w), 1614 (m), 1600 (m), 1580 (m), 1568 (m), 1557 (m), 1539 (w), 
1520 (w), 1505 (w), 1480 (m), 1464 (s), 1442 (s), 1428 (s), 1386 (w), 1364 (m), 1327 (w), 1296 
(w), 1249 (s), 1219 (s), 1185 (m), 1145 (m), 1117 (s), 1096 (s), 1078 (m), 1058 (s), 1045 (s), 
1008 (s), 976 (m), 955 (m), 913 (w), 901 (w), 886 (w), 872 (s), 825 (m), 800 (m), 772 (m), 749 
(w), 733 (m), 700 (m), 684 (w), 661 (w), 629 (s), 609 (s), 572 (w), 541 (w). 
 
Methyl 10-benzoyl-13-oxo-2-oxa-4,8-diazapentacyclo[12.8.0.03,12.04,9.017,22]docosa-
1(14),9,11,15,17(22),18,20-heptaene-3-carboxylate (25g): 
 Starting with 3-methoxalylbenzo[h]chromone 4g (0.282 g, 1.0 
mmol) and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), 
the product 25g was isolated as a yellow-brawn solid (0.438 g, 
94%), mp 282-284 ºC; 
1H NMR (250 MHz, CDCl3): δ = 2.06-2.19 (m, 1H, CH), 2.23-2.32 (m, 1H, CH), 3.45-3.56 (m, 
1H, CH), 3.64 (s, 4H, OCH3, CH), 3.78-3.88 (m, 1H, CH), 3.99-4.10 (m, 1H, CH), 7.40-7.62 (m, 
8H, HAr), 7.80 (d, 3J = 7.5 Hz, 1H, HAr), 7.90-7.93 (m, 2H, HAr), 8.24 (d, 3J = 7.9 Hz, 1H, HAr), 
12.21 (s, 1H, NH); 13C NMR (62.9 MHz, CDCl3): δ = 19.4 (CH2), 38.6 (NCH2), 41.6 (NCH2), 
53.5 (OCH3), 92.3 and 93.8 (3-C and 10-C), 104.9, 117.0, 122.0, 122.1, 122.7, 124.2, 126.1, 
O N
O
O
Ph
NH
Cl
H3CO O
18
19
3 4
10
2
5 6
7
8
11131415
1 N
O
NHO
H3CO O
Ph
O16
20
 Supplement 1. Experimental part 
 
 
 
 
 151
128.0, 128.2, 2ˣ128.3, 128.9, 130.0, 130.1, 137.2, 138.9, 140.1, 153.1, 155.4, 167.8, 177.3, 192.6 
(C=O); MS (EI, 70 eV) m/z (%): 466 ([M]+, 10), 408 (84), 379 (86), 349 (47), 301 (14), 274 (13), 
246 (15), 189 (34), 175 (11), 127 (13), 114 (48), 105 (85), 91 (100), 77 (91), 59 (23), 51 (17); 
HRMS (EI): calcd for C28H22N2O5 ([M]+) 466.15232, found 466.15166; IR (ATR, cm–1): ~ν  = 
3065 (w), 2951 (w), 2922 (w), 2853 (w), 1747 (m), 1641 (w), 1615 (m), 1574 (s), 1557 (s), 1539 
(m), 1506 (w), 1489 (m), 1479 (s), 1430 (s), 1417 (m), 1398 (m), 1381 (m), 1368 (m), 1346 (m), 
1323 (m), 1297 (m), 1256 (s), 1240 (s), 1230 (s), 1208 (m), 1189 (m), 1175 (m), 1148 (m), 1140 
(m), 1111 (m), 1093 (m), 1062 (m), 1045 (m), 1024 (m), 1007 (s), 984 (m), 954 (m), 921 (w), 
899 (w), 868 (w), 837 (w), 820 (w), 802 (s), 787 (m), 776 (m), 766 (s), 747 (s), 718 (m), 700 (s), 
686 (m), 657 (s), 638 (s), 605 (m), 574 (s). 
 
16-Benzoyl-10-phenyl-9-oxa-11,14-diazatetracyclo[8.7.0.03,8.011,15]heptadeca-
1(17),3(8),4,6,15-pentaen-2-one (26a): 
 Starting with 3-benzoylchromone 6a (0.250 g, 1.0 mmol) and HKA 
24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26a was 
isolated as a yellow solid (0.059 g, 14%), mp 284-286 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.23-3.33 (m, 1H, CH), 3.65-3.83 (m, 
2H, CH), 4.04-4.16 (m, 1H, CH), 6.88 (td, 4J = 0.9 Hz, 3J = 7.5 Hz, 1H, HAr), 7.00 (d, 3J = 7.7 
Hz, 1H, HAr), 7.17-7.25 (m, 3H, HAr), 7.31-7.41 (m, 6H, HAr), 7.51-7.54 (m, 2H, HAr), 7.71 (dd, 
4J = 1.6 Hz, 3J = 7.8 Hz, 1H, HAr), 7.98 (s, 1H, 17-H), 9.28 (s, 1H, NH); 13C NMR (62.9 MHz, 
CDCl3): δ = 42.5 (NCH2), 42.7 (NCH2), 91.4 and 91.7 (10-C and 16-C), 112.6, 117.4, 122.1, 
123.2, 2ˣ126.9, 127.5, 2ˣ128.1, 2ˣ128.4, 2ˣ128.6, 129.0, 130.3, 135.2, 136.6, 138.5, 139.6, 155.4, 
158.9, 179.4, 191.5 (C=O); MS (EI, 70 eV) m/z (%): 420 ([M]+, 76), 391 (56), 343 (100), 315 
(32), 77 (10); HRMS (ESI): calcd for C27H21N2O5 ([M+H]+) 421.15467, found 421.15482; IR 
(ATR, cm–1): ~ν  = 3272 (w), 3060 (w), 3030 (w), 2982 (w), 2961 (w), 2901 (w), 2888 (w), 1643 
(w), 1624 (w), 1601 (w), 1545 (s), 1484 (m), 1472 (m), 1450 (m), 1441 (s), 1406 (w), 1374 (m), 
1321 (m), 1311 (m), 1284 (m), 1253 (m), 1217 (m), 1204 (m), 1189 (m), 1172 (m), 1147 (m), 
1126 (m), 1097 (w), 1077 (w), 1052 (m), 1023 (m), 1008 (m), 997 (m), 978 (w), 969 (w), 957 
(m), 942 (w), 929 (m), 917 (w), 898 (w), 863 (w), 834 (w), 804 (w), 791 (w), 759 (s), 748 (s), 
707 (s), 696 (s), 679 (m), 658 (w), 642 (w), 628 (s), 621 (s), 609 (s), 591 (m), 559 (m), 536 (w), 
531 (m); 
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16-Benzoyl-5-methyl-10-(3-nitrophenyl)-9-oxa-11,14-diazatetracyclo-[8.7.0.03,8.011,15]-
heptadeca-1(17),3(8),4,6,15-pentaen-2-one (26b):  
Starting with 6-methyl-3-(3-nitrobenzoyl)chromone 6h (0.309 g, 
1.0 mmol) and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 
mL), the product 26b was isolated as a yellow solid (0.201 g, 42%), 
mp 305-306 ºC; 
1H NMR (500 MHz, DMSO-d6): δ = 2.19 (s, 3H, CH3), 3.21-3.25 
(m, 1H, CH), 3.73 (td, 3J = 4.8 Hz, 2J = 10.9 Hz, 1H, CH), 3.78-3.82 (m, 1H, CH), 4.15 (td, 3J = 
4.7 Hz, 2J = 10.0 Hz, 1H, CH), 7.19 (d, 3J = 9.0 Hz, 1H, HAr), 7.38-7.39 (m, 2H, HAr), 7.54-7.59 
(m, 5H, HAr), 7.69 (t, 3J = 8.0 Hz, 1H, HAr), 7.82 (s, 1H, 17-H), 7.85 (d, 3J = 7.8 Hz, 1H, HAr), 
8.11 (t, 4J = 2.0 Hz, 1H, HAr), 8.17-8.18 (m, 1H, HAr), 9.50 (s, 1H, NH); 13C NMR (125.8 MHz, 
DMSO-d6): δ = 19.9 (CH3), 42.0 (NCH2), 43.1 (NCH2), 90.4 and 91.2 (10-C and 16-C), 110.1, 
117.8, 120.9, 122.3, 124.1, 126.3, 2ˣ127.7, 2ˣ128.4, 130.2, 130.6, 131.8, 133.2, 136.5, 137.1, 
139.9, 140.4, 147.9, 152.6, 157.2, 177.0, 189.6 (C=O); MS (EI, 70 eV) m/z (%): 479 ([M]+, 34), 
450 (19), 449 (14), 358 (19), 357 (100); HRMS (ESI): calcd for C28H22N3O5 ([M+H]+) 
480.15540, found 480.15591; IR (ATR, cm–1): ~ν  = 3318 (w), 3097 (w), 3076 (w), 3051 (w), 
3023 (w), 2958 (w), 2924 (w), 2857 (w), 1731 (w), 1652 (m), 1619 (w), 1611 (w), 1564 (s), 1534 
(s), 1478 (s), 1454 (s), 1402 (m), 1377 (m), 1346 (m), 1310 (s), 1277 (s), 1253 (m), 1215 (m), 
1198 (m), 1173 (m), 1155 (m), 1133 (m), 1091 (m), 1077 (m), 1053 (m), 1033 (w), 1015 (m), 
979 (m), 938 (w), 924 (w), 899 (w), 867 (w), 850 (w), 827 (m), 819 (m), 796 (w), 777 (w), 752 
(s), 740 (s), 709 (s), 681 (m), 670 (m), 631 (s), 571 (m), 538 (m).   
 
16-Benzoyl-10-(4-nitrophenyl)-9-oxa-11,14-diazatetracyclo[8.7.0.03,8.011,15]heptadeca- 
1(17),3(8),4,6,15-pentaen-2-one (26c):  
Starting with 3-(4-nitrobenzoyl)chromone 6i (0.295g, 1.0 mmol) and 
HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26c 
was isolated as a orange solid (0.149 g, 32%), mp 278-280 ºC; 
1H NMR (500 MHz, DMSO-d6): δ = 3.20-3.24 (m, 1H, CH), 3.75 (td, 2J 
= 10.9 Hz, 3J = 4.9 Hz, 1H, CH), 3.79-3.83 (m, 1H, CH), 4.15 (td, 2J = 
10.2 Hz, 3J = 4.9 Hz, 1H, CH), 7.02 (t, 3J = 7.5 Hz, 1H, HAr), 7.27 (d, 3J 
= 8.0 Hz, 1H, HAr), 7.53-7.60 (m, 7H, HAr), 7.68 (t, 3J = 8.9 Hz, 2H, HAr), 7.81 (s, 1H, 17-H), 
8.21 (dt, 3J = 8.9 Hz, 4J = 2.0 Hz, 2H, HAr), 9.53 (s, 1H, NH); 13C NMR (125.8 MHz, DMSO-
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d6): δ = 42.1 (NCH2), 43.0 (NCH2), 90.8 and 91.1 (10-C and 16-C), 109.8, 118.0, 122.5, 122.6, 
2ˣ123.9, 126.5, 2ˣ127.8, 2ˣ128.2, 2ˣ128.3, 130.1, 135.7, 137.1, 139.8, 144.8, 147.7, 154.6, 157.1, 
177.0, 189.6 (C=O); MS (EI, 70 eV) m/z (%): 465 ([M]+, 50), 437 (10), 436 (31), 435 (11), 390 
(15), 360 (33), 344 (24), 343 (100), 241 (11), 222 (10), 105 (13), 77 (16), 44 (12), 43 (28), 40 
(15); HRMS (ESI): calcd for C27H20N3O5 ([M+H]+) 466.13975, found 466.13992, calcd for 
C27H19NaN3O5 ([M+Na]+) 488.12169, found 488.12142; IR (ATR, cm–1): ~ν  = 3309 (w), 3061 
(w), 2984 (w), 2921 (w), 2851 (w), 1728 (w), 1645 (w), 1618 (w), 1603 (w), 1577 (m), 1554 (s), 
1519 (w), 1486 (m), 1474 (s), 1460 (s), 1441 (s), 1376 (w), 1343 (m), 1317 (s), 1283 (m), 1232 
(m), 1205 (s), 1175 (s), 1129 (m), 1114 (m), 1065 (m), 1046 (m), 1034 (m), 1023 (m), 1008 (m), 
977 (m), 953 (m), 922 (m), 896 (w), 851 (m), 792 (w), 748 (s), 724 (s), 702 (s), 672 (m), 649 
(m), 631 (s), 589 (m), 561 (m), 530 (m). 
 
13-Benzoyl-5a-phenyl-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphen-11-one (26d):  
Starting with 3-benzoylchromone 6a (0.250 g, 1.0 mmol) and HKA 
24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26d was 
isolated as a yellow solid (0.395 g, 91%), mp 287-288 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.51-1.63 (m, 1H, CH), 1.94-2.07 
(m, 1H, CH), 3.29-3.38 (m, 1H, CH), 3.39-3.46 (m, 2H, CH), 3.90-4.00 (m, 1H, CH), 7.01 (t, 3J 
= 7.6 Hz, 1H, HAr), 7.27-7.41 (m, 6H, HAr), 7.50-7.61 (m, 7H, HAr), 7.67 (s, 1H, 12-H), 11.66 (s, 
1H, NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 19.1 (CH2), 38.2 (NCH2), 39.1 (NCH2), 92.0 
and 92.2 (5a-C and 13-C), 110.2, 117.9, 122.3, 122.4, 2ˣ126.3, 2ˣ127.8, 2ˣ128.2, 2ˣ128.6, 128.9, 
2ˣ129.7, 135.6, 135.9, 139.7, 140.6, 153.8, 155.2, 177.3, 190.7 (C=O); MS (EI, 70 eV) m/z (%): 
434 ([M]+, 48), 405 (22), 358 (20), 357 (100), 330 (12), 329 (58), 301 (21), 91 (11); HRMS 
(ESI): calcd for C28H23N2O3 ([M+H]+) 435.17032, found 435.17090, calcd for C28H22NaN2O3 
([M+Na]+) 457.15226, found 457.15269; IR (ATR, cm–1): ~ν  = 3057 (w), 2944 (w), 2872 (w), 
1650 (w), 1576 (m), 1558 (s), 1480 (m), 1461 (s), 1435 (s), 1368 (m), 1328 (m), 1314 (m), 1287 
(m), 1269 (w), 1248 (s), 1217 (m), 1203 (m), 1187 (m), 1179 (w), 1167 (w), 1156 (w), 1135 (m), 
1104 (w), 1084 (w), 1076 (w), 1063 (m), 1027 (m), 1000 (w), 962 (m), 943 (m), 924 (m), 889 
(w), 872 (w), 829 (m), 810 (m), 784 (m), 747 (s), 726 (m), 698 (s), 678 (s), 654 (w), 630 (s), 606 
(m), 575 (m), 558 (m), 544 (w). 
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13-(4-Chlorobenzoyl)-5a-phenyl-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphen-11-one 
(26e): 
Starting with 3-benzoylchromone 6a (0.250 g, 1.0 mmol) and HKA 24c 
(0.237 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26e was 
isolated as a yellow solid (0.459 g, 98%), mp 280-282 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 1.55-159 (m, 1H, CH), 1.97-2.01 
(m, 1H, CH), 3.29-3.45 (m, 3H, CH), 3.89-4.00 (m, 1H, CH), 7.01 (t, 3J 
= 7.3 Hz, 1H, HAr), 7.30 (m, 6H, HAr), 7.53-7.62 (m, 7H, HAr), 11.60 (s, 
1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.1 (CH2), 38.3 (NCH2), 39.1 (NCH2), 92.0 
and 92.1 (5a-C and 13-C), 110.5, 117.9, 122.2, 122.3, 2ˣ126.3, 2ˣ128.3, 2ˣ128.6, 128.7, 128.9, 
2ˣ129.7, 134.4, 135.4, 135.6, 139.3, 139.6, 153.8, 155.2, 177.3, 189.1 (C=O); MS (EI, 70 eV) 
m/z (%): 468 ([M]+, 70), 439 (32), 391 (100), 363 (11), 329 (75), 301 (29), 149 (21), 71 (14), 57 
(21); HRMS (ESI): calcd for C28H2235ClN2O3 ([M+H]+) 469.13135, found 469.13210, calcd for 
C28H2237ClN2O3 ([M+H]+) 471.12971, found 471.13006; IR (ATR, cm–1): ~ν  = 3055 (w), 2923 
(w), 2854 (w), 1658 (w), 1606 (m), 1580 (s), 1574 (s), 1557 (m), 1538 (w), 1504 (w), 1480 (m), 
1471 (m), 1457 (m), 1435 (m), 1417 (w), 1395 (w), 1368 (m), 1330 (m), 1292 (m), 1274 (m), 
1246 (m), 1216 (m), 1191 (m), 1181 (m), 1172 (w), 1141 (m), 1104 (m), 1087 (m), 1067 (m), 
1038 (m), 1029 (m), 1013 (m), 972 (m), 953 (m), 939 (m), 882 (w), 842 (w), 825 (m), 792 (s), 
781 (m), 752 (s), 734 (m), 719 (w), 694 (s), 666 (m), 644 (m), 636 (m), 606 (w), 579 (m), 558 
(w), 544 (m), 530 (m). 
 
13-Benzoyl-5a-(2-fluorophenyl)-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphen-11-one 
(26f):  
Starting with 3-(2-fluorobenzoyl)chromone 6b (0.268 g, 1.0 mmol) and 
HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26f 
was isolated as a yellow solid (0.416 g, 92%), mp 278-280 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.51-1.63 (s, 1H, CH), 1.94-2.06 (s, 
1H, CH), 3.20-3.29 (m, 2H, CH), 3.39-3.46 (m, 1H, CH), 3.86-3.94 (m, 
1H, CH), 7.03-7.13 (m, 2H, HAr), 7.20-7.41 (m, 4H, HAr), 7.43-7.52 (m, 5H, HAr), 7.54 (s, 1H, 
12-H), 7.58-7.64 (m, 2H, HAr), 11.69 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.1 
(CH2), 38.3 (NCH2), 39.8 (NCH2), 91.2 (d, JC,F = 1.4 Hz, 5a-C or 13-C), 92.7 (d, JC,F = 2.7 Hz, 
5a-C or 13-C), 108.1, 117.2 (d, JC,F = 22.3 Hz), 117.5, 122.1, 122.3, 124.0 (d, JC,F = 2.8 Hz), 
126.2 (d, JC,F = 10.5 Hz), 126.3, 2ˣ127.7, 2ˣ128.2, 128.6 (d, JC,F = 1.9 Hz), 129.7, 131.4 (d, JC,F = 
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9.0 Hz), 135.7, 136.4 (d, JC,F = 3.0 Hz), 140.6, 154.1 (d, JC,F = 0.9 Hz), 154.9, 160.6 (d, 1JC,F = 
250.6 Hz, CArF), 177.3, 190.6 (C=O); 19F NMR (282.4 MHz, DMSO-d6): δ = -111.2 (s, 1F, F); 
MS (EI, 70 eV) m/z (%): 452 ([M]+, 100), 423 (91), 395 (12), 347 (70), 329 (11), 319 (40), 122 
(35), 105 (57), 84 (20), 77 (35), 57 (24), 43 (33); HRMS (EI): calcd for C28H21FN2O3 ([M]+) 
452.15307, found 452.15366; IR (ATR, cm–1): ~ν  = 3058 (w), 2953 (w), 2921 (w), 2851 (w), 
1714 (w), 1651 (m), 1605 (m), 1581 (s), 1564 (s), 1557 (s), 1505 (m), 1481 (m), 1462 (s), 1446 
(s), 1436 (m), 1416 (m), 1368 (m), 1328 (m), 1288 (m), 1277 (m), 1249 (s), 1215 (s), 1202 (s), 
1177 (m), 1160 (m), 1140 (m), 1102 (m), 1181 (m), 1066 (s), 1047 (m), 1025 (s), 983 (m), 961 
(m), 924 (m), 887 (w), 873 (w), 827 (m), 816 (m), 802 (m), 784 (m), 770 (s), 756 (s), 719 (m), 
699 (s), 672 (s), 649 (m), 630 (s), 605 (m), 572 (m), 543 (m), 532 (m). 
 
13-Benzoyl-5a-(thiophen-2-yl)-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphen-11-one 
(26g): 
Starting with 3-(2-thenoyl)chromone 6c (0.256 g, 1.0 mmol) and HKA 
24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26g was 
isolated as a yellow solid (0.278 g, 63%), mp 281-283 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 1.58-1.74 (m, 1H, CH), 1.96-2.11 
(m, 1H, CH), 3.34-3.46 (m, 2H, CH), 3.72-3.82 (m, 1H, CH), 3.92-4.03 (m, 1H, CH), 6.93-6.96 
(m, 1H, HAr), 7.03-7.08 (m, 2H, HAr), 7.21 (d, 3J = 8.1 Hz, 1H, HAr), 7.50-7.58 (m, 7H, HAr), 
7.62-7.64 (m, 2H, HAr), 11.58 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.1 (CH2), 
38.3 (NCH2), 39.8 (NCH2), 90.1 and 92.8 (5a-C and 13-C), 109.9, 118.0, 122.2, 122.6, 126.3, 
126.8, 127.0, 127.7, 2ˣ127.9, 2ˣ128.3, 129.9, 135.2, 135.6, 140.5, 143.6, 153.7, 154.9, 176.5, 
190.8 (C=O); MS (EI, 70 eV) m/z (%): 440 ([M]+, 80), 411 (43), 383 (15), 357 (62), 335 (100), 
307 (53), 105 (22), 91 (19), 77 (24); HRMS (EI): calcd for C26H20N2O3S ([M]+) 440.11891, 
found 440.11869; IR (ATR, cm–1): ~ν  = 2954 (w), 2922 (w), 2852 (w), 1732 (w), 1645 (m), 1600 
(m), 1580 (s), 1575 (s), 1564 (s), 1557 (s), 1505 (w), 1482 (m), 1457 (s), 1434 (s), 1381 (m), 
1368 (s), 1330 (s), 1297 (m), 1285 (m), 1265 (s), 1244 (s), 1218 (s), 1201 (s), 1174 (m), 1166 
(m), 1157 (m), 1136 (s), 1102 (s), 1065 (s), 1043 (m), 1024 (s), 979 (m), 962 (m), 931 (m), 918 
(m), 883 (m), 861 (m), 836 (m), 807 (s), 782 (s), 756 (s), 741 (s), 721 (s), 706 (s), 693 (s), 672 
(s), 653 (m), 635 (s), 626 (s), 606 (m), 594 (s), 560 (s), 538 (m). 
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13-Benzoyl-5a-(3-nitrophenyl)-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphen-11-one 
(26h):  
Starting with 3-(3-nitrobenzoyl)chromone 6g (0.295 g, 1.0 mmol) and 
HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26h 
was isolated as a yellow solid (0.359 g, 75%), mp 301-302 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 1.57-1.74 (m, 1H, CH), 1.95-2.11 
(m, 1H, CH), 3.35-3.48 (m, 3H, CH), 3.96-4.08 (m, 1H, CH), 7.05 (td, 3J 
= 7.4 Hz, 5J = 0.8 Hz, 1H, HAr), 7.40 (d, 3J = 7.8 Hz, 1H, HAr), 7.51-7.66 (m, 7H, HAr), 7.70 (d, 
3J = 7.8 Hz, 1H, HAr), 7.75 (s, 1H, 12-H), 7.88 (d, 3J = 8.3 Hz, 1H, HAr), 8.13-8.18 (m, 2H, HAr), 
11.63 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.1 (CH2), 38.3 (NCH2), 39.1 
(NCH2), 91.1 and 92.4 (5a-C and 13-C), 109.1, 118.0, 120.8, 122.3, 122.8, 124.0, 126.4, 2ˣ127.8, 
2ˣ128.3, 129.9, 130.6, 132.7, 135.8, 136.9, 140.5, 141.6, 147.8, 153.9, 154.7, 176.6, 191.1 
(C=O); MS (EI, 70 eV) m/z (%): 479 ([M]+, 14), 449 (16), 374 (12), 358 (20), 357 (100), 344 
(13), 329 (12), 91 (15), 77 (10); HRMS (EI): calcd for C28H21N3O5 ([M]+) 479.14757, found 
479.14801; IR (ATR, cm–1): ~ν  = 3079 (w), 3055 (w), 2919 (w), 2881 (w), 2852 (w), 1989 (w), 
1838 (w), 1732 (w), 1650 (m), 1603 (w), 1582 (s), 1562 (s), 1532 (s), 1481 (s), 1459 (s), 1433 
(m), 1371 (m), 1339 (s), 1274 (s), 1251 (s), 1224 (m), 1181 (m), 1148 (m), 1100 (m), 1071 (m), 
1050 (m), 1026 (m), 971 (m), 902 (w), 881 (w), 853 (w), 829 (m), 816 (m), 780 (m), 765 (s), 740 
(s), 712 (s), 651 (m), 632 (s), 608 (m), 579 (m), 548 (w), 534 (w).  
 
13-(4-Chlorobenzoyl)-5a-(3-nitrophenyl)-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetra-
phen-11-one (26i):  
Starting with 3-(3-nitrobenzoyl)chromone 6g (0.295 g, 1.0 mmol) and 
HKA 24c (0.237 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26i 
was isolated as a yellow solid (0.308 g, 60%), mp 322-323 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.58-1.75 (m, 1H, CH), 1.95-2.11 
(m, 1H, CH), 3.34-3.48 (m, 3H, CH), 3.97-4.07  (m, 1H, CH), 7.06 (t, 3J 
= 7.2 Hz, 1H, HAr), 7.40 (d, 3J = 8.2 Hz, 1H, HAr), 7.54-7.68 (m, 8H, 
HAr), 7.88 (d, 3J = 7.4 Hz, 1H, HAr), 8.12-8.18 (m, 2H, HAr), 11.57 (s, 
1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.1 (CH2), 39.4 (NCH2), 39.7 (NCH2), 91.1 
and 92.3 (5a-C and 13-C), 109.5, 117.9, 120.7, 122.2, 122.8, 124.0, 126.4, 2ˣ128.4, 2ˣ129.7, 
130.6, 132.8, 134.6, 135.9, 136.4, 139.2, 141.6, 147.8, 153.8, 154.7, 176.6, 189.5 (C=O); MS 
(EI, 70 eV) m/z (%): 513 ([M]+, 37), 484 (13), 391 (100), 374 (32), 346 (21), 129 (24), 125 (23), 
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115 (12), 111 (17), 101 (12), 98 (17), 94 (18), 87 (18), 73 (68), 69 (36), 60 (75), 55 (61), 41 (72); 
HRMS (ESI): calcd for C28H2135ClN3O5 ([M+H]+) 514.11642, found 514.11693, calcd for 
C28H2137ClN3O5 ([M+H]+) 516.11487, found 516.11522, calcd for C28H2035ClNaN3O5 ([M+Na]+) 
536.09837, found 536.09865, calcd for C28H2037ClNaN3O5 ([M+Na]+) 538.09681, found 
538.09729; IR (ATR, cm–1): ~ν  = 3079 (w), 3030 (w), 2964 (w), 2874 (w), 1652 (w), 1603 (m), 
1574 (s), 1558 (s), 1530 (s), 1481 (s), 1470 (m), 1457 (s), 1444 (m), 1434 (m), 1397 (w), 1384 
(m), 1341 (s), 1292 (m), 1275 (s), 1250 (s), 1227 (m), 1202 (m), 1191 (m), 1175 (m), 1147 (m), 
1099 (m), 1087 (m), 1070 (m), 1047 (w), 1029 (w), 1014 (m), 972 (m), 957 (w), 943 (w), 904 
(w), 881 (w), 852 (m), 826 (m), 811 (w), 795 (w), 784 (m), 765 (s), 739 (s), 718 (s), 705 (s), 682 
(m), 658 (w), 636 (m), 606 (w), 584 (w), 555 (m). 
 
13-Benzoyl-5a-(4-nitrophenyl)-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphen-11-one 
(26j): 
Starting with 3-(4-nitrobenzoyl)chromone 6i (0.295 g, 1.0 mmol) and 
HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26j 
was isolated as a yellow solid (0.335 g, 70%), mp 213-214 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.57-1.69 (m, 1H, CH), 1.95-2.09 
(m, 1H, CH), 3.35-3.38 (m, 1H, CH), 3.40-3.48 (m, 2H, CH), 3.96-4.05 
(m, 1H, CH), 7.05 (td, 3J = 7.8 Hz, 4J = 0.9 Hz, 1H, HAr), 7.35 (d, 3J = 
7.8 Hz, 1H, HAr), 7.54-7.64 (m, 7H, HAr), 7.68 (d, 3J = 8.9 Hz, 2H, HAr), 7.72 (s, 1H, 12-H), 8.20 
(d, 3J = 8.9 Hz, 2H, HAr), 11.68 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.1 (CH2), 
38.3 (NCH2), 39.1 (NCH2), 91.4 and 92.4 (5a-C and 13-C), 109.0, 118.0, 122.3, 122.7, 2ˣ123.9, 
126.4, 2ˣ127.8, 2ˣ127.9, 2ˣ128.3, 129.9, 135.8, 136.8, 140.4, 146.2, 147.6, 153.9, 154.7, 176.7, 
191.1 (C=O); MS (EI, 70 eV) m/z (%): 479 ([M]+, 86), 450 (21), 374 (32), 358 (25), 357 (100), 
346 (18); HRMS (ESI): calcd for C28H22N3O5 ([M+H]+) 480.15540, found 480.15588, calcd for 
C28H21NaN3O5 ([M+Na]+) 502.13734, found 502.13772; IR (ATR, cm–1): ~ν  = 3105 (w), 3077 
(w), 3045 (w), 3011 (w), 9244 (w), 2873 (w), 2860 (w), 1657 (w), 1606 (w), 1581 (s), 1564 (m), 
1518 (m), 1484 (m), 1461 (s), 1439 (m), 1416 (w), 1401 (w), 1374 (m), 1334 (s), 1301 (w), 1289 
(m), 1277 (m), 1244 (s), 1222 (m), 1205 (w), 1171 (m), 1142 (m), 1107 (m), 1085 (m), 1072 
(m), 1051 (w), 1023 (w), 1010 (w), 1001 (w), 975 (w), 954 (w), 942 (m), 926 (w), 903 (w), 857 
(w), 846 (s), 821 (w), 797 (w), 781 (m), 747 (s), 726 (s), 711 (w), 700 (s), 684 (m), 673 (m), 647 
(w), 633 (s), 606 (m), 571 (m), 540 (m).  
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13-(4-Chlorobenzoyl)-5a-(4-nitrophenyl)-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetra-
phen-11-one (26k):  
Starting with 3-(4-nitrobenzoyl)chromone 6i (0.295 g, 1.0 mmol) and 
HKA 24c (0.237 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 26k 
was isolated as a orange solid (0.319 g, 62%), mp 327-329 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.58-1.69 (m, 1H, CH), 1.99-2.02 
(m, 1H, CH), 3.41-3.45 (m, 3H, CH), 3.98-4.03 (m, 1H, CH), 7.05 (t, 3J 
= 7.4 Hz, 1H, HAr), 7.36 (d, 3J = 7.9 Hz, 1H, HAr), 7.59-7.70 (m, 9H, 
HAr), 8.17-8.20 (m, 2H, HAr), 11.61 (s, 1H, NH); 13C NMR (62.9 MHz, 
DMSO-d6): δ = 19.0 (CH2), 40.2 (NCH2), 40.5 (NCH2), 91.3 and 92.3 
(5a-C and 13-C), 109.4, 118.0, 122.2, 122.7, 2ˣ123.9, 126.4, 127.8, 2ˣ128.3, 2ˣ129.8, 134.5, 
135.8, 136.3, 139.0, 139.1, 146.1, 147.6, 153.8, 154.8, 176.7, 189.5 (C=O); MS (EI, 70 eV) m/z 
(%): 513 ([M]+, 42), 484 (18), 391 (100), 374 (43), 346 (21), 125 (11); HRMS (ESI): calcd for 
C28H2135ClN3O5 ([M+H]+) 514.11642, found 514.11701, calcd for C28H2137ClN3O5 ([M+H]+) 
516.11487, found 516.11543, calcd for C28H2035ClNaN3O5  ([M+Na]+) 536.09837, found 
536.09876, calcd for C28H2037ClNaN3O5 ([M+Na]+) 538.09681, found 538.09723; IR (ATR, cm–
1): ~ν  = 3105 (w), 3052 (w), 2874 (w), 1645 (m), 1605 (m), 1577 (s), 1564 (s), 1557 (s), 1520 (s), 
1478 (s), 1457 (s), 1435 (s), 1394 (w), 1378 (m), 1361 (w), 1337 (s), 1318 (m), 1285 (m), 1269 
(s), 1239 (s), 1209 (s), 1190 (s), 1169 (s), 1142 (s), 1111 (m), 1101 (m), 1083 (m), 1071 (s), 1044 
(m), 1030 (w), 1013 (m), 986 (w), 974 (m), 964 (m), 953 (m), 941 (m), 906 (w), 889 (w), 865 
(m), 849 (m), 841 (m), 814 (s), 786 (m), 764 (w), 753 (s), 738 (s), 721 (m), 712 (m), 703 (s), 692 
(m), 678 (w), 652 (m), 635 (s), 605 (m), 579 (m), 547 (m). 
 
13-Benzoyl-5a-(3,5-dinitrophenyl)-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphen-11-
one (26l):  
Starting with 3-(3,5-dinitrobenzoyl)chromone 6j (0.340 g, 1.0 mmol) 
and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 
26l was isolated as a red solid (0.461 g, 88%), mp 301-303 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.72-1.76 (m, 1H, CH), 1.98-2.02 
(m, 1H, CH), 3.37-3.50 (m, 3H, CH), 4.01-4.07 (m, 1H, CH), 7.09 (t, 3J 
= 7.4 Hz, 1H, HAr), 7.47 (d, 3J = 8.1 Hz, 1H, HAr), 7.51-7.62 (m, 6H, HAr), 7.66 (td, 3J = 7.7 Hz, 
4J = 1.7 Hz, 1H, HAr), 7.81 (s, 1H, 12-H), 8.47 (d, 4J = 1.0 Hz, 2H, HAr), 8.71 (t, 4J = 2.0 Hz, 1H, 
HAr), 11.59 (s, 1H, NH);  13C NMR (62.9 MHz, DMSO-d6): δ = 18.9 (CH2), 38.4 (NCH2), 39.2 
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(NCH2), 90.5 and 92.8 (5a-C and 13-C), 108.3, 117.9, 119.2, 122.2, 123.2, 2ˣ126.1, 126.6, 
2ˣ127.8, 2ˣ128.4, 130.2, 136.0, 137.7, 140.4, 143.2, 2ˣ148.4, 153.9, 154.3, 175.9, 191.3 (C=O); 
MS (EI, 70 eV) m/z (%): 524 ([M]+, 20), 419 (11), 357 (100), 329 (11), 91 (7), 44 (10); HRMS 
(EI): calcd for C28H21N4O7 ([M+H]+) 525.14048, found 525.14072, calcd for C28H20NaN4O7 
([M+Na]+) 547.12242, found 547.12187; IR (ATR, cm–1): ~ν  = 3017 (w), 2965 (w), 2883 (w), 
2855 (w), 1650 (w), 1607 (w), 1583 (s), 1535 (s), 1481 (s), 1462 (s), 1441 (s), 1368 (m), 1332 
(s), 1294 (m), 1274 (s), 1243 (s), 1218 (m), 1199 (m), 1173 (w), 1144 (m), 1104 (m), 1090 (m), 
1070 (m), 1047 (m), 1024 (w), 995 (m), 962 (w), 948 (m), 920 (w), 907 (w), 894 (w), 872 (m), 
839 (w), 824 (m), 800 (w), 753 (s), 724 (s), 711 (s), 704 (s), 686 (s), 662 (m), 635 (s), 612 (m), 
596 (m), 572 (w), 535 (w). 
 
13-Benzoyl-5a-[(E)-2-phenylethenyl]-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diazatetraphen-11-
one (26m):  
Starting with 3-[(2E)-3-phenylprop-2-enoyl]chromone 7 (0.276 g, 1.0 
mmol) and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the 
product 26lm was isolated as a yellow solid (0.387 g, 84%), mp 186 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.84-1.95 (m, 1H, CH), 2.06-2.16 
(m, 1H, CH), 3.39-3.49 (m, 1H, CH), 3.51-3.60 (m, 1H, CH), 3.82-3.92 
(m, 1H, CH), 3.93-4.02 (m, 1H, CH), 6.51 (d, 3J = 15.9 Hz, 1H, =CH),  6.61 (d, 3J = 15.9 Hz, 
1H, =CH), 7.06 (td, J = 0.6 Hz, 3J = 7.5 Hz, 1H, HAr), 7.16 (d, 3J = 7.8 Hz, 1H, HAr), 7.21-7.31 
(m, 3H, HAr), 7.41-7.44 (m, 2H, HAr), 7.47-7.57 (m, 6H, HAr), 7.63 (s, 1H, 12-H), 7.70 (dd, 4J = 
1.6 Hz, 3J = 7.8 Hz, 1H, HAr), 11.60 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.3 
(CH2), 38.3 (NCH2), 39.8 (NCH2), 91.6 and 92.9 (5a-C and 13-C), 107.6, 117.8, 122.2, 122.4, 
126.3, 126.5, 2ˣ127.2, 2ˣ127.9, 2ˣ128.2, 128.5, 2ˣ128.6, 129.7, 132.8, 134.8, 135.0, 136.4, 140.6, 
154.0, 154.8, 177.0, 190.7 (C=O); MS (EI, 70 eV) m/z (%): 460 ([M]+, 55), 444 (11), 431 (19), 
355 (100), 329 (10), 327 (14), 207 (15), 105 (12), 91 (13), 77 (10), 73 (18), 60 (12), 57 (11), 43 
(15); HRMS (ESI): calcd for C30H25N2O3 ([M+H]+) 461.18597, found 461.18169; IR (ATR, cm–
1): ~ν  = 3055 (w), 3019 (w), 2954 (w), 2872 (w), 1652 (m), 1605 (m), 1581 (s), 1560 (s), 1483 
(s), 1461 (s), 1442 (s), 1384 (m), 1371 (m), 1339 (s), 1321 (m), 1291 (s), 1279 (s), 1246 (s), 1218 
(m), 1203 (m), 1152 (m), 1111 (s), 1098 (m), 1064 (m), 1025 (m), 995 (m), 978 (m), 934 (m), 
865 (w), 842 (w), 804 (m), 777 (s), 753 (s), 738 (s), 717 (m), 687 (s), 666 (m), 632 (s), 604 (m), 
575 (m), 558 (m), 542 (m). 
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13-(4-Chlorobenzoyl)-5a-[(E)-2-phenylethenyl]-1,2,3,4,5a,11-hexahydro-6-oxa-1,5-diaza-
tetraphen-11-one (26n): 
Starting with 3-[(2E)-3-phenylprop-2-enoyl]chromone 7 (0.276 g, 1.0 
mmol) and HKA 24c (0.237 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the 
product 26n was isolated as a yellow solid (0.431 g, 87%), mp 254 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.85-1.95 (m, 1H, CH), 2.07-2.17 
(m, 1H, CH), 3.39-3.50 (m, 1H, CH), 3.52-3.62 (m, 1H, CH), 3.83-3.92 
(m, 1H, CH), 3.93-4.02 (m, 1H, CH), 6.51 (d, 3J = 15.9 Hz, 1H, =CH),  
6.60 (d, 3J = 15.9 Hz, 1H, =CH), 7.07 (td, J = 0.8 Hz, 3J = 7.5 Hz, 1H, 
HAr), 7.17 (d, 3J = 7.9 Hz, 1H, HAr), 7.22-7.32 (m, 3H, HAr), 7.41-7.46 (m, 2H, HAr), 7.49-7.59 
(m, 6H, HAr), 7.69 (dd, 4J = 1.6 Hz, 3J = 7.8 Hz, 1H, HAr), 11.51 (s, 1H, NH);  13C NMR (75.5 
MHz, DMSO-d6): δ = 19.3 (CH2), 38.3 (NCH2), 39.8 (NCH2), 91.6 and 92.6 (5a-C and 13-C), 
108.0, 117.7, 122.2, 122.3, 126.3, 126.4, 2ˣ127.2, 2ˣ128.3, 2ˣ128.5, 128.6, 2ˣ129.9, 132.9, 134.5, 
134.8, 135.1, 135.9, 139.4, 153.9, 154.9, 177.0, 189.1 (C=O); MS (EI, 70 eV) m/z (%): 494 
([M]+, 54), 465 (21), 391 (42), 355 (100), 327 (13), 139 (16), 125 (14), 111 (10); HRMS (ESI): 
calcd for C30H2435ClN2O3 ([M+H]+) 495.14700, found 495.14757, calcd for C30H2437ClN2O3 
([M+H]+) 497.14552, found 497.14586; IR (ATR, cm–1): ~ν  = 3060 (w), 3030 (w), 2922 (w), 
2852 (w), 1648 (w), 1604 (m), 1568 (s), 1480 (s), 1460 (s), 1439 (s), 1394 (w), 1366 (m), 1339 
(m), 1319 (w), 1289 (m), 1277 (s), 1261 (w), 1242 (s), 1216 (s), 1202 (s), 1156 (m), 1145 (m), 
1108 (s), 1094 (m), 1084 (s), 1062 (s), 1029 (m), 1012 (s), 968 (m), 953 (m), 907 (w), 892 (w), 
859 (w), 833 (m), 811 (m), 797 (m), 782 (m), 756 (s), 739 (s), 720 (m), 703 (s), 688 (s), 666 (w), 
652 (m), 633 (s), 608 (w), 577 (m), 570 (w), 549 (m). 
 
9-Benzoyl-3-(trifluoromethyl)-2-oxa-4,7-diazapentacyclo[11.8.0.03,11.04,8.016,21]henicosa-
1(13),8,10,14,16(21),17,19-heptaen-12-one (26o):  
 Starting with 3-(trifluoroacetyl)chromone 5a (0.242 g, 1.0 mmol) 
and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the 
product 26o was isolated as a yellow solid (0.083 g, 18%), mp 292-
293 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.99-4.19 (m, 2H, CH), 4.29-4.38 (m, 1H, CH), 4.45-4.54 (m, 
1H, CH), 7.44-7.64 (m, 8H, HAr), 7.83 (d, 3J = 7.8 Hz, 1H, HAr), 7.99 (d, 3J = 8.6 Hz, 1H, HAr), 
8.14 (s, 1H, 10-H), 8.24 (d, 3J = 8.1 Hz, 1H, HAr), 9.55 (s, 1H, NH); 13C NMR (75.5 MHz, 
CDCl3): δ = 43.7 (NCH2), 44.0 (NCH2), 88.9 (q, 2JC,F = 32.5 Hz), 92.7, 102.1, 122.0, 122.2, 
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122.6, 123.7, 126.4, 2ˣ128.1, 2ˣ128.3, 2ˣ128.5, 129.1, 131.0, 137.1, 138.9, 141.1, 151.6, 159.5, 
176.9, 192.1 (C=O); 19F NMR (282.4 MHz, CDCl3): δ = –80.1 (s, 1F, F);  MS (EI, 70 eV) m/z 
(%): 462 ([M]+, 6), 394 (24), 393 (100), 105 (5), 77 (6); HRMS (ESI): calcd for C26H18F3N2O3 
([M+H]+) 463.12640, found 463.12649, calcd for C26H17F3NaN2O3 ([M+Na]+) 485.10835, found 
485.10814; IR (ATR, cm–1): ~ν  = 3346 (w), 3085 (w), 3061 (w), 2953 (w), 2923 (w), 2896 (w), 
2852 (w), 1650 (m), 1630 (w), 1614 (w), 1558 (s), 1541 (s), 1508 (w), 1490 (m), 1467 (m), 1436 
(s), 1409 (w), 1384 (s), 1318 (s), 1273 (m), 1240 (s), 1217 (s), 1189 (s), 1177 (s), 1161 (s), 1133 
(s), 1102 (s), 1069 (m), 1030 (s), 1005 (s), 919 (s), 871 (m), 846 (w), 826 (m), 784 (w), 765 (s), 
744 (s), 704 (s), 657 (s), 636 (s), 577 (s), 566 (s), 527 (m). 
 
16-Benzoyl-10-(dichloromethyl)-9-oxa-11,14-diazatetracyclo[8.7.0.03,8.011,15]heptadeca-
1(17),3(8),4,6,15-pentaen-2-one (26p): 
Starting with 3-(2,2-dichloroacetyl)chromone 8 (0.257 g, 1.0 mmol) 
and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 
26p was isolated as a green-brawn solid (0.175 g, 41%), mp 221 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.81-4.03 (m, 2H, CH), 4.19-4.37 
(m, 2H, CH), 6.87 (s, 1H, CHCl2), 7.05 (d, 3J = 8.1 Hz, 1H, HAr), 7.12 (d, 3J = 7.2 Hz, 1H, HAr), 
7.43-7.58 (m, 6H, HAr), 7.74-7.78 (m, 2H, HAr), 9.56 (s, 1H, NH); 13C NMR (75.5 MHz, DMSO-
d6): δ = 43.7 (NCH2), 43.8 (NCH2), 77.0 (CHCl2), 91.0 and 93.0 (10-C and 16-C), 103.8, 117.0, 
121.8, 122.5, 126.4, 2ˣ127.8, 2ˣ128.3, 130.4, 135,1 139.6, 140.9, 154.2, 158.8, 176.1, 189.6 
(C=O); MS (GC, 70 eV) m/z (%): 351 ([M-Ph], 44), 323 (100), 295 (11), 164 (11), 105 (11), 77 
(50), 51 (14); HRMS (ESI): calcd for C22H1735Cl2N2O3 ([M+H]+) 427.06101, found 427.06107, 
calcd for C22H1737Cl2N2O3 ([M+H]+) 429.05883, found 429.05860, calcd for C22H1635Cl2NaN2O3 
([M+Na]+) 449.04281, found 449.04302, calcd for C22H1637Cl2NaN2O3 ([M+Na]+) 451.03993, 
found 451.04054; IR (ATR, cm–1): ~ν  = 3213 (w), 3068 (w), 2981 (w), 2920 (w), 2851 (w), 1634 
(w), 1621 (w), 1602 (w), 1580 (w), 1568 (w), 1539 (s), 1505 (w), 1477 (m), 1460 (m), 1435 (s), 
1385 (m), 1325 (s), 1292 (m), 1277 (m), 1233 (m), 1201 (s), 1172 (m), 1151 (m), 1129 (m), 1105 
(m), 1074 (m), 1013 (m), 977 (s), 952 (m), 932 (w), 897 (w), 862 (w), 834 (w), 817 (m), 786 
(m), 736 (s), 715 (s), 701 (s), 678 (s), 667 (s), 649 (m), 628 (s), 603 (s), 576 (s), 550 (s), 533 (m). 
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2-{6,8-Dibenzoyl-2H,3H-imidazo[1,2-a]pyridin-5-yl}phenol (27a):  
Starting with 3-benzoylchromone 6a (0.250 g, 1.0 mmol) and HKA 24a 
(0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 27a was isolated 
as a orange solid (0.319 g, 76%), mp 240-241 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.67-3.87 (m, 4H, CH), 6.65-6.74 
(m, 2H, HAr), 7.03 (d, 3J = 7.6 Hz, 1H, HAr), 7.09 (td, 4J = 1.6 Hz, 3J = 7.8 
Hz, 1H, HAr), 7.25-7.29 (m, 2H, HAr), 7.35-7.40 (m, 2H, HAr), 7.49-7.53 (m, 4H, HAr), 7.62 (tt, 4J 
= 1.3 Hz, 3J = 7.3 Hz, 1H, HAr), 7.82-7.85 (m, 2H, HAr), 10.32 (s, 1H, OH); 13C NMR (75.5 
MHz, DMSO-d6): δ = 47.8 (NCH2), 52.4 (NCH2), 113.7, 115.9, 118.6, 118.7, 119.9, 120.3, 
2ˣ127.7, 4ˣ128.4, 2ˣ129.2, 129.3, 131.3, 131.5, 132.8, 137.0, 138.7, 141.7, 153.4, 154.2, 192.0 
(C=O), 192.3 (C=O); MS (GC, 70 eV) m/z (%): 403 ([M-OH], 9), 402 (38), 401 (69), 375 (14), 
374 (64), 373 (100), 325 (13), 297 (13), 295 (12), 148 (11), 77 (27); HRMS (ESI): calcd for 
C27H21N2O3 ([M+H]+) 421.15467, found 421.15474, calcd for C27H20NaN2O3 ([M+Na]+) 
443.13661, found 443.13685; IR (ATR, cm–1): ~ν  = 3060 (w), 3024 (w), 2972 (w), 2956 (w), 
2910 (w), 2883 (w), 2851 (w), 1660 (m), 1642 (m), 1617 (m), 1593 (s), 1504 (m), 1449 (s), 1420 
(w), 176 (s), 1337 (w), 1299 (m), 1252 (s), 1217 (s), 1195 (m), 1186 (w), 1171 (m), 1162 (m), 
1138 (w), 1117 (m), 1078 (w), 1045 (w), 1034 (w), 1012 (m), 1001 (m), 994 (m), 925 (w), 887 
(w), 871 (m), 846 (w), 833 (w), 814  (w), 789 (m), 763 (m), 747 (m), 732 (s), 704 (m), 694 (s), 
671 (m), 658 (w), 646 (s), 621 (m), 611 (m), 585 (m), 554 (m), 534 (w). 
 
2-[8-Benzoyl-6-(2-fluorobenzoyl)-2H,3H-imidazo[1,2-a]pyridin-5-yl]phenol (27b):  
Starting with 3-(2-fluorobenzoyl)chromone 6b (0.268 g, 1.0 mmol) and 
HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 27b 
was isolated as a orange solid (0.420 g, 96%), mp 225-227 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.62-3.79 (m, 4H, CH), 6.64 (d, 3J = 
7.9 Hz, 1H, HAr), 6.68 (t, 3J = 7.5 Hz, 1H, HAr), 6.90-6.93 (m, 1H, HAr), 
6.99 (td, 3J = 7.5 Hz, 4J = 0.9 Hz, 1H, HAr), 7.04-7.08 (m, 2H, HAr), 7.23-7.27 (m, 2H, HAr), 
7.51-7.54 (m, 3H, HAr), 7.63 (tt, 3J = 7.4 Hz, 4J = 1.3 Hz, 1H, HAr), 7.82-7.84 (m, 2H, HAr), 
10.25 (s, 1H, OH); 13C NMR (125.8 MHz, DMSO-d6): δ = 47.6 (NCH2), 52.5 (NCH2), 114.2, 
115.3 (d, JC,F = 21.4 Hz), 115.8, 118.6, 119.8, 120.7, 123.6 (d, JC,F = 2.8 Hz), 127.7, 128.3, 
2ˣ128.5, 129.0 (d, JC,F = 28.9 Hz), 2ˣ129.2, 131.4, 131.9 (d, JC,F = 8.3 Hz), 133.0, 136.8, 140.6, 
153.1, 153.9, 154.7, 158.3 (d, 1JC,F = 247.9 Hz, CArF), 187.8 (C=O), 192.3 (C=O); 19F NMR 
(282.4 MHz, DMSO-d6): δ = -114.4 (s, 1F, F); MS (EI, 70 eV) m/z (%): 438 ([M]+, 16), 437 
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(45), 421 (12), 420 (31), 419 (67), 418 (79), 417 (100), 415 (15), 409 (13), 392 (36), 391 (64), 
390 (61), 389 (84), 388 (11), 387 (13), 362 (17), 361 (21), 325 (28), 209 (13), 105 (12), 77 (34); 
HRMS (ESI): calcd for C27H20FN2O3 ([M+H]+) 439.14525, found 439.14546; IR (ATR, cm–1): 
~ν
 = 3063 (w), 3026 (w), 2967 (w), 2915 (w), 2853 (w), 1660 (m), 1648 (w), 1633 (w), 1614 (w), 
1595 (m), 1502 (m), 1482 (w), 1451 (m), 1422 (w), 1378 (m), 1337 (w), 1328 (w), 1300 (m), 
1273 (m), 1252 (m), 1216 (m), 1172 (w), 1161 (w), 1139 (w), 1116 (m), 1079 (w), 1045 (w), 
1033 (w), 1013 (m), 995 (m), 937 (w), 925 (w), 888 (w), 869 (m), 848 (w), 829 (m), 808 (w), 
783 (m), 762 (s), 744 (m), 723 (m), 692 (s), 668 (m), 640 (s), 621 (s), 611 (s), 590 (m), 569 (m), 
554 (m), 545 (m), 527 (m). 
 
2-[8-Benzoyl-6-(thiophene-2-carbonyl)-2H,3H-imidazo[1,2-a]pyridin-5-yl]phenol (27c): 
Starting with 3-(2-thenoyl)chromone 6c (0.256 g, 1.0 mmol) and HKA 24a 
(0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 27c was isolated 
as a orange solid (0.264 g, 62%), mp 281-283 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.68-3.93 (m, 4H, CH), 6.74 (t, 3J = 
7.5 Hz, 1H, HAr), 6.84 (d, 3J = 7.9 Hz, 1H, HAr), 7.03 (dd, 3J = 3.8 Hz, 3J = 
4.9 Hz, 1H, HAr), 7.07 (dd, 3J = 7.6 Hz, 4J = 1.6 Hz, 1H, HAr), 7.19 (td, 3J = 7.8 Hz, 4J = 1.6 Hz, 
1H, HAr), 7.46 (s, 1H, 7-HAr), 7.49-7.54 (m, 2H, HAr), 7.58 (dd, 3J = 3.8 Hz, 4J = 1.1 Hz, 1H, 
HAr), 7.62 (tt, 3J = 7.3 Hz, 4J = 1.3 Hz, 1H, HAr), 7.81 (dd, 4J = 1.1 Hz, 3J = 4.9 Hz, 1H, HAr), 
7.83-7.86 (m, 2H, HAr), OH was not detected; 13C NMR (75.5 MHz, DMSO-d6): δ = 47.8 
(NCH2), 52.3 (NCH2), 114.0, 116.0, 118.8, 119.7, 120.4, 127.8, 2ˣ128.5, 129.1, 2ˣ129.2, 131.3, 
132.9, 133.1, 134.0, 137.0, 141.3, 144.0, 152.7, 153.4, 154.4, 183.6 (C=O), 192.3 (C=O); MS 
(GC, 70 eV) m/z (%): 409 ([M-OH], 14), 408 (44), 407 (65), 381 (18), 380 (67), 379 (100), 351 
(10), 295 (12), 77 (27); HRMS (ESI): calcd for C25H19N2O3S ([M+H]+) 427.11109, found 
427.11168, calcd for C25H18NaN2O3S ([M+Na]+) 449.09303, found 449.09347; IR (ATR, cm–1): 
~ν
 = 3083 (w), 3065 (w), 2953 (w), 2911 (w), 2883 (w), 2851 (w), 1657 (s), 1615 (s), 1595 (s), 
1536 (w), 1503 (s), 1453 (s), 1409 (s), 1376 (s), 1352 (m), 1326 (m), 1300 (m), 1278 (w), 1256 
(s), 1234 (m), 1217 (s), 1195 (m), 1182 (m), 1163 (m), 1119 (m), 1080 (w), 1059 (m), 1044 (w), 
1034 (m), 1010 (s), 969 (m), 939 (w), 908 (w), 891 (w), 873 (m), 853 (w), 842 (m), 831 (m), 804 
(m), 779 (m), 759 (s), 742 (s), 710 (s), 693 (s), 673 (m), 648 (s), 621 (m), 612 (m), 580 (m), 556 
(m), 531 (w). 
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2-[8-Benzoyl-6-(2-nitrobenzoyl)-2H,3H-imidazo[1,2-a]pyridin-5-yl]phenol (27d):  
Starting with 3-(2-nitrobenzoyl)chromone 6d (0.295g, 1.0 mmol) and 
HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 27d 
was isolated as a yellow solid (0.363 g, 78%), mp 251-253 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.48-3.64 (m, 2H, CH), 3.72-3.79 (m, 
2H, CH), 6.51-6.61 (m, 2H, HAr), 6.96-7.02 (m, 2H, HAr), 7.27 (d, 3J = 7.4 
Hz, 1H, HAr), 7.39 (t, 3J = 7.7 Hz, 1H, HAr), 7.47-7.58 (m, 3H, HAr), 7.66 (t, 3J = 7.3 Hz, 1H, 
HAr), 7.75 (s, 1H, 7-HAr), 7.81-7.88 (m, 3H, HAr), 10.23 (s, 1H, OH); 13C NMR (62.9 MHz, 
DMSO-d6): δ = 47.7 (NCH2), 52.6 (NCH2), 112.7, 115.5, 118.6, 118.7, 119.5, 121.5, 123.8, 
128.3, 2ˣ128.6, 2ˣ129.3, 129.8, 131.6, 133.1, 133.6, 136.5, 136.7, 139.9, 144.6, 152.8, 153.3, 
155.0, 188.0 (C=O), 192.3 (C=O); MS (GC, 70 eV) m/z (%): 465 ([M]+, 6), 464 (17), 418 (32), 
417 (100), 390 (15), 389 (41), 361 (8), 105 (11), 77 (20), 44 (19); HRMS (ESI): calcd for 
C27H20N3O5 ([M+H]+) 466.13963, found 466.13975; IR (ATR, cm–1): ~ν  = 3070 (w), 3051 (w), 
2949 (w), 2925 (w), 2876 (w), 2679 (w), 2561 (w), 1662 (m), 1640 (m), 1616 (m), 1589 (s), 
1520 (s), 1505 (m), 1471 (w), 1449 (s), 1430 (m), 1375 (s), 1339 (s), 1313 (m), 1293 (s), 1258 
(m), 1247 (s), 1223 (s), 1174 (m), 1156 (m), 1107 (w), 1079 (w), 1037 (w), 1012 (m), 997 (m), 
975 (w), 945 (m), 926 (w), 867 (w), 856 (w), 836 (w), 811 (w), 798 (m), 789 (s), 760 (s), 711 (s), 
688 (s), 679 (s), 654 (m), 639 (m), 614 (m), 586 (m), 554 (m), 545 (m). 
 
2-[8-Benzoyl-6-(3-nitrobenzoyl)-2H,3H-imidazo[1,2-a]pyridin-5-yl]-4-methylphenol (27e): 
Starting with 6-methyl-3-(3-nitrobenzoyl)chromone 6h (0.309 g, 1.0 
mmol) and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the 
product 27e was isolated as a yellow solid (0.259 g, 54%), mp 248 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.00 (s, 3H, CH3), 3.65-3.85 (m, 4H, 
CH), 6.44 (d, 3J = 8.3 Hz, 1H, HAr), 6.76 (d, 3J = 8.3 Hz, 1H, HAr), 6.81 
(s, 1H, HAr), 7.46 (t, 3J = 7.9 Hz, 1H, HAr), 7.52-7.55 (m, 2H, HAr), 7.58 
(s, 1H, HAr), 7.63-7.66 (m, 1H, HAr), 7.72 (d, 3J = 7.7 Hz, 1H, HAr), 7.88 (d, 3J = 7.3 Hz, 2H, 
HAr), 8.05 (s, 1H, HAr), 8.07 (d, 3J = 8.2 Hz, 4J = 1.3 Hz, 1H, HAr), 10.10 (s, 1H, OH); 13C NMR 
(62.9 MHz, DMSO-d6): δ = 19.5 (CH3), 47.8 (NCH2), 52.6 (NCH2), 113.2, 115.6, 119.3, 121.1, 
122.3, 124.9, 127.6, 2ˣ128.5, 129.2, 2ˣ129.3, 129.9, 132.2, 133.0, 133.8, 136.8, 140.7, 141.0, 
146.4, 151.8, 153.3, 154.0, 190.3 (C=O), 192.3 (C=O); MS (EI, 70 eV) m/z (%): 479 ([M]+, 72), 
450 (29), 449 (14), 374 (17), 358 (29), 357 (100), 105 (26), 77 (29); HRMS (ESI): calcd for 
C28H22N3O5 ([M+H]+) 480.15540, found 480.15555, calcd for C28H21NaN3O5 ([M+Na]+) 
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502.13734, found 502.13690; IR (ATR, cm–1): ~ν  = 2955 (w), 2913 (w), 2876 (w), 2849 (w), 
1664 (m), 1642 (w), 1595 (s), 1526 (s), 1503 (s), 1474 (w), 1435 (m), 1373 (m), 1342 (s), 1285 
(s), 1252 (s), 1218 (s), 1196 (s), 1176 (s), 1140 (w), 1118 (s), 1094 (w), 1081 (w), 1042 (w), 
1001 (s), 938 (w), 890 (w), 871 (s), 859 (w), 817 (m), 795 (m), 770 (w), 746 (w), 717 (s), 688 
(s), 659 (m), 633 (m), 613 (m), 595 (m), 569 (m).  
 
2-[8-Benzoyl-6-(4-nitrobenzoyl)-2H,3H-imidazo[1,2-a]pyridin-5-yl]phenol (27f):  
Starting with 3-(4-nitrobenzoyl)chromone 6i (0.295g, 1.0 mmol) and 
HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 27f 
was isolated as a orange solid (0.237 g, 51%), mp 248-250 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.78 (s, 4H, CH), 6.59-6.67 (m, 2H, 
HAr), 7.01-7.06 (m, 2H, HAr), 7.51-7.59 (m, 5H, HAr), 7.64 (tt, 3J = 6.8 
Hz, 4J = 1.2 Hz, 1H, HAr), 7.85-7.88 (m, 2H, HAr), 7.98-8.01 (m, 2H, 
HAr), 10.38 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 47.8 (NCH2), 52.5 (NCH2), 
113.5, 116.0, 118.8, 119.9, 120.9, 2ˣ122.5, 2ˣ128.5, 2ˣ129.0, 2ˣ129.3, 129.8, 131.8, 133.0, 136.8, 
140.7, 145.1, 148.0, 153.3, 154.1, 192.3 (C=O); MS (EI, 70 eV) m/z (%): 465 ([M]+, 25), 464 
(64), 463 (36), 462 (70), 447 (38), 446 (67), 436 (25), 435 (32), 434 (42), 420 (20), 419 (82), 418 
(100), 313 (20), 285 (48), 77 (22); HRMS (ESI): calcd for C27H20N3O5 ([M+H]+) 466.13975, 
found 466.14014, calcd for C27H19NaN3O5 ([M+Na]+) 488.12169, found 488.12159; IR (ATR, 
cm–1): ~ν  = 3063 (w), 2943 (w), 2879 (w), 2661 (w), 2559 (w), 2472 (w), 1664 (s), 1651 (m), 
1619 (m), 1597 (s), 1566 (w), 1518 (m), 1500 (m), 1453 (s), 1422 (w), 1404 (w), 1380 (m), 1337 
(s), 1316 (m), 1301 (s), 1248 (s), 1219 (s), 1195 (m), 1164 (m), 1139 (w), 1106 (w), 1047 (w), 
1036 (w), 1012 (m), 996 (m), 945 (w), 925 (w), 863 (m), 851 (m), 831 (w), 805 (w), 789 (s), 777 
(w), 765 (s), 747 (m), 733 (m), 698 (s), 685 (m), 652 (m), 627 (m), 587 (m), 556 (m), 538 (w). 
 
2-[9-Benzoyl-7-(2-nitrobenzoyl)-2H,3H,4H-pyrido[1,2-a]pyrimidin-6-yl]phenol (27g):  
 Starting with 3-(2-nitrobenzoyl)chromone 6d (0.295g, 1.0 mmol) and 
HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 27g 
was isolated as a yellow solid (0.441 g, 92%), mp 224-225 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.63-1.74 (m, 2H, CH), 3.19-3.23 (m, 
1H, CH), 3.31-3.45 (m, 3H, CH), 6.45 (d, 3J = 7.9 Hz, 1H, HAr), 6.60 (t, 3J 
= 7.3 Hz, 1H, HAr), 6.95-7.00 (m, 2H, HAr), 7.20 (dd, 3J = 7.3 Hz, 4J = 1.3 
Hz, 1H, HAr), 7.40 (td, 3J = 7.8 Hz, 4J = 1.3 Hz, 1H, HAr), 7.45-7.48 (m, 2H, HAr), 7.51-7.56 (m, 
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2H, HAr), 7.64 (t, 3J = 7.3 Hz, 1H, HAr), 7.84 (dd, 3J = 8.1 Hz, 4J = 0.9 Hz, 1H, HAr), 7.91-7.93 
(m, 2H, HAr), 10.20 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 20.2 (CH2), 43.5 
(NCH2), 46.2 (NCH2), 113.8, 115.2, 118.8, 118.9, 123.8, 128.2, 128.3, 2ˣ128.6, 2ˣ129.1, 129.7, 
129.8, 130.4, 131.7, 133.2, 133.5, 136.4, 136.6, 144.4, 146.8, 154.3, 154.6, 189.7 (C=O), 194.5 
(C=O); MS (EI, 70 eV) m/z (%): 433 ([M-NO2], 8), 432 (43), 431 (90), 405 (11), 404 (75), 403 
(100), 375 (33), 77 (11); HRMS (ESI): calcd for C28H22N3O5 ([M+H]+) 480.15579, found 
480.15540; IR (ATR, cm–1): ~ν  = 3054 (w), 2942 (w), 2849 (w), 2678 (w), 2543 (w), 1668 (m), 
1635 (m), 1615 (s), 1603 (s), 1573 (s), 1531 (m), 1519 (s), 1506 (m), 1472 (w), 1450 (s), 1417 
(w), 1366 (s), 1344 (s), 1310 (m), 1293 (m), 1250 (s), 1189 (m), 1171 (s), 1156 (m), 1144 (m), 
1109 (m), 1087 (m), 1072 (m), 1045 (m), 1020 (m), 970 (m), 954 (m), 932 (m), 877 (m), 853 
(m), 826 (w), 805 (w), 789 (m), 773 (w), 755 (s), 740 (s), 716 (m), 706 (s), 689 (s), 680 (s), 650 
(w), 636 (m), 610 (m), 596 (m), 557 (w), 530 (w). 
 
(2E)-1-[8-Benzoyl-5-(2-hydroxyphenyl)-2H,3H-imidazo[1,2-a]pyridin-6-yl]-3-phenyl-prop-
2-en-1-one (27h): 
Starting with 3-[(2E)-3-phenylprop-2-enoyl]chromone 7 (0.276 g, 1.0 
mmol) and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the 
product 27h was isolated as a yellow solid (0.290 g, 65%), mp 184 ºC; 
1H NMR (500 MHz, DMSO-d6): δ = 3.63-3.69 (m, 1H, CH), 3.76-3.83 
(m, 2H, CH), 3.83-3.89 (m, 1H, CH), 6.44 (d, 3J = 15.7 Hz, 1H, =CH-), 
6.86 (t, 3J = 7.4 Hz, 1H, HAr), 7.10 (d, 3J = 8.2 Hz, 1H, HAr), 7.16-7.20 (m, 3H, HAr), 7.26-7.33 
(m, 5H, HAr), 7.51-7.54 (m, 2H, HAr), 7.64 (tt, 3J = 7.4 Hz, 4J = 1.2 Hz, 1H, HAr), 7.73 (s, 1H, 7-
HAr), 7.82-7.82 (m, 2H, HAr), OH was not detected; 13C NMR (125.8 MHz, DMSO-d6): δ = 47.8 
(NCH2), 52.6 (NCH2), 115.2, 116.8, 188.9, 121.1, 121.2, 124.8, 2ˣ127.8, 2ˣ128.5, 2ˣ128.7, 
2ˣ129.2, 129.5, 129.9, 132.0, 132.9, 134.7, 137.0, 140.0, 140.6, 153.2, 153.3, 153.9, 185.3 
(C=O), 192.6 (C=O); MS (EI, 70 eV) m/z (%): 446 ([M]+, 27), 445 (69), 429 (49), 428 (100), 
427 (54), 399 (41), 341 (36), 330 (40), 315 (40), 313 (44), 165 (33), 138 (46), 131 (27), 120 (88), 
105 (97), 77 (71), 44 (45); HRMS (ESI): calcd for C29H23N2O3 ([M+H]+) 447.17032, found 
447.17099, calcd for C29H22NaN2O3 ([M+Na]+) 469.15226, found 469.15173; IR (ATR, cm–1): 
~ν
 = 3056 (w), 3026 (w), 2924 (w), 2871 (w), 1726 (w), 1645 (w), 1615 (w), 1591 (m), 1574 (m), 
1493 (w), 1447 (m), 1422 (w), 1374 (m), 1349 (w), 1319 (w), 1294 (m), 1276 (m), 1201 (s), 
1154 (m), 1108 (w), 1070 (w), 1033 (w), 1014 (m), 1000 (m), 975 (m), 860 (w), 832 (w), 817 
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(w), 802 (w), 752 (s), 731 (s), 694 (s), 666 (s), 653 (m), 642 (s), 587 (w), 562 (s), 537 (m), 530 
(m).  
      
8-Benzoyl-6-(2-hydroxybenzoyl)-5-(trifluoromethyl)-1H,2H,3H,5H-imidazolidino-[1,2-
a]pyridin-5-ol (28a): 
Starting with 3-(trifluoroacetyl)chromone 5a (0.242 g, 1.0 mmol) and 
HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 28a 
was isolated as a yellow solid (0.202 g, 47%), mp 150-151 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.80-4.00 (m, 4H, CH), 6.76-6.84 
(m, 2H, HAr), 7.12 (dd, 3J = 7.6 Hz, 4J = 1.7 Hz, 1H, HAr), 7.20 (dd, 3J = 7.7 Hz, 4J = 1.7 Hz, 1H, 
HAr), 7.36-7.42 (m, 6H, HAr), 9.04, 9.46, 9.99 (all three s, 3H, 2OH and NH); 13C NMR (75.5 
MHz, DMSO-d6): δ = 42.8 (NCH2), 43.5 (NCH2), 84.3 (q, 2JC,F = 32.8 Hz, 5-C), 91.7 (8-C), 
105.9, 116.1, 118.8, 125.6, 2ˣ128.0, 2ˣ128.1, 129.4, 130.5, 131.7, 138.6, 148.9, 154.9, 158.0, 
188.6 (C=O), 195.2 (C=O); 19F NMR (282.4 MHz, DMSO-d6): δ = –81.6 (s, 1F, F); MS (EI, 70 
eV) m/z (%): 362 ([M-CF3+H], 17), 361 (80), 345 (12), 344 (73), 343 (100), 268 (19), 267 (88), 
265 (12), 105 (19), 89 (11), 78 (28), 71 (12), 69 (11), 63 (29), 57 (19), 45 (17); HRMS (EI): 
calcd for C22H17F3N2O4 ([M]+) 430.11349, found 430.11384; IR (ATR, cm–1): ~ν  = 3311 (w), 
3046 (w), 2899 (w), 1619 (m), 1571 (s), 1549 (s), 1506 (m), 1476 (s), 1445 (m), 1395 (m), 1354 
(w), 1292 (w), 1277 (w), 1320 (m), 1206 (s), 1167 (s), 1151 (s), 1123 (s), 1033 (s), 1014 (s), 980 
(s), 952 (s), 921 (s), 864 (m), 790 (w), 761 (s), 697 (s), 675 (s), 637 (s), 615 (s), 529 (s). 
 
8-Benzoyl-6-(2-hydroxy-4-methoxybenzoyl)-5-(trifluoromethyl)-1H,2H,3H,5H-
imidazolidino[1,2-a]pyridin-5-ol (28b):  
Starting with 7-methoxy-3-(trifluoroacetyl)chromone 5b (0.272 
g, 1.0 mmol) and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane 
(6-7 mL), the product 28b was isolated as a yellow solid (0.281 
g, 61%), mp 194-196 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.73 (s, 3H, OCH3), 3.78-4.00 (m, 4H, CH), 6.39 (d, 4J = 
2.3 Hz, 1H, HAr), 6.45 (dd, 3J = 8.6 Hz, 4J = 2.3 Hz, 1H, HAr), 7.24 (d, 3J = 8.7 Hz, 1H, HAr), 
7.32 (s, 1H, 7-H), 7.39-7.48 (m, 5H, HAr), 9.02, 9.45, 10,62 (all three s, 3H, 2OH and NH); 13C 
NMR (62.9 MHz, DMSO-d6): δ = 42.9 (NCH2), 43.4 (NCH2), 55.4 (OCH3), 84.3 (q, 2JC,F = 32.5 
Hz, 5-C), 91.1 (8-C), 101.3, 105.3, 105.7, 116.8, 2ˣ128.1, 2ˣ128.2, 130.5, 132.1, 138.9, 147.2, 
157.8, 159.1, 163.2, 188.7 (C=O), 195.6 (C=O); 19F NMR (282.4 MHz, DMSO-d6): δ = –81.4 (s, 
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1F, F); MS (EI, 70 eV) m/z (%): 391 ([M-CF3], 14) 375 (14), 374 (65), 373 (100), 267 (54), 203 
(12), 187 (10), 99 (13), 84 (11), 69 (15), 57 (14), 44 (22); HRMS (EI): calcd for C23H19F3N2O5 
([M]+) 460.12406, found 460.12484; IR (ATR, cm–1): ~ν  = 3328 (w), 3042 (w), 3004 (w), 2963 
(w), 2934 (w), 2907 (w), 2838 (w), 1621 (w), 1572 (m), 1547 (m), 1504 (m), 1482 (w), 1440 
(w), 1409 (w), 1389 (w), 1363 (w), 1323 (w), 1284 (w), 1240 (m), 1204 (s), 1148 (s), 1099 (s), 
1029 (m), 1015 (m), 980 (m), 953 (s), 921 (s), 839 (m), 823 (w), 776 (s), 748 (s), 708 (s), 682 
(s), 647 (s), 606 (s), 552 (m), 529 (s). 
 
8-Benzoyl-6-(5-chloro-2-hydroxybenzoyl)-5-(trifluoromethyl)-1H,2H,3H,5H-
imidazolidino[1,2-a]pyridin-5-ol (28c): 
Starting with 6-chloro-3-(trifluoroacetyl)chromone 5c (0.276 g, 1.0 
mmol) and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the 
product 28c was isolated as a yellow solid (0.223 g, 48%), mp 167 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.78-4.01 (m, 4H, CH), 6.84 (d, 3J 
= 8.7 Hz, 1H, HAr), 7.06 (d, 4J = 2.7 Hz, 1H, HAr), 7.22 (dd, 3J = 8.7 Hz, 4J = 2.7 Hz, 1H, HAr), 
7.34 (s, 1H, 7-H), 7.37-7.46 (m, 5H, HAr), 8.78, 9.48, 10.23 (all three s, 3H, 2OH and NH); 13C 
NMR (62.9 MHz, DMSO-d6): δ = 42.9 (NCH2), 43.5 (NCH2), 84.1 (q, 2JC,F = 33.1 Hz, 5-C), 
92.6 (8-C), 105.8, 117.8, 122.3, 127.8, 2ˣ128.0, 2ˣ128.1, 128.2, 130.6, 130.8, 138.5, 149.3, 
153.4, 157.9, 188.6 (C=O), 192.5 (C=O); 19F NMR (282.4 MHz, DMSO-d6): δ = –81.4 (s, 1F, 
F); MS (EI, 70 eV) m/z (%): 395 ([M-CF3], 24), 380 (16), 379 (81), 378 (53), 377 (100), 267 
(30), 149 (10), 105 (11), 99 (33), 78 (51), 77 (10), 63 (55), 57 (13); HRMS (EI): calcd for 
C22H1635ClF3N2O4 ([M]+) 464.07452, found 464.07463; IR (ATR, cm–1): ~ν  = 3274 (w), 1619 
(w), 1562 (s), 1496 (m), 1463 (s), 1445 (m), 1395 (m), 1319 (m), 1280 (w), 1247 (m), 1210 (s), 
1159 (s), 1099 (s), 1032 (m), 1013 (s), 984 (m), 965 (m), 954 (m), 922 (s), 903 (m), 836 (w), 825 
(m), 800 (w), 781 (s), 743 (s), 728 (m), 697 (s), 657 (s), 639 (s), 578 (s), 528 (s). 
 
8-Benzoyl-6-(1-hydroxynaphthalene-2-carbonyl)-5-(trifluoromethyl)-1H,2H,3H,5H-
imidazolidino[1,2-a]pyridin-5-ol (28d): 
Starting with 3-(trifluoroacetyl)benzo[h]chromone 5e (0.292 g, 1.0 
mmol) and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 
mL), the product 28d was isolated as a yellow solid (0.163 g, 
34%), mp 177-178 ºC; 
OH O
N
Ph
O
HO
F3C
NH
Cl
OH O
N
Ph
O
HO
F3C
NH
 Supplement 1. Experimental part 
 
 
 
 
 169
1H NMR (300 MHz, DMSO-d6): δ = 3.82-4.04 (m, 4H, CH), 7.31-7.34 (m, 3H, HAr), 7.37 (s, 1H, 
7-H), 7.40-7.47 (m, 4H, HAr), 7.52-7.64 (m, 2H, HAr), 7.86 (d, 3J = 8.1 Hz, 1H, HAr), 8.27 (d, 3J 
= 8.1 Hz, 1H, HAr), 8.83, 9.49, 10.76 (all three s, 3H, 2OH and NH); 13C NMR (75.5 MHz, 
DMSO-d6): δ = 42.9 (NCH2), 43.3 (NCH2), 84.4 (q, 2JC,F = 32.8 Hz, 5-C), 91.3 (8-C), 104.9, 
115.8, 118.3, 123.1, 124.5 (q, 1JC,F = 295.7 Hz), 124.6, 125.9, 126.3, 127.6, 2ˣ127.9, 2ˣ128.1, 
128.9, 130.3, 135.7, 138.9, 147.4, 156.7, 157.6, 188.9 (C=O), 196.7 (C=O); 19F NMR (282.4 
MHz, DMSO-d6): δ = -80.9 (s, 1F, F); MS (EI, 70 eV) m/z (%): 463 ([M-OH], 11), 462 (40), 411 
(26), 395 (28), 394 (84), 393 (100), 391 (11), 268 (12), 267 (74), 231 (18), 196 (12), 105 (20), 77 
(17), 69 (12), 57 (12), 44 (16); HRMS (EI): calcd for C26H19F3N2O4 ([M]+) 480.12914, found 
480.12930; IR (ATR, cm–1): ~ν  = 3308 (w), 3049 (w), 2954 (w), 2895 (w), 1614 (w), 1588 (m), 
1564 (m), 1549 (m), 1502 (m), 1479 (w), 1451 (m), 1400 (m), 1357 (w), 1318 (w), 1241 (m), 
1204 (s), 1193 (s), 1164 (s), 1145 (s), 1128 (s), 1097 (s), 1025 (m), 1015 (m), 998 (m), 955 (m), 
923 (s), 882 (m), 830 (m), 803 (m), 794 (m), 760 (s), 745 (s), 698 (s), 658 (s), 610 (m), 593 (s), 
581 (s), 556 (s), 536 (s). 
 
9-Benzoyl-7-(2-hydroxybenzoyl)-6-(trifluoromethyl)-1H,2H,3H,4H,6H-pyrido[1,2-a]- 
pyrimidin-6-ol (28e): 
Starting with 3-(trifluoroacetyl)chromone 5a (0.242 g, 1.0 mmol) and 
HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 28e 
was isolated as a yellow solid (0.391 g, 88%), mp 177-178 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.81-1.91 (m, 1H, CH), 2.02-2.09 
(m, 1H, CH), 3.39-3.48 (m, 1H, CH), 3.55-3.61 (m, 2H, CH), 3.80-3.85 (m, 1H, CH), 6.72-6.80 
(m, 2H, HAr), 7.06 (dd, 3J = 7.6 Hz, 4J = 1.6 Hz, 1H, HAr), 7.13-7.18 (m, 1H, HAr), 7.29 (s, 1H, 8-
H), 7.36-7.39 (m, 5H, HAr), 9.88, 10.01, 11.47 (all three s, 3H, 2OH and NH); 13C NMR (62.9 
MHz, DMSO-d6): δ = 19.1 (CH2), 38.6 (NCH2), 39.8 (NCH2), 84.3 (q, 2JC,F = 32.7 Hz, 6-C), 
94.4 (9-C), 103.8, 116.0, 118.7, 125.0 (q, 1JC,F = 296.5 Hz), 125.3, 128.0, 128.3, 129.0, 129.1, 
130.4, 131.3, 131.4, 139.1, 149.3, 154.5, 154.8, 190.4 (C=O), 195.6 (C=O); 19F NMR (282.4 
MHz, DMSO-d6): δ = -83.9 (s, 1F, F); MS (EI, 70 eV) m/z (%): 444 ([M]+, 9), 397 (12), 376 
(45), 375 (92), 357 (42), 282 (41), 281 (100), 105 (19), 91 (12), 77 (13); HRMS (ESI): calcd for 
C23H20F3N2O4 ([M+H]+) 445.13697, found 445.13743, calcd for C23H19F3NaN2O4 ([M+Na]+) 
467.11891, found 467.11891; IR (ATR, cm–1): ~ν  = 3066 (w), 2937 (w), 2865 (w), 1733 (w), 
1610 (m), 1597 (m), 1575 (m), 1538 (w), 1512 (w), 1475 (m), 1446 (m), 1379 (m), 1351 (w), 
1327 (m), 1287 (w), 1263 (m), 1234 (m), 1206 (m), 1173 (s), 1151 (s), 1132 (s), 1074 (m), 1051 
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(w), 1037 (w), 992 (w), 965 (m), 938 (s), 866 (w), 847 (w), 817 (w), 803 (w), 760 (s), 733 (s), 
702 (s), 676 (s), 642 (s), 593 (m), 566 (m), 531 (m). 
 
9-Benzoyl-7-(2-hydroxy-4-methoxybenzoyl)-6-(trifluoromethyl)-1H,2H,3H,4H,6H-
pyrido[1,2-a]pyrimidin-6-ol (28f): 
Starting with 7-methoxy-3-(trifluoroacetyl)chromone 5b (0.272 
g, 1.0 mmol) and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane 
(6-7 mL), the product 28e was isolated as a yellow solid (0.341 
g, 72%), mp 187-188 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.78-1.94 (m, 1H, CH), 2.00-2.12 (m, 1H, CH), 3.39-3.48 
(m, 1H, CH), 3.52-3.63 (m, 2H, CH), 3.70 (s, 3H, OCH3), 3.77-3.86 (m, 1H, CH), 6.34 (d, 4J = 
2.3 Hz, 1H, HAr), 6.39 (dd, 3J = 8.6 Hz, 4J = 2.3 Hz, 1H, HAr), 7.12 (dd, 3J = 8.6 Hz, 1H, HAr), 
7.28 (s, 1H, 8-H), 7.39-7.44 (m, 5H, HAr), 10.03, 10.26, 11.51 (all three s, 3H, 2OH and NH); 
13C NMR (62.9 MHz, DMSO-d6): δ = 19.2 (CH2), 38.6 (NCH2), 39.8 (NCH2), 55.3 (OCH3), 84.4 
(q, 2JC,F = 32.5 Hz, 6-C), 93.9 (9-C), 101.3, 103.6, 105.4, 117.2, 2ˣ128.2, 2ˣ128.3, 130.3, 131.5, 
139.4, 148.3, 154.7, 157.8, 162.6, 190.5 (C=O), 195.7 (C=O); 19F NMR (282.4 MHz, DMSO-
d6): δ = -83.9 (s, 1F, F); MS (EI, 70 eV) m/z (%): 474 ([M]+, 14), 406 (31), 405 (100), 389 (20), 
388 (85), 387 (89), 359 (23), 282 (81), 281 (79), 203 (11), 179 (16), 151 (13), 135 (20), 105 (25), 
91 (33), 77 (18), 69 (68), 51 (28); HRMS (EI): calcd for C24H21F3N2O5 ([M]+) 474.13971, found 
474.13995; IR (ATR, cm–1): ~ν  = 3061 (w), 3038 (w), 3004 (w), 2926 (w), 2851 (w), 1738 (w), 
1598 (m), 1568 (s), 1506 (m), 1473 (w), 1456 (w), 1440 (m), 1423 (w), 1407 (w), 1388 (m), 
1369 (m), 1349 (s), 1316 (w), 1294 (w), 1264 (m), 1240 (s), 1225 (s), 1199 (s), 1171 (s), 1155 
(s), 1134 (s), 1108 (s), 1076 (m), 1060 (m), 1025 (m), 999 (w), 985 (m), 972 (m), 949 (s), 939 
(s), 920 (m), 877 (w), 862 (w), 826 (s), 777 (s), 754 (s), 736 (s), 706 (s), 697 (s), 668 (m), 644 
(s), 610 (s), 577 (m), 535 (s). 
 
9-Benzoyl-7-(5-chloro-2-hydroxybenzoyl)-6-(trifluoromethyl)-1H,2H,3H,4H,6H-pyrido[1,2-
a]pyrimidin-6-ol (28g):  
Starting with 6-chloro-3-(trifluoroacetyl)chromone 5c (0.276 g, 1.0 
mmol) and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the 
product 28g was isolated as a yellow solid (0.454 g, 95%), mp 171 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.78-1.94 (m, 1H, CH), 2.00-2.13 
(m, 1H, CH), 3.42-3.50 (m, 1H, CH), 3.51-3.65 (m, 2H, CH), 3.77-3.88 (m, 1H, CH), 6.80 (d, 3J 
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= 8.7 Hz, 1H, HAr), 7.02 (d, 4J = 1.7 Hz, 1H, HAr), 7.19 (dd, 3J = 8.7 Hz, 4J = 1.7 Hz, 1H, HAr), 
7.25 (s, 1H, 8-H), 7.36-7.40 (m, 5H, HAr), 9.72, 10.19, 11.42 (all three s, 3H, 2OH and NH); 13C 
NMR (125.8 MHz, DMSO-d6): δ = 19.0 (CH2), 38.7 (NCH2), 39.7 (NCH2), 84.2 (q, 2JC,F = 32.4 
Hz, 6-C), 94.8 (9-C), 103.7, 117.7, 122.2, 124.9 (q, 1JC,F = 296.2 Hz), 127.2, 127.9, 2ˣ128.0, 
2ˣ128.1, 130.4, 130.7, 139.1, 149.6, 153.2, 154.8, 190.6 (C=O), 193.0 (C=O); 19F NMR (282.4 
MHz, DMSO-d6): δ = -83.8 (s, 1F, F); MS (EI, 70 eV) m/z (%): 411 ([M-CF3+2H], 52), 410 
(32), 409 (99), 393 (26), 392 (13), 391 (66), 282 (26), 281 (100), 253 (10), 105 (21), 91 (16), 77 
(16); HRMS (ESI): calcd for C23H1835ClF3N2O4 ([M+H]+) 479.09800, found 479.09794, calcd 
for C23H1837ClF3N2O4 ([M+H]+) 481.09605, found 481.09590; IR (ATR, cm–1): ~ν  = 3070 (w), 
2955 (w), 2919 (w), 2867 (w), 2851 (w), 1600 (m), 1568 (m), 1516 (m), 1462 (m), 1456 (m), 
1443 (w), 1405 (m), 1381 (m), 1365 (m), 1318 (w), 1293 (m), 1263 (m), 1231 (m), 1216 (m), 
1149 (s), 1130 (s), 1074 (m), 1055 (m), 1025 (m), 998 (m), 980 (w), 942 (s), 907 (m), 874 (w), 
848 (w), 836 (m), 817 (w), 783 (s), 743 (m), 724 (m), 701 (s), 642 (s), 596 (m), 555 (m), 534 
(m). 
 
9-Benzoyl-7-(1-hydroxynaphthalene-2-carbonyl)-6-(trifluoromethyl)-1H,2H,3H,4H,6H- 
pyrido[1,2-a]pyrimidin-6-ol (28h): 
Starting with 3-(trifluoroacetyl)benzo[h]chromone 5e (0.292 g, 1.0 
mmol) and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), 
the product 28h was isolated as a yellow solid (0.385 g, 78%), mp 
192-193 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.81-1.97 (m, 1H, CH), 2.01-2.14 (m, 1H, CH), 3.43-3.51 
(m, 1H, CH), 3.54-3.67 (m, 2H, CH), 3.80-3.92 (m, 1H, CH), 7.27-7.40 (m, 8H, HAr), 7.50-7.61 
(m, 2H, HAr), 7.82 (d, 3J = 8.0 Hz, 1H, HAr), 8.27 (d, 3J = 8.0 Hz, 1H, HAr), 9.82, 11.00, 11.46 
(all three s, 3H, 2OH and NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 19.2 (CH2), 38.7 (NCH2), 
39.7 (NCH2), 84.5 (q, 2JC,F = 32.6 Hz, 6-C), 94.3 (9-C), 103.3, 107.8, 116.8, 118.5, 123.0, 124.6, 
125.8, 126.1, 127.6, 2ˣ128.1, 2ˣ128.2, 128.4, 130.2, 135.4, 139.4, 148.6, 154.7, 190.8 (C=O), 
196.3 (C=O); 19F NMR (282.4 MHz, DMSO-d6): δ = -83.6 (s, 1F, F); MS (EI, 70 eV) m/z (%): 
494 ([M]+, 6), 426 (9), 425 (34), 409 (9), 408 (21), 407 (92), 282 (15), 281 (100), 69 (38), 51 
(26); HRMS (EI): calcd for C27H21F3N2O4 ([M]+) 494.14479, found 494.14498; IR (ATR, cm–1): 
~ν
 = 3059 (w), 3027 (w), 2875 (w), 1617 (w), 1589 (m), 1569 (m), 1538 (w), 1515 (m), 1458 
(m), 1438 (m), 1405 (m), 1367 (m), 1323 (w), 1289 (w), 1266 (m), 1240 (s), 1208 (m), 1160 (s), 
1144 (s), 1130 (s), 1094 (m), 1058 (s), 1024 (m), 1006 (m), 940 (s), 894 (w), 880 (w), 858 (w), 
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809 (m), 787 (s), 758 (s), 742 (s), 718 (m), 695 (s), 688 (s), 667 (s), 657 (s), 643 (s), 601 (s), 578 
(m), 570 (m), 544 (w). 
 
9-Benzoyl-6-(dichloromethyl)-7-(2-hydroxybenzoyl)-1H,2H,3H,4H,6H-pyrido[1,2-a]-
pyrimidin-6-ol (28i): 
Starting with 3-(2,2-dichloroacetyl)chromone 8 (0.257 g, 1.0 mmol) and 
HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 28i 
was isolated as a yellow solid (0.230 g, 50%), mp 150-151 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.90-2.08 (m, 2H, CH), 3.37-3.47 
(m, 1H, CH), 3.48-3.59 (m, 2H, CH), 3.99-4.08 (m, 1H, CH), 6.62 (s, 1H, CHCl2), 6.75-6.80 (m, 
2H, HAr), 7.14-7.20 (m, 3H, HAr), 7.34-7.38 (m, 5H, HAr), 9.39, 9.81, 11.33 (all three s, 3H, 2OH 
and NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 19.3 (CH2), 38.4 (NCH2), 39.8 (NCH2), 78.6 
(CHCl2), 88.4 (6-C), 94.8 (9-C), 107.5, 116.3, 118.5, 124.8, 2ˣ127.9, 2ˣ128.3, 129.5, 130.0, 
131.5, 139.6, 148.3, 154.9, 155.5, 190.1 (C=O), 195.7 (C=O); IR (ATR, cm–1): ~ν  = 3053 (w), 
2996 (w), 2954 (w), 2921 (w), 2871 (w), 1612 (m), 1580 (s), 1519 (m), 1477 (m), 1421 (m), 
1370 (m), 1345 (w), 1317 (m), 1304 (m), 1268 (m), 1205 (s), 1179 (s), 1145 (s), 1094 (m), 1074 
(m), 1056 (m), 1029 (m), 997 (m), 956 (m), 943 (m), 886 (w), 874 (w), 846 (w), 793 (s), 781 
(m), 742 (s), 702 (s), 690 (s), 673 (s), 642 (s), 616 (s), 562 (m), 532 (m). 
 
12-Benzoyl-8-oxa-14,17-diazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),3,5,11,13-
hexaen-9-one (29a):  
Starting with 3-(heptafluorobutanoyl)chromone 5q (0.342 g, 1.0 mmol) 
and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 
29a was isolated as a red solid (0.311 g, 91%), mp 256-257 ºC; 
1H NMR (500 MHz, DMSO-d6, 100 °C): δ = 4.03 (t, 3J = 9.6 Hz, 2H, 
CH), 4.65 (t, 3J = 9.6 Hz, 2H, CH), 7.43-7.45 (m, 2H, HAr), 7.50-7.53 (m, 
2H, HAr), 7.60 (s, 1H, 11-HAr), 7.63 (td, 4J = 1.2 Hz, 3J = 7.4 Hz, 1H, HAr), 7.74 (td, 4J = 1.2 Hz, 
3J = 7.4 Hz, 1H, HAr), 7.86-7.88 (m, 2H, HAr), 8.35 (d, 3J = 8.6 Hz, 1H, HAr); 13C NMR (125.6 
MHz, DMSO-d6, 100 °C): δ = 49.9 (NCH2), 54.1 (NCH2), 99.0, 112.7, 117.5, 123.9, 124.7, 
126.3, 127.8, 2ˣ127.9, 2ˣ128.6, 132.6, 133.1, 135.2, 136.2, 147.9, 153.3, 157.8, 191.4 (C=O); MS 
(EI, 70 eV) m/z (%): 342 ([M]+, 100), 341 (83), 340 (11), 339 (23), 327 (16), 315 (55), 314 (96), 
313 (83), 312 (36), 311 (60), 299 (11), 287 (22), 286 (75), 285 (17), 268 (12), 258 (10), 242 (13), 
O
N NH
Ph
OOH
HO
Cl2HC
N Ph
ON
O O
1234
5
6 7 8
9
10
12
16 13
11
15 14
17
 Supplement 1. Experimental part 
 
 
 
 
 173
240 (10), 239 (42), 171 (22), 105 (17), 77 (73), 51 (10); HRMS (ESI): calcd for C21H15N2O3 
([M+H]+) 343.10772, found 343.10788; IR (ATR, cm–1): ~ν  = 3353 (w), 3060 (w), 2961 (w), 
2933 (w), 2886 (w), 1715 (w), 1634 (s), 1596 (m), 1562 (s), 1518 (s), 1492 (s), 1449 (m), 1369 
(m), 1340 (m), 1300 (m), 1214 (s), 1189 (s), 1176 (s), 1157 (s), 1126 (s), 1048 (m), 1001 (s), 947 
(s), 918 (s), 859 (m), 840 (s), 796 (s), 745 (s), 720 (s), 687 (s), 667 (s), 653 (s), 634 (s), 584 (m), 
554 (s), 533 (s). 
 
12-Benzoyl-5-methoxy-8-oxa-14,17-diazatetracyclo[8.7.0.02,7.013,17]heptadeca-
1(10),2(7),3,5,11,13-hexaen-9-one (29b): 
Starting with 7-methoxy-3-(trifluoroacetyl)chromone 5b (0.372 g, 
1.0 mmol) and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 
mL), the product 29b was isolated as a red solid (0.115 g, 31%), 
mp 309-310 ºC; 
1H NMR (250 MHz, DMSO-d6, 100 °C): δ = 3.94 (s, 3H, OCH3), 4.02 (t, 3J = 9.6 Hz, 2H, CH), 
4.59 (t, 3J = 9.6 Hz, 2H, CH), 7.00-7.04 (m, 2H, HAr), 7.47-7.53 (m, 3H, HAr), 7.60 (s, 1H, 11-
HAr), 7.83-7.87 (m, 2H, HAr), 8.27 (d, 3J = 9.7 Hz, 1H, HAr); 13C NMR (62.9 MHz, DMSO-d6, 
100 °C): δ = 49.1 (NCH2), 54.0 (NCH2), 55.6 (OCH3), 97.0, 101.8, 105.8, 111.8, 123.2, 127.6, 
127.7, 2ˣ127.8, 2ˣ128.5, 132.3, 135.8, 136.4, 148.1, 153.3, 155.5, 163.1, 191.3 (C=O); IR (ATR, 
cm–1): ~ν  = 3361 (w), 2953 (w), 2884 (w), 1733 (w), 1635 (w), 1611 (w), 1554 (s), 1502 (s), 
1412 (s), 1367 (w), 1329 (m), 1276 (m), 1253 (m), 1176 (m), 1153 (s), 1232 (w), 1196 (m), 1186 
(m), 1107 (s), 1049 (m), 1020 (m), 997 (m), 964 (w), 951 (w), 930 (w), 918 (w), 881 (w), 843 
(m), 796 (s), 755 (s), 727 (s), 709 (s), 692 (s), 659 (s), 645 (s), 623 (s), 588 (s), 554 (s), 534 (s). 
 
8-Benzoyl-12-oxa-3,6-diazapentacyclo[11.8.0.02,10.03,7.014,19]henicosa-
1(13),2(10),6,8,14(19),15,17,20-octaen-11-one (29c): 
Starting with 3-(heptafluorobutanoyl)benzo[h]chromone 5w (0.392 g, 
1.0 mmol) and HKA 24a (0.207 g, 1.1 mmol) in 1,4-dioxane (6-7 
mL), the product 29c was isolated as a red solid (0.329 g, 84%), mp 
337-339 ºC; 
1H NMR (500 MHz, DMSO-d6, 100 °C): δ = 4.06 (t, 3J = 9.5 Hz, 2H, 
CH), 4.73 (t, 3J = 9.5 Hz, 2H, CH), 7.52 (t, 3J = 7.5 Hz, 2H, HAr), 7.64 
(t, 3J = 7.5 Hz, 1H, HAr), 7.67 (s, 1H, 9-HAr), 7.73-7.80 (m, 2H, HAr), 7.87-7.90 (m, 3H, HAr), 
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8.04 (d, 3J = 8.1 Hz, 1H, HAr), 8.33 (d, 3J = 9.3 Hz, 1H, HAr), 8.47 (d, 3J = 8.1 Hz, 1H, HAr); 13C 
NMR (125.8 MHz, DMSO-d6, 100 °C): δ = 49.4 (NCH2), 53.8 (NCH2), 98.8, 107.7, 120.6, 
121.8, 122.3, 123.0, 124.6, 126.8, 126.9, 2ˣ127.7, 2ˣ128.4, 129.1, 132.3, 134.1, 134.9, 136.2, 
148.6, 150.8, 153.1, 157.4, 191.1 (C=O); MS (EI, 70 eV) m/z (%): 392 ([M]+, 42), 391 (100), 
365 (14), 364 (30), 363 (88), 362 (11), 361 (17), 336 (13), 289 (20), 77 (13); HRMS (ESI): calcd 
for C25H17N2O3 ([M+H]+) 393.12337, found 393.12345, calcd for C25H16NaN2O3 ([M+Na]+) 
415.10531, found 415.10520; IR (ATR, cm–1): ~ν  = 3337 (w), 3054 (w), 2926 (w), 2873 (w), 
1732 (w), 1633 (m), 1558 (s), 1519 (s), 1497 (s), 1417 (s), 1397 (s), 1355 (m), 1330 (m), 1300 
(m), 1280 (m), 1265 (m), 1242 (m), 1204 (s), 1188 (s), 1156 (s), 1095 (s), 1052 (s), 1015 (s), 988 
(s), 948 (s), 880 (m), 796 (s), 745 (s), 745 (s), 717 (s), 688 (s), 669 (s), 651 (s), 639 (s), 620 (s), 
594 (s), 574 (s). 
 
9-Benzoyl-7-(2-hydroxy-5-methylbenzoyl)-1H,2H,3H,4H,6H-pyrido[1,2-a]pyrimidin-6-one 
(30a): 
Starting with 3-(heptafluorobutanoyl)chromone 5r (0.356 g, 1.0 mmol) 
and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), the product 
30a was isolated as a yellow solid (0.295 g, 76%), mp 165-166 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.00-2.06 (m, 2H, CH), 2.19 (s, 
3H, CH3), 3.52-3.55 (m, 2H, CH), 3.89-3.93 (m, 2H, CH), 6.74 (d, 3J = 8.7 Hz, 1H, HAr), 7.10-
7.13 (m, 2H, HAr), 7.43-7.55 (m, 5H, HAr), 7.81 (s, 1H, 8-HAr), 10.34, 10.96 ( both s, 2H, OH  
and NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 18.3 (CH2), 19.9 (CH3), 38.4 (NCH2), 39.2 
(NCH2), 97.6 (9-C), 112.0, 116.3, 124.6, 127.1, 2ˣ127.9, 2ˣ128.3, 2ˣ130.6, 133.7, 139.3, 147.4, 
155.0, 155.5, 158.4, 193.3 (C=O), 193.9 (C=O); MS (EI, 70 eV) m/z (%): 388 ([M]+, 8), 254 
(13), 253 (13), 203 (88), 202 (100), 187 (42), 186 (10), 185 (16), 173 (28), 126 (11), 125 (47), 
109 (30), 105 (17), 78 (13), 77 (16); HRMS (EI): calcd for C23H20N2O4 ([M]+) 388.14176, found 
388.14250; IR (ATR, cm–1): ~ν  = 3179 (w), 3054 (w), 2983 (w), 2951 (w), 2920 (w), 2876 (w), 
1675 (w), 1592 (s), 1557 (s), 1502 (m), 1481 (s), 1442 (m), 1403 (m), 1370 (m), 1344 (m), 1326 
(m), 1287 (m), 1276 (m), 1258 (m), 1238 (s), 1204 (s), 1177 (s), 1079 (m), 1050 (m), 1028 (m), 
1000 (w), 981 (m), 956 (w), 941 (w), 917 (w), 885 (w), 861 (w), 833 (w), 824 (m), 799 (m), 770 
(s), 753 (s), 703 (s), 676 (s), 642 (s), 551 (m), 540 (m). 
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7-(5-Chloro-2-hydroxybenzoyl)-9-(4-chlorobenzoyl)-1H,2H,3H,4H,6H-pyrido[1,2-a]-
pyrimidin-6-one (30b): 
Starting with 6-chloro-3-(heptafluorobutanoyl)chromone 5t 
(0.356 g, 1.0 mmol) and HKA 24c (0.237 g, 1.1 mmol) in 1,4-
dioxane (6-7 mL), the product 30b was isolated as a yellow 
solid (0.310 g, 70%), mp 216-217 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.01 (m, 2H, CH), 3.53 (m, 2H, CH), 3.88 (m, 2H, CH), 
6.83 (d, 3J = 8.7 Hz, 1H, HAr), 7.18 (d, 4J = 2.4 Hz, 1H, HAr), 7.27 (dd, 3J = 8.7 Hz, 4J = 2.7 Hz, 
1H, HAr), 7.50-7.56 (m, 4H, HAr), 7.88 (s, 1H, 8-HAr), 10.21, 10.85 ( both s, 2H, OH  and NH); 
13C NMR (75.5 MHz, DMSO-d6): δ = 18.2 (CH2), 38.5 (NCH2), 39.2 (NCH2), 98.2 (9-C), 111.6, 
117.8, 122.1, 2ˣ128.5, 2ˣ129.2, 2ˣ129.9, 131.0, 135.4, 137.9, 147.6, 154.7, 155.1, 158.5, 190.7 
(C=O), 192.1 (C=O); MS (EI, 70 eV) m/z (%): 442 ([M+], 46), 288 (100), 139 (11), 111 (8); 
HRMS (ESI): calcd for C22H1735Cl2N2O4 ([M+H]+) 443.05599, found 443.05675, calcd for 
C22H1737Cl2N2O4 ([M+H]+) 445.05353, found 445.05419; IR (ATR, cm–1): ~ν  = 2992 (w), 2873 
(w), 1667 (w), 1651 (w), 1588 (s), 1564 (s), 1558 (s), 1503 (m), 1471 (m), 1396 (m), 1371 (m), 
1352 (m), 1314 (m), 1292 (m), 1261 (s), 1244 (s), 1205 (s), 1180 (s), 1112 (w), 1088 (m), 1048 
(w), 1014 (m), 982 (m), 947 (w), 914 (w), 885 (w), 848 (m), 827 (m), 808 (m), 779 (s), 732 (m), 
688 (s), 674 (m), 644 (m), 598 (w), 561 (m), 539 (m). 
 
9-Benzoyl-7-(5-bromo-2-hydroxybenzoyl)-1H,2H,3H,4H,6H-pyrido[1,2-a]pyrimidin-6-one 
(30c): 
Starting with 6-bromo-3-(heptafluorobutanoyl)chromone 5v (0.421 g, 
1.0 mmol) and HKA 24b (0.222 g, 1.1 mmol) in 1,4-dioxane (6-7 mL), 
the product 30c was isolated as yellow solid (0.344 g, 76%), mp 206-
208 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 1.97-2.06 (m, 2H, CH), 3.50-3.57 (m, 2H, CH), 3.86-3.90 
(m, 2H, CH), 6.79 (d, 3J = 8.7 Hz, 1H, HAr), 7.26 (d, 4J = 2.5 Hz, 1H, HAr), 7.37 (d, 4J = 2.5 Hz, 
3J = 8.7 Hz, 1H, HAr), 7.48-7.55 (m, 5H, HAr), 7.94 (s, 1H, 8-HAr), 10.25, 10.93 ( both s, 2H, OH  
and NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 18.3 (CH2), 38.5 (NCH2), 39.2 (NCH2), 98.2 (9-
C), 109.5, 111.4, 118.3, 2ˣ128.0, 2ˣ128.4, 130.0, 130.7, 131.2, 133.7, 139.2, 147.9, 155.1, 155.2, 
158.5, 190.5 (C=O), 193.5 (C=O); MS (EI, 70 eV) m/z (%): 452 ([M]+, 39), 255 (17), 254 (100), 
253 (99), 105 (8); HRMS (EI): calcd for C22H1779BrN2O4 ([M]+) 452,03662 found 452.03659, 
calcd for C22H1781BrN2O4 ([M]+) 454,03457 found 454.03485; IR (ATR, cm–1): ~ν  = 3063 (w), 
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2976 (w), 2905 (w), 2869 (w), 1665 (w), 1620 (w), 1596 (s), 1558 (s), 1496 (m), 1463 (s), 1447 
(m), 1399 (w), 1373 (m), 1359 (m), 1329 (m), 1310 (m), 1289 (m), 1267 (s), 1238 (s), 1196 (s), 
1178 (s), 1122 (m), 1078 (m), 1052 (m), 1020 (w), 1010 (w), 977 (m), 950 (w), 939 (w), 914 
(w), 905 (w), 883 (w), 854 (w), 823 (m), 804 (m), 795 (m), 780 (w), 748 (s), 705 (s), 678 (s), 643 
(s), 624 (s), 595 (m), 547 (w), 530 (s). 
 
9-Benzoyl-7-(1-hydroxynaphthalene-2-carbonyl)-1H,2H,3H,4H,6H-pyrido[1,2-a]-
pyrimidin-6-one (30d):  
Starting with 3-(heptafluorobutanoyl)benzo[h]chromone 5w 
(0.392 g, 1.0 mmol) and HKA 24b (0.222 g, 1.1 mmol) in 1,4-
dioxane (6-7 mL), the product 30d was isolated as a yellow solid 
(0.322 g, 76%), mp 268-269 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.07 (s, 2H, CH), 3.57 (s, 2H, CH), 3.96 (m, 2H, CH), 7.30 
(d, 3J = 8.7 Hz, 1H, HAr), 7.44-7.58 (m, 7H, HAr), 7.68 (t, 3J = 7.8 Hz, 1H, HAr), 7.83-7.88 (m, 
2H, HAr), 8.30 (d, 3J = 8.1 Hz, 1H, HAr), 10.97, 13.53 ( both s, 2H, OH  and NH); 13C NMR (62.9 
MHz, DMSO-d6): δ = 18.3 (CH2), 38.4 (NCH2), 39.8 (NCH2), 98.1 (9-C), 111.5, 114.0, 117.3, 
123.4, 124.3, 125.8, 127.5, 127.7, 2ˣ127.9, 2ˣ128.4, 129.9, 130.6, 136.6, 139.3, 146.9, 155.1, 
158.4, 160.4, 193.3 (C=O), 197.2 (C=O); MS (EI, 70 eV) m/z (%): 424 ([M]+, 77), 377 (10), 281 
(9), 255 (33), 254 (100), 253 (99), 225 (9), 177 (12), 131 (9), 115 (9), 105 (10), 77 (11), 69 (30); 
HRMS (ESI): calcd for C26H21N2O4 ([M+H]+) 425.14958, found 425.14982; IR (ATR, cm–1): ~ν  
= 3063 (w), 2963 (w), 2915 (w), 2875 (w), 1666 (m), 1590 (s), 1567 (s), 1557 (s), 1496 (s), 1456 
(s), 1404 (m), 1374 (m), 1359 (s), 1314 (m), 1298 (s), 1249 (s), 1227 (s), 1199 (s), 1169 (s), 1146 
(s), 1107 (s), 1080 (m), 1058 (s), 1025 (s), 953 (m), 906 (m), 882 (m), 862 (m), 804 (m), 780 (s), 
738 (s), 717 (m), 699 (s), 667 (s), 642 (s), 614 (s), 598 (s), 588 (s), 573 (s), 536 (m). 
 
 
1.2.4 Supplement for Chapter 5 
 
General procedure for the synthesis of compounds 32 and 33: 
To a stirred reaction mixture of the corresponding 3-halochromone 9-11 (1.0 mmol) and β-
ketoamide 31 (1.1 mmol) in dioxane (6-7 mL), DBU (1.3 mmol) was slowly added by syringe at 
room temperature. Stirring at room temperature was continued until the chromone was consumed 
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(approximately 3-4 h for 3-chlorochromones 11 and 10-12 h in case of 3-iodochromones 9 and 
3-bromochromones 10). The solvent was distilled off under reduced pressure, and the resulting 
residue was washed with a diluted aqueous solution of HCl. The formed precipitate was filtered 
off. In some cases, it was necessary to purify the obtained product by washing with a mixture of 
isopropanol and heptane (1:10) or by chromatography (silica gel, heptane/ ethyl acetate). 
 
1-{5-[(2-Hydroxyphenyl)carbonyl]-2-(phenylamino)furan-3-yl}ethan-1-one (32a):  
Starting with 3-bromochromone 10a (0.225 g, 1.0 mmol), 
acetoacetanilide 31a (0.195 g, 1.1 mmol) and DBU (0.20 mL, 1.3 
mmol) in 1,4-dioxane (6-7 mL), the product 32a was isolated as a 
yellow solid (0.279 g, 87%), mp 141-143 ºC; 
1H NMR (300 MHz, СDCl3): δ = 2.39 (s, 3H, CH3), 6.87 (t, 3J = 7.6 Hz, 1H, HAr), 6.98 (t, 3J = 
8.0 Hz, 1H, HAr), 7.12 (t, 3J = 7.3 Hz, 1H, HAr),  7.33-7.47 (m, 5H, HAr), 7.55 (s, 1H, 4-HAr), 7.98 
(dd, 4J = 1.4 Hz, 3J = 8.0 Hz, 1H, HAr),  10.15, 11.81 ( both s, 2H, OH and NH); 13C NMR (62.9 
MHz, CDCl3): δ = 27.1 (CH3), 103.5, 118.6, 118.8, 118.9, 2ˣ119.3, 123.0, 124.9, 2ˣ129.7, 130.1, 
135.5, 136.3, 141.7, 159.7, 162.6, 182.4 (C=O), 193,4 (C=O); MS (GC, 70 eV) m/z (%) 321 
([M]+, 51), 201 (24), 172 (32), 130 (35), 121 (18), 93 (100), 77 (26), 65 (15), 43 (19); HRMS 
(EI): calcd for C19H15NO4 ([M]+) 321.09956, found 321.09941; IR (ATR, cm–1): ~ν   = 3250 (w), 
2922 (w), 2852 (w), 2732 (w), 1651 (m), 1616 (s), 1600 (m), 1575 (m), 1532 (s), 1472 (s), 1436 
(m), 1417 (m), 1354 (w), 1323 (m), 1302 (m), 1288 (m), 1235 (m), 1222 (m), 1205 (s), 1181 (s), 
1150 (s), 1110 (m), 1064 (w), 1034 (w), 1018 (w), 966 (m), 954 (m), 896 (m), 870 (w), 852 (m), 
823 (m), 791 (w), 776 (w), 752 (s), 726 (s), 701 (s), 686 (m), 656 (s), 633 (s), 613 (m), 600 (m), 
582 (s), 567 (m), 550 (m). 
 
1-{5-[(5-Chloro-2-hydroxy-4-methylphenyl)carbonyl]-2-(phenylamino)furan-3-yl}ethan-1-
one (32b):  
Starting with 3-bromo-6-chloro-7-methylchromone 10c (0.274 g, 
1.0 mmol), acetoacetanilide 31a (0.195 g, 1.1 mmol) and DBU 
(0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 32b was 
isolated as a orange solid (0.365 g, 99%), mp 187-188 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.32 (s, 3H, CH3), 2.40 (s, 3H, CH3), 6.96 (s, 1H, HAr), 7.18 
(t, 3J = 7.4 Hz, 1H, HAr), 7.39-7.44 (m, 2H, HAr), 7.56-7.59 (m, 3H, HAr), 7.84 (s, 1H, 4-HAr), 
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10.23, 10.77 ( both s, 2H, OH and NH); 13C NMR (75.5 MHz, CDCl3): δ = 20.7 (CH3), 27.1 
(CH3), 103.5, 117.4, 2ˣ119.2, 120.5, 123.2, 124.3, 125.0, 2ˣ129.8, 129.9, 136.1, 142.1, 144.8, 
159.5, 161.5, 180.5 (C=O), 193.5 (C=O); MS (GC, 70 eV) m/z (%): 369 ([M]+, 45), 201 (51), 
172 (29), 169 (18), 130 (38), 93 (100), 77 (52), 69 (10), 51 (13), 43 (21); HRMS (EI): calcd for 
C20H1635ClNO4 ([M]+) 369.07624, found 369.07613; IR (ATR, cm–1): ~ν  = 3239 (w), 3203 (w), 
3140 (w), 3054 (w), 2952 (w), 2916 (w), 1722 (w), 1713 (w), 1641 (s), 1621 (m), 1601 (m), 
1580 (m), 1514 (s), 1478 (s), 1458 (m), 1444 (m), 1384 (w), 1374 (m), 1343 (s), 1320 (m), 1230 
(s), 1200 (s), 1166 (s), 1113 (m), 1021 (w), 950 (m), 879 (w), 858 (w), 837 (s), 815 (m), 744 (m), 
728 (s), 689 (m), 648 (s), 610 (m), 597 (m), 531 (s). 
 
1-{5-[(2-Hydroxy-4-methoxyphenyl)carbonyl]-2-(phenylamino)furan-3-yl}ethan-1-one 
(32c):  
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), acetoacetanilide 31a (0.195 g, 1.1 mmol) and DBU (0.20 
mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 32c was 
isolated as a yellow solid (0.344 g, 98%), mp 169-171 ºC; 
Yield 98%, yellow solid, mp: 169-171 °C; 1H NMR (300 MHz, CDCl3): δ = 2.44 (s, 3H, CH3), 
3.85 (s, 3H, OCH3), 4.44-6.47 (m, 2H, HAr), 7.17 (t, 3J = 7,5 Hz, 1H, HAr), 7,40 (t, 3J = 8.4 Hz, 
2H, HAr), 7.47-7.49 (m, 2H, HAr), 7.56 (s, 1H, 4-HAr), 8.01 (d, 3J = 8.7 Hz, 1H, HAr), 10.15, 
12.73 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, CDCl3): δ = 27.1 (CH3), 55.6 (OCH3), 
101.2, 103.2, 107.7, 112.4, 119.3, 120.3, 121.7, 124.8, 129.1, 129.6, 131.8, 136.4, 141.9, 159.3, 
165.7, 166.1, 181.2 (C=O), 193.4 (C=O); MS (GC, 70 eV) m/z (%): 351 ([M]+, 57), 259 (23), 
258 (100), 243 (43), 217 (33), 216 (12), 201 (18), 188 (13), 172 (26), 161 (10), 151 (45), 130 
(45), 128 (10), 108 (11), 93 (84), 77 (37), 69 (14), 51 (10), 43 (20); HRMS (EI): calcd for 
C20H17NO5 ([M]+) 351.11012, found 351.10989; IR (ATR, cm–1): ~ν  = 3152 (w), 3056 (w), 1681 
(m), 1641 (w), 1621 (m), 1592 (s), 1524 (w), 1510 (w), 1486 (w), 1466 (m), 1435 (m), 1411 (m), 
1383 (m), 1357 (m), 1296 (m), 1278 (m), 1223 (m), 1206 (s), 1196 (m), 1178 (m), 1153 (m), 
1138 (m), 1089 (m), 1031 (w), 1010 (w), 989 (w), 941 (w), 925 (w), 890 (w), 976 (w), 811 (m), 
773 (m), 728 (s), 697 (m), 680 (s), 638 (s), 606 (m), 580 (m), 565 (s), 549 (m). 
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1-{5-[(1-Hydroxynaphthalen-2-yl)carbonyl]-2-(phenylamino)furan-3-yl}ethan-1-one (32d):  
Starting with 3-chlorobenzo[h]chromone 11c (0.231 g, 1.0 mmol), 
acetoacetanilide 31a (0.195 g, 1.1 mmol) and DBU (0.20 mL, 1.3 
mmol) in 1,4-dioxane (6-7 mL), the product 32d was isolated as a 
orange solid (0.197 g, 53%), mp 206-208 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.45 (s, 3H, CH3), 7.21 (t, 3J = 7.3 Hz, 1H, HAr), 7.38-7.48 
(m, 3H, HAr), 7.55-7.63 (m, 3H, HAr), 7.69 (t, 3J = 7.0 Hz, 1H, HAr), 7.91 (d, 3J = 8.1 Hz, 1H, 
HAr), 8.04 (d, 3J = 8.9 Hz, 1H, HAr), 8.12 (s, 1H, 4-HAr), 8.33 (t, 3J = 8.2 Hz, 1H, HAr), 10.27, 
13.9 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 27.3 (CH3), 104.0, 112.4, 
118.4, 2ˣ120.5, 123.4, 124.5, 124.8, 2ˣ125.1, 126.1, 127.5, 2ˣ129.3, 129.9, 136.2, 136.6, 140.6, 
158.9, 160.9, 181.0 (C=O), 193.0 (C=O); MS (EI, 70 eV) m/z (%): 371 ([M]+, 41), 278 (21), 263 
(13), 237 (15), 201 (100), 186 (10), 171 (18), 130 (17), 93 (53), 77 (11), 69 (12), 43 (9); HRMS 
(ESI): calcd for C23H18NO4 ([M+H] +) 372.12303, found 372.12341, calcd for C23H17NaNO4 
([M+Na]+) 394.10498, found 394.10503;  IR (ATR, cm–1): ~ν  = 3235 (w), 3065 (w), 2921 (w), 
2851 (w), 1641 (w), 1621 (m), 1602 (w), 1574 (m), 1520 (s), 1482 (w), 1455 (m), 1409 (m), 
1382 (m), 1350 (m), 1322 (m), 1263 (m), 1243 (s), 1202 (s), 1156 (m), 1145 (m), 1128 (s), 1096 
(m), 1062 (w), 1023 (m), 1000 (w), 955 (m), 922 (w), 906 (w), 880 (w), 857 (m), 809 (w), 790 
(s), 749 (s), 718 (s), 691 (s), 650 (s), 628 (m), 612 (m), 596 (w), 572 (m), 529 (s).   
 
1-{2-[(2,4-Dimethylphenyl)amino]-5-[(2-hydroxyphenyl)carbonyl]furan-3-yl}ethan-1-one 
(32e):  
Starting with 3-bromochromone 10a (0.225 g, 1.0 mmol), N-(2,4-
dimethylphenyl)-3-oxobutanamide 31b (0.226 g, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
32e was isolated as a orange solid (0.325 g, 93%), mp 141-143 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.25 (s, 3H, CH3), 2.27 (s, 
3H, CH3), 2.38 (s, 3H, CH3), 6.86-6.98 (m, 2H, HAr), 7.07-7.11 (m, 
2H, HAr), 7.42 (td, 3J = 7.8 Hz, 4J = 1.6 Hz, 1H, HAr), 7.54-7.60 (m, 2H, HAr), 7.75 (s, 1H, 4-
HAr), 10.15, 10.70 (both s, 2H, OH and NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 17.3 (CH3), 
20.4 (CH3), 27.0 (CH3), 103.1, 116.9, 118.9, 120.6, 123.1, 123.9, 127.3, 128.6, 129.7, 131.3, 
132.4, 133.1, 134.4, 141.5, 157.6, 159.7, 180.5 (C=O), 193.3 (C=O); MS (GC, 70 eV) m/z (%): 
349 ([M]+, 61), 229 (18), 200 (19), 121 (100), 105 (12), 77 (12), 65 (12), 43 (10); HRMS (EI): 
calcd for C21H19NO4 ([M]+) 349.13086, found 349.13057; IR (ATR, cm–1): ~ν  = 3097 (w), 3042 
OH O
O
NH
O
H3C
Ph
OH O
O
NH
O
H3C
CH3
CH3
 Supplement 1. Experimental part 
 
 
 
 
 180
(w), 3012 (w), 2959 (w), 2919 (w), 2853 (w), 2731 (w), 1650 (m), 1606 (m), 1565 (m), 1526 (s), 
1481 (s), 1435 (m), 1392 (w), 1376 (w), 1349 (m), 1293 (m), 1285 (m), 1264 (w), 1231 (s), 1205 
(ss), 1177 (m), 1152 (s), 1134 (m), 1116 (m), 1034 (m), 1018 (m), 956 (m), 932 (m), 889 (m), 
866 (w), 842 (s), 805 (s),796 (s), 775 (m),754 (s), 726 (s), 696 (s), 672 (s), 625 (s), 583 (s), 547 
(s). 
 
1-{2-[(2,4-Dimethylphenyl)amino]-5-[(2-hydroxy-4-methoxyphenyl)carbonyl]-furan-3-
yl}ethan-1-one (32f):  
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 
1.0 mmol), N-(2,4-dimethylphenyl)-3-oxobutanamide 31b 
(0.226 g, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-
dioxane (6-7 mL), the product 32f was isolated as a braun 
solid (0.262 g, 69%), mp 137-139 ºC; 
1H NMR (300 MHz,CDCl3): δ = 2.33 (s, 3H, СH3), 2.37 (s, 
3H, CH3), 2.45 (s, 3H, CH3), 3.85 (s, 3H, OCH3), 6.42-6.47 (m, 2H, HAr), 7.08-7.10 (m, 2H, 
HAr), 7.60 (s, 1H, 4-HAr), 7.69 (d, 3J = 7.8 Hz, 1H, HAr), 8.02 (d, 3J = 9.0 Hz, 1H, HAr), 10.16, 
12.84 (both s, 2H, OH and NH); 13C NMR (125.8 MHz, CDCl3): δ = 17.7 (CH3), 20.8 (CH3), 
26.9 (CH3), 55.5 (OCH3), 101.1, 103.2, 107.7, 112.4, 119.6, 121.9, 127.7, 127.8, 131.7, 131.9, 
132.4, 134.8, 141.8, 160.0, 165.6, 166.2, 181.1 (C=O), 193.3 (C=O); MS (GC, 70 eV) m/z (%): 
379 ([M]+, 22), 217 (20), 151 (20), 121 (100); HRMS (EI): calcd for C22H21NO5 ([M]+) 
379.14142, found 379.14136; IR (ATR, cm–1): ~ν  = 3012 (w), 2971 (w), 2920 (w), 2850 (w), 
1725 (w), 1710 (w), 1689 (w), 1642 (m), 1607 (m), 1572 (m), 1530 (s), 1502 (m), 1484 (m), 
1469 (m), 1442 (m), 1412 (w), 1369 (m), 1355 (m), 1329 (w), 1294 (w), 1243 (s), 1207 (s), 1184 
(m), 1162 (w), 1129 (s), 1021 (w), 950 (m), 932 (w), 877 (w), 867 (w), 851 (w), 829 (m), 800 
(m), 757 (w), 729 (m), 691 (m), 632 (s), 614 (w), 585 (m), 551 (w). 
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1-{2-[(2,4-Dimethylphenyl)amino]-5-[(1-hydroxynaphthalen-2-yl)carbonyl]furan-3-
yl}ethan-1-one (32g):  
Starting with 3-chlorobenzo[h]chromone 11c (0.231 g, 1.0 
mmol), N-(2,4-dimethylphenyl)-3-oxobutanamide 31b (0.226 
g, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane 
(6-7 mL), the product 32g was isolated as a yellow solid 
(0.303 g, 76%), mp 161-163 ºC; 
1H NMR (300 MHz, CDCl3): δ = 2.36 (s, 3H, CH3), 2.40 (s, 
3H, CH3), 2.48 (s, 3H, CH3), 7.10 (s, 1H, 3′′-HAr), 7.15 (d, 3J = 8.1 Hz, 1H, HAr), 7.28 (d, 3J = 8.1 
Hz, 1H, HAr), 7.54 (dt, 3J = 6.9 Hz, 5J = 0.9 Hz, 1H, HAr), 7.63 (dt, 3J = 8.1 Hz, 4J = 1.2 Hz, 1H, 
HAr), 7.70 (s, 1H, 4-HAr), 7.76-7.80 (m, 2H, HAr), 8.06 (d, 3J = 9.0 Hz, 1H, HAr), 8.48 (d, 3J = 8.3 
Hz, 1H, HAr), 10.20, 14.12 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, CDCl3): δ = 17.8 
(CH3), 20.9 (CH3), 27.0 (CH3), 103.5, 112.0, 118.2, 119.6, 122.7, 124.4, 124.7, 125.5, 125.9, 
127.3, 127.7, 127.8, 130.0, 131.7, 132.4, 134.8, 136.8, 141.9, 160.1, 163.6, 182.0 (C=O), 193.4 
(C=O); MS (EI, 70 eV) m/z (%): 399 ([M]+, 52), 237 (16), 230 (12), 229 (93), 200 (10), 171 (12), 
121 (100); HRMS (EI): calcd for C25H21NO4 ([M]+) 399.14651, found 399.14623; IR (ATR, cm–
1): ~ν  = 3118 (w), 3051 (w), 3015 (w), 2972 (w), 2922 (w), 2860 (w), 1642 (m), 1626 (m), 1611 
(w), 1601 (w), 1568 (m), 1528 (s), 1503 (m), 1482 (w), 1461 (s), 1420 (m), 1376 (m), 1354 (m), 
1328 (w), 1271 (w), 1244 (s),1205 (s), 1150 (m), 1130 (m), 1117 (m), 1098 (m), 1061 (w), 1025 
(w), 999 (w), 958 (m), 931 (w), 920 (w), 874 (m), 802 (m), 787 (s), 754 (s), 732 (m), 716 (m), 
660 (w), 631 (s), 587 (w), 572 (m), 551 (w). 
 
1-{5-[(2-Hydroxyphenyl)carbonyl]-2-[(2-methylphenyl)amino]furan-3-yl}ethan-1-one 
(32h):  
Starting with 3-chlorochromone 11a (0.181 g, 1.0 mmol), N-(2-
methylphenyl)-3-oxobutanamide 31c (0.210 g, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
32h was isolated as a yellow solid (0.285 g, 85%), mp 109-111 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.31 (s, 3H, CH3), 2.41 (s, 
3H, CH3), 6.89-6.99 (m, 2H, HAr), 7.14 (td, 3J = 7.4 Hz, 4J = 1.1 Hz, 1H, HAr), 7.27-7.34 (m, 2H, 
HAr), 7.42 (td, 3J = 7.7 Hz, 4J = 1.7 Hz, 1H, HAr), 7.59 (dd, 3J = 7.7 Hz, 4J = 1.7 Hz, 1H, HAr), 
7.72 (d, 3J = 8.00 Hz, 1H, HAr), 7.78 (s, 1H, 4-HAr), 10.23, 10.66 (both s, 2H, OH and NH); 13C 
NMR (75.5 MHz, DMSO-d6): δ = 17.3 (CH3), 27.0 (CH3), 103.2, 116.9, 118.9, 120.3, 123.2, 
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123.6, 125.0, 127.0, 128.5, 129.6, 130.8, 133.1, 135.0, 141.7, 157.5, 159.5, 180.6 (C=O), 193.5 
(C=O); MS (GC, 70 eV) m/z (%): 335 ([M]+, 62), 215 (18), 186 (28), 144 (17), 121 (18), 107 
(100), 91 (31), 65 (27), 43 (14); HRMS (EI): calcd for C20H17NO4 ([M]+) 335.11521, found 
335.11497; IR (ATR, cm–1): ~ν  = 3145 (w), 2969 (w), 2734 (w), 1641 (s), 1615 (m), 1594 (s), 
1577 (m), 1538 (s), 1481 (s), 1440 (m), 1403 (m), 1379 (w), 1348 (m), 1324 (m), 1295 (s), 1237 
(s), 1216 (s), 1187 (m), 1151 (s), 1112 (m), 1033 (w), 996 (w), 968 (m), 957 (m), 899 (w), 862 
(m), 824 (m), 794 (w), 781 (w), 752 (s), 734 (s), 699 (s), 678 (m), 653 (s), 631 (s), 591 (m), 573 
(m), 558 (w).    
 
1-{5-[(5-Chloro-2-hydroxy-4-methylphenyl)carbonyl]-2-[(2-methylphenyl)amino]furan-3-
yl}ethan-1-one (32i):  
Starting with 3-bromo-6-chloro-7-methylchromone 10c 
(0.274 g, 1.0 mmol), N-(2-methylphenyl)-3-oxobutan-amide 
31c (0.210 g, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 
1,4-dioxane (6-7 mL), the product 32i was isolated as a 
yellow solid (0.379 g, 99%), mp 166-167 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.31 (s, 6H, 2ˣCH3), 2.40 (s, 3H, CH3), 6.94 (s, 1H, 3′-HAr), 
7.14 (t, 3J = 6.7 Hz, 1H, HAr), 7.31 (m, 2H, HAr), 7.58 (s, 1H, 6′-HAr), 7.70 (d, 3J = 7.6 Hz, 1H, 
HAr), 7.84 (s, 1H, 4-HAr), 10.24, 10.84 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, DMSO-
d6): δ = 17.3 (CH3), 19.9 (CH3), 27.1 (CH3), 103.3, 119.3, 120.5, 122.5, 123.0, 124.1, 125.2, 
127.0, 128.7, 129.2, 130.9, 134.9, 140.7, 141.7, 156.2, 159.6, 178.7 (C=O), 193.5 (C=O); MS 
(GC, 70 eV) m/z (%): 383 ([M]+, 33), 215 (29), 186 (18), 169 (12), 144 (12), 107 (100), 91 (27), 
77 (13), 65 (11), 43 (13); HRMS (ESI): calcd for C21H1935ClNO4 ([M+H]+) 384.09971, found 
384.09934, calcd for C21H1937ClNO4 ([M+H]+) 386.09763, found 386.09792; IR (ATR, cm–1): ~ν  
= 3140 (w), 3113 (w), 3027 (w), 2918 (w), 2858 (w), 1641 (s), 1621 (m), 1597 (m), 1574 (m), 
1531 (s), 1505 (m), 1479 (m), 1464 (m), 1415 (w), 1372 (m), 1344 (m), 1323 (m), 1307 (m), 
1247 (s), 1227 (s), 1178 (m), 1168 (m), 1112 (m), 1049 (w), 1021 (w), 1001 (w), 958 (m), 947 
(m), 870 (w), 847 (m), 807 (m), 778 (w), 743 (w), 690 (m), 647 (m), 622 (m), 599 (m), 555 (w), 
536 (m). 
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1-{5-[(2-Hydroxy-4-methoxyphenyl)carbonyl]-2-[(2-methylphenyl)amino]furan-3-yl}ethan-
1-one (32j):  
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 
1.0 mmol), N-(2-methylphenyl)-3-oxobutanamide 31c 
(0.210 g, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-
dioxane (6-7 mL), the product 32j was isolated as a yellow 
solid (0.358 g, 98%), mp 156-158 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.32 (s, 3H, СH3), 2.45 (s, 3H, CH3), 3.82 (s, 3H, OCH3), 
6.48-6.51 (m, 2H, HAr), 7.14 (t, 3J = 8.1 Hz, 1H, HAr), 7.31 (t, 3J = 7.5 Hz, 2H, HAr), 7.71 (d, 3J = 
7.8 Hz, 1H, HAr), 7.85 (d, 3J = 8.7 Hz, 1H, HAr), 7.98 (s, 1H, 4-HAr), 10.22, 12.11 (both s, 2H, 
OH and NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 17.6 (CH3), 27.3 (CH3), 55.8 (OCH3), 
101.5, 103.4, 107.0, 113.6, 121.0, 123.8, 125.4, 127.2, 129.1, 131.0, 132.2, 135.2, 141.0, 160.0, 
163.4, 164.7, 180.3 (C=O), 193.6 (C=O); MS (GC, 70 eV) m/z (%): 365 ([M]+, 32), 258 (18), 
217 (19), 186 (11), 151 (25), 144 (12), 107 (100), 91 (25), 65 (13), 43 (12); HRMS (ESI): calcd 
for C21H20NO5 ([M+H]+) 366.13360, found 366.13368, calcd for C21H19NaNO5 ([M+Na]+) 
388.11554, found 388.11563; IR (ATR, cm–1): ~ν   = 3100 (w), 3031 (w), 3014 (w), 2985 (w), 
2951 (w), 2917 (w), 2894 (w), 2849 (w), 1639 (s), 1617 (m), 1592 (s), 1574 (s), 1556 (w), 1528 
(s), 1503 (s), 1475 (m), 1462 (s), 1430 (m), 1397 (w), 1359 (s), 1322 (m), 1307 (w), 1296 (w), 
1254 (s), 1229 (s), 1202 (s), 1183 (m), 1172 (s), 1140 (s), 1128 (s), 1107 (s), 1062 (w), 1048 (w), 
1024 (s), 960 (m), 948 (m), 878 (w), 851 (m), 835 (s), 809 (w), 799 (m), 780 (w), 744 (s), 729 
(s), 686 (s), 647 (m), 631 (s), 599 (m), 555 (m), 526 (m). 
 
1-{5-[(1-Hydroxynaphthalen-2-yl)carbonyl]-2-[(2-methylphenyl)amino]furan-3-yl}-ethan-
1-one (32k):  
Starting with 3-chlorobenzo[h]chromone 11c (0.231 g, 1.0 
mmol), N-(2-methylphenyl)-3-oxobutanamide 31c (0.210 g, 
1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 
mL), the product 32k was isolated as a yellow solid (0.358 g, 
93%), mp 166-168 ºC; 
1H NMR (300 MHz, CDCl3): δ = 2.44 (s, 3H, CH3), 2.48 (s, 3H, CH3), 7.14 (t, 3J = 7.5 Hz, 1H, 
HAr), 7.26-7.30 (m, 2H, HAr), 7.35 (t, 3J = 7.5 Hz, 1H, HAr), 7.50-7.56 (m, 1H, HAr), 7.60-7.65 
(m, 1H, HAr), 7.69 (s, 1H, 4-HAr), 7.74 (d, 3J = 7.8 Hz, 1H, HAr), 7.92 (d, 3J = 8.1 Hz, 1H, HAr), 
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8.03 (d, 3J = 9.0 Hz, 1H, HAr), 8.46 (d, 3J = 8.1 Hz, 1H, HAr), 10.31, 14.12 (both s, 2H, OH and 
NH); 13C NMR (62.9 MHz, CDCl3): δ = 17.6 (CH3), 26.8 (CH3), 103.4, 111.7, 118.0, 119.1, 
122.3, 124.1, 124.4, 124.7, 125.2, 125.7, 127.1, 127.1, 127.3, 129.8, 130.8, 134.8, 136.6, 141.8, 
159.6, 163.4, 182.1 (C=O), 193.3 (C=O); MS (EI, 70 eV) m/z (%): 385 ([M]+, 53), 237 (15), 216 
(11), 215 (96), 186 (12), 171 (17), 170 (11), 152 (39), 151 (40), 144 (11), 137 (14), 123 (18), 115 
(12), 107 (100), 98 (12), 96 (17), 91 (16), 69 (15), 43 (10), 41 (10); HRMS (EI): calcd for 
C24H19NO4 ([M]+) 385.13086, found 385.13065; IR (ATR, cm–1): ~ν  = 3122 (w), 3067 (w), 2915 
(w), 2859 (w), 1643 (s), 1619 (m), 1594 (m), 1573 (m), 1524 (s), 1459 (s), 1415 (m), 1375 (m), 
1356 (m), 1328 (w), 1294 (w), 1265 (m), 1243 (s), 1229 (s), 1209 (m), 1194 (m), 1177 (w), 1148 
(m), 1129 (m), 1111 (m), 1096 (w), 1050 (w), 1023 (w), 998 (w), 958 (m), 911 (m), 867 (m), 809 
(w), 797 (m), 790 (m), 775 (m), 755 (s), 732 (s), 721 (s), 694 (w), 660 (w), 644 (s), 626 (m), 572 
(m), 544 (m). 
 
1-{2-[(4-Chlorophenyl)amino]-5-[(2-hydroxyphenyl)carbonyl]furan-3-yl}ethan-1-one (32l):  
Starting with 3-iodochromone 9a (0.272 g, 1.0 mmol), N-(4-
chlorophenyl)-3-oxobutanamide 31d (0.233 g, 1.1 mmol) and DBU 
(0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 32l was 
isolated as a braun solid (0.163 g, 46%), mp 175-177 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.39 (s, 3H, CH3), 6.91-7.00 (m, 
2H, HAr), 7.42-7.45 (m, 3H, HAr), 7.58-7.60 (m, 3H, HAr), 7.77 (s, 1H, 
4-HAr), 10.24, 10.64 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 27.3 
(CH3), 103.8, 116.9, 118.9, 2ˣ121.7, 123.2, 123.4, 128.2, 2ˣ129.0, 129.7, 133.2, 135.8, 141.8, 
157.4, 158.2, 180.7 (C=O), 192.9 (C=O); MS (GC, 70 eV) m/z (%): 355 ([M]+, 44), 235 (24), 
206 (22), 187 (26), 164 (35), 127 (100), 111 (13), 65 (18), 43 (30); HRMS (ESI): calcd for 
C19H1535ClNO4 ([M+H]+) 356.06841, found 356.06842, calcd for C19H1537ClNO4 ([M+H]+) 
358.06621, found 358.06626; IR (ATR, cm–1): ~ν  = 3237 (w), 3196 (w), 3154 (w), 3099 (w), 
3054 (w), 1643 (w), 1615 (m), 1587 (w), 1574 (m), 1557 (w), 1526 (s), 1505 (m), 1479 (s), 1435 
(m), 1417 (m), 1385 (w), 1337 (m), 1295 (m), 1282 (m), 1241 (m), 1229 (m), 1203 (m), 1181 
(m), 1155 (s), 1093 (m), 1062 (w), 1034 (w), 1014 (w), 958 (m), 891 (m), 864 (w), 852 (w), 836 
(m), 808 (s), 755 (s), 725 (s), 697 (s), 671 (s), 633 (m), 617 (s), 592 (m), 567 (s), 529 (s). 
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1-{2-[(4-Chlorophenyl)amino]-5-[(2-hydroxy-5-methylphenyl)carbonyl]furan-3-yl}-ethan-
1-one (32m):  
Starting with 3-bromo-6-methylchromone 10b (0.239 g, 1.0 mmol), 
N-(4-chlorophenyl)-3-oxobutanamide 31d (0.233 g, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 32m 
was isolated as a yellow solid (0.365 g, 99%), mp 188-190 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.24 (s, 3H, CH3), 2.39 (s, 3H, 
CH3), 6.88 (d, 3J = 8.3 Hz, 1H, HAr), 7.22 (d, 3J = 8.1 Hz, 1H, HAr), 
7.40-7.43 (m, 3H, HAr), 7.57-7.59 (m, 2H, HAr), 7.78 (s, 1H, 4-HAr), 10.24, 10.61 (both s, 2H, 
OH and NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 19.9 (CH3), 27.3 (CH3), 103.7, 116.8, 
2ˣ121.8, 123.3, 127.6, 128.2, 2ˣ129.0, 129.6, 134.1, 135.8, 141.9, 155.6, 155.7, 158.2, 180.8 
(C=O), 192.9 (C=O); MS (GC, 70 eV) m/z (%): 369 ([M]+, 58), 242 (13), 237 (20), 235 (57), 227 
(10), 206 (23), 201 (27), 166 (14), 164 (45), 135 (48), 127 (100), 111 (21), 107 (11), 77 (38), 75 
(15), 69 (16), 53 (11), 43 (47);  HRMS (EI): calcd for C20H1635ClNO4 ([M]+) 369.07624, found 
369.07589, calcd for C20H1637ClNO4 ([M]+) 371.07329, found 371.07380; IR (ATR, cm–1): ~ν  = 
3233 (w), 3190 (w), 2917 (w), 2859 (w), 2710 (w), 1643 (w), 1608 (m), 1567 (m), 1520 (s), 
1478 (s), 1418 (m), 1384 (m), 1341 (s), 1324 (s), 1291 (m), 1284 (m), 1253 (m), 1244 (m), 1230 
(s), 1213 (s), 1201 (s), 1161 (s), 1107 (m), 1092 (s), 1061 (m), 1027 (w), 1011 (m), 978 (w), 961 
(m), 913 (w), 889 (w), 870 (w), 800 (s), 762 (m), 738 (s), 697 (m), 679 (s), 635 (m), 619 (s), 588 
(m), 573 (m), 549 (m). 
 
1-{5-[(5-Chloro-2-hydroxy-4-methylphenyl)carbonyl]-2-[(4-chlorophenyl)amino]furan-3-
yl}ethan-1-one (32n):  
Starting with 3-bromo-6-chloro-7-methylchromone 10c (0.274 
g, 1.0 mmol), N-(4-chlorophenyl)-3-oxobutanamide 31d (0.233 
g, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 
mL), the product 32n was isolated as a yellow solid (0.395 g, 
98%), mp 214-216 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.32 (s, 3H, CH3), 2.40 (s, 
3H, CH3), 6.96 (s, 1H, 3′-HAr), 7.43-7.48 (m, 2H, HAr), 7.57-7.61 (m, 3H, HAr), 7.83 (s, 1H, 4-
HAr), 10.27, 10.78 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 19.9 (CH3), 
27.3 (CH3), 103.9, 119.2, 2ˣ122.0, 122.7, 123.01, 123.9, 128.4, 2ˣ129.1, 129.2, 135.7, 140.7, 
141.8, 156.1, 158.4, 178.8 (C=O), 192.9 (C=O); MS (GC, 70 eV) m/z (%): 403 ([M]+, 42), 237 
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(25), 236 (10), 235 (74), 206 (30), 169 (26), 166 (12), 164 (32), 129 (32), 127 (100), 111 (14), 77 
(20), 75 (11), 69 (12), 43 (30); HRMS (ESI): calcd for C20H1635Cl2NO4 ([M+H]+) 404.04509, 
found 404.04507, calcd for C20H1637Cl2NO4 ([M+H]+) 406.04256, found 406.04260; IR (ATR, 
cm–1): ~ν  = 3242 (w), 3196 (w), 3109 (w), 2979 (w), 2919 (w), 2855 (w), 1641 (m), 1621 (m), 
1573 (m), 1525 (s), 1494 (s), 1373 (m), 1340 (s), 1310 (m), 1247 (s), 1202 (s), 1167 (s), 1118 
(m), 1092 (m), 1061 (w), 1011 (m), 968 (w), 947 (m), 880 (w), 842 (m), 803 (m), 742 (m), 690 
(m), 634 (w), 618 (m), 592 (m), 546 (m). 
 
1-{2-[(4-Chlorophenyl)amino]-5-[(2-hydroxy-4-methoxyphenyl)carbonyl]furan-3-yl}-ethan-
1-one (32o):  
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), N-(4-chlorophenyl)-3-oxobutanamide 31d (0.233 g, 
1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 
mL), the product 32o was isolated as a yellow solid (0.181 g, 
47%), mp 187-189 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.43 (s, 3H, CH3), 3.83 (s, 
3H, OCH3), 6.52-6.56 (m, 2H, HAr), 7.46 (d, 3J = 8.7 Hz, 2H, HAr), 7.59 (d, 3J = 9.0 Hz, 2H, 
HAr), 7.87 (d, 3J = 8.4 Hz, 1H, HAr), 7.95 (s, 1H, 4-HAr), 10.25, 12.08 (both s, 2H, OH and NH); 
13C NMR (62.9 MHz, DMSO-d6): δ = 27.5 (CH3), 55.8 (OCH3), 101.5, 104.0, 107.0, 113.6, 
2ˣ122.1, 123.6, 128.5, 2ˣ129.3, 132.2, 136.0, 141.1, 158.3, 163.3, 164.8, 180.4 (C=O), 193.1 
(C=O); MS (GC, 70 eV) m/z (%): 385 ([M]+, 37), 258 (100), 243 (40), 235 (12), 217 (46), 206 
(15), 188 (12), 166 (11), 164 (35), 151 (53), 129 (23), 127 (63), 111 (16), 75 (10), 69 (17), 43 
(29); HRMS (ESI): calcd for C20H1735ClNO5 ([M+H]+) 386.07898, found 386.07883, calcd for 
C20H1737ClNO5 ([M+H]+) 388.07688, found 388.07679; IR (ATR, cm–1): ~ν  = 3231 (w), 3119 
(w), 3008 (w), 2916 (w), 2849 (w), 1643 (m), 1618 (m), 1573 (m), 1525 (s), 1500 (s), 1438 (m), 
1418 (w), 1374 (m), 1351 (m), 1320 (w), 1296 (w), 1245 (s), 1205 (s), 1183 (m), 1136 (s), 1110 
(m), 1091 (m), 1061 (w), 1027 (w), 1021 (w), 1013 (w), 952 (s), 881 (w), 834 (s), 806 (m), 757 
(w), 722 (m), 706 (w), 694 (w), 694 (m), 675 (w), 638 (m), 619 (m), 593 (w), 562 (s), 528 (w). 
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1-{2-[(4-Chlorophenyl)amino]-5-[(1-hydroxynaphthalen-2-yl)carbonyl]furan-3-yl}ethan-1-
one (32p):  
Starting with 3-iodobenzo[h]chromone 9b (0.322 g, 1.0 mmol), 
N-(4-chlorophenyl)-3-oxobutanamide 31d (0.233 g, 1.1 mmol) 
and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the 
product 32p was isolated as a yellow solid (0.227 g, 56%), mp 
230-232 ºC; 
1H NMR (300 MHz, CDCl3): δ = 2.45 (s, 3H, CH3), 7.27-7.40 
(m, 3H, HAr), 7.45-7.48 (m, 2H, HAr), 7.53 (t, 3J = 7.7 Hz, 1H, HAr), 7.61-7.64 (m, 2H, HAr), 7.77 
(d, 3J = 8.0 Hz, 1H, HAr), 7.98 (d, 3J = 8.8 Hz, 1H, HAr), 8.46 (d, 3J = 8.3 Hz, 1H, HAr), 10.19, 
13.92 (both s, 2H, OH and NH); 13C NMR (62.3 MHz, CDCl3): δ = 27.1 (CH3), 103.6, 111.9, 
118.3, 2ˣ120.4, 122.3, 124.3, 124.4, 125.4, 126.0, 127.3, 2ˣ129.7, 129.9, 130.2, 135.0, 136.9, 
142.1, 159.1, 163.5, 182.2 (C=O), 193.6 (C=O); MS (EI, 70 eV) m/z (%): 405 ([M]+, 32), 278 
(28), 263 (14), 235 (100), 171 (42), 164 (21), 127 (47), 115 (17), 110 (15), 43 (11); HRMS 
(ESI): calcd for C23H1635ClNO4 ([M-H]-) 404.06951, found 404.07002, calcd for C23H1637ClNO4 
([M-H]-) 406.06755, found 406.06784; IR (ATR, cm–1): ~ν  = 3240 (w), 3119 (w), 3049 (w), 2961 
(w), 2923 (w), 2853 (w), 1731 (w), 1651 (m), 1620 (m), 1575 (m), 1537 (s), 1494 (m), 1464 (m), 
1422 (m), 1385 (m), 1349 (m), 1317 (w), 1271 (m), 1253 (s), 1209 (m), 1181 (w), 1150 (m), 
1094 (m), 1062 (w), 1027 (w), 1016 (w), 1004 (m), 962 (m), 925 (w), 863 (m), 803 (s), 787 (m), 
751 (m), 723 (m), 712 (m), 691 (w), 650 (w), 637 (m), 619 (m), 571 (m), 547 (m).  
 
Methyl 2-amino-5-[(2-hydroxyphenyl)carbonyl]furan-3-carboxylate (32q): 
Starting with 3-chlorochromone 11a (0.181 g, 1.0 mmol), methyl 2-
carbamoylacetate 31e (0.129 g, 1.1 mmol) and DBU (0.20 mL, 1.3 
mmol) in 1,4-dioxane (6-7 mL), the product 32q was isolated as a yellow 
solid (0.128 g, 49%), mp 142-144 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.70 (s, 3H, OCH3), 6.87-6.95 (m, 2H, HAr), 7.18 (s, 1H, 4-
HAr), 7.38 (td, 3J = 7.7 Hz, 4J = 1.7 Hz, 1H, HAr), 7.53 (dd, 3J = 7.7 Hz, 4J = 1.6 Hz, 1H, HAr), 
8.09 (s, 2H, NH2), 10.59 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 50.9 (OCH3), 91.2, 
116.8, 118.9, 123.4, 125.2, 129.5, 132.8, 140.7, 157.2, 163.2, 164.6, 179.7 (C=O); MS (GC, 70 
eV) m/z (%): 261 ([M]+, 33), 244 (100), 213 (20), 184 (10), 158 (21), 141 (23), 121 (42), 109 
(28), 93 (11), 65 (22), 52 (19), 39 (11); HRMS (EI): calcd for C13H11NO5 ([M]+) 261.06317, 
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found 261.06323; IR (ATR, cm–1): ~ν  = 3370 (w), 3307 (w), 3244 (w), 3174 (w), 1699 (m), 1668 
(m), 1628 (w), 1568 (m), 1557 (m), 1537 (s), 1470 (m), 1427 (w), 1372 (m), 1315 (m), 1287 (m), 
1247 (s), 1223 (s), 1182 (m), 1150 (s), 1115 (m), 1093 (m), 1041 (m), 962 (w), 947 (w), 893 (m), 
876 (w), 865 (w), 821 (w), 806 (m), 777 (m), 738 (s), 708 (m), 695 (m), 668 (m), 627 (s), 580 
(m). 
 
Methyl 2-amino-5-[(2-hydroxy-5-methylphenyl)carbonyl]furan-3-carboxylate (32r):  
Starting with 3-bromo-6-methylchromone 10b (0.239 g, 1.0 mmol), 
methyl 2-carbamoylacetate 31e (0.129 g, 1.1 mmol) and DBU (0.20 mL, 
1.3 mmol) in 1,4-dioxane (6-7 mL), the product 32r was isolated as a 
yellow solid (0.248 g, 90%), mp 111-113 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.24 (s, 3H, CH3), 3.70 (s, 3H, OCH3), 6.82 (d, 3J = 8.3 Hz, 
1H, 3′-HAr), 7.17-7.19 (m, 2H, 4′,6′-HAr), 7.32 (s, 1H, 4-HAr), 8.08 (s, 2H, NH2), 10.38 (s, 1H, 
OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 20.0 (CH3), 50.9 (OCH3), 91.1, 116.7, 123.1, 125.1, 
127.6, 129.4, 133.4, 140.7, 155.0, 163.3, 164.6, 179.9 (C=O); MS (GC, 70 eV) m/z (%): 275 
([M]+, 38), 258 (100), 230 (17), 227 (18), 172 (15), 141 (40), 135 (64), 109 (36), 107 (13), 77 
(31), 52 (23); HRMS (EI): calcd for C14H13NO5 ([M]+) 275.07882, found 275.07859; IR (ATR, 
cm–1): ~ν  = 3418 (w), 3368 (w), 3307 (w), 3242 (w), 3152 (w), 2952 (w), 2922 (w), 2860 (w), 
1699 (m), 1682 (w), 1674 (w), 1668 (w), 1651 (w), 1627 (m), 1615 (m), 1574 (s), 1568 (s), 1557 
(s), 1538 (s), 1531 (s), 1526 (s), 1520 (s), 1480 (s), 1428 (m), 1408 (w), 1371 (w), 1345 (w), 
1307 (w), 1285 (s), 1245 (m), 1226 (s), 1165 (s), 1141 (s), 1125 (s), 1090 (m), 1044 (m), 953 
(w), 919 (w), 868 (w), 851 (w), 820 (m), 810 (m), 774 (s), 734 (m), 709 (m), 697 (m), 678 (s), 
574 (m), 534 (s). 
 
Methyl 2-amino-5-[(2-hydroxy-4-methoxyphenyl)carbonyl]furan-3-carboxylate (32s):  
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), methyl 2-carbamoylacetate 31e (0.129 g, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
32s was isolated as a braun solid (0.230 g, 79%), mp 116-118 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 3.72 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 6.47-6.53 (m, 2H, 
3 ′,5 ′-HAr), 7.42 (s, 1H, 4-HAr), 7.87 (d, 3J = 8.6 Hz, 1H, 6′-HAr), 8.08 (s, 2H, NH2), 12.25 (s, 1H, 
OH); 13C NMR (62.3 MHz, DMSO-d6): δ = 50.9 (OCH3), 55.5 (OCH3), 91.4, 101.3, 106.8, 
113.4, 124.6, 131.9, 140.0, 163.2, 163.3, 164.3, 164.4, 179.6 (C=O); MS (GC, 70 eV) m/z (%): 
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291 ([M]+, 30), 274 (100), 259 (11), 246 (26), 243 (24), 231 (18), 188 (12), 151 (46), 109 (13), 
108 (10), 52 (13); HRMS (EI): calcd for C14H13NO6 ([M]+) 291.07374, found 291.07358; IR 
(ATR, cm–1): ~ν  = 3365 (w), 3308 (w), 3234 (w), 3171 (w), 2949 (w), 2843 (w), 2207 (w), 1697 
(w), 1672 (w), 1613 (m), 1566 (m), 1529 (s), 1503 (m), 1468 (m), 1453 (w), 1432 (m), 1373 (w), 
1328 (w), 1314 (w), 1293 (w), 1251 (s), 1230 (s), 1209 (s), 1185 (s), 1160 (s), 1121 (s), 1097 (s), 
1050 (m), 1022 (m), 969 (w), 884 (w), 870 (w), 819 (m), 807 (m), 778 (m), 756 (w), 738 (m), 
706 (m), 693 (m), 665 (w), 642 (w), 618 (s), 580 (s), 558 (s). 
 
Methyl 2-amino-5-[(1-hydroxynaphthalen-2-yl)carbonyl]furan-3-carboxylate (32t):  
Starting with 3-chlorobenzo[h]chromone 11c (0.231 g, 1.0 mmol), 
methyl 2-carbamoylacetate 31e (0.129 g, 1.1 mmol) and DBU (0.20 
mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 32t was 
isolated as a yellow solid (0.274 g, 88%), mp 192-194 ºC; 
1H NMR (300 MHz, CDCl3): δ = 3.85 (s, 3H, OCH3), 6.32 (s, 2H, NH2), 7.26 (d, 3J = 9.0 Hz, 
1H, HAr), 7.49-7.54 (m, 1H, HAr), 7.56 (s, 1H, 4-HAr), 7.58-7.63 (m, 1H, HAr), 7.74 (d, 3J = 7.8 
Hz, 1H, HAr), 7.86 (d, 3J = 9.0 Hz, 1H, HAr), 8.43 (d, 3J = 8.1 Hz, 1H, HAr), 13.78 (s, 1H, OH); 
13C NMR (62.9 MHz, CDCl3): δ = 51.7 (OCH3), 93.6, 112.1, 118.5, 2ˣ124.5, 124.8, 125.6, 126.1, 
127.5, 130.1, 137.0, 141.3, 163.1, 164.0, 164.7, 182.5 (C=O); MS (EI, 70 eV) m/z (%): 311 
([M]+, 59), 295 (21), 294 (100), 266 (15), 263 (23), 197 (25), 196 (24), 171 (59), 170 (45), 142 
(10), 141 (88), 115 (24), 114 (29), 109 (52); HRMS (EI): calcd for C17H13NO5 ([M]+) 311.07882, 
found 311.07879; IR (ATR, cm–1): ~ν  = 3435 (w), 3422 (w), 3310 (w), 3258 (w), 3151 (w), 3055 
(w), 2948 (w), 1693 (m), 1623 (m), 1600 (w), 1564 (m), 1536 (m), 1479 (w), 1454 (s), 1427 (m), 
1413 (m), 1385 (w), 1317 (w), 1268 (s), 1251 (s), 1210 (m), 1163 (s), 1148 (s), 1105 (m), 1023 
(m), 978 (w), 914 (w), 871 (w), 837 (w), 805 (w), 792 (s), 761 (s), 737 (s), 716 (m), 660 (w), 638 
(w), 602 (m), 549 (m), 526 (m). 
 
2-{[4-Benzoyl-5-(phenylamino)furan-2-yl]carbonyl}phenol (32u):  
Starting with 3-chlorochromone 11a (0.181 g, 1.0 mmol), 3-oxo-N,3-
diphenylpropanamide 31f (0.263 g, 1.1 mmol) and DBU (0.20 mL, 1.3 
mmol) in 1,4-dioxane (6-7 mL), the product 32u was isolated as a yellow 
solid (0.241 g, 63%), mp 170-172 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 6.88-6.98 (m, 2H, HAr), 7.21 (t, 3J = 7.4 Hz, 1H, HAr), 7.37-
7.47 (m, 4H, HAr), 7.53-7.66 (m, 6H, HAr), 7.79-7.81 (m, 2H, HAr), 10.54, 10.65 (both s, 2H, OH 
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and NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 101.8, 116.8, 119.0, 2ˣ120.4, 123.2, 123.6, 
124.7, 2ˣ128.0, 2ˣ128.8, 129.3, 2ˣ129.7, 132.0, 133.1, 136.6, 138.4, 142.1, 157.0, 160.6, 180.6 
(C=O), 188.2 (C=O); MS (EI, 70 eV) m/z (%): 383 ([M]+, 44), 291 (13), 263 (18), 234 (14), 171 
(9), 121 (10), 105 (100), 93 (99), 91 (18), 77 (78), 66 (11), 51 (11); HRMS (EI): calcd for 
C24H17NO4 ([M]+) 383.11521, found 383.11551; IR (ATR, cm–1): ~ν  = 3051 (w), 1635 (s), 1599 
(m), 1587 (m), 1578 (m), 1566 (s), 1542 (s), 1499 (m), 1481 (m), 1470 (m), 1445 (m), 1394 (m), 
1351 (w), 1336 (w), 1325 (w), 1299 (m), 1289 (m), 1265 (m), 1245 (s), 1218 (m), 1203 (m), 
1178 (m), 1147 (s), 1137 (m), 1103 (w), 1031 (w), 1000 (w), 972 (m), 937 (m), 923 (w), 890 
(m), 870 (w), 846 (w), 822 (w), 799 (w), 786 (m), 761 (m), 739 (s), 710 (m), 690 (s), 657 (s), 
616 (m), 601 (m), 575 (m), 565 (m), 530 (m). 
 
2-{[4-Benzoyl-5-(phenylamino)furan-2-yl]carbonyl}-4-chloro-5-methylphenol (32v):  
Starting with 3-bromo-6-chloro-7-methylchromone 10c (0.274 g, 
1.0 mmol), 3-oxo-N,3-diphenylpropanamide 31f (0.263 g, 1.1 
mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the 
product 32v was isolated as a yellow solid (0.310 g, 72%), mp 200-
202 ºC; 
1H NMR (250 MHz, CDCl3): δ = 2.40 (s, 3H, CH3), 6.92 (s, 1H, 3′-HAr), 7.21-7.26 (m, 1H, HAr), 
7.47-7.56 (m, 7H, HAr), 7.82-7.84 (m, 3H, HAr), 8.24 (s, 1H, 4-HAr), 10.75, 12.17 (both s, 2H, 
OH and NH); 13C NMR (62.3 MHz, CDCl3): δ = 20.7 (CH3), 102.3, 117.4, 2ˣ119.5, 120.5, 124.2, 
124.3, 125.1, 125.2, 2ˣ128.2, 2ˣ128.8, 2ˣ130.0, 132.2, 136.1, 138.5, 142.4, 144.9, 161.3, 161.6, 
180.8 (C=O), 189.7 (C=O); MS (GC, 70 eV) m/z (%): 431 ([M]+, 52), 263 (51), 234 (17), 169 
(21), 105 (100), 93 (82), 77 (80), 53 (14), 51 (14); HRMS (ESI): calcd for C25H1935ClNO4 
([M+H]+) 432.09971, found 432.09984, calcd for C25H1937ClNO4 ([M+H]+) 434.09789, found 
434.09821; IR (ATR, cm–1): ~ν  = 3234 (w), 3062 (w), 2991 (w), 2949 (w), 2916 (w), 1628 (m), 
1594 (w), 1579 (w), 1525 (s), 1495 (m), 1485 (m), 1471 (m), 1455 (w), 1443 (m), 1385 (w), 
1369 (w), 1331 (m), 1315 (m), 1312 (m), 1248 (m), 1228 (m), 1200 (w), 1170 (s), 1123 (m), 
1114 (m), 1078 (w), 1031 (w), 1014 (w), 1001 (w), 960 (w), 936 (w), 924 (w), 909 (m), 880 (w), 
871 (w), 864 (w), 841 (w), 811 (w), 797 (m), 788 (m), 751 (m), 740 (m), 733 (s), 714 (m), 692 
(s), 681 (s), 665 (m), 652 (s), 637 (s), 609 (m), 596 (s), 578 (m), 546 (s), 528 (s). 
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2-{[4-Benzoyl-5-(phenylamino)furan-2-yl]carbonyl}-5-methoxyphenol (32w):  
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), 3-oxo-N,3-diphenylpropanamide 31f (0.263 g, 1.1 mmol) 
and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the 
product 32w was isolated as a yellow solid (0.285 g, 69%), mp 
181-183 ºC; 
1H NMR (250 MHz, CDCl3): δ = 3.85 (s, 3H, OCH3), 6.42-6.49 (m, 2H, HAr), 7.17-7.24 (m, 1H, 
HAr), 7.42–7.60 (m, 7H, HAr), 7.66 (s, 1H, 4-HAr), 7.79-7.83 (m, 2H, HAr), 8.01 (d, 3J = 8.8 Hz, 
1H, HAr), 10.67, 12.74 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, CDCl3): δ = 55.6 
(OCH3), 101.2, 102.0, 107.7, 112.4, 2ˣ119.5, 122.7, 124.9, 2ˣ128.1, 2ˣ128.7, 2ˣ129.7, 131.9, 
132.0, 136.4, 138.7, 142.2, 161.2, 165.8, 166.2, 181.4 (C=O), 189.6 (C=O); MS (EI, 70 eV) m/z 
(%): 413 ([M]+, 38), 321 (24), 320 (100), 151 (14), 105 (98), 93 (32), 78 (13), 77 (23), 71 (11), 
69 (16), 63 (13), 57 (18), 55 (11), 44 (18), 43 (11); HRMS (EI): calcd for C25H19NO5 ([M]+) 
413.12577, found 413.12575; IR (ATR, cm–1): ~ν  = 3266 (w), 3152 (w), 3106 (w), 3055 (w), 
3014 (w), 2975 (w), 2917 (w), 2847 (w), 1626 (s), 1601 (m), 1579 (m), 1566 (m), 1526 (s), 1500 
(s), 1494 (s), 1469 (m), 1450 (m), 1415 (w), 1362 (m), 1347 (m), 1301 (w), 1249 (s), 1198 (m), 
1185 (s), 1167 (m), 1140 (s), 1127 (s), 1081 (m), 1025 (m), 1002 (w), 983 (w), 959 (w), 949 (w), 
930 (m), 908 (w), 873 (w), 827 (s), 802 (m), 739 (s), 692 (s), 670 (s), 650 (s), 628 (m), 614 (m), 
595 (m), 560 (s), 526 (m). 
 
2-{[4-Benzoyl-5-(phenylamino)furan-2-yl]carbonyl}naphthalen-1-ol (32x):  
Starting with 3-chloro-7-methoxychromone 11c (0.211 g, 1.0 
mmol), 3-oxo-N,3-diphenylpropanamide 31f (0.263 g, 1.1 mmol) 
and DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the product 
32x was isolated as a orange solid (0.303 g, 70%), mp 165-167 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 7.26 (t, 3J = 7.4 Hz, 1H, HAr), 
7.38 (d, 3J = 8.9 Hz, 1H, HAr), 7.49 (t, 3J = 7.9 Hz, 2H, HAr), 7.55-7.65 (m, 4H, HAr), 7.65-7.71 
(m, 3H, HAr), 7.75 (s, 1H, 4-HAr), 7.85-7.91 (m, 3H, HAr), 7.99 (d, 3J = 8.9 Hz, 1H, HAr), 8.32 (d, 
3J = 8.3 Hz, 1H, HAr), 10.73, 13.65 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, DMSO-d6): 
δ = 102.3, 112.6, 118.4, 2ˣ120.9, 123.4, 124.5, 124.7, 125.0, 125.1, 126.1, 127.5, 2ˣ128.2, 
2ˣ128.8, 2ˣ129.3, 129.9, 132.1, 136.2, 136.5, 138.3, 141.1, 160.7, 160.8, 181.2 (C=O), 188.1 
(C=O); MS (EI, 70 eV) m/z (%): 433 ([M]+, 33), 340 (39), 263 (100), 171 (11), 105 (74), 93 (35), 
77 (20); HRMS (ESI): calcd for C28H20NO4 ([M+H]+) 434.13868, found 434.13892, calcd for 
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C28H19NaNO4 ([M+Na]+) 456.12063, found 456.12034; IR (ATR, cm–1): ~ν  = 3275 (w), 3054 
(w), 2921 (w), 2851 (w), 1653 (w), 1626 (w), 1597 (w), 1577 (w), 1565 (w), 1524 (s), 1462 (s), 
1444 (m), 1410 (m), 1381 (m), 1348 (m), 1337 (m), 1320 (m), 1253 (s), 1206 (m), 1177 (m), 
1150 (m), 1125 (m), 1098 (m), 1078 (m), 1026 (m), 995 (m), 941 (m), 930 (m), 917 (m), 891 
(m), 867 (m), 851 (m), 809 (m), 787 (m), 752 (s), 738 (s), 721 (s), 689 (s), 667 (s), 648 (s), 625 
(s), 599 (s), 581 (m), 569 (s), 549 (s).  
 
N-(4-chlorophenyl)-5-[(1-hydroxynaphthalen-2-yl)carbonyl]-2-methylfuran-3-carboxamide 
(33):  
Starting with 3-chloro-7-methoxychromone 11b 
(0.211 g, 1.0 mmol), N-(4-chlorophenyl)-3-
oxobutanamide 31d (0.233 g, 1.1 mmol) and DBU 
(0.20 mL, 1.3 mmol) in 1,4-dioxane (6-7 mL), the 
product 33 was isolated as a pale yellow solid (0.027 g, 7%), mp 214-216 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 2.71 (s, 3H, CH3), 3.84 (s, 3H, OCH3), 6.56 (d, 4J = 2.4 Hz, 
1H, HAr), 6.61 (dd, 3J = 8.9 Hz, 4J = 2.5 Hz, 1H, HAr), 7.40 (dt, 3J = 8.9 Hz, 4J = 2.5 Hz, 2H, 
HAr), 7.76 (dd, 3J = 8.9 Hz, 4J = 2.5 Hz, 2H, HAr), 8.00-8.04 (m, 2H, HAr), 10.07, 11.96 (both s, 
2H, OH and NH); 13C NMR (75.5 MHz, DMSO-d6): δ = 14.0 (CH3), 55.7 (OCH3), 101.3, 107.2, 
113.7, 118.3, 119.7, 2ˣ121.8, 127.4, 2ˣ128.5, 132.6, 137.6, 148.5, 160.6, 162.4, 163.5, 165.1, 
181.9 (C=O); MS (GC, 70 eV) m/z (%): 385 ([M]+, 36), 260 (15), 259 (100), 258 (87), 243 (15), 
217 (24), 151 (47), 129 (15), 127 (42), 109 (99), 108 (10), 43 (14); HRMS (ESI): calcd for 
C20H1735ClNO5 ([M+H]+) 386.07898, found 386.07870, calcd for C20H1737CNO5 ([M+H]+) 
388.07688, found 388.07690; IR (ATR, cm–1): ~ν  = 3325 (w), 3016 (w), 2923 (w), 2851 (w), 
1734 (w), 1713 (w), 1650 (w), 1626 (m), 1606 (m), 1594 (m), 1575 (m), 1531 (m), 1515 (s), 
1495 (m), 1454 (w), 1441 (w), 1403 (w), 1371 (s), 1342 (s), 1314 (m), 1294 (w), 1271 (m), 1255 
(s), 1223 (m), 1213 (m), 1196 (s), 1177 (m), 1157 (w), 1136 (s), 1093 (w), 1082 (m), 1024 (w), 
1016 (m), 999 (m), 962 (s), 894 (w), 874 (m), 853 (m), 835 (s), 815 (s), 760 (m), 735 (w), 711 
(w), 698 (m), 685 (m), 656 (m), 634 (w), 623 (s), 611 (m), 596 (w), 534 (m). 
 
 
 
 
 
OH O
O
H3CO CH3
O
HN Cl
 Supplement 1. Experimental part 
 
 
 
 
 193
General procedure for the synthesis of compound 35: 
Method A. To a stirred reaction mixture of the corresponding 3-halochromone 10 or 11 (1.0 
mmol) and 3H-indole-2-thione 34 (1.1 mmol) in 1,4-dioxane (12 mL), DBU (1.3 mmol) was 
slowly added by syringe at room temperature. Stirring was continued until the starting 3-
halochromone was consumed (TLC control, 3-4 hours). The solvent was distilled off under 
reduced pressure. The resulting residue was purified by column chromatography (silica gel, 
heptane/ethyl acetate). 
 
Method B. To a stirred reaction mixture of the corresponding 3-halochromone 9-11 (1.0 mmol) 
and 3H-indole-2-thione 34 (1.1 mmol) in DMF (12 mL), K2CO3 (4 mmol) was added at room 
temperature. Stirring was continued until the chromone was consumed (TLC control, 3-4 hours). 
The solvent was distilled off under reduced pressure. The resulting residue was purified by 
column chromatography (silica gel, heptane/ethyl acetate). 
 
2-{8H-Thieno[2,3-b]indole-2-carbonyl}phenol (35a): 
Starting with 3-chlorochromone 11a (0.181 g, 1.0 mmol), indoline-2-
thione 34a (0.164 g, 1.1 mmol) and DBU (0.20 mL, 1.3 mmol) in 1,4-
dioxane (12 mL), the product 35a was isolated as a orange solid (0.167 
g, 57%), mp 212-213 ºC, (Method A);  
Starting with 3-chlorochromone 11a (0.181 g, 1.0 mmol), indoline-2-
thione 34a (0.164 g, 1.1 mmol) and K2CO3 (0.552 g, 4 mmol) in DMF (12 mL), the product 35a 
was isolated as a orange solid (0.217 g, 74%), (Method B); 
1H NMR (300 MHz, DMSO-d6): δ = 6.94-7.02 (m, 2H, HAr), 7.14 (td, 4J = 1.0 MHz, 3J = 7.5 
MHz, 1H, HAr), 7.27 (td, 4J = 1.2 MHz, 3J = 7.6 MHz, 1H, HAr), 7.41 (td, 4J = 1.7 MHz, 3J = 7.8 
MHz, 1H, HAr), 7.50-7.53 (m, 2H, HAr), 7.90 (d, 3J = 7.6 MHz, 1H, HAr), 7.98 (s, 1H, 3′-HAr), 
10.21, 12.09 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 112.0, 116.7, 
118.9, 119.8, 120.2, 121.9, 123.5, 125.1, 125.4, 128.6, 129.4, 132.0, 135.7, 142.5, 148.1, 155.9, 
188.3 (C=O); MS (GC, 70 eV) m/z (%): 293 ([M]+, 42), 261 (20), 260 (100), 174 (14), 173 (93), 
172 (29), 128 (16), 65 (14); HRMS (EI): calcd for C17H11NO2S ([M]+) 293.05050, found 
293.05043; IR (ATR, cm–1): ~ν  = 3256 (w), 3079 (w), 3055 (w), 1651 (w), 1623 (w), 1583 (w), 
1544 (w), 1504 (m), 1484 (w), 1470 (s), 1446 (m), 1400 (s), 1333 (m), 1312 (w), 1299 (m), 1233 
(s), 1215 (s), 1154 (m), 1131 (m), 1115 (m), 1099 (w), 1085 (m), 1035 (w), 1014 (w), 979 (w), 
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947 (w), 924 (w), 892 (w), 880 (w), 866 (m), 825 (m), 775 (m), 752 (s), 729 (s), 715 (m), 694 
(s), 662 (s), 628 (m), 600 (s), 590 (m), 566 (m), 552 (m), 544 (m). 
 
5-Methoxy-2-{8H-thieno[2,3-b]indole-2-carbonyl}phenol (35b): 
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), indoline-2-thione 34a (0.164 g, 1.1 mmol) and K2CO3 
(0.552 g, 4 mmol) in DMF (12 mL), the product 35b was isolated 
as a yellow solid (0.181 g, 56%), mp 228-229 ºC, (Method B); 
1H NMR (300 MHz, DMSO-d6): δ = 3.84 (s, 3H, OCH3), 6.56-
6.62 (m, 2H, HAr), 7.17 (t, 3J = 7.4 MHz, 1H, HAr), 7.28 (td, 4J = 0.9 MHz, 3J = 7.6 MHz, 1H, 
HAr), 7.53 (d, 3J = 8.1 MHz, 1H, HAr), 7.84 (d, 3J = 8.7 MHz, 1H, HAr), 7.93 (d, 3J = 7.7 MHz, 
1H, HAr), 8.23 (s, 1H, 3′-HAr), 11.65 (s, 2H, OH, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 
55.5 (OCH3), 101.5, 106.4, 112.1, 115.4, 119.9, 120.3, 122.0, 123.5, 125.5, 128.1, 132.3, 134.9, 
142.6, 147.9, 161.3, 163.9, 187.8 (C=O); MS (EI, 70 eV) m/z (%): 323 ([M]+, 21), 291 (17), 290 
(100), 173 (34); HRMS (ESI): calcd for C18H14NO3S ([M+H]+) 324.06889, found 324.06883; IR 
(ATR, cm–1): ~ν  = 3246 (w), 3079 (w), 3059 (w), 3004 (w), 2982 (w), 2952 (w), 2904 (w), 2835 
(w), 2719 (w), 2635 (w), 1633 (m), 1581 (m), 1550 (w), 1504 (s), 1473 (m), 1446 (m), 1396 (m), 
1372 (m), 1346 (m), 1314 (w), 1278 (m), 1266 (s), 1237 (s), 1214 (s), 1194 (m), 1156 (m), 1145 
(m), 1130 (w), 1101 (m), 1086 (m), 1029 (m), 1015 (w), 966 (w), 922 (w), 866 (w), 842 (m), 823 
(w), 801 (w), 784 (m), 767 (m), 748 (w), 729 (s), 708 (w), 692 (s), 640 (w), 617 (m), 591 (s), 562 
(w), 542 (w). 
 
2-{8H-Thieno[2,3-b]indole-2-carbonyl}naphthalen-1-ol (35c): 
Starting with 3-chlorobenzo[h]chromone 11c (0.231 g, 1.0 mmol), 
indoline-2-thione 34a (0.164 g, 1.1 mmol) and K2CO3 (0.552 g, 4 
mmol) in DMF (12 mL), the product 35c was isolated as a dark 
yellow solid (0.268 g, 78%), mp 282-284 ºC, (Method B); 
1H NMR (300 MHz, DMSO-d6): δ = 7.19 (t, 3J = 7.4 MHz, 1H, HAr), 7.30 (t, 3J = 7.4 MHz, 1H, 
HAr), 7.53-7.64 (m, 3H, HAr), 7.71 (t, 3J = 7.4 MHz, 1H, HAr), 7.97 (d, 3J = 7.8 MHz, 2H, HAr), 
8.08 (d, 3J = 8.8 MHz, 1H, HAr), 8.36 (d, 3J = 8.3 MHz, 1H, HAr), 8.46 (s, 1H, 3′-HAr), 12.19, 
13.03 (both s, 2H, OH and NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 112.2, 114.2, 118.6, 
120.1, 120.4, 122.0, 123.4, 123.8, 124.7, 126.0, 2ˣ126.1, 127.6, 129.1, 129.5, 134.4, 136.0, 
142.7, 148.6, 158.9, 188.9 (C=O); MS (EI, 70 eV) m/z (%): 343 ([M]+, 37), 311 (10), 310 (49), 
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174 (22), 173 (100), 172 (21), 155 (10); HRMS (ESI): calcd for C21H14NO2S ([M+H]+) 
344.07398, found 344.07393; IR (ATR, cm–1): ~ν  = 3247 (w), 3077 (w), 3056 (w), 1629 (w), 
1600 (w), 1574 (m), 1554 (m), 1502 (m), 1476 (w), 1456 (m), 1445 (m), 1424 (w), 1399 (s), 
1333 (m), 1312 (m), 1274 (m), 1257 (w), 1235 (s), 1209 (m), 1190 (m), 1156 (m), 1129 (m), 
1089 (m), 1025 (w), 1014 (w), 986 (w), 956 (m), 931 (w), 918 (w), 911 (w), 879 (w), 866 (w), 
847 (w), 825 (w), 796 (s), 765 (m), 753 (s), 746 (s), 733 (s), 704 (m), 684 (m), 658 (m), 638 (m), 
615 (m), 596 (m), 582 (s), 573 (s), 548 (m), 527 (m). 
 
4-Methyl-2-{8-methyl-8H-thieno[2,3-b]indole-2-carbonyl}phenol (35d): 
Starting with 3-bromo-6-methylchromone 10b (0.239 g, 1.0 mmol), 1-
methylindoline-2-thione 34b (0.179 g, 1.1 mmol) and DBU (0.20 mL, 
1.3 mmol) in 1,4-dioxane (12 mL), the product 35d was isolated as a 
yellow solid (0.138 g, 43%), mp 141-143 ºC, (Method A); 
1H NMR (300 MHz, DMSO-d6): δ = 2.29 (s, 3H, CH3), 3.92 (s, 3H, 
NCH3), 6.90 (d, 3J = 8.2 MHz, 1H, HAr), 7.18-7.23 (m, 2H, HAr), 7.29 (d, 4J = 1.8 MHz, 1H, 
HAr), 7.35 (td, 4J = 1.2 MHz, 3J = 7.7 MHz, 1H, HAr), 7.60 (d, 3J = 8.2 MHz, 1H, HAr), 7.94 (d, 3J 
= 7.7 MHz, 1H, HAr), 8.02 (s, 1H, 3′-HAr), 9.93 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ 
= 20.0 (CH3), 32.3 (NCH3), 110.3, 116.6, 120.0, 120.5, 121.9, 123.4, 123.6, 125.1, 127.6, 128.9, 
129.4, 132.6, 135.8, 142.9, 150.4, 153.7, 188.1 (C=O); MS (GC, 70 eV) m/z (%): 321 ([M]+, 32), 
288 (45), 187 (100), 172 (18), 115 (12), 77 (17); HRMS (EI): calcd for C19H15NO2S ([M]+) 
321.08180, found 321.08162; IR (ATR, cm–1): ~ν  = 3046 (w), 2917 (w), 1621 (w), 1575 (w), 
1553 (m), 1506 (m), 1495 (m), 1480 (s), 1461 (s), 1429 (m), 1422 (m), 1399 (s), 1385 (s), 1347 
(m), 1315 (s), 1287 (m), 1267 (s), 1241 (s), 1211 (s), 1194 (s), 1130 (s), 1089 (m), 1052 (m), 
1015 (m), 930 (m), 906 (w), 882 (w), 868 (w), 847 (w), 821 (s), 789 (s), 781 (s), 746 (s), 696 
(m), 685 (m), 673 (m), 625 (s), 598 (m), 571 (w), 543 (m), 541 (m). 
 
5-Methoxy-2-{8-methyl-8H-thieno[2,3-b]indole-2-carbonyl}phenol (35e): 
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), 1-methylindoline-2-thione 34b (0.179 g, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (12 mL), the product 
35e was isolated as a yellow solid (0.155 g, 46%), mp 158-159 
ºC, (Method A); 
OH O
S
N
CH3
CH3
OH O
S
N
CH3
H3CO
 Supplement 1. Experimental part 
 
 
 
 
 196
1H NMR (300 MHz, CDCl3): δ = 3.74 (s, 3H, CH3), 3.80 (s, 3H, CH3), 6.44-6.48 (m, 2H, HAr), 
7.14-7.19 (m, 1H, HAr), 7.26-7.28 (m, 2H, HAr), 7.73 (d, 3J = 7.7 Hz, 1H, HAr), 7.86-7.89 (m, 2H, 
HAr), 12.25 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 32.4 (NCH3), 55.5 (OCH3), 
101.3, 107.2, 109.4, 113.3, 119.8, 120.7, 122.3, 123.5, 124.2, 127.0, 132.7, 134.7, 143.0, 150.7, 
164.8, 165.2, 188.7 (C=O); MS (GC, 70 eV) m/z (%): 337 ([M]+, 27), 304 (100), 187 (64), 172 
(12), 155 (14); HRMS (ESI): calcd for C19H16NO3S ([M+H]+) 338.08450, found 338.08450, 
calcd for C19H15NaNO3S ([M+Na]+) 360.06650, found 360.06620; IR (ATR, cm–1): ~ν  = 2971 
(w), 2930 (w), 2848 (w), 1612 (m), 1573 (m), 1552 (w), 1491 (s), 1454 (s), 1441 (m), 1397 (m), 
1364 (s), 1330 (s), 1317 (s), 1297 (m), 1250 (s), 1206 (s), 1172 (m), 1163 (s), 1139 (s), 1126 (s), 
1089 (s), 1052 (s), 1023 (s), 1015 (s), 963 (s), 894 (m), 850 (s), 822 (m), 808 (s), 757 (s), 747 (s), 
735 (s), 708 (s), 694 (s), 671 (m), 644 (m), 637 (s), 594 (s), 546 (s). 
 
2-{8-Methyl-8H-thieno[2,3-b]indole-2-carbonyl}naphthalen-1-ol (35f): 
Starting with 3-chloro-4H-benzo[h]chromone 11c (0.231 g, 1.0 
mmol), 1-methylindoline-2-thione 34b (0.179 g, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (12 mL), the product 
35f was isolated as a yellow solid (0.196 g, 55%), mp 180-181 
ºC, (Method A); 
1H NMR (300MHz, DMSO-d6): δ = 3.93 (s, 3H, NCH3), 7.24 (td, 4J = 0.9 MHz, 3J = 7.5 MHz, 
1H, HAr),  7.37 (td, 4J = 1.2 MHz, 3J = 7.7 MHz, 1H, HAr), 7.53 (d, 3J = 8.8 MHz, 1H, HAr), 7.58-
7.63 (m, 2H, HAr), 7.71 (td, 4J = 1.3 MHz, 3J = 7.5 MHz, 1H, HAr), 7.95-8.01 (m, 2H, HAr), 8.06 
(d, 3J = 8.8 MHz, 1H, HAr), 8.36 (d, 3J = 8.3 MHz, 1H, HAr), 8.47 (s, 1H, 3′-HAr), 13.01 (s, 1H, 
OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 32.5 (NCH3), 110.5, 114.1, 118.6, 120.2, 120.7, 
121.9, 123.4, 123.7, 124.5, 124.7, 125.7, 126.1, 127.6, 129.4, 129.5, 134.4, 136.0, 143.1, 150.8, 
158.9, 188.6 (C=O); MS (EI, 70 eV) m/z (%): 357 ([M]+, 30), 324 (21), 187 (100), 172 (11); 
HRMS (ESI): calcd for C22H16NO2S ([M+H]+) 358.08963, found 358.08948, calcd for 
C22H15NaNO2S ([M+Na]+) 380.07157, found 380.07118; IR (ATR, cm–1): ~ν  = 3047 (w), 2935 
(w), 1658 (w), 1642 (w), 1628 (m), 1599 (w), 1574 (m), 1556 (w), 1536 (w), 1508 (m), 1493 
(m), 1454 (s), 1425 (m), 1415 (m), 1398 (s), 1380 (s), 1343 (m), 1317 (m), 1277 (m), 1264 (s), 
1253 (s), 1210 (m), 1197 (m), 1155 (m), 1139 (m), 1129 (m), 1116 (m), 1091 (m), 1052 (m), 
1024 (m), 1017 (m), 953 (m), 919 (w), 883 (m), 865 (m), 843 (m), 820 (m), 804 (m), 791 (m), 
772 (s), 756 (m), 733 (s), 717 (s), 704 (m), 686 (m), 658 (m), 637 (m), 605 (m), 586 (s), 572 (m), 
546 (m), 532 (m). 
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2-{8-Phenyl-8H-thieno[2,3-b]indole-2-carbonyl}phenol (35g): 
Starting with 3-chlorochromone 11a (0.181 g, 1.0 mmol), 1-
phenylindoline-2-thione 34c (0.248 g, 1.1 mmol) and DBU (0.20 mL, 
1.3 mmol) in 1,4-dioxane (12 mL), the product 35g was isolated as a 
orange solid (0.221 g, 60%), mp 156-157 ºC, (Method A); 
1H NMR (300MHz, DMSO-d6): δ = 6.98 (td, J = 0.9 MHz, 3J = 7.4 
MHz, 1H, HAr), 7.02 (dd, J = 0.7 MHz, 3J = 8.3 MHz, 1H, HAr), 7.29 (td, J = 0.9 MHz, 3J = 7.4 
MHz, 1H, HAr), 7.36 (td, 4J = 1.4 MHz, 3J = 7.7 MHz, 1H, HAr), 7.43 (td, 4J = 1.7 MHz, 3J = 7.7 
MHz, 1H, HAr), 7.51 (dd, 4J = 1.7 MHz, 3J = 7.7 MHz, 1H, HAr), 7.56 (d, 3J = 7.7 MHz, 2H, 
HAr), 7.71 (t, 3J = 7.7 MHz, 2H, HAr), 7.78-7.81 (m, 2H, HAr), 8.05 (dd, J = 0.9 MHz, 3J = 7.4 
MHz, 1H, HAr), 8.12 (s, 1H, 3′-HAr), 10.19 (s, 1H, OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 
110.9, 116.7, 118.9, 120.5, 121.7, 122.7, 2ˣ123.8, 124.3, 125.3, 125.5, 128.1, 128.7, 129.4, 
2ˣ130.6, 132.2, 135.9, 137.2, 141.7, 148.8, 155.8, 188.4 (C=O); MS (GC, 70 eV) m/z (%): 369 
([M]+, 57), 352 (17), 337 (20), 336 (81), 250 (20), 249 (100), 248 (12), 247 (15), 204 (19), 65 
(10); HRMS (ESI): calcd for C23H16NO2S ([M+H]+) 370.08963, found 370.08972; IR (ATR, cm–
1): ~ν  = 3052 (w), 2921 (w), 2852 (w), 1615 (w), 1579 (m), 1557 (w), 1515 (w), 1500 (m), 1482 
(m), 1467 (s), 1452 (m), 1443 (m), 1399 (s), 1373 (m), 1335 (m), 1325 (m), 1299 (m), 1275 (m), 
1249 (m), 1210 (s), 1183 (m), 1150 (s), 1130 (m), 1099 (m), 1081 (m), 1035 (w), 1024 (w), 985 
(w), 968 (w), 951 (w), 929 (w), 916 (w), 895 (m), 877 (w), 870 (w), 852 (w), 845 (w), 811 (w), 
781 (m), 767 (s), 755 (s), 747 (s), 737 (s), 726 (s), 695 (s), 662 (s), 638 (m), 626 (m), 612 (m), 
597 (s), 566 (w), 535 (m). 
 
5-Methoxy-2-{8-phenyl-8H-thieno[2,3-b]indole-2-carbonyl}phenol (35h): 
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), 1-phenylindoline-2-thione 34c (0.248 g, 1.1 mmol) and 
DBU (0.20 mL, 1.3 mmol) in 1,4-dioxane (12 mL), the product 
35h was isolated as a orange solid (0.140 g, 35%); mp 149-150 
ºC, (Method A); 
1H NMR (250MHz, DMSO-d6): δ = 3.84 (s, 3H, OCH3), 6.58-6.63 (m, 2H, HAr), 7.28-7.40 (m, 
2H, HAr), 7.52-7.59 (m, 2H, HAr), 7.68-7.85 (m, 5H, HAr), 8.07 (d, 3J = 7.2 MHz, 1H, HAr), 8.35 
(s, 1H, 3′-HAr), 11.33 (s, 1H, OH); 13C NMR (62.9 MHz, DMSO-d6): δ = 55.5 (OCH3), 101.6, 
106.5, 110.8, 110.9, 115.4, 120.5, 121.7, 122.7, 2ˣ123.7, 124.3, 125.7, 128.1, 2ˣ130.5, 132.2, 
135.1, 137.3, 141.7, 148.4, 161.1, 164.0, 187.7 (C=O); MS (GC, 70 eV) m/z (%): 399 ([M]+, 31), 
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367 (26), 366 (100), 250 (13), 249 (69), 204 (11), 186 (13); HRMS (ESI): calcd for C24H18NO3S 
([M+H]+) 400.10019, found 400.10018; IR (ATR, cm–1): ~ν  = 3083 (w), 3054 (w), 3011 (w), 
2952 (w), 2921 (w), 2852 (w), 2705 (w), 2659 (w), 1741 (w), 1621 (w), 1595 (w), 1568 (m), 
1551 (w), 1515 (w), 1500 (m), 1467 (m), 1452 (m), 1445 (m), 1403 (s), 1384 (m), 1366 (s), 1335 
(m), 1324 (m), 1300 (w), 1280 (w), 1253 (s), 1231 (s), 1216 (s), 1204 (s), 1188 (s), 1159 (m), 
1144 (m), 1130 (s), 1102 (m), 1082 (s), 1044 (m), 1019 (s), 962 (m), 953 (m), 917 (w), 885 (w), 
828 (s), 799 (s), 765 (m), 758 (m), 737 (s), 710 (s), 695 (s), 665 (m), 643 (m), 631 (m), 612 (m), 
592 (s), 574 (s). 
  
2-{8-Phenyl-8H-thieno[2,3-b]indole-2-carbonyl}naphthalen-1-ol (35i): 
Starting with 3-chlorobenzo[h]chromone 11c (0.231 g, 1.0 mmol), 
1-phenylindoline-2-thione 34c (0.248 g, 1.1 mmol) and DBU 
(0.20 mL, 1.3 mmol) in 1,4-dioxane (12 mL), the product 35i was 
isolated as a orange solid (0.243 g, 58%), mp 164ºC, (Method A); 
1H NMR (300MHz, DMSO-d6): δ = 7.30-7.41 (m, 2H, HAr), 7.53-
7.64 (m, 4H, HAr), 7.69-7.74 (m, 3H, HAr), 7.80 (d, 3J = 7.5 MHz, 2H, HAr), 7.97 (d, 3J = 8.1 
MHz, 1H, HAr), 8.05-8.12 (m, 2H, HAr), 8.36 (d, 3J = 8.3 MHz, 1H, HAr), 8.56 (s, 1H, 3′-HAr), 
12.87 (s, 1H, OH); 13C NMR (75.5 MHz, DMSO-d6): δ = 110.9, 114.2, 118.8, 120.6, 121.8, 
122.6, 123.4, 2ˣ123.7, 124.5, 124.7, 125.8, 126.1, 126.2, 127.6, 128.2, 129.1, 129.6, 2ˣ130.5, 
134.6, 136.1, 137.2, 141.8, 149.0, 158.9, 188.9 (C=O); MS (EI, 70 eV) m/z (%): 419 ([M]+, 36), 
386 (16), 384 (12), 250 (25), 249 (100); HRMS (ESI): calcd for C27H18NO2S ([M+H]+) 
420.10528, found 420.10519, calcd for C27H17NaNO2S ([M+Na]+) 442.08722, found 442.08734; 
IR (ATR, cm–1): ~ν  = 3056 (w), 2953 (w), 2922 (w), 2852 (w), 1623 (w), 1593 (w), 1557 (w), 
1514 (w), 1496 (m), 1446 (s), 1416 (m), 1399 (s), 1373 (m), 1339 (m), 1317 (m), 1296 (m), 1262 
(m), 1250 (s), 1214 (s), 1186 (m), 1159 (m), 1149 (m), 1137 (m), 1095 (m), 1088 (m), 1075 (m), 
1023 (m), 960 (m), 938 (w), 917 (m), 908 (m), 871 (w), 848 (m), 834 (m), 810 (m), 792 (m), 763 
(s), 748 (s), 738 (s), 724 (s), 693 (s), 669 (m), 657 (m), 643 (m), 627 (m), 613 (m), 596 (w), 583 
(s), 574 (s), 530 (m). 
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General procedure for the synthesis of compound 36a: 
To a solution of 2-benzoylfuran 32m (1.0 mmol) in DCM (10 ml), I2 (2.0 mmol) was added in 
solid form. Subsequently, DBU (3.0 mmol) was slowly added by syringe and the mixture was 
stirred vigorously at room temperature. The progress of the reaction was monitored by TLC. 
When the starting 2-benzoylfuran 32m was consumed (≈ 2-3 hour), an aqueous solution of 
K2S2O3 (2 mmol) and K2CO3 (2.0 mmol) was added and the solution was extracted with CHCl3 
(3 x 15 ml). The combined organic layers were concentrated in vacuo, and the residue was 
purified by column chromatography on silica gel (heptane/ethylacetate, 3:1). 
 
3-Acetyl-2-[(4-chlorophenyl)amino]-7-methyl-9H-furo[3,2-b]chromen-9-one (36a): 
Starting with 1-{2-[(4-chlorophenyl)amino]-5-[(2-hydroxy-5-
methylphenyl)carbonyl]furan-3-yl}ethan-1-one 32m (0.111 g, 
0.3 mmol), I2 (0.152 g, 0.6 mmol) and DBU (0.14 mL, 0.9 
mmol) in dichloromethane (2-3 ml), the product 36a was 
isolated as a white solid (0.035 g, 32%), mp 228-230 ºC; 
1H NMR (300 MHz, CDCl3): δ = 2.48 (s, 3H, CH3), 2.69 (s, 3H, 
CH3),  7.36-7.39 (m, 2H, HAr), 7.46-7.52 (m, 4H, HAr), 8.16 (s, 1H, 8-HAr), 10.61 (s, 1H, NH); 
13C NMR (75.5 MHz, CDCl3): δ = 20.9 (CH3), 28.7 (CH3), 93.6, 117.4, 2ˣ121.0, 125.9, 128.8, 
2ˣ129.8, 130.5, 133.6, 134.3, 135.2, 152.7, 153.5, 159.6, 162.5, 191.9 (C=O); MS (GC, 70 eV) 
m/z (%): 367 ([M]+, 100), 366 (28), 325 (16), 296 (18), 242 (44), 160 (12), 111 (14), 43 (13); 
HRMS (ESI): calcd for C20H1535ClNO4 ([M+H]+) 368.06841, found 368.06838, calcd for 
C20H1537ClNO4 ([M+H]+) 370.06627, found 370.06631, calcd for C20H1435ClNaNO4 ([M+Na]+) 
390.05036, found 390.05035, calcd for C20H1437ClNaNO4 ([M+Na]+) 392.04822, found 
392.04803; IR (ATR, cm–1): ~ν  = 3045 (w), 2923 (w), 2853 (w), 1734 (w), 1709 (w), 1659 (m), 
1631 (s), 1615 (s), 1594 (s), 1573 (m), 1562 (s), 1502 (s), 1479 (s), 1435 (s), 1382 (m), 1347 (w), 
1313 (w), 1290 (w), 1275 (w), 1251 (m), 1235 (m), 1198 (m), 1145 (w), 1115 (m), 1095 (m), 
1060 (w), 1044 (w), 1011 (m), 959 (s), 931 (w), 894 (w), 851 (w), 828 (s), 814 (s), 794 (w), 770 
(m), 759 (m), 736 (m), 710 (w), 693 (w), 673 (m), 653 (w), 631 (m), 614 (m), 548 (m). 
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General procedure for the synthesis of compound 36b-h and 37: 
To a stirred mixture of 3-halochromone 10 or 11 (1.0 mmol) and β-ketoamide 31 (1.1 mmol) in 
dioxane (6-7 mL), DBU (1.3 mmol) was added slowly by syringe at room temperature. Stirring 
was continued until the 3-halochromone was completely consumed (TLC control, 3-4 hours). 
DCM (10 mL), I2 (2.0 mmol) and DBU (3.0 mmol) were added, and the mixture was stirred 
vigorously for 2-3 hours at room temperature. The progress of the reactions was again monitored 
by TLC. An aqueous solution of K2S2O3 (2 mmol) and K2CO3 (2.0 mmol) was added, and the 
solution was extracted with CHCl3 (3 x 15 ml). The combined organic layers were concentrated 
in vacuo, and the residue was purified by column chromatography (silica gel, heptane/ 
ethylacetate = 3:1). In the case of the reaction of 3-bromochromone 10d, the second step of the 
reaction was carried out in refluxing DMF. 
 
3-Acetyl-2-(phenylamino)-9H-furo[3,2-b]chromen-9-one (36b): 
Starting with 3-bromochromone 10a (0.225 g, 1.0 mmol), 
acetoacetanilide 31a (0.195 g, 1.1 mmol), DBU (0.20 mL, 1.3 mmol), 
1,4-dioxane (6-7 mL), I2 (0.508 g, 2.0 mmol) and DBU (0.45 mL, 3.0 
mmol) in dichloromethane (10 mL), the product 36b was isolated as a 
white solid (0.118 g, 37%), mp 258-260 ºC; 
1H NMR (300 MHz, CDCl3): δ = 2.68 (s, 3H, CH3), 7.21 (t, 3J = 7.4 Hz, 1H, HAr), 7.40-7.48 (m, 
3H, HAr), 7.55-7.58 (m, 3H, HAr), 7.66 (td, 3J = 7.7 Hz, 4J = 1.6 Hz, 1H, HAr), 8.40 (dd, 3J = 7.9 
Hz, 4J = 1.6 Hz, 1H, HAr), 10.62 (s, 1H, NH); 13C NMR (75.5 MHz, CDCl3): δ = 28.7 (CH3), 
93.4, 117.6, 2ˣ119.9, 125.1, 125.2, 125.3, 126.4, 128.6, 2ˣ129.7, 132.4, 135.6, 152.9, 155.2, 
160.0, 162.2, 191.8 (C=O); MS (GC, 70 eV) m/z (%): 319 ([M]+, 100), 318 (37), 277 (20), 248 
(20), 228 (27), 146 (11), 77 (31), 76 (9), 43 (13); HRMS (EI): calcd for C19H13NO4 ([M]+) 
319.08391, found 319.08370; IR (ATR, cm–1): ~ν  = 3151 (w), 3049 (w), 3014 (w), 1660 (m), 
1637 (s), 1620 (s), 1596 (s), 1581 (s), 1555 (s), 1510 (s), 1459 (s), 1426 (s), 1384 (m), 1360 (m), 
1326 (m), 1313 (w), 1275 (w), 1251 (m), 1205 (w), 1187 (m), 1143 (m), 1102 (m), 1082 (w), 
1062 (w), 1025 (w), 999 (w), 958 (s), 898 (m), 866 (w), 845 (w), 831 (w), 802 (w), 783 (w), 745 
(s), 733 (s), 704 (m), 687 (s), 656 (s), 639 (w), 624 (s), 611 (m), 593 (m), 563 (w), 538 (w). 
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3-Acetyl-6-methoxy-2-(phenylamino)-9H-furo[3,2-b]chromen-9-one (36c):  
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), acetoacetanilide 31a (0.195 g, 1.1 mmol), DBU (0.20 mL, 
1.3 mmol), 1,4-dioxane (6-7 mL), I2 (0.508 g, 2.0 mmol) and 
DBU (0.45 mL, 3.0 mmol) in dichloromethane (10 mL), the 
product 36c was isolated as a white solid (0.098 g, 28%), mp 259-261 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 2.63 (s, 3H, CH3), 3.94 (s, 3H, OCH3), 7.09 (dd, 3J = 8.8 
Hz, 2J = 2.4 Hz, 1H, HAr), 7.22-7.29 (m, 2H, HAr), 7.43-7.58 (m, 4H, HAr), 8.09 (d, 3J = 8.8 Hz, 
1H, HAr), 10.41 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 27.9 (CH3), 55.6 (OCH3), 
92.9, 101.1, 113.0, 117.7, 2ˣ120.5, 124.7, 126.0, 127.2, 2ˣ128.8, 135.4, 151.8, 156.1, 158.8, 
160.6, 162.6, 190.0 (C=O); MS (GC, 70 eV) m/z (%): 349 ([M]+, 100), 307 (15), 292 (16), 278 
(20), 258 (27), 77 (24), 43 (11); HRMS (EI): calcd for C20H15NO5 ([M]+) 349.09447, found 
349.09448; IR (ATR, cm–1): ~ν  = 3223 (w), 3065 (w), 3044 (w), 3013 (w), 2990 (w), 2948 (w), 
2840 (w), 1660 (w), 1652 (w), 1616 (s), 1602 (s), 1592 (s), 1579 (s), 1553 (m), 1495 (m), 1458 
(m), 1441 (s), 1378 (w), 1359 (w), 1346 (w), 1323 (w), 1271 (m), 1244 (s), 1201 (w), 1151 (w), 
1133 (w), 1095 (s), 1059 (w), 1023 (m), 953 (s), 903 (w), 877 (w), 856 (m), 826 (w), 801 (w), 
761 (m), 747 (s), 737 (s), 714 (m), 688 (s), 649 (m), 621 (m), 610 (s), 589 (s). 
 
15-Acetyl-14-(phenylamino)-13,17-dioxatetracyclo[8.7.0.02,7.012,16]heptadeca-
1(10),2(7),3,5,8,12(16),14-heptaen-11-one (36d).  
Starting with 3-bromobenzo[h]chromone 10d (0.275 g, 1.0 mmol), 
acetoacetanilide 31a (0.195 g, 1.1 mmol), DBU (0.20 mL, 1.3 mmol), 
1,4-dioxane (6-7 mL), I2 (0.508 g, 2.0 mmol) and DBU (0.45 mL, 3.0 
mmol) in dichloromethane (10 mL), the product 36d was isolated as 
a pale yellow solid (0.052 g, 14%), mp 292-294 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 2.82 (s, 3H, CH3), 7.28 (d, 3J = 7.3 Hz, 1H, HAr), 7.46-7.53 
(m, 2H, HAr), 7.58-7.62 (m, 2H, HAr), 7.78-7.83 (m, 2H, HAr), 7.96 (d, 3J = 8.7 Hz, 1H, HAr), 
8.09-8.12 (m, 1H, HAr), 8.20 (d, 3J = 8.7 Hz, 1H, HAr), 8.55-8.58 (m, 1H, HAr), 10.44 (s, 1H, 
NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 27.9 (CH3), 92.8, 119.9, 2ˣ120.4, 120.5, 120.9, 
121.6, 124.2, 124.6, 126.9, 127.3, 127.8, 128.1, 2ˣ128.6, 134.3, 135.3, 157.9, 158.9, 160.5, 
162.9, 189.6 (C=O); MS (GC, 70 eV) m/z (%): 369 ([M]+, 100), 327 (12), 298 (17), 278 (27), 
196 (11), 171 (11), 77 (23), 43 (11); HRMS (EI): calcd for C23H15NO4 ([M]+) 369.09956, found 
369.09932; IR (ATR, cm–1): ~ν  = 3246 (w), 3205 (w), 3169 (w), 3060 (w), 1665 (m), 1648 (s), 
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1635 (s), 1619 (s), 1595 (s), 1577 (s), 1556 (m), 1510 (s), 1501 (s), 1459 (m), 1438 (s), 1426 (s), 
1378 (m), 1340 (m), 1324 (w), 1267 (w), 1242 (m), 1223 (m), 1188 (w), 1177 (w), 1145 (w), 
1110 (w), 1093 (w), 1076 (w), 1060 (w), 1027 (w), 986 (w), 960 (m), 941 (w), 900 (w), 875 (w), 
869 (w), 843 (w), 826 (m), 780 (w), 786 (w), 765 (m), 756 (s), 741 (m), 734 (m), 710 (w), 686 
(m), 672 (m), 649 (w), 631 (m), 619 (w), 606 (m), 598 (w), 579 (w), 566 (m), 532 (w). 
 
3-Benzoyl-2-(phenylamino)-9H-furo[3,2-b]chromen-9-one (36e):  
Starting with 3-chlorochromone 11a (0.181 g, 1.0 mmol), 3-oxo-N,3-
diphenylpropanamide 31f (0.263 g, 1.1 mmol), DBU (0.20 mL, 1.3 
mmol), 1,4-dioxane (6-7 mL), I2 (0.508 g, 2.0 mmol) and DBU (0.45 
mL, 3.0 mmol) in dichloromethane (10 mL), the product 36e was 
isolated as a white solid (0.160 g, 42%), mp 223-225 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 7.22-7.32 (m, 2H, HAr), 7.43-7.53 (m, 3H, HAr), 7.57-7.73 
(m, 6H, HAr), 7.88-7.92 (m, 2H, HAr), 8.19  (dd, 3J = 7.9 Hz, 4J = 1.6 Hz, 1H, HAr), 10.79 (s, 1H, 
NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 92.1, 117.0, 2ˣ120.9, 124.3, 124.4, 124.8, 125.0, 
2ˣ127.4, 127.5, 2ˣ127.6, 2ˣ128.8, 121.5, 132.1, 135.4, 138.2, 151.2, 154.1, 160.6, 160.8, 186.9 
(C=O); MS (GC, 70 eV) m/z (%): 381 ([M]+, 100), 352 (21), 248 (20), 105 (63), 77 (51), 51 (9); 
HRMS (ESI): calcd for C24H16NO4 ([M+H]+) 382.10738, found 382.10739; IR (ATR, cm–1): ~ν  
= 3061 (w), 1660 (m), 1633 (m), 1610 (m), 1591 (m), 1579 (m), 1555 (s), 1497 (m), 1469 (w), 
1457 (m), 1421 (s), 1348 (m), 1336 (m), 1323 (m), 1310 (m), 1275 (w), 1263 (s), 1206 (m), 1186 
(m), 1162 (m), 1145 (w), 1104 (m), 1079 (w), 1027 (w), 1001 (w), 987 (m), 960 (w), 934 (w), 
911 (m), 897 (s), 873 (w), 843 (w), 823 (w), 800 (w), 784 (m), 744 (s), 691 (s), 684 (s), 665 (s), 
657 (s), 637 (m), 614 (m), 592 (s), 570 (w), 536 (w), 531 (w). 
 
3-Benzoyl-6-methoxy-2-(phenylamino)-9H-furo[3,2-b]chromen-9-one (36f): 
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), 3-oxo-N,3-diphenylpropanamide 31f (0.263 g, 1.1 mmol), 
DBU (0.20 mL, 1.3 mmol), 1,4-dioxane (6-7 mL), I2 (0.508 g, 2.0 
mmol) and DBU (0.45 mL, 3.0 mmol) in dichloromethane (10 
mL), the product 36f was isolated as a pale yellow solid (0.086 g, 21%), mp 249-251 ºC; 
1H NMR (250 MHz, DMSO-d6): δ = 3.87 (s, 3H, OCH3), 6.65 (d, 4J = 2.3 Hz, 1H, HAr), 7.06 
(dd, 3J = 8.9 Hz, 4J = 2.3 Hz, 1H, HAr), 7.28 (t, 3J = 7.3 Hz, 1H, HAr), 7.46-7.52 (m, 2H, HAr), 
7.58-7.63 (m, 4H, HAr), 7.68 (d, 3J = 7.1 Hz, 1H, HAr), 7.88-7.91 (m, 2H, HAr), 8.09 (d, 3J = 8.8 
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Hz, 1H, HAr), 10.72 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 55.3 (OCH3), 92.1, 
100.8, 112.5, 117.8, 2ˣ120.6, 124.7, 126.0, 2ˣ127.3, 127.4, 2ˣ127.5, 2ˣ128.7, 131.3, 135.4, 138.1, 
150.7, 155.6, 160.2, 160.8, 162.4, 186.8 (C=O); MS (GC, 70 eV) m/z (%): 411 ([M]+, 100), 410 
(50), 382 (21), 278 (28), 105 (75), 77 (56), 51 (7); HRMS (ESI): calcd for C25H18NO5 ([M+H]+) 
412.11795, found 412.11770, calcd for C25H17NaNO5 ([M+Na]+) 434.09989, found 434.09988; 
IR (ATR, cm–1): ~ν  = 3046 (w), 3004 (w), 2922 (w), 2852 (w), 1660 (m), 1631 (s), 1618 (s), 
1592 (s), 1577 (m), 1568 (m), 1553 (s), 1506 (m), 1494 (m), 1455 (m), 1435 (m), 1418 (m), 1381 
(m), 1368 (m), 1347 (w), 1334 (w), 1317 (w), 1278 (m), 1267 (m), 1245 (m), 1212 (m), 1197 
(w), 1187 (w), 1165 (m), 1153 (w), 1143 (w), 1110 (s), 1099 (m), 1045 (w), 1028 (m), 988 (m), 
941 (w), 905 (m), 889 (w), 870 (m), 843 (s), 821 (m), 811 (w), 791 (m), 748 (s), 738 (s), 715 
(m), 696 (s), 680 (s), 667 (s), 637 (m), 625 (m), 614 (w), 590 (m), 579 (m), 547 (w). 
 
Methyl 5'-amino-3,3'-dioxo-3H,3'H-spiro[1-benzofuran-2,2'-furan]-4'-carboxylate (37a): 
Starting with 3-bromochromone 10a (0.225 g, 1.0 mmol), methyl 2-
carbamoylacetate 31e (0.129 g, 1.1 mmol), DBU (0.20 mL, 1.3 mmol), 
1,4-dioxane (6-7 mL), I2 (0.508 g, 2.0 mmol) and DBU (0.45 mL, 3.0 
mmol) in dichloromethane (10 mL), the product 37a was isolated as a 
white solid (0.083 g, 30%), mp 292-294 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.69 (s, 3H, OCH3), 7.33 (t, 3J = 7.5 Hz, 1H, 5-HAr), 7.46 
(d, 3J = 8.3 Hz, 1H, 7-HAr), 7.89 (d, 3J = 7.6 Hz, 1H, 4-HAr), 7.91 (td, 3J = 7.8 Hz, 4J = 1.2 Hz, 
1H, 6-HAr), 9.11 (s, 1H, NH), 10.15 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 50.7 
(OCH3), 84.4, 101.7 (2-C), 113.5, 118.0, 124.4, 125.3, 140.7, 162.6, 171.4 (7a-C), 178.0 (5′-C), 
180.8 (3′-C), 192.1 (3-C); MS (EI, 70 eV) m/z (%): 275 ([M]+, 23), 151 (15), 150 (100), 121 
(11), 105 (25), 68 (12), 44 (18); HRMS (ESI): calcd for C13H10NO6 ([M+H]+) 276.05026, found 
276.05037; IR (ATR, cm–1): ~ν  = 3451 (w), 3101 (w), 3028 (w), 2962 (w), 1743 (m), 1729 (m), 
1671 (m), 1640 (s), 1616 (s), 1492 (s), 1477 (s), 1460 (s), 1362 (w), 1323 (m), 1304 (m), 1237 
(m), 1231 (m), 1202 (m), 1170 (m), 1153 (m), 1107 (w), 1012 (s), 1007 (s), 902 (w), 866 (m), 
812 (w), 799 (m), 785 (m), 759 (s), 727 (m), 712 (w), 692 (m), 631 (s), 569 (w). 
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Methyl 5'-amino-6-methoxy-3,3'-dioxo-3H,3'H-spiro[1-benzofuran-2,2'-furan]-4'-
carboxylate (37b): 
Starting with 3-chloro-7-methoxychromone 11b (0.211 g, 1.0 
mmol), methyl 2-carbamoylacetate 31e (0.129 g, 1.1 mmol), DBU 
(0.20 mL, 1.3 mmol), 1,4-dioxane (6-7 mL), I2 (0.508 g, 2.0 
mmol) and DBU (0.45 mL, 3.0 mmol) in dichloromethane (10 
mL), the product 37b was isolated as a white solid (0.084 g, 27%), mp 294-296 ºC; 
1H NMR (300 MHz, DMSO-d6): δ = 3.69 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 6.86 (dd, 3J = 8.7 
Hz, 4J = 2.0 Hz, 1H, 5-HAr), 7.02 (d, 4J = 1.9 Hz, 1H, 7-HAr), 7.67 (d, 3J = 8.7 Hz, 1H, 4-HAr), 
9.06 (s, 1H, NH), 10.10 (s, 1H, NH); 13C NMR (62.9 MHz, DMSO-d6): δ = 50.7 (OCH3), 56.8 
(OCH3), 84.4, 97.3, 102.7 (2-C), 110.8, 113.4, 126.4, 162.7, 169.6 (6-C), 174.1 (7a-C), 178.0 (5′-
C), 181.0 (3′-C), 189.0 (3-C); MS (EI, 70 eV) m/z (%): 305 ([M]+, 27), 181 (14), 180 (100), 165 
(11), 151 (15), 135 (27), 78 (15), 68 (13), 63 (19), 59 (13), 44 (28); HRMS (ESI): calcd for 
C14H12NO7 ([M+H]+) 306.06083 found 306.06078, calcd for C14H11NaNO7 ([M+Na]+) 
328.04277 found 328.04291; IR (ATR, cm–1): ~ν  = 3381 (w), 3084 (w), 3024 (w), 2964 (w), 
2844 (w), 1724 (m), 1689 (m), 1644 (s), 1626 (s), 1590 (m), 1501 (s), 1460 (w), 1454 (w), 1445 
(m), 1424 (w), 1348 (m), 1297 (m), 1282 (m), 1265 (m), 1218 (w), 1188 (w), 1182 (w), 1158 
(m), 1139 (s), 1120 (s), 1050 (m), 1023 (m), 1009 (s), 959 (w), 930 (w), 867 (w), 840 (w), 827 
(w), 797 (m), 775 (w), 766 (m), 755 (w), 730 (w), 661 (m), 634 (s), 555 (w). 
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Supplement 2 
 
Crystallographic data 
 
Crystal data and structure refinement for 13b: 
 
Identification code is_is52 
 
Empirical formula C20H18O9 
Formula weight 402.34 g/mol 
Temperature 173 K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.) P -1 
Space group (Hall) -P 1 
Unit cell dimensions a = 8.9975 (8)Å α = 107.022 (8)º 
 b = 10.6797 (11)Å β = 99.434 (8)º 
 c = 11.4242 (17)Å γ = 111.650 (5)º 
Volume 928.83 (19) Å3 
Z 2 
Calculated density 1.439 mg/m3 
Absorption coefficient 0.115 mm−1 
F(000) 420 
Crystal size 0.27 × 0.20 × 0.04 mm3 
Θ range for data collection 3.3 - 28.0° 
Limiting indices -12≤h≤12, -14≤k≤14, -15≤l≤15  
Reflections collected  18251 
Indepent reflections 5026 [R(int) = 0.035] 
Completeness to Θ = 29.50° 97.1% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9954 and 0.9696 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5026/0/274 
Goodness-of-fit on F2 1.052 
Final R indices [I > σ2(I)] R1 = 0.0465, wR2 = 0.1176 
R indices (all data) R1 = 0.0820, wR2 = 0.1294 
Largest diff. peak and hole 0.33 and -0.21 e Å−3 
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Crystal data and structure refinement for 13c: 
 
Identification code is_is73 
 
Empirical formula C20H18O10 
Formula weight 418.34 g/mol 
Temperature 173 K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group (H.-M.) Pbca 
Space group (Hall) -P 2ac 2ab 
Unit cell dimensions a = 11.3807 (5)Å α = 90.00º 
 b = 8.1698 (4)Å β = 90.00º 
 c = 40.6850 (16)Å γ = 90.00º 
Volume 3782.8 (3) Å3 
Z 8 
Calculated density 1.469 mg/m3 
Absorption coefficient 0.120 mm−1 
F(000) 1744 
Crystal size 0.80 × 0.48 × 0.25 mm3 
Θ range for data collection 2.7 - 30.3° 
Limiting indices -15≤h≤15, -11≤k≤11, -56≤l≤55  
Reflections collected  41068 
Indepent reflections 5272 [R(int) = 0.048] 
Completeness to Θ = 29.50° 99.8% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9707 and 0.9103 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5272/0/284 
Goodness-of-fit on F2 1.090 
Final R indices [I > σ2(I)] R1 = 0.0516, wR2 = 0.1209 
R indices (all data) R1 = 0.0611, wR2 = 0.1248 
Largest diff. peak and hole 0.39 and -0.26 e Å−3 
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Crystal data and structure refinement for 14o: 
 
Identification code is_is82 
 
Empirical formula C20H13F7O7 
Formula weight 498.30 g/mol 
Temperature 173 K 
Wavelength 
Crystal system 
Space group (H.-M.) 
0.71073 Å 
Monoclinic 
P21 
Space group (Hall) P 2yb 
Unit cell dimensions a = 10.7404 (19)Å α = 90.00º 
 b = 7.6871 (15)Å β = 91.526 (12)º 
 c = 12.188 (2)Å γ = 90.00º 
Volume 1005.9 (3) Å3 
Z 2 
Calculated density 1.645 mg/m3 
Absorption coefficient 0.164 mm−1 
F(000) 504 
Crystal size 0.80 × 0.12 × 0.05 mm3 
Θ range for data collection 4.990 - 61.299° 
Limiting indices -15≤h≤14, -7≤k≤10, -17≤l≤17  
Reflections collected  11496 
Indepent reflections 5141 [R(int) = 0.028] 
Completeness to Θ = 30.00° 99.9% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9918 and 0.8798 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5141/1/317 
Goodness-of-fit on F2 1.025 
Final R indices [I > σ2(I)] R1 = 0.0397, wR2 = 0.0895 
R indices (all data) R1 = 0.0564, wR2 = 0.0975 
Largest diff. peak and hole 0.25 and -0.22 e Å−3 
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Crystal data and structure refinement for 15: 
 
Identification code is_is752 
 
Empirical formula C19H15F3O8 
Formula weight 428.31 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/n 
Space group (Hall) -P 2yn 
Unit cell dimensions a = 8.5463 (5)Å α = 90.00º 
 b = 17.9015 (12)Å β = 107.863 (3)º 
 c = 12.7567 (8)Å γ = 90.00º 
Volume 1857.6 (2) Å3 
Z 4 
Calculated density 1.532 mg/m3 
Absorption coefficient 0.138 mm−1 
F(000) 880 
Crystal size 0.44 × 0.10 × 0.07 mm3 
Θ range for data collection 2.28 - 25.14° 
Limiting indices -12≤h≤10, -25≤k≤25, -17≤l≤17  
Reflections collected  26427 
Indepent reflections 5391 [R(int) = 0.064] 
Completeness to Θ = 30.00° 99.6% 
Absorption correction Multi-scan 
Max. and min. transmission  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5391/0/281 
Goodness-of-fit on F2 1.042 
Final R indices [I > σ2(I)] R1 = 0.0469, wR2 = 0.1009 
R indices (all data) R1 = 0.0867, wR2 = 0.1192 
Largest diff. peak and hole 0.31 and -0.30 e Å−3 
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Crystal data and structure refinement for 16: 
 
Identification code ah_is388_1 
 
Empirical formula C18H14O8 
Formula weight 358.29 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/c 
Space group (Hall) -P 2ybc 
Unit cell dimensions a = 8.1090 (5)Å α = 90.00º 
 b = 16.4208 (9)Å β = 100.506 (3)º 
 c = 12.1650 (7)Å γ = 90.00º 
Volume 1592.69 (16) Å3 
Z 4 
Calculated density 1.494 Mg/m3 
Absorption coefficient 0.119 mm−1 
F(000) 744 
Crystal size 0.24 × 0.18 × 0.13 mm3 
Θ range for data collection 2.84 - 29.60° 
Limiting indices -11≤h≤11, -23≤k≤19, -13≤l≤16  
Reflections collected  21690 
Indepent reflections 4560 [R(int) = 0.048] 
Completeness to Θ = 29.85° 99.6% 
Absorption correction Multi-scan 
Max. and min. transmission 0.7459 and 0.6834 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4560/0/243 
Goodness-of-fit on F2 1.045 
Final R indices [I > σ2(I)] R1 = 0.0432, wR2 = 0.1075 
R indices (all data) R1 = 0.0650, wR2 = 0.1205 
Largest diff. peak and hole 0.34 and -0.21 e Å−3 
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Crystal data and structure refinement for 17a: 
 
Identification code ch_is2001 
O O
O
OCH3
O
H
H3CO O
H
 
Empirical formula C23H18O7 
Formula weight 406.37 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.) P -1 
Space group (Hall) -P 1 
Unit cell dimensions a = 9.4746 (4)Å α = 65.728 (2)º 
 b = 10.2347 (4)Å β = 71.993 (2)º 
 c = 11.4323 (4)Å γ = 82.309 (2)º 
Volume 961.06 (6) Å3 
Z 2 
Calculated density 1.404 mg/m3 
Absorption coefficient 0.105 mm−1 
F(000) 424 
Crystal size 0.25 × 0.15 × 0.09 mm3 
Θ range for data collection 4.4 - 61.8° 
Limiting indices -13≤h≤13, -14≤k≤14, -16≤l≤16  
Reflections collected  27835 
Indepent reflections 6112 [R(int) = 0.052] 
Completeness to Θ = 31.00° 99.7% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9906 and 0.9743 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6112/0/281 
Goodness-of-fit on F2 1.032 
Final R indices [I > σ2(I)] R1 = 0.0461, wR2 = 0.1131 
R indices (all data) R1 = 0.0700, wR2 = 0.1280 
Largest diff. peak and hole 0.34 and -0.22 e Å−3 
 
 Supplement 2. Crystallographic data 
 
 
 
 
 211
Crystal data and structure refinement for 17b 
 
Identification code is_is93 
 
Empirical formula C23H17FO7 
Formula weight 424.37 g/mol 
Temperature 173(2) K 
Wavelength 
Crystal system 
Space group (H.-M.) 
0.71073 Å 
Monoclinic 
C2/c 
Space group (Hall) -C 2yc 
Unit cell dimensions a = 22.8935 (6)Å α = 90.00º 
 b = 8.2045 (2)Å β = 98.132 (1)º 
 c = 21.6152 (5)Å γ = 90.00º 
Volume 4019.15 (17) Å3 
Z 8 
Calculated density 1.403 mg/m3 
Absorption coefficient 0.110 mm−1 
F(000) 1760 
Crystal size 0.27 × 0.24 × 0.07 mm3 
Θ range for data collection 2.6 - 30.5° 
Limiting indices -31≤h≤32, -11≤k≤9, -30≤l≤30  
Reflections collected  21758 
Indepent reflections 5845 [R(int) = 0.035] 
Completeness to Θ = 30.00° 99.6% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9923 and 0.9708 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5845/0/290 
Goodness-of-fit on F2 1.047 
Final R indices [I > σ2(I)] R1 = 0.0492, wR2 = 0.1252 
R indices (all data) R1 = 0.0772, wR2 = 0.1353 
Largest diff. peak and hole 0.89 and -0.44 e Å−3 
 
 Supplement 2. Crystallographic data 
 
 
 
 
 212
Crystal data and structure refinement for 18a: 
 
Identification code av_is2002 
 
Empirical formula C22H14O6 
Formula weight 374.33 g/mol 
Temperature 173(2) K 
Wavelength 
Crystal system 
Space group (H.-M.) 
0.71073 Å 
Triclinic 
P -1 
Space group (Hall) -P 1 
Unit cell dimensions a = 8.0894 (4)Å α = 95.198 (2)º 
 b = 8.8477 (4)Å β = 97.489 (2)º 
 c = 11.6944 (5)Å γ = 90.900 (2)º 
Volume 826.12 (7) Å3 
Z 2 
Calculated density 1.505 mg/m3 
Absorption coefficient 0.111 mm−1 
F(000) 388 
Crystal size 0.20 × 0.18 × 0.08 mm3 
Θ range for data collection 4.6 - 60.2° 
Limiting indices -11≤h≤10, -12≤k≤12, -16≤l≤16  
Reflections collected  16616 
Indepent reflections 4647 [R(int) = 0.027] 
Completeness to Θ = 30.00° 96.5% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9912 and 0.9782 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4657/0/258 
Goodness-of-fit on F2 1.043 
Final R indices [I > σ2(I)] R1 = 0.0436, wR2 = 0.1064 
R indices (all data) R1 = 0.0703, wR2 = 0.1233 
Largest diff. peak and hole 0.38 and -0.24 e Å−3 
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Crystal data and structure refinement for 18d: 
 
Identification code av_is149 
O O
O
H
O
OCH3
O
N
O
O
H
 
Empirical formula C22H13NO8 
Formula weight 419.33 g/mol 
Temperature 173(2) K 
Wavelength 
Crystal system 
Space group (H.-M.) 
0.71073 Å 
Triclinic 
P -1 
Space group (Hall) -P 1 
Unit cell dimensions a = 8.6996 (3)Å α = 87.360 (2)º 
 b = 9.4687 (3)Å β = 71.996 (1)º 
 c = 11.8581 (4)Å γ = 77.073 (1)º 
Volume 905.14 (5) Å3 
Z 2 
Calculated density 1.539 mg/m3 
Absorption coefficient 0.119 mm−1 
F(000) 432 
Crystal size 0.44 × 0.13 × 0.10 mm3 
Θ range for data collection 4.4 - 65.1° 
Limiting indices -12≤h≤13, -14≤k≤14, -17≤l≤17  
Reflections collected  23897 
Indepent reflections 6501 [R(int) = 0.023] 
Completeness to Θ = 32.50° 99.4% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9882 and 0.9493 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6501/0/285 
Goodness-of-fit on F2 1.043 
Final R indices [I > σ2(I)] R1 = 0.0453, wR2 = 0.1158 
R indices (all data) R1 = 0.0571, wR2 = 0.1239 
Largest diff. peak and hole 0.38 and -0.28 e Å−3 
 
 Supplement 2. Crystallographic data 
 
 
 
 
 214
Crystal data and structure refinement for 20c: 
 
Identification code av_is2081_b 
O O
OH
H
 
Empirical formula C31H22O3 
Formula weight 442.49 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/c 
Space group (Hall) -P 2ybc 
Unit cell dimensions a = 18.3936 (4) Å α = 90.00º 
 b = 5.9331 (1) Å β = 96.666 (2)º 
 c = 21.3185 (5) Å γ = 90.00º 
Volume 2310.78 (8) Å3 
Z 4 
Calculated density 1.272 mg/m3 
Absorption coefficient 0.081 mm−1 
F(000) 928 
Crystal size 0.56 × 0.07 × 0.06 mm3 
Θ range for data collection 5.5 - 60.7° 
Limiting indices -24≤h≤26, -6≤k≤8, -30≤l≤30  
Reflections collected  26898 
Indepent reflections 7113 [R(int) = 0.054] 
Completeness to Θ = 30.67° 99.2% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9952 and 0.9561 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7113/0/315 
Goodness-of-fit on F2 1.008 
Final R indices [I > σ2(I)] R1 = 0.0577, wR2 = 0.1041 
R indices (all data) R1 = 0.1228, wR2 = 0.1310 
Largest diff. peak and hole 0.30 and -0.26 e Å−3 
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Crystal data and structure refinement for 20d: 
 
Identification code av_is1761 
 
Empirical formula C29H20O3S 
Formula weight 448.51 g/mol 
Temperature 173(2) K 
Wavelength 
Crystal system 
Space group (H.-M.) 
0.71073 Å 
Monoclinic 
P21/c 
Space group (Hall) -P 2ybc 
Unit cell dimensions a = 18.4149 (9)Å α = 90.00º 
 b = 5.8081 (3)Å β = 96.645 (3)º 
 c = 21.3309 (12)Å γ = 90.00º 
Volume 2266.1 (2) Å3 
Z 4 
Calculated density 1.315 mg/m3 
Absorption coefficient 0.172 mm−1 
F(000) 936 
Crystal size 0.85 × 0.06 × 0.05 mm3 
Θ range for data collection 4.7 - 52.8° 
Limiting indices -25≤h≤24, -7≤k≤6, -29≤l≤29  
Reflections collected  28745 
Indepent reflections 6003 [R(int) = 0. 115] 
Completeness to Θ = 29.00° 99.9% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9914 and 0.8675 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6003/8/319 
Goodness-of-fit on F2 1.029 
Final R indices [I > σ2(I)] R1 = 0.0612, wR2 = 0.1038 
R indices (all data) R1 = 0.1405, wR2 = 0.1322 
Largest diff. peak and hole 0.26 and -0.29 e Å−3 
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Crystal data and structure refinement for 20f: 
 
Identification code ch_is209 
O O
OH
H
N
OO
 
Empirical formula C31H21NO5 
Formula weight 487.49 g/mol 
Temperature 173(2) K 
Wavelength 
Crystal system 
Space group (H.-M.) 
Space group (Hall) 
0.71073 Å 
Orthorhombic 
Fdd2 
F 2 -2d 
Unit cell dimensions a = 36.4369 (12)Å α = 90.00º 
 b = 40.2125 (14)Å β = 90.00º 
 c = 6.8319 (2)Å γ = 90.00º 
Volume 10010.2 (6) Å3 
Z 16 
Calculated density 1.294 mg/m3 
Absorption coefficient 0.088 mm−1 
F(000) 4064 
Crystal size 0.51 × 0.09 × 0.07 mm3 
Θ range for data collection 4.6 - 52.7° 
Limiting indices -48≤h≤43, -52≤k≤52, -9≤l≤8  
Reflections collected  43251 
Indepent reflections 5916 [R(int) = 0.061] 
Completeness to Θ = 28.00° 99.8% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9939 and 0.9564 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5916/1/342 
Goodness-of-fit on F2 1.089 
Final R indices [I > σ2(I)] R1 = 0.0519, wR2 = 0.0914 
R indices (all data) R1 = 0.0894, wR2 = 0.1055 
Largest diff. peak and hole 0.18 and -0.22 e Å−3 
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Crystal data and structure refinement for 21b: 
 
Identification code is_is1762 
OH
O
S
OH
 
Empirical formula C29H20O3S 
Formula weight 448.51 g/mol 
Temperature 173(2) K 
Wavelength 
Crystal system 
Space group (H.-M.) 
0.71073 Å 
Orthorhombic 
Pbca 
Space group (Hall) -P 2ac 2ab 
Unit cell dimensions a = 7.6625 (7)Å α = 90.00º 
 b = 22.434 (2)Å β = 90.00º 
 c = 25.438 (3)Å γ = 90.00º 
Volume 4372.9 (7) Å3 
Z 8 
Calculated density 1.363 mg/m3 
Absorption coefficient 0.178 mm−1 
F(000) 1872 
Crystal size 0.60 × 0.17 × 0.03 mm3 
Θ range for data collection 4.8 - 44.1° 
Limiting indices -9≤h≤5, -29≤k≤23, -32≤l≤31  
Reflections collected  29592 
Indepent reflections 5009 [R(int) = 0.112] 
Completeness to Θ = 27.50° 99.9% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9947 and 0.9005 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5009/0/306 
Goodness-of-fit on F2 1.003 
Final R indices [I > σ2(I)] R1 = 0.0646, wR2 = 0.1225 
R indices (all data) R1 = 0.1469, wR2 = 0.1549 
Largest diff. peak and hole 0.31 and -0.45 e Å−3 
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Crystal data and structure refinement for 21e: 
 
Identification code is_is163 
H3CO
OH
O
OH
N
O
O
 
Empirical formula C32H23NO6 
Formula weight 517.51 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group (H.-M.) Pbca 
Space group (Hall) -P 2ac 2ab 
Unit cell dimensions a = 16.0280 (12)Å α = 90.00º 
 b = 14.4028 (12)Å β = 90.00º 
 c = 21.1809 (18)Å γ = 90.00º 
Volume 4889.6 (7) Å3 
Z 8 
Calculated density 1.406 Mg/m3 
Absorption coefficient 0.098 mm−1 
F(000) 2160 
Crystal size 0.41 × 0.23 × 0.11 mm3 
Θ range for data collection 2.7 - 27.4° 
Limiting indices -20≤h≤20, -18≤k≤18, -27≤l≤27  
Reflections collected  45522 
Indepent reflections 5615 [R(int) = 0.100] 
Completeness to Θ = 27.50° 99.9% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9893 and 0.9611 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5615/27/393 
Goodness-of-fit on F2 1.032 
Final R indices [I > σ2(I)] R1 = 0.0553, wR2 = 0.1514 
R indices (all data) R1 = 0.0823, wR2 = 0.1638 
Largest diff. peak and hole 0.34 and -0.24 e Å−3 
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Crystal data and structure refinement for 25f: 
 
Identification code is_is246 
 
Empirical formula C24H19ClN2O5 
Formula weight 450.86 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.) P -1 
Space group (Hall) -P 1 
Unit cell dimensions a = 7.4502 (3)Å α = 68.214 (3)º 
 b = 11.0719 (5)Å β = 82.026 (3)º 
 c = 14.3255 (7)Å γ = 71.014 (3)º 
Volume 1037.37 (8) Å3 
Z 2 
Calculated density 1.443 mg/m3 
Absorption coefficient 0.225 mm−1 
F(000) 468 
Crystal size 0.19 × 0.17 × 0.08 mm3 
Θ range for data collection 6.1 - 65.5° 
Limiting indices -11≤h≤10, -16≤k≤16, -21≤l≤21  
Reflections collected  37516 
Indepent reflections 7499 [R(int) = 0.049] 
Completeness to Θ = 32.50° 99.9% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9822 and 0.9585 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7499/0/294 
Goodness-of-fit on F2 1.004 
Final R indices [I > σ2(I)] R1 = 0.0487, wR2 = 0.1007 
R indices (all data) R1 = 0.0970, wR2 = 0.1214 
Largest diff. peak and hole 0.39 and -0.44 e Å−3 
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Crystal data and structure refinement for 26g: 
 
Identification code ch_is255 
O N N
O
O
H
S
 
Empirical formula C26H20N2O3S 
Formula weight 440.50 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/n 
Space group (Hall) -P 2yn 
Unit cell dimensions a = 7.8696 (2)Å α = 90.00º 
 b = 16.2835 (5)Å β = 95.653 (2)º 
 c = 16.1443 (5)Å γ = 90.00º 
Volume 2058.74 (10) Å3 
Z 4 
Calculated density 1.421 mg/m3 
Absorption coefficient 0.019 mm−1 
F(000) 920 
Crystal size 0.36 × 0.21 × 0.06 mm3 
Θ range for data collection 5.6 - 61.1° 
Limiting indices -11≤h≤11, -23≤k≤19, -23≤l≤23  
Reflections collected  33282 
Indepent reflections 6557 [R(int) = 0.052] 
Completeness to Θ = 31.00° 99.9% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9887 and 0.9346 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6557/0/312 
Goodness-of-fit on F2 1.028 
Final R indices [I > σ2(I)] R1 = 0.0501, wR2 = 0.1038 
R indices (all data) R1 = 0.0877, wR2 = 0.1203 
Largest diff. peak and hole 0.33 and -0.24 e Å−3 
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Crystal data and structure refinement for 26m: 
 
Identification code is_is252 
O N N
O
O
H
 
Empirical formula C30H24N2O3 
Formula weight 460.51 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.) P -1 
Space group (Hall) -P 1 
Unit cell dimensions a = 10.2821 (12)Å α = 107.939 (6)º 
 b = 10.3291 (12)Å β = 98.029 (6)º 
 c = 13.0613 (14)Å γ = 115.540 (6)º 
Volume 1129.2 (2) Å3 
Z 2 
Calculated density 1.354 mg/m3 
Absorption coefficient 0.088 mm−1 
F(000) 484 
Crystal size 0.28 × 0.10 × 0.06 mm3 
Θ range for data collection 4.8 - 49.7° 
Limiting indices -12≤h≤12, -11≤k≤12, -16≤l≤16  
Reflections collected  15811 
Indepent reflections 4235 [R(int) = 0.066] 
Completeness to Θ = 26.00° 95.8% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9947 and 0.9758 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4235/0/321 
Goodness-of-fit on F2 1.001 
Final R indices [I > σ2(I)] R1 = 0.0565, wR2 = 0.1216 
R indices (all data) R1 = 0.1164, wR2 = 0.1512 
Largest diff. peak and hole 0.27 and -0.26 e Å−3 
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Crystal data and structure refinement for 26n: 
 
Identification code is_is264 
O N N
O
O
H
Cl
 
Empirical formula C30H23ClN2O3 
Formula weight 494.95 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/c 
Space group (Hall) -P 2ybc 
 
Unit cell dimensions a = 8.1449 (2)Å α = 90.00º 
 b = 12.9178 (3)Å β = 93.823 (1)º 
 c = 22.4376 (4)Å γ = 90.00º 
Volume 2355.50 (9) Å3 
Z 4 
Calculated density 1.396 mg/m3 
Absorption coefficient 0.199 mm−1 
F(000) 1032 
Crystal size 0.48 × 0.10 × 0.06 mm3 
Θ range for data collection 4.8 - 60.3° 
Limiting indices -11≤h≤11, -18≤k≤18, -29≤l≤32  
Reflections collected  36329 
Indepent reflections 7489 [R(int) = 0.047] 
Completeness to Θ = 31.00° 99.8% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9881 and 0.9104 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7489/0/329 
Goodness-of-fit on F2 1.007 
Final R indices [I > σ2(I)] R1 = 0.0475, wR2 = 0.0944 
R indices (all data) R1 = 0.0928, wR2 = 0.1134 
Largest diff. peak and hole 0.35 and -0.26 e Å−3 
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Crystal data and structure refinement for 26o: 
 
Identification code is_is4602 
 
Empirical formula C26H17F3N2O3 
Formula weight 462.41 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/n 
Space group (Hall) -P 2yn 
Unit cell dimensions a = 7.4706 (7)Å α = 90.00º 
 b = 19.1877 (17)Å β = 95.507 (4)º 
 c = 14.3379 (11)Å γ = 90.00º 
Volume 2045.8 (3) Å3 
Z 4 
Calculated density 1.501 mg/m3 
Absorption coefficient 0.117 mm−1 
F(000) 952 
Crystal size 0.27 × 0.08 × 0.04 mm3 
Θ range for data collection 2.9 - 21.3° 
Limiting indices -7≤h≤9, -18≤k≤24, -18≤l≤18  
Reflections collected  22066 
Indepent reflections 4507 [R(int) = 0.085] 
Completeness to Θ = 27.09° 99.7% 
Absorption correction Multi-scan 
Max. and min. transmission 0.7455 and 0.6852 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4507/3/324 
Goodness-of-fit on F2 1.000 
Final R indices [I > σ2(I)] R1 = 0.0539, wR2 = 0.0903 
R indices (all data) R1 = 0.1384, wR2 = 0.1185 
Largest diff. peak and hole 0.23 and -0.28 e Å−3 
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Crystal data and structure refinement for 26p: 
 
Identification code is_2701 
O
O
N
O
CH
N
Cl
Cl
H
 
Empirical formula C22H16Cl2N2O3 
Formula weight 427.27 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.) P -1 
Space group (Hall) -P 1 
Unit cell dimensions a = 9.9068 (6)Å α = 114.988 (3)º 
 b = 10.0544 (6)Å β = 100.724 (3)º 
 c = 10.9014 (7)Å γ = 100.864 (3)º 
Volume 922.51 (10) Å3 
Z 2 
Calculated density 1.538 mg/m3 
Absorption coefficient 0.381 mm−1 
F(000) 440 
Crystal size 0.21 × 0.16 × 0.08 mm3 
Θ range for data collection 5.2 - 62.0° 
Limiting indices -13≤h≤13, -14≤k≤14, -15≤l≤15  
Reflections collected  20836 
Indepent reflections 5335 [R(int) = 0.027] 
Completeness to Θ = 30.00° 99.3% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9702 and 0.9243 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5335/0/226 
Goodness-of-fit on F2 1.019 
Final R indices [I > σ2(I)] R1 = 0.0388, wR2 = 0.0880 
R indices (all data) R1 = 0.0582, wR2 = 0.0975 
Largest diff. peak and hole 0.38 and -0.28 e Å−3 
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Crystal data and structure refinement for 27b: 
 
Identification code is_is404 
N
N O
O
F
OH
OH
H2
C
H
 
Empirical formula C27H19FN2O3·CH4O 
Formula weight 470.48 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group (H.-M.) Pbca 
Space group (Hall) -P 2ac 2ab 
Unit cell dimensions a = 13.6829 (4)Å α = 90.00º 
 b = 13.6968 (5)Å β = 90.00º 
 c = 24.0304 (7)Å γ = 90.00º 
Volume 4503.6 (2) Å3 
Z 8 
Calculated density 1.388 mg/m3 
Absorption coefficient 0.098 mm−1 
F(000) 1968 
Crystal size 0.60 × 0.23 × 0.10 mm3 
Θ range for data collection 2.3 - 29.4° 
Limiting indices -18≤h≤18, -18≤k≤16, -32≤l≤32  
Reflections collected  61437 
Indepent reflections 5973 [R(int) = 0.072] 
Completeness to Θ = 29.00° 99.8% 
Absorption correction Multi-scan 
Max. and min. transmission 0.7461 and 0.7002 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5973/21/347 
Goodness-of-fit on F2 1.023 
Final R indices [I > σ2(I)] R1 = 0.0554, wR2 = 0.1169 
R indices (all data) R1 = 0.0979, wR2 = 0.1394 
Largest diff. peak and hole 0.30 and -0.38 e Å−3 
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Crystal data and structure refinement for 27d: 
 
Identification code is_is268 
OH N
N O
O
N
O
O
 
Empirical formula C27H19N3O5 
Formula weight 465.45 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/n 
Space group (Hall) -P 2yn 
Unit cell dimensions a = 12.1392 (3)Å α = 90.00º 
 b = 13.7350 (3)Å β = 96.476 (1)º 
 c = 13.1589 (3)Å γ = 90.00º 
Volume 2180.01 (9) Å3 
Z 4 
Calculated density 1.418 mg/m3 
Absorption coefficient 0.100 mm−1 
F(000) 968 
Crystal size 0.26 × 0.19 × 0.17 mm3 
Θ range for data collection 2.4 - 30.7° 
Limiting indices -17≤h≤15, -14≤k≤19, -18≤l≤17  
Reflections collected  32868 
Indepent reflections 6327 [R(int) = 0.057] 
Completeness to Θ = 30.00° 99.5% 
Absorption correction Multi-scan 
Max. and min. transmission 0.7463 and 0.6916 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6327/0/317 
Goodness-of-fit on F2 1.014 
Final R indices [I > σ2(I)] R1 = 0.0538, wR2 = 0.1092 
R indices (all data) R1 = 0.1129, wR2 = 0.1328 
Largest diff. peak and hole 0.31 and -0.28 e Å−3 
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Crystal data and structure refinement for 27h: 
 
Identification code av_is405 
OH N
N O
O
O
H
 
Empirical formula C29H22N2O3·0.5(C3H8O) 
Formula weight 476.53 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) C 2/c 
Space group (Hall) -C 2yc 
Unit cell dimensions a = 24.3897(15)Å α = 90.00º 
 b = 14.4367 (9) Å β = 95.522 (4)° 
 c = 14.2172 (9) Å γ = 90.00 º 
Volume 4982.7 (5) Å3 
Z 8 
Calculated density 1.270 mg/m3 
Absorption coefficient 0.08 mm−1 
F(000) 2008 
Crystal size 0.08 × 0.08 × 0.02 mm3 
Θ range for data collection 2.8 - 20.6 ° 
Limiting indices -29≤h≤29, -17≤k≤16, -17≤l≤17  
Reflections collected  23255 
Indepent reflections 4642 [R(int) = 0.118] 
Completeness to Θ = 25.50° 99.8% 
Absorption correction Multi-scan 
Max. and min. transmission 0.7453 and 0.6574 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4642 /1/345 
Goodness-of-fit on F2 1.001 
Final R indices [I > σ2(I)] R1 = 0.0591, wR2 = 0.1142 
R indices (all data) R1 = 0.1486, wR2 = 0.1550 
Largest diff. peak and hole 0.32 and -0.24 e Å−3 
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Crystal data and structure refinement for 28e: 
 
Identification code is_is4061 
O O
H
N
O
N
O
H
H
F
F F
 
Empirical formula C23H19F3N2O4 
Formula weight 444.40 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.) P -1 
Space group (Hall) -P 1 
Unit cell dimensions a = 11.4582 (2)Å α = 91.229 (1)º 
 b = 11.8588 (2)Å β = 111.145 (1)º 
 c = 15.5620 (3)Å γ = 91.826 (1)º 
Volume 1969.97 (6) Å3 
Z 4 
Calculated density 1.498 mg/m3 
Absorption coefficient 0.122 mm−1 
F(000) 920 
Crystal size 0.25 × 0.21 × 0.16 mm3 
Θ range for data collection 2.5 - 30.6° 
Limiting indices -16≤h≤16, -16≤k≤16, -21≤l≤21  
Reflections collected  44219 
Indepent reflections 11474 [R(int) = 0.038] 
Completeness to Θ = 30.00° 99.9% 
Absorption correction Multi-scan 
Max. and min. transmission 0.7463 and 0.6857 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11474/0/601 
Goodness-of-fit on F2 1.008 
Final R indices [I > σ2(I)] R1 = 0.0468, wR2 = 0.0932 
R indices (all data) R1 = 0.0855, wR2 = 0.1123 
Largest diff. peak and hole 0.35 and -0.22 e Å−3 
 
 Supplement 2. Crystallographic data 
 
 
 
 
 229
Crystal data and structure refinement for 29b: 
 
Identification code ah_is4594 
 
Empirical formula C22H16N2O4 
Formula weight 372.37 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/c 
Space group (Hall) -P 2ybc 
Unit cell dimensions a = 15.2230 (4)Å α = 90.00º 
 b = 6.7516 (1)Å β = 104.295 (1)º 
 c = 16.7885 (4)Å γ = 90.00º 
Volume 1672.09 (6) Å3 
Z 4 
Calculated density 1.479 mg/m3 
Absorption coefficient 0.103 mm−1 
F(000) 776 
Crystal size 0.22 × 0.20 × 0.04 mm3 
Θ range for data collection 2.5 - 30.5° 
Limiting indices -20≤h≤16, -8≤k≤6, -21≤l≤22  
Reflections collected  20211 
Indepent reflections 4019 [R(int) = 0.045] 
Completeness to Θ = 28.00° 99.9% 
Absorption correction Multi-scan 
Max. and min. transmission 0.7462 and 0.6950 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4019/0/254 
Goodness-of-fit on F2 1.027 
Final R indices [I > σ2(I)] R1 = 0.0860, wR2 = 0.0920 
R indices (all data) R1 = 0.0860, wR2 = 0.1090 
Largest diff. peak and hole 0.25 and -0.25 e Å−3 
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Crystal data and structure refinement for 30b: 
 
Identification code is_is2451 
O
NO N
O
Cl
H
O
Cl
H
 
Empirical formula C22H16Cl2N2O4·H2O 
Formula weight 461.28 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/c 
Space group (Hall) -P 2ybc 
Unit cell dimensions a = 14.6744 (16)Å α = 90.00º 
 b = 7.8448 (9)Å β = 104.472 (5)º 
 c = 18.406 (2)Å γ = 90.00º 
Volume 2051.7 (4) Å3 
Z 4 
Calculated density 1.493 mg/m3 
Absorption coefficient 0.355 mm−1 
F(000) 952 
Crystal size 0.25 × 0.21 × 0.04 mm3 
Θ range for data collection 4.6 - 46.8° 
Limiting indices -17≤h≤17, -8≤k≤9, -21≤l≤21  
Reflections collected  16757 
Indepent reflections 3576 [R(int) = 0.054] 
Completeness to Θ = 25.00° 98.8% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9859 and 0.9164 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3576/0/279 
Goodness-of-fit on F2 0.992 
Final R indices [I > σ2(I)] R1 = 0.0502, wR2 = 0.1030 
R indices (all data) R1 = 0.0937, wR2 = 0.1154 
Largest diff. peak and hole 0.34 and -0.44 e Å−3 
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Crystal data and structure refinement for 32e: 
 
Identification code is_is29d1_c 
 
Empirical formula C21H19NO4 
Formula weight 349.37 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group (H.-M.) Aba2 
Space group (Hall) A 2 -2ac 
Unit cell dimensions a = 53.4482 (16)Å α = 90.00º 
 b = 16.9847 (5)Å β = 90.00º 
 c = 7.5348 (3)Å γ = 90.00º 
Volume 6840.1 (4) Å3 
Z 16 
Calculated density 1.357 mg/m3 
Absorption coefficient 0.094 mm−1 
F(000) 2944 
Crystal size 0.30 × 0.20 × 0.10 mm3 
Θ range for data collection 5.0 - 50.1 ° 
Limiting indices -69≤h≤69, -22≤k≤21, -9≤l≤9  
Reflections collected  15265 
Indepent reflections 6289 [R(int) = 0.038] 
Completeness to Θ = 28.00° 92.4% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9906 and 0.9723 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6289 /1/491 
Goodness-of-fit on F2 1.033 
Final R indices [I > σ2(I)] R1 = 0.0458, wR2 = 0.0854 
R indices (all data) R1 = 0.0619, wR2 = 0.0926 
Largest diff. peak and hole 0.21 and -0.23 e Å−3 
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Crystal data and structure refinement for 32x: 
 
Identification code is_is361 
 
Empirical formula C28H19NO4 
Formula weight 433.44 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/c 
Space group (Hall) -P 2ybc 
Unit cell dimensions a = 15.6057 (3)Å α = 90.00º 
 b = 13.4479 (2)Å β = 94.359 (1)º 
 c = 9.9275 (2)Å γ = 90.00º 
Volume 2077.40 (7) Å3 
Z 4 
Calculated density 1.386 mg/m3 
Absorption coefficient 0.093 mm−1 
F(000) 904 
Crystal size 0.30 × 0.24 × 0.18 mm3 
Θ range for data collection 5.1 - 61.5° 
Limiting indices -23≤h≤17, -20≤k≤18, -13≤l≤14  
Reflections collected  34884 
Indepent reflections 7154 [R(int) = 0.036] 
Completeness to Θ = 31.90° 99.9% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9834 and 0.9726 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7154/0/306 
Goodness-of-fit on F2 1.024 
Final R indices [I > σ2(I)] R1 = 0.0492, wR2 = 0.1052 
R indices (all data) R1 = 0.0929, wR2 = 0.1249 
Largest diff. peak and hole 0.32 and -0.25 e Å−3 
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Crystal data and structure refinement for 33: 
 
Identification code is_is3801 
 
Empirical formula C20H16ClNO5·C2H6OS 
Formula weight 463.92 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/m 
Space group (Hall) -P 2yb 
Unit cell dimensions a = 9.7020 (2)Å α = 90.00º 
 b = 6.8943 (1)Å β = 91.201 (1)º 
 c = 16.0179 (3)Å γ = 90.00º 
Volume 1071.18 (3) Å3 
Z 2 
Calculated density 1.438 mg/m3 
Absorption coefficient 0.316 mm−1 
F(000) 484 
Crystal size 0.28 × 0.27 × 0.13 mm3 
Θ range for data collection 4.9 - 70.7° 
Limiting indices -14≤h≤14, -10≤k≤10, -23≤l≤23  
Reflections collected  18612 
Indepent reflections 3979 [R(int) = 0.022] 
Completeness to Θ = 32.00° 99.7% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9601 and 0.9168 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3979/0/192 
Goodness-of-fit on F2 1.025 
Final R indices [I > σ2(I)] R1 = 0.0382, wR2 = 0.1038 
R indices (all data) R1 = 0.0465, wR2 = 0.1126 
Largest diff. peak and hole 0.47 and -0.37 e Å−3 
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Crystal data and structure refinement for 35i: 
 
Identification code is_is447 
 
Empirical formula C27H17NO2S 
Formula weight 419.48 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.) P21/c 
Space group (Hall) -P 2ybc 
Unit cell dimensions a = 10.4820 (5)Å α = 90.00º 
 b = 9.7696 (4)Å β = 105.020 (2)º 
 c = 19.8471 (8)Å γ = 90.00º 
Volume 1963.00 (15) Å3 
Z 4 
Calculated density 1.419 mg/m3 
Absorption coefficient 0.191 mm−1 
F(000) 872 
Crystal size 0.44 × 0.30 × 0.22 mm3 
Θ range for data collection 2.9 - 32.5° 
Limiting indices -15≤h≤15, -12≤k≤14, -30≤l≤28  
Reflections collected  32487 
Indepent reflections 7065 [R(int) = 0.028] 
Completeness to Θ = 32.50° 99.5% 
Absorption correction Multi-scan 
Max. and min. transmission 0.7464 and 0.6868 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7065/0/284 
Goodness-of-fit on F2 1.032 
Final R indices [I > σ2(I)] R1 = 0.0407, wR2 = 0.1086 
R indices (all data) R1 = 0.0537, wR2 = 0.1206 
Largest diff. peak and hole 0.39 and -0.21 e Å−3 
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Crystal data and structure refinement for 36e: 
 
Identification code is_is411 
O
O
O
N
O
H
 
Empirical formula C24H15NO4 
Formula weight 381.37 g/mol 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system Orthorhombic 
Space group (H.-M.) P212121 
Space group (Hall) P 2ac 2ab 
Unit cell dimensions a = 4.9114 (4)Å α = 90.00º 
 b = 9.9314 (7)Å β = 90.00º 
 c = 36.687 (3)Å γ = 90.00º 
Volume 1789.5 (2) Å3 
Z 4 
Calculated density 1.416 mg/m3 
Absorption coefficient 0.097 mm−1 
F(000) 792 
Crystal size 0.99 × 0.10 × 0.04 mm3 
Θ range for data collection 4.7 - 44.1° 
Limiting indices -6≤h≤6, -13≤k≤13, -49≤l≤48  
Reflections collected  18306 
Indepent reflections 4548 [R(int) = 0.072] 
Completeness to Θ = 28.50° 100% 
Absorption correction Multi-scan 
Max. and min. transmission 0.9961 and 0.9099 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4548/0/267 
Goodness-of-fit on F2 1.010 
Final R indices [I > σ2(I)] R1 = 0.0480, wR2 = 0.0925 
R indices (all data) R1 = 0.0937, wR2 = 0.1105 
Largest diff. peak and hole 0.20 and -0.20 e Å−3 
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List of abbreviations  
 
 
A Absorption 
AMP Adenosine monophosphate 
Ar Aromatic 
ATP Adenosine triphosphate 
d Day 
2D Two-dimensional 
CN Nitrile 
COSY Correlation spectroscopy 
DABCO 1,4-Diazabicyclo[2.2.2]octane 
DBN 1,5-Diazabicyclo[4.3.0]non-5-ene 
DBU 1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCM Dichloromethane 
DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DMF N,N-Dimethylformamide 
DMF-DMA N,N-Dimethylformamide dimethyl acetal 
DNA Deoxyribonucleic acid 
ε Extinction coefficient 
EI Electron ionization 
ESI Electrospray ionization 
Et Ethyl 
GC Gas chromatography 
GTP Guanosine-5'-triphosphate 
h Hour 
HAr Aromatic hydrogen atom 
HCl Hydrochloric acid 
HIV Human immunodeficiency virus 
HKA Heterocyclic ketene aminal 
HMBC Heteronuclear multiple bond correlation 
HRMS High resolution mass spectroscopy 
Hz Hertz 
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IR Infrared spectroscopy 
IMPDH Inosine-5′-monophosphate dehydrogenase 
J Coupling constant 
λ Wavelength 
Me Methyl 
MeCN Acetonitrile 
MS Mass spectrometry 
mp Melting point 
NAD Nicotinamide adenine dinucleotide 
NMR Nuclear magnetic resonance 
Nu Nucleophile 
Ph Phenyl 
r. t. Room temperature 
RF Polyfluoroalkyl group 
RNA Ribonucleic acid 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
UV Ultraviolet 
* Chiral atom (centre) 
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